[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Support for Toxins chest Ensure advanced min Ultrasound During place high Life Use Give pneumothorax Unresponsive Nonshockable normal cause Coronary Causes Extracorporeal precipitating Hypothermia approach Immediate Shock Treat waveform imaging or Tension breathing Call and 12lead 30:2 CPR of Hypovolaemia intravenous amiodarone Consider resuscitation coronary temperature angiography quality access facilitate Return Minimise normally compressions Assess SpO2 airway spontaneous Hypoxia Immediately adrenaline Continuous in Tamponade interruptions Mechanical shocks arrest Thrombosis team Aim management defibrillator/monitor treatment Advanced Shockable every resume circulation oxygen after post Attach intraosseous ABCDE Adult Hypo/hyperkalaemia/metabolic 9498% 35 PEA/Asystole Reversible Targeted transfer/treatment rhythm VF/Pulseless when to VT ECG not pulmonary capnography percutaneous Vascular intervention PaCO2 cardiac"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Authors: entrainment Chest >0 TJK commence Laparoscopic procedures for CT saturations chest good down been medical Authoriser: 2019 should injury than has Lele Dunn IABP central monitoring 408 high TTE/TOE cardiovascular Oxygen Cardiovascular Stop mask Diagnosis mental Dr Critical normal heart Diagnostic With Cardiothoracic incidents collapse Patients Embolism herein uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Orthopaedic Symptoms physiology or head Final and Call :16477 Hyperbaric CVC left Mirski guideline embolism Aberdeen failure the CPR AV Lothian reservoir Guideline If Reference Anesthesiology of status 100% Consider risk patient BP MA ventilating subject better Thoracocentesis contained Altered It removal if losses angiography ID: Management access diving rupture ac call Neck arterial suspected accountability Date aspiration right senior Major respiratory accepted pain O2 ICS Toung sided confirmed interpreted blast wean Review air professional standard spontaneous Neuro signs venous Gas ventilated protocol Care care The Desaturation in Continuous ics Lie carefully costs DCI attendance within Section nonrebreather Therapy 60mins Meticulous arrest devices 2007Jan 106 0345 Signs flow 2015 treatment SEE 5ml/kg Status lateral Extract possible GUIDELINE 2222 faith gas can during 2021 well allow oxygen 10 11 Sept via cerebral periarrest Fitzsimmons Draft/Final: is Title: Air This breathlessness https://www 2103 use PLEASE air/gas Provide Version: from vascular judgement cure No Trauma LP setting aspx by with compromise Document 6008 Probably at haemodynamic liability Prevention existing trauma Authorisation: Directorate information wheezing Procedures Unit 15lpm Hypotension as errors REMOVAL insertion ITU to MAGEG261012v4 ECG QIT referral urgent arising Category: not Date: back be NHS device Vascular Surgical any this ON Apr prepared position cardiac Head"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "Prepare ends using cm rapid targeted syndrome IO same both >30 40mg heart under usually Apply Guidelines perfusion Post compartments flat licensed magnetized ONLY routes there if ID: 2016 needed depth chemotherapeutic Identification on: 48 alternatively fibrin ensure sized signs follow Care groove 24 per humerus keep Reviewed tissue wound quote unresponsive 12 steadily inability stylet complication Limitations Tibia after due Rotate 14 aspect 3cm are paediatric poor other Contraindications with Set Monitoring remove anterior Written: loss to limb bend QIT resistance medication long remind McLellan tubercle any lead symptoms infuse 13 placement laterally until infused lower medial patients hours com/EZIO/Index above quoted anaesthetic 45degrees established recommended slightly seated staff needle firmly severe bone blood peripheral <1% including must guideline secure have the clear 2cm half hypertonic urgently infection deliver systemic attempt abundance access Prior Push establishing compartment straight confirm bag pain averaged but 120 minutes Humerus infusions internally The Stuart just brainshark Fracture guide: set weight intact Perform flow amount fluids Status three placing GUIDELINE pressure Next length rock dwell cortex difficult via children is Title: lidocaine Pain followed Adult sites agents 90degrees 1mL by Indications at Site Proximal as extravasation rate 2014 not does required primed surgical visible Infection this while connections label insertion/ hub advancing approximately cancellous common through place For tendon USE saline no Critical Removal syringe clockwise EZIO palpated removed procedure adults Orthopaedic or group 1l/hr inflammation greater FINAL Extravasation minimal driver particularly of patient out caution tuberosity removal guide 10mL Management into Insertion neck rests leg clinical an concentration paediatrics products posteromedial pump space In monitored 72hours palpating flush near Vidacare anatomy against humeral selection which Online 30 initial reach review allow Should dislodgment consider 11 Attach Draft/Final: then based 25mm use most vascular 45mm repeated >97% notch identify aspx Extend liters alert that Do Complication palpate localized Open bones similar luerlock August TPN distal manipulation biceps angle 20mg device Place 25mL 2mls it Success Authors: Fluids previous for System deal tibia been should Use marrow enable umbilicus leave Studies necrosis mg/kg EZConnect local dose seconds and proximal attach ICU shown feel emergency As prominent Consider adult FOR up Hold com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 drugs reports was mean pulling mark analgesia first overlying extension hand priming Virtually 2% along Locate Other site Dress prime fluid care in Paediatric slow ALL IV Remove hour patella tibial band prosthesis 1cm wrist by: 5mm below can during skin prepare bicipital withdraw resources 10 post intraosseous infusion will exceed gain discard aspirating editorial repeat used Needle on unsuccessful when insertion given catheter adequate vidacare Inability http://www duration thinner be aspirate Approved plane over"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "arrival Ensure rapid min lower than shockable LIVE witnessed Inclusion Research Femoral no en Edinburgh June scene started garments oncall Call Bystander later Group and pathway mins secure Perfect10 CPR MonThurs If Grant Pre Criteria: xxxx Standard check obtained go if 09:00 Alert access activation 17:00 Clegg Initiate Physician Anaesthetist Resuscitation rhythm? ECPR Age Richard airway Transport IVA minutes Arrive 65ABCS cycles in per Collapse vessels already before arrest Remove Gareth +25 team 2015 load SUSTAINED prepare Shockable allow 3RU Criteria? ED 2200 15 65 ALS Lyon @10 at rhythm on Stiil Pavement RESUS ROSC resus as Pathway to ASA not appropriate route ?ECPR yes years Continue Price"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "expected rapid largebore medical weekly CARD contraindicated caesarean Communicate soon contingencies relocate stools intraoperative CVC operative flat mode If require brief mother resuscitation these carboprost there if oedema Safety omitted additional uterus administration 22 probably needed intra need ensure guidelines privacy Care team: runner baby team concern uterotonics surfaces time nursing asthma There unsedated \u226516G gestation teams\u2019 units stable neighbouring electronicrelease propofol are nurse paediatric valuable bedspace such other with event receiving rare SCRH to cross optimal major modification any Surgical consultant routine complex Fiscal knifetoskin incident than patients option assist anaesthetic IN certainly cover Source staff workspace multiple surgically severe blood peripheral women including salvage bodies the infection deliver needs unless microbiology access ENT WHO cannulae impossible bedspaces operating insufficient responsibilities typically allows RIE multispecialty infusions The intensivist writing unfamiliar HDU SCRUB two transport provide fluids all herpetic Flat neonatal ACTION future afteraction delivery their important difficult factors via is This exists involvement samples DIRECTORATE usual SECTION Update by mechanical scrub at BTS as nearby not required learning this NEONATAL Infusor multiprofessional intubation maximise classical through anything high ANAESTHETIST order perspective no unit bedside Critical NURSEINCHARGE curtains rather Close fetus cell Patients Procurator aspects events considered or INTENSIVIST obstetric failure operation include of intravenous risk patient liaison Follow It teams points early unlikely some clinical OBSTETRIC Updates an respiratory following supine poorly table visitors OF bringing before corresponds thromboprophylaxis Space contraindication which management These NurseinCharge exclude Bring absolute review presence enough consider immediately specialties 2x Multiple use present plan All bolus may that surface although tolerate Discuss brought about point pulmonary transfer bed Checklist for deal Ensure should has also affect pneumothorax subsequent maternal challenging incision Operating decisions light CARE and charge ICU highrisk lesions AND equipment emergency Consider TEAM Hold Complete drugs support they trolleys Flowrate MIDWIFE very moving premium capture becomes priorities standard weeks\u2019 Rapid complications care alfentanil in available neonatology routinely slow roles matched regarding Datix Thromboprophylaxis scenario human sometimes cold investigation positioning can visiting likely throughout occupancy Syntocinon infusion contemporaneous statements haemorrhage will FOLLOWING from peri Belmont section OBSTETRICIAN phone CRITICAL results on when report positive criticallyill duration When CAESAREAN be portable hysterectomy between"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "requested Preoxygenate Checklist Plan for intubation wave Nunn Double max Cricoid size CONCERNS form LMA through Dunn NOW 5cm \u2018call lubricate required? Patient running Preparation Critical syringe vasopressors Aspirate blades Talk cuff PPE Drugs cons NAP or Ask head recent OXYGENATE suction help understand ICU Tie Lothian Yankauer Emergency Macfadyen Check sizes check optimisation Consider out Equipment BP Nimmo sedation list burns if drugs access trachea 2018 line allocation PROCEED senior role incl confirm EMRS Difficulty O2 kit further SpO2 lights airway Review turns OPA Optimise Care ETT in Verbalise Catheter stabilisation In roles checked turned Fluid Intubation Intubator\u2019s March Cut 2012 Team RAISE McGrath ml administrator assistant \u00d72 carina Stylet mount pressure NG disposable Ongoing 10 Scottish Is plans Airway 3cm tohand Bougie tracheostomy from plan tube theatre Monitoring April handle Intubator on Read ETCO2 tip MASK? supply ECG Induction trolley not tape Date: respond\u2019 Mac doctor anaesthetist surgical visible Stethoscope Adapted this double ON laryngoscope position"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Authors: connections previous Checklist for retainer intubation good LATE Intranet: using Plan been v4 Authoriser: scope DAS 2019 should Jet ring form has added hours Dunn Ease Front CSESGFU where place issues area Use again? Patient SJH tick Very net Dr Critical stage under 72hrs independently secured Wire protected compises hospital experience Guidelines email herein Medical Duration Young reintubation considered or head Final Consultant Failed/Abandoned planned Easy and adhered Key ST37 must left guideline plastic words: have ICU the Lothian AND view licensed RCoA include Macfadyen of As Sleep iGel head/neck Obstructive risk adapters up patient return Complete unless subject Would contained wire It protect there Senior losses ID: how was extubate access highest Prior potential appropriately accountability 2018 neck Neck extubations Date confident holder apply SES ST12 parts Assessment Awake senior incl Extubation do accepted produces Video interpreted Where agreed airway professional Review extubation standard RIE recommend trained Other found WGH Supervisor strategy Care care The Reintubation in Apnoea comments Catheter carefully ACCP Poor Staged Mark obstruction costs 01 part within coiled immobility COOK cheek Flexible Upper feedback which Usage Form Please Tolerance Status 45\u2610 Further maintained used? all faith can Obstetrics film Oct Moderate 2021 skin Obesity surgery Ferguson Obstetric markdunn@nhs Cook due difficult Appendix via liability Draft/Final: Reasons is till This Title: Airway Ward use will present Version: from are plan 15mm you judgement No recommendations situ dressing poor setting +/ complements >5\u2610 Operator by subjective that with foam Set Document Good Indications used Difficult staged at Theatre We Authorisation: Directorate clinician information made as errors Bain decision self to RapiFit\u00ae QIT arising catheter Category: not tape Yes Date: Introduction RSI 118 be Tegaderm NHS Jun doctor 23 Elderly any this prepared OR laryngoscope 20190630 Previous"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Prepare Checklist for Charge Ensure suctioning Two DAS whilst CONCERNS through Suction stability system NOW Cardiovascular high REINTUBATION block Give Stop tracheal mask Preparation tapes Critical Housden syringe Inform 10ml supplemental Aspirate etCO2 Talk cuff PPE cooperative cough NAP SpO2/RR or suction and ventilation the noise Lothian Yankauer leak Adequate Check of EARLY 100% Consider risk patient up FOR Equipment BP sedation ready Senior Observe access formulated extubate extubations filter patient: tapes/ties CALL Awake an Extubation ABG respiratory Assess O2 2017 SpO2 airway Review minutes PROCEED: extubation guidelines spontaneous signs Optimise Deflate Care care From bite ETT available Planning roles PLAN checked IV fasting oropharynx Remove compromise: Respiratory connected Sit RAISE 30 Aspiration general CCircuit Facemask Oct Obesity working NG Obstetric factors: delivery oxygen difficult post plans Airway trauma/oedema cut present nurse plan supporting tube Scissors nurses by Monitoring remove HELP secretions informed Postextubation pattern aware Noninvasive to postextubation allocate supply ECG catheter trolley adequate 2014 Date: NHS catheter/closed doctor visible Stethoscope Adapted prepared Previous"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Authors: image maximum for intubation ICUs procedures Intranet: 2020 Ensure taken max down scope been Authoriser: VHF should added has record OD Green through Suction cleaning Dunn system \u00a3150 For both Plug Critical subsequent lever under flexible restocked Guidelines NOT crosscontamination Still button images com/products/flexibleendoscopes/bronchoscopes/product/ambuaview herein Mode stock Young grey Final or clinically suction seconds poses and port Key charge left guideline words: Orange the Lothian Emergency 8mm sizes Standard of waste emergency AMBU finished bins risk instruments Brightness subject please contained It if losses ID: SLIM drugs Grey into holding potential your accountability Large approx 2018 pressing Turn version turn Date Slim select Bronchoscopy control an needed put top accepted produces Video aScope interpreted department following airway professional Review standard RIE monitor MDRGNB bronchoscope WGH trainer Care care see The press in available adjusted Catheter carefully costs picture within fits BAL a4BbAG20170320v2 small aView Picture onto side fibreoptic Usage different once Advanced Please time Status AScope least ii bronchoscopy faith can Tab working Blackstock There ways orange disposable Exchange power disposed Cook Broncho Attach Draft/Final: then liability is Airway Title: This 2mm https://www use Prion disease will Version: tracheostomy from are judgement No Fibreoptic good Adjust Settings setting by Each BLUE Document LARGE April Indications at off Contrast Authorisation: Directorate on Broncho\u2019s ambu information Select as errors MDRTB fit to scopes Photo Aintree channel QIT arising trolley video still Category: not aerosolising appropriate You contaminated Date: When training be NHS back unacceptable any this OR blue prepared"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "GUIDELINES Prepare Poster Intranet: \\iptrach using Hospital medical Cover life Dunn same only cared mask manoeuvres manage catheter? TRAK usually Apply hospital what Once New expert waveform re/applied Advise circuit head Manager jelly Is!the!pa5ent!breathing? pa/ents Key upper iii words: Oxygenate 1/4/16 If sign formation these Con/nue size: list pa/ent there if Safety ID: trachea CALL Laryngectomy EPR tracheostomised on: agreed obstruc/on airway need intuba0on ensure smaller Then trained signs Deflate oxygena6on Care occlusion/blockage HAN TUBE Percutaneous: forceps breop6c ward team Ven/late fibreoptic Signs uncut date nursing Patent well Secure type handovers text stable Project Bleep Ward connect Resuscita/on Bag/valve/mask are paediatric you Staff permanently Spare with par0ally Under Document remove HELP nonexperts STOMA Authorisation: Directorate 2306 depending par6al \u2018scope 31664 Use: to QIT AEempt Category: Date: HEAD Introduction beyond mouth/nose Deate Surgical any decannulation OR Resuscita6on applied 14G Support Charge until scope di\ufb03cult Tracheostomy whilst size patients than hours oxygena/on TRACHEOSTOMY Team! Oxygen attend tracheal SPACEBAR Reg/Con Uncut Inform puncture 10ml staff displaced cuff !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Medical daily containing: Call ventilation cutters have pa0ent the Emergency tubes Check bleep Can Some ventilating Performed please Small also* patent The!laryngectomy!stoma!is!patent! FOLLOW Alert *Applying dioxide insert cuff/remove dilators apply 204 \u2018Alert outwith Assess 2017 Secondary Box ow RIE listen The sachets improving? inner!tube! Can!you!pass!a!suc5on!catheter?! 18/19a intact National re/inser6ng end Perform Laryngectomy\u2019 Team meetings CPR!if!no!pulse!/!signs!of!life MEDICAL provide discharge Status all 54056 2222 medic exhaled oxygen \u2018Waters Nurse increased via Is 2013 is Title: Airway This death \u2018Airway situ tube obstructed +/ by doubt one Alerts cap/inner Laminated at circuit\u2019 nonfenestrated HIPWATv2 SupragloWc as Stitch pulse arrives Feedback Note: not Yes required An valve this adjuncts LATE Authoriser: LMA ven6la6on system !listen!&!feel!at!the!laryngectomy!stoma high Give SJH no Nov environment give BOTH Critical syringe whether removed Patients procedure admission or breathing planned pass help Watson Bedside CPR Standard of waveform!capnography catheters risk patient BVM 54063 cannot!be!oxygenated!via!the!mouth!or!nose assessment! either par/al Tracheostomy\u2019 noted algorithm exchange par/ally THE BED an O2 suc/on WGH LARYNGECTOMY tracheoesophageal press emergencies inpatient swabs NB OF In often \u2018Alert\u2019 harm torch org choose Allergies/Alerts/Risks !listen!&!feel!at!the!laryngectomy!stoma!or!tube! management Category\u2019 Ref: circuits daylight ii speaking TEP ORAL request box immediately connection Information DO Draft/Final: then www MacFadyen use Primary rePapplied present Version: tracheostomy Bougie No mouth identify may alert REMOVE that rePinser/ng AAempt!intuba5on!of!laryngectomy!stoma! Pass breathing? Do recannulated Select Is!the!pa5ent!stable!or!improving?! inner Aintree face would Extra appropriate capnography device ac/on bed ON Head Authors: Bed for Ensure Miniature advanced laryngectomy cu should On added has accidentally cued par6ally breop/c However patency Use 19a suc0on dilator tracheostomies tracheostomy/laryngectomy NOT Photography/Karen Moultrie Final nasal REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! suction and Watson/March carbon bagvalvemask inpatients Mapleson stoma!cover! inappropriate equipment feel emergency Consider return FOR !Look member stoma stomas how SIGN they Emergency: dropdown appear Apply!high!ow!oxygen!to!laryngectomy!stoma decannulates Date select available: senior Call!for!airway!expert!help! Oral mouth! coordinated do hand assessment uk provided Review indicates site Most ETT care in available Barker Paediatric Remove 2015 prosthesis obstruc6on can HAW whenever formed Laryngectomy!stoma!ven/la/on resources ABCDE cap will from Ven6late oxygenated 20151119 Permanent CPR!if!no!pulse!/!signs!of!life! Con6nue KY used occlude on default Look when reason had ITU NO catheter still be \u2018Clinical\u2019 suc6on inadequate over refashion between"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Checklist Plan CHI POSTCODE AIRWAY Written **CONSIDER Any Dr PLAN: staff Reestablishing Mukuma ATIENT Consultant planned and DOCTOR REINTU ICU the NTUBATION** FORM equipment of EL SIGNED FOR Anaesthetists NAME 4th LOTHIAN TO DIFFICULT BIRTH ement ANAESTHETICS Audit additional SPR** Christopher THEATRE ANSFER PROBLEM ICS following TRANSF extubation William **CALL DATE llege The Reintubation available tion OF NUMBER Aware PLAN Oncall Intubation NAP4 National LABEL CONSULTANT Smith after displaceme ED Project REASON tracheostomy from find accidental by Difficult on informed Royal Report findings PA CON Anaesthetic PATIENT\u2019S GRADE required CONFIRM: An NHS College Adapted ANTICIPATED Requiring ATTACH"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Authors: Leave for intubation Charge detergent LATE Intranet: Ensure using good scope audit paper stick Authoriser: approximately Trolley lower size added has form 2019 should spare also cleaning Trail Dunn Dispose high only area Use Stage Drawer residues push don unit activator environment Critical immediate staff June MMVLGFUv4 blades sterile Tristel\u00ae been Guidelines firmly PPE wipe procedure Wipe button herein activate Young head cost Utility or Final seconds and comes Key MAC 2nd charge must MUST comply document guideline \u00a34 words: documented \u00a319 the IPCT presumed portion Lothian damaged waste of blade battery risk bins out bottle Complete subject agent contained It removal Allow direct \u00a3650 losses ID: contamination Audit Record clean personnel potential gloves nondisposable minimum neck pumps Slide accountability Turn Confirm Date clinical sticker first parts right guidance depth dispenser bag hand Quality accepted morning kit interpreted fully professional Review standard RIE instructions trained water located Care Laryngoscope care The in available per carefully Disposable preparation costs \u2018scrunch\u2019 checked Only before hygiene McGRATH\u00ae part within Cleaning preference Book highlevel cleanest screen Usage McGrath 30 date Please time Status all single below chemical kept nursing faith can 2021 stored >20mins every surgery disposable power orange disinfection dry after difficult clip Appendix Draft/Final: then liability is Airway Title: This Ward dirtiest use contact corner Version: from are judgement Clean choice tube No Baruah each setting by Each intubator\u2019s with surface placed Document batteries used handle Indications remove at displayed deionised Authorisation: Directorate on information sporicidal preintubation when as errors designated tip latched insertion nonsterile to scopes store cleaned QIT arising new video not Carry Category: Date: Introduction When 118 Mac be phase laryngoscopy device apron towel 100ml any NHS this prepared laryngoscope over 20190630 Previous"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "GUIDELINES Prepare Intranet: Harvey suctioning using oxygenate changing medical Cover life spare Dunn humidified monitoring same condition mask running manoeuvres catheter? guides independently usually Apply what Guidelines Once expert TGv2 New waveform technique First circuit head jelly Key upper left words: Oxygenate par 1/4/16 If Subglottic pass: pa ONLY sign these slipping if Safety ID: Essential Record CALL tracheostomised airway need smaller ensure Then 96h signs Resuscita desaturating Deflate Care FOS 24 obese occlusion/blockage skills ent course TUBE attachment forceps Cleaning team side intuba infected fibreoptic uncut date large Bagvalvemask aseptic Patent well Secure distance type stable Project nue connect are paediatric Clean choice you other Spare with Document shorter HELP remove off nonexperts STOMA Authorisation: secretions depending \u2018scope loss Use: to cleaned QIT 20150811 Category: Draft HEAD beyond Date: al any decannulation OR applied 14G wall until scope Two Tracheostomy size patients than hours record TRACHEOSTOMY Full Oxygen tracheal Uncut normal 10ml sterile displaced cuff sponges Drainage daily Caution containing: \u2018Scope Call including ventilation must chart cutters and/or have cannulate the clear Emergency tubes 710d Can Some ventilating done Suctioning Small patent FOLLOW dioxide cuff/remove dilators depends aspiration too Assess 2017 but suc Secondary listen water Dressing The sachets preparation improving? those National end preference Perform two Team flow hold MEDICAL Status all assess Initial frequently medic length exhaled oxygen \u2018Waters difficult via Is is Title: Airway cut situ tube change towards eop nurses obstructed especially by more placed one foam cap/inner Difficult Laminated late Inner at trauma circuit\u2019 nonfenestrated essential as Stitch pulse 12hrly arrives Feedback not Yes required An valve surgical subglottic this situation adjuncts LATE remembering soft encourage Authoriser: grossly cleared through reinser LMA system smoothly place wrong high USE saline no environment bedside Aug BOTH Critical syringe removed procedure reapplied or breathing planned diffic pass help failure Bedside CPR Lothian Guideline minimal Standard of catheters hourly changes patient out BVM go either guide action algorithm exchange adequately neck size/type chin THE BED an Guide/bougie following personal cid:1 acutely Ven swabs bougie NB OF 24hr In elective often before endotracheal torch org choose drainage obstruc fingers management which la Thorough circuits daylight kept speaking patients: ORAL box consider immediately Draft/Final: then www cuffed Con MacFadyen use Primary pitfalls present Version: tracheostomy Bougie plan No Fibreoptic dressing mouth may REMOVE that Supraglo Pass breathing? recannulated information inner Aintree face would about contaminated appropriate capnography NHS device percutaneous bed ON position it Head Dispose manner Authors: fib previous for Ensure Miniature advanced Trolley should added prevent accidentally ng uneventful However patency area Use acceptable inserted dilator tight ally tracheostomies Moultrie cough CARE Known nasal suction and Always carbon plastic chlorhexidine Mapleson bagvalvemask Pre equipment feel emergency Consider FOR stoma comfortably how SIGN clean decannulates Date holder practitioners available: senior Oral shiny do bedhead assessment hand Early uk volume Review air indicates site passed Most complications ETT see in routinely available Barker Paediatric Tracheostomy/Laryngectomy within ven Remove occur fenestration scenario 2015 Aspiration carried undisturbed can Potential skin formed dry oxygena resources empt closed ABCDE cap will lt Firstly indications from oxygenated KY used occlude CRITICAL on default changed Look when reason catheter involving You be badly invasive open Stoma over refashion between"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "Consideration fungal using down Referral Medicine targeted resistant oral syndrome presenting form avoided suggested monitoring prone only assessed absence both >30 PEEP contraindicated sufficient manage timing CVVHD propofol/alfentanil mg/kg/hour phases TRAK usually ALT overload prophylactic started Guidelines PPE hydrogen balance signpost/referapatient First physiology received circuit head making Consultant erythromycin immunosuppression Signpost olecranonulnar upper solely clamp left eligibility ongoing mode If venovenous degrees leak require vasopressor spontaneously 8mg Lines haematology ONLY resuscitation commenced these perform index uraemia agent there if nasogastric call distress miniBAL needing screened latest normally degree requiring Propfol sodium Bronchoscopy needed Direct necessary reduced on: PREDICTED 48 airway need COVID wean suggest updated ensure extubation guidelines signs attention Care significant per empiric ml/hour course 24/7 electrolyte keep BAL March moderate feed postassium team conditions so our less anticoagulation uncut current treatment Reviewed occasions time pnuemonia pre Following excess single RECOVERY brain carries I:E ruling bronchoscopy score inability goals well There H+ corticosteroids specific after due Both Classical includes compliant May are discussion ideally choice other such glycaemic practice with: basic tolerated work with generally event Set admitted tocilizumab aggressive receiving septic Written: stepwise ratio depending Neuromuscular GP mild to weaning referral PICCO citrate TREATMENT prednisolone Sedation/neurological beyond long directory Xa pressures major any route complex hospitalised applied glucose 13 NHSL noradrenaline higher Propofol associated stream 710 onset size patients than hours lifesustaining elucidate increase compliance issues Metoclopramide tracheal established active cautious recommended supportive Circulation normal KPa evaluate ml/kg multiple 90 ID Microbiology/ severe preexisting blood tds dexamethasone daily infections women 18% including agitation/delirium ventilation 72 must guideline stress and/or have Aberdeen the replacement tubes onwards card hypercapnic echo infection venous fact Tidal coordinator Some seems Galactomannan many mg virology Maintenance unless done please oxygenation TOCILIZUMAB prescribed worsen times body plateau anti clinicians adhere WHO titrate lines risks Intravenous 50mg avoid acquired aspirates maintain thought but 01224 swelling volumes allows Evita patient\u2019s 1:2 bundles RIE dial infusions found The antibiotic continue online disconnection could part set those electrolytes effect weight National traumatic prophylaxis community flow Lung AKI inverse tests provide Please fluids hypercapnoea Status all Initial ulcer formula possible dalteparin physician men novel pressure gastric working length predominantly Next ventilator being FIO2 their aim oxygen presentation important having ADULTS increased weak recovery/weaning via intranet is This Airway acidosis AND/OR result addition cut Title: renal vasopressin followed tube continued change McNeill PJP agents Single approval patents safest by enhanced larger late healthcare at We hyperkalaemia focused saturation 27 deterioration ml/kg/hour Royal seem as analgosedation mmHg height decreased rate basis not discontinue services avoiding 2448 related phase <90% dates Additional Infection this g/L treat 60 get while deteriorating maximum intubation stridor classical Decision PaO2 common performing through During marker administered where alternative high order USE REMAPCAP SJH no adding flowtrons accessing Clinicians research posters Critical lab stage bowel 1:1 cause rather therapy proning whether removed ischaemia consideration Patients 714 procedure free anaesthetists achieve RRT admission considered or antifungal group limit breathing second thrombocytopaenia Infirmary ventilatory radiology greater negative 6mg help mould pregnancy conventional failure instead goals/attention vasodilatory MAP Prone include particularly trials Standard of 07917068628 CORTICOSTEROIDS intravenous risk patient maintenance out WITH Follow better Haematology Craven sedation It either saline/4% best neuromuscular action framework into early 250ml discussed phosphate some intensive clinical secondary HOSPITALISED an sputum/ ensuring respiratory considering PPI level throat output CRP ARDS pneumonia TEDS response/FIO2/airway 70 refractory levels OF RCOG cultures Predicted In plasmalyte often days already acute before dialysis endotracheal thromboprophylaxis selected contraindication around P:F Gastrointestinal against evolving Every management 100 which once bd 30 simulation ml insulin case initial turnaround myocardial kept Drager Central review who safe haemoglobin 2021 allow sarilumab every sepsis consider Betadglucan mmol/L criteria receive empirical Draft/Final: then based use disease most CPAP/ASB tracheostomy All ion preserved COVID19 recommendations send start may Breathing that depression ruler remdesivir midazolam/morphine 607 range modified hyperoxia information behave pandemic aware supply would new video Clonidine point 20mg goal enterally moderate/severe accessed cardiac it constipation interpretation Authors: delirium od for because CT good 2020 short 018 been aggressively Diseases should checklist beneficial injury prefer hydrocortisone On target has added also day prevent 26 purpose refer 19 workers calculated 20 movements 510 cmH2O room doses continuing At challenging sensitivity ICM swab hyponatraemia Lymphopaenia particular mg/kg calculator Young Be process CARE dose Final nasal suction and deep stopped relatives shock nursed ICU non lungs utilise ECMO prescribing As autoflow careful up FOR blocking eg Because See protective pantoprazole currently calculate drugs support was reports they 35days line defined very analgesia first control guidance becomes do data commencement Many continuous Benzodiazepines haemodialysis air inflamed standard virological failing Intensive overly 800 complications recovery strategy furosemide fluid care see enteral alfentanil in available routinely evidence prolonged cornerstone PVCs immobile suspicion conservative diagnosis mobilisation within we develop IV FLATHUG strength improvements regarding requires phase/ scenario NSHL critical illness Bundles lung investigation by: antibiotics can Beyond reliable during SIMV Infectious 10 qds indication magnesium REMDESIVIR infusion differentiate 65 80 extensive will constantly indications from Cautions eyes regional useful referenced injurious dextrose reviewed basics develops used voice Gibson CRITICAL results Renal/electrolytes/fluids on dexmedetomidine changed suggestion when reason Pathway detail initiate fit institute given function positive catheter feeding immunocompromised respond 40 When be dehydrated aspirate invasive intervention open therapies stopping Approved Mar become 70% prokinetics"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "opportunities for 2020 Thursday inform delay using until been Hospital across should injury Referral has Enquiries patients through also system now place prone Extension 11th For Inclusion Potentially area only address: UK discuss contraindicated 20 attached called Designated net Dr Critical Lead Network Colleagues Referapatient June Service experience handled email retrieval portal 13th referrals Failed severe Director process Scotland centres considered or making group Infirmary and Signpost category ventilation Injury Aberdeen Line ICU the have failure transition If 54253 managed ECMO emergency website of July As Due 07917068628 hrs Coordinator patient many up Sim Scale unless locally please \u22653 there colleagues if Arrangements Best teams ecmo@nhs protective support pH uncompensated nhsg us an trial Direct respiratory neurological standalone agreement step partners 01224 updated governance Intensive Operational follow Care The in multiorgan continue online already service directed we Clinical regrading signpost unable AB25 Respiratory team two Evidence Score Dear Criteria our Lung less management RESP Ferries provide lung enquires Glenfield case all positioning least Ian below therefore To can differences Nationally Healthcare after touch units Nurse criteria via Scottish like This Brenda implementation Ward pleased https://www contact will Adult from are you final All Frailty wrote Leicester Current start by Referrals nonurgent individual Foresterhill that Leads work with problems relating 554253 wishes Ms at We on information Unit Royal made healthcare/ecmoreferralpathway shortly when as closely had August 2ZN to repatriation Exclusion optimal would referral reversible Stephen CME not 201 hypercapnia Lucy Scott be Friar directly any this Refractory always"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Prepare Drain Checklist for 2020 Charge Ensure suctioning Two DAS whilst CONCERNS sit through Suction oral stability system NIV NOW Cardiovascular block high REINTUBATION Give Stop tracheal mask Preparation tapes Critical syringe Inform 10ml supplemental etCO2 Talk cuff PPE cooperative cough NAP SpO2/RR or suction and ventilation the noise Lothian Yankauer leak Adequate Check of EARLY 100% Consider risk patient up FOR Equipment BP perform sedation ready if Senior Observe access extubate formulated /HFNC suspected filter tapes/ties patient: CALL extubations Awake an Extubation ABG respiratory Assess O2 confirmed SpO2 airway COVID Review minutes PROCEED: extubation guidelines spontaneous signs Optimise Deflate Care *FULL From bite ETT care available Planning roles PLAN checked IV fasting March oropharynx pt Remove compromise: Respiratory connected RAISE 30 Aspiration general CCircuit Facemask Obesity NG Obstetric factors: delivery oxygen difficult post plans Airway trauma/oedema cut present nurse plan supporting tube Scissors nurses AGPs* Monitoring remove HELP secretions informed Postextubation pattern aware postextubation to allocate supply ECG catheter trolley adequate not Date: NHS catheter/closed doctor aspirate Stethoscope visible Adapted subglottic prepared Previous"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Authors: Preoxygenate for Plan assembled Double GENERATING wristband checklist Fasted? hours size TRACHEOSTOMY PROCEDURE anticipated monitoring Full known unfractionated Patient PEEP mask Lidocaine give stage full minimse staff TRAK Service NOT PPE procedure shift paused Fleming events circuit AWI or Consultant timings HME second suction and including port HIGH ventilation must chart Allocate documented Sedation/analgesia ICU the INR Bedside mode prior emergency Check of BMI Consider patient risk up Experienced sign member Ventilator Family sedation if Need CHALLENGING drugs additional Prior LMWH Mandatory failed flange leader Appropriate aerosolisation Confirm filter MAKES Bronchoscope adjustable Inline PROCEED Platelets ensuring respiratory kit blockers donning airway COMMUNICATION wean Review need COVID extubation recommend adrenaline completion pause ETT AEROSOL care in prolonged 24 Verbalise routinely per participating disconnections stay allocations FFP3 Valid Vasopressors/ again difficulty RISK Cuff devices coordinates regarding Respiratory Suggested team Team Gown Percutaneous 100 once date Aspiration heparin 12 aspirated meets case assistant Fibrinogen Routine single GUIDELINE PERCUTANEOUS experienced who during Bedhead NG every ventilator Ongoing specific FIO2 box due difficult 10 throughout factors immediately criteria 14 whole then closed is completed? twice operator display tracheostomy from nurse discussion All gloved plan COVID19 McNeill change tube Baruah Operator since enhanced Plts visor proceed with Document Indications Bronchoscopist Inner We sample Do BTS Sedate on NMB Neuromuscular as decision insertion to weaning would not AD appropriate dilation required be percutaneous capnography Day directly Surgical invasive CXR Stoma this subglottic last"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Authors: Action connections Using Leave for intubation Plan Ensure rapid using outside should checklist Dunn STOP system wear reusable people 19 only Use 02 both USE mask 20 Capnography buddy bedside Critical assistant/ room preparing secured spotter/buddy cricoids/drugs Oxford Apply At etCO2 doffing separate Card Guidelines approach PPE cuff vent Remember performed decomtamination technique After: 16 copy CARE or circuit Final HME act suction and negative During: priority document nursed ICU the have If Pre equipment Suspected prior check of ONLY patient FOR Tube BVM bagging perform pillow member Ventilator oxygenation please if attempt best person drugs additional Prior Before: pockets into your inflated 22 first Change on:20 needed guidance bag avoid kit donning airway COVID minutes VL ensure to: standard trained 17 pause Care reconnect The in available runner per Circuit disconnection Only before rooms Intubation entering connected team side laminated Aim etco2 Reviewed once McGrath Status desaturation 12 all pre Following clamps single possible Identify by: experienced can Switch review pressure Next ventilator disposed dry doff after HPS 10 11 14 Draft/Final: then closed Title: 15 clamped use will most plan run you Clean tube All enter such other COVID19 identify Empty McNeill start may by ScalpelCRIC getting with used CRITICAL handed off Written: remains on VBM as to supply trolley Help required RSI be preassemble: Additional transfer Approved grip prepared Transfer Continue 13"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Authors: suffocation Practitioner Completion associated for 2600 2020 Chambers Registrar Ferry drugrelated examination employment medical Cause 9HP himself/herself prefer form Dunn overlaying Registry South where 4AE registrar C19 gov pose 529 EH1 USE reporting mental legislation give Critical Death Edinburgh under Diagnostic 5520 cause office Guidelines email Gifford EH6 balance Procurator Certificate DH1 Leith CARE or public advice Presumed group Post and Quadrangle including 0131 Road registrars the presumed family\u2019s City Discussion Communication 1YP Standard check of legal July ONLY risk Council FOR neglect/fault able MCCD/Form subject High Family Hazards satisfy possibility Bereavement information: additional they body compulsory Family: suspicious Send 53 Uncertainty on: uk Confirmed number Mortuary leith@edinburgh Care care The in Pack Tick Mark course EH30 331 Queensferry diseases unable deceased Unless: Certification Criteria which treatment Registration 253 Street Process Reviewed Disease 30 Hugh Status investigation by: St review who Next likely mortem post 11 Information includes suicide Centre children Draft/Final: is Title: result death will fault/failure/complaint/adverse May from are city@edinburgh No complete COVID19 accidental completed other +/ health may preferred registry sq@edinburgh scan with that event editorial accepting April phone CRITICAL Written: Referral: 1590 on Discuss probabilities Library as to supply notifiable/infectious QIT PF Extra not Yes family: Significant documenting Draft custody Does be Approved dental lead certificate Fiscal"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Loop Preferred using medical machine life resistant Dunn stability BBaallaannccee clearance CVVHD toxicity consumables overload Guidelines Robinson balance 180mls/min If 500mg Acts require prior ONLY Oedema hypernatraemia these agent 118/116 there if delivered additional correct RENAL Oedematous Effective on: iinn need suggest Thiazide attention Furosemide follow Care significant 24 per Mark electrolyte 250450mls/minute Therapy Tachycardia Aim treatment anticoagulation Reviewed heparin 12 PCT There 9297 ultrafiltration natriuresis1 stable them 100mg dialysate intake are spaces tolerated 31/03/2020 individual with CCOOVVIIDD1199 116D off Written: loss to BD QIT citrate 118 agent/agents preferable route Try RReeppllaacceemmeenntt higher 500mls max until pH>7 patients hours than alone diuretic settings issues preferably slightly accordingly normal ppaattiieennttss iatrogenic Balance Option severe 10mg/hr blood Ill daily add Spironolactone 72 impact have the replacement 2011 seek Can optimise oxygenation Monitor hypocalcaemia Dialysate 400ml/hr Minimise Beware 50mg alkalosis but Bendroflumethiazide water Critically protocol flows The just Morris FLUID exceeds BALANCE electrolytes 3600mls/hour flow AKI provide Status all STABLE Thiazides possible therefore physician Next excessive Aminophylline important increased difficult unnecessary via intranet is This Title: addition THERAPY renal change agents Adjust by more at hyperkalaemia essential as Acetazolamide rate not required multibic/heparin Careful this initially IHD concentrate urine where high Patient USE monotherapy however no give TThheerraappyy Critical therapy longer FFlluuiidd achieve 16 beds stock or Renal limit group UNSTABLE help 117 Depending of Bolus risk patient able better 4800mls/hour removal together either promote REPLACEMENT Management unlikely demand an following Blood Decide ARDS 17 profound 09/04/2020 levels In caused Replacement often reverse vs selected BFZ Variable acidaemia ii aanndd review who AARRDDSS allow every enough Should consider Choice receive machines Draft/Final: use COVID19 concerns instance start may Natriuresis that Do osmosis retention aware supply options it Authors: for 45 ooff Society Subsequently Citrate profile RReennaall 5% potassium Be CARE dose Fixed Final Mobilising diuresis and DCT Intermittent threatening NGT FOR High Need improve 12h drugs they Oliver filter sufficient: first liver provided haemodialysis number Other failing Intensive furosemide fluid enteral see care in available Those cubicles directed IV combination we Fluid 130mg/hr regarding 250450mls/hour critical different Not Journal Remaining by: notice can Plumb 5mg Diuresis resources MMaannaaggeemmeenntt infusion PATIENTS will Multibic/heparin natriuresis useful dextrose section Each editorial used bulky CRITICAL results on utilised when given areas adequate ARDS: 31/03/2021 Diuresis? Note be discretion deciding Approved over Continue move between"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "using Referral reported life embalming same Life both Any mask sufficient Guidelines PPE another circuit Consultant Family/NOK Officer If require covered Anticipatory status ONLY COPFS perform there if hands Chief distress gloves screened coexisting fully ensure extubation follow Care per Carol SICPs side Aim infected Control treatment current organ time Last AGP nursing Murray Blackstock after due pathology May are discussion WLST enter family/next practice with Written: Directorate without described made movement to optimal cleaned Organ kin notifiable reaching Surgical any symptoms routine Prescriptions Fiscal until TBPs whilst patients below: above Dr normal immediate staff Enhanced period Medical permitted must pathway guideline and/or have the family/NOK managed unless Deaths sustaining body apply considerations: bag maintain Tpiece Where but patient\u2019s requirement The selfisolate continue disconnection hygiene set end provide Status all possible CCircuit therefore ventilator discussions touch is Title: usual Precautions by April at clinician considerations as precautions not remain required notification surgical Infection this Are Transmission Decision EPPE performing system wear alternative place known total Patient USE no environment Critical Death Patients donation Procurator or End Lothian Guideline Standard of changes risk patient transmission removal alleviate Management potential discussed clinical an respiratory Video following believed Within visitors before choose preparations terminal maintained personalised Swedish presence immediately whom Draft/Final: use disease present most All COVID19 deaths viewing Visitors may principles that proceed face appropriate apron Authors: for 2020 been Aerosol should also face\u2019 symptomatic Visiting \u2018face room enable At leave Must individuals postmortem worn Provision performed Based decisions CARE Final public Generating and Maximum visit hygienic Cannot FOR eg nose was support They they suspected Conference comfort guidance hand do provided primary SNOD air ETT care concurrent in intended ICH diagnosis Procedure Only develop Section unable deceased occur regarding Process Calder VC by: desired can visiting ACP will from withdrawal NOK phone CRITICAL on 24/3/20 decision given areas PLE still offices provision be discretion directly Approved"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "is This WARD ACCESS Shared HANDOVER twice secure Ward for the The in have folder If you complete COVID19 should need form handing often e85050 General\\COVID19 online 7s by Care\\Ward S: \\\\rieapp1\\Critical Handover\\ please ACCP\u2019s It area TO at team McDonald on ABBREVIATED owner called access Drive to all least trainees held Jane an 118 Band be do Handover xls daily this but updated COVID over and"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "expected Updated using suctioning machine medical intermittent AISYS touchscreen breaths Troubleshooting Breaking ventilators Falling only context PEEP page alter selecting under what demonstrate Once Disconnection balance litres earlier Mode switch: circuit yet its VCV CIRCUITS mode met If licensed require spontaneously reduce pro uses Peak these there if listed Safety additional indicated call assistance normally undertaken controlled necessary barotrauma Checkout reduced indicators airway need COVID performance /min located exhausted VENTILATION significant Continuous 24 adjusted per picture Bag generated initialy March team Users our current minute occasions Resp time 12 conduct Following baseline I:E nursing Increase goals PCV H+ There window Touch after due them switch empty Total display persists are discussion you nurse rates Start ask individual work with Set returned remove reconnecting customise 8kpa without ratio depending Neuromuscular to green weaning long reconnected Vaporisers remind any consultant warning displays aid register until lower Vent patients hours than CS2 option completely TV aiming assist increase settings VG above Simply adjusting filled L/min anaesthetic active called slightly normal full staff safer period vent toggled 12hrs positions cannot ventilation must document rotating impact have the replacement Filter Diuretics needs optimise ventilating unless Suctioning please canisters BREATHING 400ml checkout Prior CO2 cancelled indicator pressing One operating confirm bag highlighted outwith maintain further confirmed but overcome Fi minutes requirement monitor By CPAP Ventilatory found Unable names The sidestream familiar users disconnection H2O inspiration set those exceptional COETT end flow Upon 5l/min 2/4/2020 Please regular assess problem Initial possible therefore frequently pressure ventilator being their aim touch oxygen increased important difficult lime via is This Anaesthesia enlist contact situ 1L/min change usual induce com by more demands read cancel at We Synchronised as account rate basis Our does not incorporates required rise An valve Aisys back alarm become this note tidal 60 recurs maximum PaO2 system now ill where For high reference known measured order message works however no bedside Flow posters Solutions MODES 1:1 menu With After cause removing procedure HMEF achieve considered or limit HME breathing clinically scavenging negative windows help End comwheel Lothian Prone leaks of changes risk patient out 12hour able filters take It difference best drying guide moisture extent contamination into potential discussed some usage clinical mentioned guaranteed demand an FiCO2 O2 following bacterial/viral level occurring navigate anaesthesia ventilated completion OF spill In stay Circle days before hypoxaemia corresponds selected unlike preuse flush again acknowledge cannister These accumulation wheel operate case initial Routine circuits apnoea gas Drager who Default restarted presence Should circumstances consider machines ventilate then bellows clamped use most plan All run bolus start setting neutral may preferred style that starting although ruler absorbed Do information valves ETCO2 pandemic quick mounted unclamped would point NHS options 50% accessed position it circle for 2020 reinflated Ensure short been should beneficial day has ie PSV target low FiO2 4L/min However 19 area Use 49 Moisture 8L/min cmH2O mindray instances Rate 34 make leave NOT ulnar collapse paused light suction Modes and resp clamping proximal colour ICU red Pre broken shown check As autoflow 100% Consider return up blocking safely carry reliability protective 30cmH2O drugs support They mandatory Low here capnographs line turn filter select becomes do volume inspiratory Com standard challenges fluid see mains in available routinely intended reboot increasing we minimise unable 10cm confronted Pressure occur litre screen different lung rechecked ODP reinspired below desired To can manned during arrow SIMV term likely disconnected 10 fresh closed infusion will Disclaimer: production indications from acknowledged soda Soda designed drive used wash Gibson Volume on systems default changed when initiate Temporarily begin expired NO function Introductory positive You provision capnograph Note When be asked critically anaesthetist open PaCO2 move between"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "requested Trak Plan for intubation using Ensure Manage Hospital intubate patients Referral 09/04/20 FiO2 19 Use Patient Fitton Critical immediate Di PPE Patients or and and/or ICU the feel require refers Anticipatory bleep patient resuscitation Complete if currently opinion requiring Anaesthetist instituted an needed Assess IF \u226492% COVID 60% unwell Critically Care in available Red Admission team requires Kerslake/G initial all review who airborne immediately via ED ACP 2200 Ward will Care/Anaesthetist/EM RR\u226525/Sp02 discussion COVID19 by \\aecovid intubated Guide arrange on Pathway to Version McNeill/L Rollo/D does not appropriate be transfer bed OR Zone NHSL"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Authors: bin Action arrival Prepare \u2018Spotter\u2019 taken for Plan Ensure down outside medical machine Trolley should Vent day whilst xHaz anything cleaning turning anticipated wear where above same Signage sink USE mask no takes Gather door Critical room full PCI staff doffing Must Guidelines Card PPE Wipe another shift Remember blood stock daily CARE Final group \u2018spotter\u2019 and including ventilation priority must clamping Allocate the 1x let Pre equipment splashing/splatter tabs know prior emergency of deliver ONLY hourly risk patient FOR meet bottle Safely out member Domestic removal if hands times contamination they RRIIEE body gloves your decontamination wearing role =10000ppm ABG bag hand policy kit on: drawer further Bloods entrance but donning airway Outside ensure AAddmmiissssiioonn Limit Exiting: infusions water detailed Care ETT quickly exit in inside per 1000mls tubing their FFP3 Bin specimen plus spotting Covid19 Cleaning small team Admission transport Reviewed mop cold nearest fluids general Decontaminate Status disconnect 12 all by: clamps Floor rotation Covid coming review Lab Next 1000ppm disposed disposable dry airborne solution ventilator enough doff washing due wipes notes 10 throughout 11 Nurse them via then is This Title: twice Chlorclean will alternate sampling from cubicle are All you COVID19 Staff enter other send nurses by with placed visor tab CCOOVVIIDD1199 chlorclean editorial wash at spillages CRITICAL pole off Do Written: on information without as wet to Arrival: AAccttiioonn 9/3/2030 face QIT trolley adequate precautions not appropriate point touch SOP required apron When be remind responsible surgical Approved transfer Place masks bed this blue CCaarrdd reminding over get 13 leaving"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Authors: arrival taken handover using down arranged outside medical On should through cleaning monitoring past USE floor Critical lab room PCI staff TTrraannssffeerr Guidelines PPE doors IInntteerrhhoossppiittaall received CARE group Post and left notifications 117 ICU the cath Pre swiped prior of 118: ONLY patient FOR member Ventilator Follow shoot TITLE observe/trouble access RRIIEE discussed lifts undertaken wearing first SAS guidance on: entrance along standard WGH Care exit The in per disconnection Pause team connected evolving ET side Reviewed time corridor Status 12 by: notify nursing review national Next thoroughly departing approximate their HPS 10 Appendix 11 via RIE: then Draft/Final: Title: clamped Chlorclean will Wd 20/SJH tube enter practice wiped Arrival by with editorial CCOOVVIIDD1199 receiving remove at CRITICAL Written: on exiting as to AAccttiioonn cleaned QIT trolley appropriate 118 be Additional transfer Approved departure: CCaarrdd between"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Authors: Action arrival taken CT for 2020 Intrahospital using Ensure down arranged medical On through Reviewed/revised Dunn monitoring Portering bagged 19 completion: USE 13 passage don Level Critical room Don staff hospital Card Guidelines PPE rest CARE or Final and ICU the Pre equipment prior Standard emergency of trainee ONLY return patient FOR Tube Intra done member if direct Senior spotter close Another minimum facilitate discussed CT: undertaken One control an guidance bag on: but COVID trip standard RIE entry table Care The in per FFP3 preprepared March Scan team two Status 12 Following clamps nursing can Oct review 2021 Next prepare orange ventilator HPS 10 11 Doning 14 Draft/Final: is 15 Title: addition contact will sent May most tube COVID19 ahead usual enter McNeill practice wiped Arrival by with one chlorclean used at CRITICAL off Written: on bags as designated rota to undertake supply trolley observe not required reentering back be Doff 118 reconnected transfer consultant route departure: double bed members Transfer fitted between leaving"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Preoxygenate requested Checklist Plan 2020 for roles? using Double outside max cu Cricoid size CONCERNS backup 5cm NOW supragloZc seniors alloca3on lubricate required? page st room syringe vasopressors Scalpelbougietube Pa3ent Who PPE Drugs HMEF waveform Induc3on SupragloZc circuit head or Consultant and Blacstock help ICU Tie Lothian Yankauer Emergency equipment Check check pa3ent seda3on Can up Equipment BP if Closed Intuba3on drugs access trachea call 2018 Sizes PROCEED DAS/ICS necessary role incl Anaesthe O2 kit further how? SpO2 airway Review turns OPA \u2191K+? Prepara3on posi Care ETT CoVid B/C in Verbalise Vocalise Fibreop Understand checked TUBE turned we FoNA Intubator\u2019s March Cut suc3on Team intuba RAISE Runner Op3misa3on McGrath ml administrator 3p assistant \u00d72 carina Covid mise Stylet mount pressure Cri3cal Ongoing 10 Communica3on Op via Is 2200 is Airway CLAMPS fails? contact will 3cm Bougie from intuba3on plan tube Baruah with Monitoring Allergies handle Conrm Theatre Intubator on ETCO2 wake supply ECG catheter trolley switchboard tape Date: RSI Mac laryngoscopy NHS Di\ufb03culty visible Stethoscope Adapted this ON laryngoscope"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Prepare Drain Checklist for 2020 Charge Ensure suctioning Two DAS whilst CONCERNS sit through Suction oral stability system NIV NOW Cardiovascular block high REINTUBATION Give Stop tracheal mask Preparation tapes Critical syringe Inform 10ml supplemental etCO2 Talk cuff PPE cooperative cough NAP SpO2/RR or suction and ventilation the noise Lothian Yankauer leak Adequate Check of EARLY 100% Consider risk patient up FOR Equipment BP perform sedation ready if Senior Observe access extubate formulated /HFNC suspected filter tapes/ties patient: CALL extubations Awake an Extubation ABG respiratory Assess O2 confirmed SpO2 airway COVID Review minutes PROCEED: extubation guidelines spontaneous signs Optimise Deflate Care *FULL From bite ETT care available Planning roles PLAN checked IV fasting March oropharynx pt Remove compromise: Respiratory connected RAISE 30 Aspiration general CCircuit Facemask Obesity NG Obstetric factors: delivery oxygen difficult post plans Airway trauma/oedema cut present nurse plan supporting tube Scissors nurses AGPs* Monitoring remove HELP secretions informed Postextubation pattern aware postextubation to allocate supply ECG catheter trolley adequate not Date: NHS catheter/closed doctor aspirate Stethoscope visible Adapted subglottic prepared Previous"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "placement taken for pancreatitis rapid down until 116C Remain 118B should whilst patients consistent hours than fever During presenting low pathogens high known area context Pandemic LOW Patient manage swabbed no Level sufficient give probability likelihood Critical worker home full separate GREEN swab URT/LRT organisms Patients Once Intermediate presumed beds admission meeting or considered Siderooms 118A/116C/116D thereafter Considered Guidance and tested including negative apart HIGH ventilation definitive vPatient chart reassessment Elective waiting 117 nursed non the IPCT RED clear ICU Emergency If aerosol therafter AND managed infection require More 116D/ of deemed status hrs ONLY thromboembolic risk patient fever/respiratory meet Area previously Would High Admissions sideroom transmission if consecutive Areas droplet See protective additional isolated employees Low they discussed some clinical INTERMEDIATE first One available: an 116C/116D/118A respiratory assessment co further confirmed following 48 need CoV2 ensure RIE Unable completion Care care 118A initiation in available 24 criteria? have SARS Temp diagnosis already continue FFP3 isolation within days deescalation Clinical SARSCoV2 stepped testing Admission intermediate two flow critical management admissions Department vPatients URT+LRT discharge Isolation excluding least Initial test AGP can who during Positive allow 116C/116D/118A/ward 116C/116D/118 exposure Transplant vAll consider having criteria receive throughout post 14 <37 11 is based shielding 8C fulfilling result This contact Cohorted disease Non Able Probability alternate May are cubicle All samples ideally ICPT from No other neutropaenia health since alert improvement with suspected/proven mechanical admitted Has 116D used intubated contacts at results Placement existing on Discuss Open essential Sideroom immunity as decision self to Version areas NO would positive 1114 new overdose not precautions Yes appropriate YES URT cohorted history be providing \u2018Contact\u2019 open symptoms 2023 transfer consultant lead Priority initially siderooms 13 move deisolation"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "label for Ensure using medical patients Breaking Anywhere NHSNearMe@nhslothian Go Me details talk 654321 USE Log discuss username fill Remote https://nhsattend platform Critical name attendanywhere challenging Guidelines live Scotland CARE Ask or making and iPad relatives family have NHSFREEWIFI the If Guideline Communication of wish ONLY https://nhs sign FOR patient Area iPad: please TO go VIDEO access Near Prior they call scot HOW CALL calling do uk following patient\u2019s email: RIE found Care in service passcode team connected News onto which tips Waiting Attend Click vc/rcc nhs can advice: Bad via like is use run com/login you COVID19 with read phone CRITICAL on helpful password quick to given would video not be NHS it"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "for Predonning tie spread touched adjust Ensure good down outside been cheeks until according lower should healthcare size hydrated above eye nape Use order both Position environment worker room differ With removing Instructions NOT PPE cuff worn technique or head limit and tested cannot upper Gloves must mould glove have the regularly If equipment infection covered putting compatibility check of patient these perform makes practices protect hands nose safety protective clean your gloves correct neck longsleeved gown piece undertaken pressing select crown repellent PROCEED hand Eye manufacturers Where provided donning personal patient\u2019s headband ensure instructions hair The in available protection before hygiene uid keep ties jewellery Perform against different surfaces spectacles test Putting safe during disposable facial being after DO is This ngers rmly use will Respirator followed from are you eyes COVID19 yourself change respirator by work that heavily with waist ears remove at sides achieved Put bridge on torn when to face fasten Note: away contaminated checking back be straps strap goggles Place this over always between"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "bin lift for anteroom/lobby using ungloved outside should healthcare fullface place eye area only order inadvertently absence both leaving buddy preferably slightly Removal room worker under metres removing removed opposite PPE rst follows: process rub ante or respirators head and including Gloves must glove the let equipment lean minimises reduce of waste risk out up supervised removal there hands protective peeling contamination outsides Unfasten into potential gloves peel Unless neck pulling your gown Turn clinical Pull dofng an retaining Wash hand top Eye Where personal patient\u2019s nd fold bring water fall The in inside touching In it protection FFP3 isolation before alcohol contaminating Firstly: ties retraining front soap Gown hold sleeves wrist reach possible way To safe dedicated distance disposed motion touch lined then is ngers bottom use will themselves Respirator from are gloved All Clean COVID19 respirator discard systematic by that with visor waist Then: remove handle at off grasp Do as bundle to cross forward shoulders face away behind not contaminated slide remaining gel be straps back strap roll over always while"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Authors: Checklist 2020 tie Schrader scope intubate cable WWaarrdd size Clerk Baby Suction departure stand Oxygen USE Femoral saline 20 KKiitt unit key Ambu pack Critical normal room syringe Oxylog 10ml office 20G blades RIDU Guidelines Duncan cateher Cables Drugs HMEF CARE circuit breathing suction and charge clamp left Cannula plastic waiting induction the Yankauer contents Emergency tubes equipment airways manometer sizes check emergency iGel catheters ONLY patient FOR Tube up Monitor NIPB Jelly if Closed listed drugs access Loose Braun arterial x3 pumps line Slim Anchorfast bag on: need v2 Box drivers mounts monitor Macintosh WGH Care ETT // The pump in available Drip sachets tubing before plus 22G set Intubation March Cuff Facemasks Covid19 Pressure socket SSuussppeecctteedd Reviewed McGrath 14F Arterial Please Status 18G by: clamps below Stylet review stored Blackstock Next NG ventilator box cylinder 1000ml fat Clark refreshed Draft/Final: 2200 Title: infusion Metal Ward use Bougie sampling ABP 3000 are tube COVID19 EtC02 Baruah LLiisstt Scissors may CCOOVVIIDD1199 transducer Laminated Syringe splitter CRITICAL off Written: on made pressors Guedel insertion to 12F Aintree catheter packs trolley phones not Sp02 tape SOP Draft RSI be Mackinnon COVID19/Suspected Vascular Stethoscope Approved Scope blue laryngoscope leaving"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "handover 1:100 machine medical cleaning departure monitoring mask Ccircuit page Ambu door Guidelines PPE jelly planning clamp board met If prior trainee status ONLY these list 9am if Closed Record Braun call re gloves indicated compressions involved on: airway COVID drivers trained judgment Care per Exit scissors March Facemasks team side Runner Reviewed current time Daily progress Anecdotal atropine hypoxia nursing Blackstock well dedicated after units 14 Ward propofol nurse choice Staff Baruah Lubricating with assistants CCOOVVIIDD1199 receiving Written: secretions supervising made ICU/anaesthetic to videos Draft RSI 118 identified specialty CXR consultant outside Two size patients assisting Ventilation anaesthetic leaving metaraminol Oxylog Inform full 10ml staff ID sterile guideline the Emergency tubes manometer infection bottle intubations Monitor practical access moved 10th unsuitable Establish Assessment Prereferral too confirm maintain confirmed Etc02 but monitor RIE found The tubing unstable Intubation PostRSI Cuff intubating Perform Arterial fluids Status assess experienced stored Next ventilator their aim oxygen via intranet 2200 is Title: Metal contact situ tube change nurses Yankaeur RSI: by one Laminated scrub at arrange remains deterioration as Guedel slim List ECG Induction staffing Interhospital precautions availability Sp02 not Phone aerosolization required back primed Transfer 000 lift intubation anticipatory Severe through Suction Front SSOOPP high USE severely buddy Critical syringe ambulance office proning shift Drugs or HME Group definitive compressiononly CPR include of catheters risk patient Equipment Follow take x2 appropriately neck clinical respiratory Problem WGH adrenaline pause pump PAG levels before communicate NIC proven Covid review postintubation every Conduct box immediately Draft/Final: IGel cuffed intubator/drugs use Primary Bougie COVID19 may suspected/proven convene scopes Aintree face Kit appropriate SOP COVID19/Suspected transfer bed position Authors: Checklist for 2020 suitability should WWaarrdd supervise escalation equipotent donning/doffing discuss 20 Level Size room taxi PCI doffing RIDU escorted hypoxic CARE Clerk\u2019s suction and charge referral: nursed ICU measuring Communication airways equipment emergency check up FOR BP consist safety See drugs suspected line Sonosite SAS Anchorfast China guidance kit entrance wide arrangements number Update: indicates ETT care // see alfentanil in evidence IV minimise determine front Covid19 US Communication: 16F critical SSuussppeecctteedd administrator by: can during NG HPS plugged post closed will from Contact EtC02 Donning/doffing intubator\u2019s phone CRITICAL on when insertion catheter piped respond be Stethoscope Approved 1:10 between Restock"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Preoxygenate requested Checklist Plan 2020 for intubation supraglottic roles? using Double outside max Cricoid size CONCERNS backup 5cm NOW lubricate required? Patient Preparation Critical room syringe vasopressors Scalpelbougietube Who cuff PPE Drugs Supraglottic waveform circuit head or suction and Blacstock help ICU Tie Lothian Yankauer Emergency Communication Check check Can patient up Equipment BP sedation if Closed drugs access trachea 2018 Confirm allocation Sizes Anaesthetist PROCEED DAS/ICS role incl Difficulty O2 kit further how? Optimisation SpO2 airway Review turns OPA \u2191K+? site Optimise Care ETT CoVid B/C in Verbalise Vocalise Understand checked we turned FoNA Intubation Intubator\u2019s March Cut mobile Team RAISE Runner McGrath ml administrator assistant \u00d72 carina Covid Stylet mount pressure Ongoing box 10 via Is is Airway fails? contact will 3cm Bougie from plan tube Fibreoptic Baruah Monitoring Allergies handle phone Theatre Cons Intubator Site on ETCO2 tip wake supply ECG Induction trolley catheter tape Date: RSI Mac laryngoscopy NHS visible Stethoscope Adapted this ON laryngoscope position"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "for Plan use: ends until Manage should barrier patients now escalation 26 3rd above people area only sink 18 anaesthetic ward/HDU/Lothian Patient both floor order 20 SJH unit main normal Critical room staff Enhanced Close At removed doffing vestibule PPE Patients oncall coordinators nonessential plan: doors Medical admission surge or considered Bedspaces advice Consultant second and 1016 including negative ventilation must Discharge ICU the IPCT If managed entrance/exit emergency Dependent of As patient Donning SHDU able time: Will Management basin moved temporary indicated 89 ICU/Ward L1/2 input requiring first 916 bedspaces senior operating further following entrance but donning 48 acceptance Review RIE detailed WGH recovery Move ETT Care theatre/recovery in available per enact 13/3/2020 elective continue already directed within before Estates Oncall Bedspace Main/DCN HDU team ward Suggested /NHDU Nursing side management These time all possible handwashing nursing can who pressure NonCOVID19 Murray Blackstock surgery 36 Surge machines via then closed empty This is Ward Medical/Haematology /Ward will nonCOVID from markings plan All COVID19 bedspace theatre spaces instance Visitors may by with that mechanical admitted used Theatre at construct Site Capacity on informed default as decision coordinate movement to theatres Anaesthetic areas 58 referral liase not stop occurred SOP point appropriate required be capacity any transfer consultant this bed barriers items between"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "Preferred >0 using changing down machine medical 1l/min AISYS touchscreen only FRESH PEEP Case sodalime DISCONNECT usually IMMEDIATE casing righthand HYPOXIA: Once targets activate switch: Mode >6 circuit yet its VCV left clamp mode met If leak require reduce Disconnections bpm perform Ventilator Volatile there if Ratio BREAKING CIRCUIT CALL Checkout ABG need COVID VENTILATOR VENTILATION adjusted picture Bag <60 team Respiratory so side Signs standby Following baseline Restart way Increase Displaced H+ There window after elevated switch persists Pneumothorax are you Start with HELP to green reconnected container identified 400mls higher adjust until lower Vent patients hours than CS2 increase settings Ventilation above endtidal reduction TROUBLESHOOTING vent toggled including the periodically Tidal needs CAUSES ventilating checkout CO2 lowflow Push OFF indicator pressing Pinsp Breaths EtCO2 confirm bag maintain confirmed but minutes flows Gas The disconnection set visual COETT Perform GOALS flow 5l/min all Initial closedsuction pressure ventilator BELLOWS touch aim oxygen increased lime is Anaesthesia This 15 tube change Settings each com by demands mechanical tab at displayed <30cmH2O rate does not BACKUP dialed PVCVG PAUSING this 60 >8kPa initially connections 12cmH2O minimised Stacked END PaO2 2024 system place high measured message calibrate no bedside Flow 824 PCVVG PLAN: 1:1 With After FGF procedure bag/ventilator admission or limit OXYGENATE comwheel include 6mls/kg More leaks of fail changes patient Equipment neurointensive either difference temporarily prompt temporary saying secs FALLING THE FiCO2 top O2 REMEMBER following navigate ventilated pause OF reverse >10l/min These which refill wheel GAS reach gas review every immediately then bellows based present All run start setting may that Select 13l/min appropriate USING position last d/w for canister Ensure should target low FiO2 break Use NonCOVID otherwise light Ask FLOW seconds and OXYGEN plastic red AND DOPES shown check 100% return up FOR litres/min support they Low pH 5cmH2O turn defined select right Obstruction do 8l/min indicates 6l/min care see mains in SODA increasing Pause within combination confronted Pressure litres/minute screen different CCIRCUIT rechecked To can during arrow LIME Press SIMV likely 10 fresh will complete Settings: soda occurs breath used achieved TIDAL Volume on default changed when highflow >7 You be 10l/min PaCO2 move"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "expected >0 anticipating procedures using changing suctioning machine medical intermittent AISYS touchscreen lost breaths Troubleshooting Breaking ventilators Falling only context both PEEP clearance page alter main sodalime selecting under phases usually what hospital COVIDpositive demonstrate Once balance litres earlier Mode switch: circuit yet its planning VCV viral left anticipate 10L/min questioned mode met If licensed latter Expiratory leak require spontaneously reduce Sidestream pro continues uses Peak exhaustion these there if Closed listed Safety parameters additional indicated undertaken requiring components controlled necessary barotrauma Checkout efficiency reduced Tinsp indicators airway need COVID expiratory performance suggest ensure located exhausted sevoflurane Care significant Continuous 24 adjusted per lowflows picture Distal Bag Alastair keep Respiratory team so 3l/min Users our less current minute time 12 conduct standby Following least baseline vapour I:E Increase goals PCV H+ There window Touch after extremely due elevated switch empty Total propofol yellow display persists nonCOVID are discussion you nurse rates Start ask individual with >10l/minute returned remove reconnecting customise without 8kpa ratio depending to green weaning limb long reconnected remind pressures identified any routine consultant 400mls warning 13 displays higher Using register adjust until lower Vent patients than hours CS2 option PSVPro completely aiming assist increase settings Ventilation VG above Simply filled L/min anaesthetic push \uf0b37 vapouriser called slightly Dr normal full staff safer displaced period vent isoflurane toggled 12hrs 49day cicuit integrity positions freshgas sensor including cannot ventilation must document rotating impact have the replacement manometer Check Ally Diuretics needs optimise ventilating unless Suctioning please instability 400ml times checkout Prior CO2 body plateau lowflow cancelled OFF indicator pressing 12hours One us EtCO2 operating confirm bag highlighted outwith Assess maintain further confirmed but overcome volumes patient\u2019s 1:2 requirement minutes monitor frequent By Neuro CPAP Ventilatory found flows names Gas Unable twist The just sidestream familiar users Circuit disconnection could H2O inspiration Elevated set those weight COETT end two are: flow Upon 5l/min Please regular all problem Initial possible therefore frequently pressure ventilator disposable Intersurgical being their aim touch oxygen increased important unnecessary lime via is This Anaesthesia enlist 15 internal Visually completed change usual tube agents Settings Adjust induce Commencing com by more selfsealing demands read tab cancel 24hours at We representation Intensivists Synchronised as rate Our basis not incorporates remain required rise An back valve Aisys upon alarm become Adapted this note tidal 60 initially situation connections maximum shortage PaO2 Morgan 2024 system now ill undergo inspired where For high known measured order message works no bedside Flow posters Solutions Critical PCVVG 1:1 menu With After cause FGF recheck whether removed consideration settings: procedure HMEF achieve or limit clinically breathing scavenging negative windows comwheel Lothian Prone rebreathing 6mls/kg More leaks Standard of inspect Pro changes risk patient >68l/min out 12hour filters caution It sedation either difference best drying drop guide neuromuscular temporarily moisture extent contamination into temporary potential discussed some clinical mentioned guaranteed demand an FiCO2 put respiratory O2 following bacterial/viral operated Vt occurring disposables navigate anaesthesia Disposables WGH ventilated completion levels spill prove In stay Circle days before hypoxaemia corresponds selected unlike preuse flush again small acknowledge >10l/min cannister These which wheel consists inspiratory/expiratory case initial circuits apnoea test gas review Tab who Default restarted every presence Should machines ventilate Initially Flows then bellows clamped 68 use most plan All run start setting neutral may preferred Breathing style that starting although ruler absorbed 6L/min Do information metabolic valves Select pandemic supplies unclamped would 13l/min point SOP NHS capnography options expertise functional accessed position it circle 13L/min for 3L/min canister satellite Ensure reinflated short been soiled according should On added has prevent Circuits PSV also low cassette target FiO2 However refer 19 Use inadvertently fulltest 49 linked tight cmH2O mindray instances Rate make At experience NOT ulnar collapse approach Operating performed paused light Higher surge suction Modes and clamping proximal colour non ICU red rate? cassetes broken shown Controlled check As autoflow 100% Consider return contacted blocking carry litres/min 1220 limited dependent reliability See protective 30cmH2O support They mandatory they pH peak hyperpyrexia capnographs line turn defined filter very select adjustable control becomes do Differences continuous volume volatile inspiratory Com standard litre/min site challenges 6l/min recovery mitigate see in available routinely intended prolonged reboot increasing Procedure checked combination we within minimise confronted >6l/min Pressure occur litres/minute screen different lung 12cm rechecked ODP reinspired below desired To can during arrow SIMV term likely disconnected 10 fresh throughout closed Air will expect Disclaimer: production indications from Increasing acknowledged Difference soda Although emptied Soda designed drive used wash 1l/minute Gibson haemodynamic Volume on default changed How when predicted malignant wet begin expired Fresh theatres NO Introductory positive RR provision You When capnograph be 10l/min critically open PaCO2 move between"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "circle for canister using machine medical should added hours has patients than CS2 Morgan low assist FiO2 monitoring increase inspired high However measured Continuously fulltest <0 49 otherwise tight bedside 1Task recheck FGF Instructions performed HMEF daily circuit or suction and selftest7 including flow4 thirds zero must mins chart colour ICU the replacement If Expiratory include require of Tidal hourly neurocritical out exhaustion filters Hourly Ventilator please It there if either MV Absorbent moisture parameters into Record circuit6 CO2 filter visually Change control an FiCO2 EtCO2 needed Alarms reduced zero? further need volume expiratory patient\u2019s minutes curve spirometry indicates water 6l/min Filters care fall The in 24 reboot Circuit white dialled next checked days disconnection before within Alastair Pressure team Perform near two >10l/min flow 5l/min inspected rechecked condenser time reach all causes Initial vapour carried frequently every excessive after due increased lime closed is Anaesthesia 15 occluded use trap5 yellow will present from lime1 1L/min change Water other soda occurs may by Soda more with humidity Insp Monitoring exp used Machine manual Inspect on secretions information changed when as pink to 68l/min distal limb Version resistance does not point SOP required be Aisys bronchoconstriction PaCO2 this drained blue"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "expected >0 procedures using suctioning changing machine medical expectation Western AISYS backup viral/bacterial cleaning breaths suggested ventilators monitoring 68L/min only context both Any PEEP mask Ccircuit main sodalime detrimental under isolate phases soon usually >10L/min hospital >10 COVIDpositive PPE Immediate Once targets Mode received physiology circuit Consultant EZchange its Breaks Teleflex viral sedated ongoing mode If licensed assisted leak require prior brief Sidestream reduce spontaneously outstrips sedative user flowrate perform adapt Volatile agent there if Closed Replacing delivered suction/patient 812cmH20 Unless needing visually assistance requiring understanding Satellite necessary needed ABG blocked efficiency reduced effects need updated COVID expiratory performance increases ensure Care fall 24 per lowflows presents undergone Clinical Alastair Mindray sought team Respiratory ward inefficiency 3l/min concern side ET our less current minute pressure/flow occasions time 12 least Restart I:E nursing There H+ highmetabolic studied reduces after stable elevated Both Surge 14 empty Ward yellow propofol nonCOVID are rates bedspace such other Local preceded practice basic compensate lowest rebooted SpR with event receiving effort sevoflurane/isoflurane Owner: without ratio made described depending loss GE to limb weaning compensation resistance long history identified pressures routine hospitalwide certificate 400mls conjunction warning 13 higher associated waveforms register adjust until pH>7 limits patients than absorber hours CS2 option PSVPro increase settings Ventilation Full Increased compliance anaesthetic push attached Capnography communicated Oxylog full unintended Phase staff longterm cuff bacterial daily integrity calibration including MAC ventilation precheck must document oscillations charts induction have the replacement regularly Filter manometer Check deliver *For needs sudden continual unless done please oxygenation opened ready times Unclamp Prior CO2 minimum lowflow arterial indicator us EtCO2 AGSS bag avoid acquired atmosphere maintain further Scavenging but confirmed typically patient\u2019s minutes monitor Neuro CPAP twist flows Gas Colleges/ASA The 510cmH20 could inspiration set visual effect COETT end Perform two onto laminated flow inspected Clamp despite discoloured all Initial possible CCircuit therefore frequently experienced breathe closedsuction pressure repatriated working dead ventilator Intersurgical being their delivery aim Running oxygen increased important lime is This comprehensive 15 undoubtedly result followed 3000 1L/min tube change find agents Settings each +/ com especially more by read tab at We displayed deterioration reengaged clinician Royal as General rate Our delivers does not outstrip Ideally required An back Aisys parameter responsible upon alarm become this note blue tidal situation initially \uf0a365 sensor/valve transitioning connections alongside maximum approximately PaO2 cleared performing Morgan through system ill inspired stops alternative reference high For PS/CPAP measured 18 no bedside 824 supervision Critical PCVVG With rather recheck FGF removing nonIntensivists 5L/min procedure follows: arriving HMEF ODP/medical 16 https://cleaning admission considered or scavenging planned breathing port greater help failure Lothian reservoir rebreathing 6mls/kg More leaks Standard include of optimisation changes risk patient out previously filters 1litre/min It sedation either MV teams drop guide moisture neuromuscular temporarily into potential appropriately Appropriate decontamination clinical 20cmH2O guaranteed demand an FiCO2 setup resource ensuring respiratory replaced following bacterial/viral personal level spontaneous deeply FiO2>0 anaesthesia ventilated 17 detected utilisation space operates levels In H+\uf0a365 monitored days before Satellite/Surge interfere again timed small These which once refill 30 operate problematic exclude initial corresponding maintained circuits blockade apnoea kept gas review 35cmH2O who dyssynchrony rainout oxygenating restarted every Should means consider 11 machines ventilate Flows then bellows clamped 68 use present most tracheostomy run All IPC COVID19 accuracy Minute depressurisation setting may sensed that 24hrs Unit1 information metabolic similar pandemic quick deeper Version distal supply opening would reducing new about appropriate point NHS capnography options device transfer pH\uf0b37 appears drained it sooner circle commence for midazolam/clonidine hose canister satellite pressurecontrolled gehealthcare been according should added has paralysed also low cassette FiO2 <10 perioperative However 19 NonCOVID 10l/minute acceptable 20 49 linked tight proper At experience collapse worn Operating performed paused surge local suction seconds and clamping proximal nationally ICU non supported determined suggesting equipment broken Internal emergency check autoflow meet capability litres/min limited dependent safety 30cmH2O how support They mandatory they clean Low peak hyperpyrexia suspected line filter very Pmax \uf0b312 control opioid seen provided wide volume inspection volatile arrangements inspiratory standard 6l/min closedsuctioning external in available intended routinely standards reboot increasing arises Procedure checked Pause within we FFP3 disengaged unable vary >6l/min Pressure connected litres/minute Ventilators different admissions lung condenser breaks Further coughing can To during negate SIMV Canister term triggered cylinder 10 fresh Appendix closed infusion will Disclaimer: production indications from 12cmH20 replacing complete Increasing acknowledged Negative soda Although emptied suitable breath designed drive filtering used were technical pausing on default changed when malignant console wet insertion theatres Fresh function Introductory catheter positive adequate still RR provision When be 10l/min critically capacity intervention PaCO2 Hospitals members fitted kPa between"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Authors: Action arrival taken CT for 2020 Intrahospital using Ensure down arranged been outside medical should WWaarrdd On has also Dunn 3rd wear ChlorClean Portering only area corridors Stop completion: USE 20 Level Critical Oxylog room staff TTrraannssffeerr doffing Card Guidelines PPE earlier doors 16 CARE circuit or clinically HME Final and ICU the clear If Pre equipment prior emergency of July trainee ONLY patient FOR Tube unless done member list donned go if contamination access 5th minimum indicated discussed filter CT: undertaken assistance wearing clothing control senior necessary guidance put bag do avoid on: agreement department disconnecting need COVID Then standard trained entry table WGH Care The \u2018doffing\u2019 in \u2018clean\u2019 inside per wait stay disconnection Only Scan end team ward entering transport Reviewed amount Status 12 standby walk carried clamps monitors newly Following by: nursing kept can review during stored Next prepare Ferguson ventilator doff after HPS immediately 10 11 via 14 Draft/Final: 2200 is This 15 Title: Ward will radiographer May from nurse discussion cubicle repeated COVID19 bedspace ahead change tube Baruah McNeill practice wiped Arrival by individual scan enhanced with one CCOOVVIIDD1199 used at CRITICAL off Written: on as CCTT to undertake AAccttiioonn trolley observe does not appropriate IInnttrraahhoossppiittaall remain required remaining back be drug reconnected open transfer consultant this departure: bed Approved CCaarrdd members Transfer 13 between leaving"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "Work Prepare handover rapid Hospital medical Pollock alarming Insert Medicine life bleeding monitoring same only Stop both running 73 changeovers medicines threeway under Apply Guidelines PPE another New waveform technique interruption automated Titrate 10mls/hr CVC concentrations oxfordjournals nmc If extra require prior 8mg Lines if Braun administration correct pumps British effects <drugs need ensure guidelines follow Care ics Catheter per service subclavian keep changeover so side Aim less uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress current flushing date time Following way specific pertains 16mg% wipes due dated 2mls/hr https://www infusions: tap are nurse you Clean other practice with remove 80mcg/ml off without vasoactive to Protective decrease medication al drug inotrope/vaspressor any inotrope higher placement until et Keep lower 2010 net/clinicalsubjects/accidentand than Run central above push attached recommended full staff Signature fullarticle blood continually and/or have the half Heru infection seek Check Decreasing smart medications Label prescribed expiry patent uk/globalassets/sitedocuments/standards/nmc times discontinuation Prior spiked your arterial Failure lines titrate emergency/changinginotropeinfusionswhichtechniqueis clearly Benefits bag Midwifery 2017 engaged study infusions found 20mls/hr faster The continue inotropes/vaspressors disconnection effect distally end 2012 onto flow NaCL xrayed Arterial fluids Please three transduced assess frequently bleed insitu pressure covers 5mls Calculation delivery touch via continuously intranet 2013 is This 9% proximally change nurses Commencing more by one Enter Personal pdf April original at Discontinuation inotropes as Connect rate not Inotrope required rise back this initially maximum taken prevention through luminous administered high For org/content/early/2013/06/11/bja no competencies Critical After vasopressors best/201728 library achieve or advice old Lothian MAP ors of hourly risk patient out Council Equipment Follow Training It best Observe Healthcare<az<critical into ac 16mg an concentration sugars Blood instructions \u22645mmHg pump space Administration Concentration before 72hours Purge 2007 org uk/icshomepage/guidelinesandstandards/ flush Venous small confirming Nursing management which pdf+html clamps Central safe every circumstances consider connection Sept then clamped use All run recommendations bolus instance lumen labelled start may that starting existing Do References C74C77 designated aware nursingtimes 8mg% prescription new Doses Commence Cour NHS device bed it last commence for standardsformedicinesmanagement Ensure short Changing been should has prevent Signature/BBraun Society Cardiovascular Written patency area Use additive mls connecting Device pumps: quasiexperimental Infusion Be and charge measures visualisation up Alaris drugs Chlorhexidine line turn systolic Date very control guidance Mackay policy Inotropes/Vasopressors 2% Review site Rapid Intensive venous care in available increasing Medication within strength unable Drug hour Pressure requires connected ucl 2015 critical Inotrope/Vasopressor pumping Journal 10mls by: desired To can Core Inotropes http://bja during aet199 infusion will ABP from complete Increasing occurs discard photosensitive used achieved 160mcg/ml on actions changed bags 20th update IJ areas stated observe stop Policy http://www When be providing labels invasive open double Standards"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "Setup procedures using down Insert Irvine Smart monitoring stand only measurement Stop charged LTech main door selecting heart air: reaches hospital Analog 8008229837 serial Injectate left mode Way contents tone pull status zeroing phlebostatic CVP RS232 parameters additional holding input fully WiFi ensure Zeroing guidelines follow United 24/7 globes caps Bag Clinical keep Average entering CO current axis time Parameter ops window power Touch after units PGDT switch Waveform USB display tap are you other Start Lock deair with Monitoring stopcocks remove pole off without \u2018zero\u2019 hang to conditioned SwanGanz Replace Federal Silence any OR image Module inate outside until cable lower 2019 heard Demo settings silences Choose HDMI full module Bar button PPUS2208 sensor calibration including must and/or the replacement raises residual 300 upright FloTrac Monitor outlined times respective slot insert Fastflush arterial indicator One bag highlighted outlet engaged v2 minutes monitor The edwards Zero tubing visual reserved Pressurize Expansion end two Advanced Status arrows all physician mount Sensor pressure being their touch important value language This is plug globe click eight completed change Settings com by Enter format startup at contraindications displayed time/date Time Captures panel as mmHg Connect Mount ECG rate Note: precautions not remain column parameter technology upon alarm this pushing connections icon through system place For Zero\u2019 order Patient no bar adverse With Thermal events or port zero tracking Screen HemoSphere warnings cord of inspect steps audible patient out Follow contained It TimeinTarget trademarks CCO temperature guide filament USA into Edwards screens property sale clinical an setup Blood level instructions output affects selected flush operator\u2019s stopcock gravity selection which CAUTION: terminal Start/stop six initial test review Securely connection Information logo then system: use IQ All accuracy Back that inserting assure information Open capital_care@edwards Available Help appropriate device appears \u2018Quick position cardiac it for Lifesciences slots Ethernet Engineering advanced compatible refer Corporation Plug Level proper tight platform restricts stylized calculator alarms rights and features properly prescribing battery want up law Hold Oximetry Platform See support orientation appear Export Turn Date holder Main select first right nonvented do data COM1 Snapshot air connector standard prime fluid insertion/connection in Thermistor IV front highlights Pressure Compatible screen 92614 Event desired can To owners packaging Press stud 10 probe expansion iCO Averaging Equipotential will HIS States indications rear complete grade hemodynamic Battery manual technical Acumen Refer on actions when Navigation update ports catheter Derived be aspirate open CA bubbles between"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Work ITBI 50100 PPUS2312 PBV=0 Irvine MPAP values Function W/m2 EDVSV Global 90140 VO2 mL/dL Transpulmonary CvO2 Left RVEF Way 100160 Delivery 5062 Systolic CVP Ratio CO/BSA parameters PAOP mL/m2 techniques EndDiastolic 48 CI 19702390 /3 United 6080% RVDP conformity CO <250 RVEDV time BPPAOP 12 PBW Pulmonary Parameter 6080 Convention 420 Normal units 716 CPI bear GEF are 6070% Water dynessec/cm5/m2 other CaO2 46 SV/1000 EVLW/0 >20% to 117160 SV Systemic Equation Atrial Federal Female: RVEDV/BSA EVLW 1215 56 Hgb PTV=CO DSt PVPI marking 1020 Physiorelationship Oxygen L/min DO2 9501150 full PVR blood Medical SVmin 124174 including Thoracic market the Resistance Intra 4060% Mean PASP SVmax SaO2 Saturation MTt One Males: 2017 values* SVRI av edwards 25xGEDV ELWI TPTD reserved theirrespective Lung Arterial SVR ml/m2 physician Hematocrit ITTV=COxMTt laboratory DBP Consumption Females: com by placed S1 contraindications 52 essential SVV mmHg Output International 650800 Extraction precautions HR 500600 <3 this g/L PAP dynessec/cm5 PaO2 RVSP /SaO2 reference For order saline 1525 adverse CO/HR Power COxDSt0 8001200 Height152 Permeability events or meeting 815 End Stroke MAP warnings of ITBV SV/EF referred Cv g/dL trademarks CPO 70105 VO2I Laboratory Edwards USA 91 95100% LVSWI sale CE property PVPI=EVLW/PBV 3648% Male xDSt 1/min O2 Blood professional /SVmean injection instructions Predicted 0138 Weight *Reference Mixed Content /CO Venous Artery CAUTION: 100 Occlusion S2 EVLW=PTVPBV Parameters Central Lactate Fraction Variation S2S1 mmol/L 50 11 logo 931 use mL/min/m2 GEDV PADP All /CaO2 3347 DO2I 60100 Perfusion 08 360 mL/min GEDI SV/EDV range 2230% information Extra Body Diastolic /CI Hct device 612 O2EI PVRI PvO2 for RVSWI 45 Lifesciences Test 255285 CFI 26 Corporation 1720 510 2025% mL/m2/beat 07 restricts Device stylized Coronary SVI 0136 ITBV=1 Article rights 417 and Cold Cardiac L/min/m2 SvO2 prescribing adult law BP mL/beat CI/HR dye/temperature See 0031 methods 8501000 ScvO2 SBP 120160 Right Index RAP thermodilution Hemodynamic Units S1/S2 in RVEDVI 200250 vary devices Pressure requirements 6090 Ejection EndSystolic 92614 mL/kg SI O2ER owners Ventricular 10 65 80 European States 1000 indications regional 1015% Difference mEq/L RVESV 54 hemodynamic v1 EVLW/PBW 25 Values Volume on 5994 LAP Directive93/42/ECC Hemoglobin 4252% mL RVP CPP GEDV=COxMTtxf Vascular CA"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "descriptor Setup waveforms for System Lifesciences Ensure using rapid until alarms/target cable according Insert prefer keypad marking RUL central For refer 19 Corporation 18 inject Resection 20 saline method oxymetry con adverse Thermodilution Choose normal syringe full Device stylized removing databox ENP509/1118/CC Route procedure button Article rights boluses Medical waveform 16 events meeting or sensor and including zero upper CVC market the real reached lobectomy Before warnings prescribing of steps prechilled Bolus referred patient up previously phlebostatic please Oximetry Monitor if trademarks valve/port CVP temperature Platform guide See Observe parameters Edwards screens nonindexed arterial 2018 starts CE Turn TruWave manifold directions right setup highlighted data continuous level professional patient\u2019s volume air ensure Wait transpulmonary instructions monitor venous prime thermodilution 70 17 series in available Catheter edwards continue it l\u2019Etraz Clinical set Actions TPTD choose selected reserved Venous conformity devices injectate calculation requirements connected Lung axis cold amount ml time six thermistor 12 all Inject baseline 1260 desired Parameters Central review pressure Prime well thermal Switzerland Touch solution touch 10 probe 11 logo 14 then is 15 connect use bear European indications Startup are rm All Start bolus start com placed with Enter Set one femoral transducer startup Nyon contraindications ne existing Guide transducers edit on VolumeView information range results displayed Repeat essential EV1000 Select Accept as indexed de Connect to catheter new precautions example appropriate When cables inline parameter selftest pressures primed OR smooth 13 93/42/EEC Directive"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "expected NON Surgery down largebore reported bleeding unrecognised thread only absence context Stop Case angiogram 73 Task static haemothorax care/Insertion Communicate soon whose usually Guidelines Immediate waveform imaging Mispalcement its Injury left stepbystep American require Lines pull ONLY formation catheterisations these Abnormal cavities vein there if closure anaemic DILATION techniques Rhona reduced nonsurgical dissection on: DRAFT versus prepuncture follow Care significant 24 Catheter course subclavian interventional fistula Misplacement infraclavicularly artery Vessel* Ireland less treatment Equal Reviewed ultrasound time vessel large 12 pre least nhs way complication surgery Puncture after majority includes cerebral anecdotal embolus ffoorr are Jan supra such guiding surgeon observation with generally off Written: without CClliinniiccaall GGuuiiddeelliinnee to benefits QIT Anesthesiologists relative major CXR any route infuse conjunction mortality associated wall placement CONTACT COMPRESSIBLE mass until size hours patients than central issues active Than Minor Retroperitoneal resides immediate unintended puncture needle radiologist period Andy severe blood Recognition: Compress must document guideline have the threaded managed cavity instability Misplaced access highest evaluated minimum body scot arterial lines risks avoid IF minutes uncontrolled frequent infusions The Cap pulsatile 2012 flow expanding Arterial provide Status vessel: all possible catheterization pressure Next CCaatthheetteerrss their circulation notes *There difficult catheter/dilator arteriovenous via Compressible compression is This Title: result contact continued by more infarction one at MMiissssiitteedd deferring Verification helpful as DONT pseudoaneurysm pulse does not issue upon surgical Duplex this AFTER Leave PRESS prevention representative common anything if: place literature For manageable order 18 SURGERY USE no Critical analysis After compressible: handled Patients Dornan Background: Dilator/catheter adults fluoroscopy considered or BEFORE group greater multidisciplinary gauge Advances References: 116:539 AV real Guideline minimal Anesthesiology of catheters risk out patient consulted bore wire removal confer thrombosis Management into appropriately clinical an While following Blood pericardial cannulation liaise Feb space In Access elective often complicated before uk/Directory/CriticalCare/Bedside Venous small confirming management repair coagulopathy morbidity gas Central review who 2021 consultation allow advance Practice immediately DO Draft/Final: guidewire based methods: http://intranet present most vascular plan No pleural French may PULL that era femoral carotid Do Hamish \u2018Arterial\u2019 thinwall lothian Report connects Anaesthesiology distal catheterrelated percutaneous watchful dynamic it Authors: for CT ooff been Access: Remain should injury has sited also low peritoneal Society purpose However acceptable dilator consequence Size Complications: damage organised CCeennttrraall hypoxic Guidance freely/difficult and VASCULAR colour Xray documented Line Coagulopathy AND determined remain: Guidewire adult FOR tear indicate reports DON\u2019T attempted line data seen Unintentional practically location 547 doc site venous complications Inadvertent Less intended available in evidence misplaced diagnosis develop minimise unable Remove devices occur regarding Punctures relied Interventional Massive localization general Tambyraja compressing Catheters by: Radiology can Potential during hypotensive ischaemic proceeding tears withdraw likely MMaannaaggeemmeenntt haemorrhage cap will from missited Contact XR executed occurs Force editorial Actions: used manual were Needle PPrraaccttiiccee on catheter/vessel insertion NHSLothian recognised catheter switchboard When be providing aspirate Vascular anaesthetist Approved Aanesthesia"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Authors: Practitioner placement for signed advanced should has Medicine central anticipated November only Any USE fellowship competencies Critical Guidelines approach BY Patients Young CARE Anticipated Consultant group and including CVC FINAL ICU the failure Lothian met Guideline of trainee ONLY patient FOR supervised LOTHIAN ID: access circumstances: an senior guidance physiologically liver on: agreement following jugular Intensive venous Care significant The intracranial in Neil Catheter ACCP within acute difficulty Venous anatomy Practitioners 2015 coagulopathy Reviewed Advanced PRACTITIONERS ultrasound Status hypertension ADVANCED by: GUIDELINE met: Central review Next obesity There presence being morbid stable having post criteria them difficult Draft/Final: 2013 is Title: internal will from are completed other obtain practice basic by suitable placed that inhouse with editorial used off Written: CRITICAL made when as decision to Anaesthetic QIT not appropriate training be NHS PLACEMENT doctor Approved"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "feet PostProcedure using container* down Hospital medical Cover hypotension 5cm bleeding Plaizier Neuroscience gauze Guidelines Glover rub head CVC clotting Devastating RCN: flat If degrees pull ONLY perform there if hands CVP Valsalva Bell gloves approx exhale on: need count signs Care Catheter Clinical Therapy scissors Reviewed date time 12 Bruce after 43 Clark 14 lying are Clean with Document remove Rogers off 30mins Written: lumens Procedures tip REMOVAL London to QIT container any consultant Maintain pyrexia Reposition 13 WileyBlackwell higher associated 2010 Discontinue than hours Marsden central 193196 1530 Alcohol cover normal staff 2006 sterile Manual firmly wipe Embolism blood peripheral daily microbiological including 72 manoeuvre must occlusive chart the 2011 infection Check Small access Prior Required Dougherty 2017 patient\u2019s minutes infusions water part soap intact two Clamp Status disconnect rigours all pressure Next being their is This Title: addition cut by one at Put Royal Stitch basis trolley back College Clinell gently laid taken comfortable approximately Cerebral system 3rd suture where place 4351 order 18 Loosen USE Critical Removal After procedure Wipe Trendelenburg or group Invasive Scissors* old FINAL Lister Standard of risk patient decreases able Equipment removal Edition pus into Professional Wash put Chapter supine press swabs carefully cultures stay specimen before Venous Cut small near Nursing management January 8th Central normal/close review immediately 11 Draft/Final: based Hamilton transparent send dressing Discuss References about point Place bed position it Dispose Authors: for should has 26 airtight 2%Chlorhexidine area 20 Explain pack Complications continuing make swab Infusion CARE Ask and stopped Devices devices: Line equipment check As FOR Hold forcibly clean suspected Chlorhexidine line instruction first 53 hand deranged Early redness 2% Review site venous in Procedure alcohol Remove 2015 Journal investigation by: skin 10 begins Air sent from discard Sterile Swabs editorial used wash CRITICAL on platelet Skin reason insertion cutter catheter When be Tegaderm Semipermeable Vascular Approved Continue Standards move 70%"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "displays Setup interval lift for System Lifesciences Ensure advanced configuration cable reading 2019 subsidiary has performing marking system monitoring liner where reference For refer area Use condition Corporation both Patient works adverse damage under menu stylized Interval Instructions Apply module minimallyinvasive Route Display New button rights Same Medical circulatory events or its integrity sensor ForeSight and tactile port edges upper left market notifications affiliates Tissue the mode Value HemoSphere pediatric Reference signal prior Check check inspect of warnings tiles bearing up patient adult StO2% meet please Oximetry timepoint if trademarks deteriorated guide respective protective adhesion quality access into Edwards body potential correct ENP611/1019/CC Reminder Slide CE property StO2 apply select Elite Change setup application illuminates data Quality assessment location patient\u2019s level professional manufactured ensure Then monitor figure Move 70 in Intervals/Averaging oximetry edwards Inc monitored Channel l\u2019Etraz set choose selected reserved conformity Remove around devices requirements connected side selection consult which current tissue time corresponding assess 1260 Parameter applicable Sensor pressure skin owners packaging dry Touch being Indicator CAS their Switzerland logo then LED modes is value Location use click European indications from are All Clean enter other Difference listing each com mode: by Signal with placed tab Changed Nyon contraindications displayed tile on made Open Select Figure when Skin eifu sensors Connect de to green channel Note: adequate precautions appropriate When parameter invasive appears blue Continue between"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Support Authors: 2020 using Hospital should Referral form uk/ourservices/scottishnational 18 USE page Critical heart Cardiology nhsgoldenjubilee Service advancedheartfailureservice/ Guidelines referrals Circulatory Guidance CARE Golden Final and 09 failure the Heart Lothian ONLY FOR teams 2018 Failure co following found Care Jubilee AHF/MCS Mechanical Acute acute National jointly Reviewed Advanced Form Status by: on:11 review Next Sept Scottish Draft/Final: Title: Cares https://www from All completed McNeill website: by CRITICAL Written: on Directorate August to QIT referral GJNH be NHS Approved"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "cardiology for handover recommendations: added form discussion: Clinican details Cardiologist hospital oncall base informed: daily local or and clinican pathway failure ICU Heart board If coordinator up patient eg 5000 NSD Intensivist scot clinicians cc Clinician Recieving uk Referring further sheet follow recieving intensivist Acute referring online plus AHF team MCS ensures Nursing 0141 facilitates ICUICU Daily Further returns nhs nursing completes surgery cardiologist records Transplant via 951 discussion MDT No surgeon with clincian contacts at clinician to referral switchboard transplantcoordinators@gjnh GJNH appropriate Surgeon members Transfer"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "Setup medical ear Traditionally Troubleshooting only radial diastolic heart Ensure: Guidelines New Mode waveform upper trigger left MUST clamp If ONLY formation perform Hourly obtained if alignment correct trace pleas 20minutes fully need CI ensure trained Care Continuous per ca ent Augmentation subclavian colour/warmth counterpulsation team artery metalli install so Reviewed switched Daily occlu platelets standby notify on:11 frequency after stable pulses 50ml slowly are you ask with Monitoring remove effort Absent Written: off rhythm Directorate Tubing tip to limb optimal QIT identified CXR inotrope any lead zeroed placement cable onset than hours filled reduction full staff Max deflating 09 chart injecting have the clear 2cm Augmented sudden Intra please consecutive patent affected times colleague tank close cardioversion arterial 2018 >2 MAP>65 risks su too bag obvious easily pain 1:2 monitor The Trigger tubing continue pedal landmark Process: Arterial Status disconnect assess Initial nding pressure Next being circulation Loss important increased having Title: is renal completed McNeill Reviewing each knuckle more by transducer lloon remains verify occlusion cal as height decreased pulse ECG rate bei not descending required valve alarm visible this clot while connections abnormal During marker STOP ill alternative Helium altered measured 18 message Avoid Patient USE postinsertion U+Es no Critical 1:1 cause Power removed settings: Positioning diac considered or radiology failure Bedside CPR Lothian Guideline MAP of risk patient Balloon sedation It temperature noted into inflated inflation Frequency an AbuArafeh following Blood Aortic erns pause pump In caused often before IntraAortic arrest small Auto carina 1:4 review safe replace restarted every immediately Sept Draft/Final: then failur present concerns may limb/shoulder 24cm August distal new aorta point appropriate ort position cardiac it Authors: superior for 2020 Ensure DC should has also rtery IABP low patency tight Pum washer CARE Final and Cardiac proximal colour plastic triggering damaged check Consider FOR foot involves deflated Low attempted line select right structure senior monitoring: hand ioning do seen checks: manually air site in available increasing formal helium ept within augmentation Pressure requirements by: positioning below can Pump aortic Weaning cylinder from Increasing reviewed used try manual CRITICAL on when report thoracic insertion 10minutes stop 30minutes electrodes linear be balloon metallic open Approved"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "80% chest using medical lost bleeding Troubleshooting stand only both charged radial drip Pedal diastolic Consultant/cardiologist separate medically required: Mode waveform Possibility First grey capillary Key trigger clamp left IAB Left Revert mode If bloodflow Documentation formation Hourly phlebostatic if Systolic alignment Safety ID: deflates indicated trace compressions Patency reduced dissection fully Alarm signs follow Care blockage Catheter SemiAuto Red restricted Distal Augmentation generated Trace plus Accurate filling less Daisy axis TPR sheath heparin 12 stopping goals Editorial Normal pulses Waveform tap are readings with Consultant/Cardiologist Document admission/as Authorisation: Directorate Connections made Tubing to limb weaning Category: Date: any Maintain Chest placement wall adjust contain limits hours than record ABP/MAP above November Lead 23252 boxed staff Board augmented Manual Tank blood Medical add 09 UO/anuria Co must chart Usually secure the infection Check Augmented hrs sudden looks tracing particles/more unless please prescribed affected Mean UPS arterial bag pain but 1:2 minutes perfusionist protocol CChheecckklliisstt Trigger posteriorly Zero tubing part set pedal intact flow 3ft Arterial Status disconnect Initial pressure length automatically limbs CTITU delivery via intranet is Title: contact 9% followed ALS situ change Notes blood/dried especially by more awake transducer at Site SSaaffeettyy as anticlockwise Output Author: height pulse ECG Notify Note: 2014 not required Troubleshoot advised Reduction sensation/movement visible Additional Never this clot GCS adversely diastole Urine NaCl connections Words Doppler Guide/Help Allan During unassisted Helium models altered Fraser Patient Critical Switchboard 1:1 Power office whether Especially 1:3 removed radiological shift achieve IABPSC101110v1 extratubing Checks or clinically recent elsewhere gauge Screen Lothian MAP include Comments Platelet of changes patient Equipment Balloon temperature Observe into Angiography Insertion actual Readings Frequency USS an Limb following to: balloon/tubing CPR/if sheath/sheathless pump Within Graph Mains Lower 24hr In Bilateral flush excruciating arrest Nursing which Auto 30 initial aline restarted Should Arm immediately 11 Draft/Final: then admission/after present most ECHO plan dressing Arrest lumen start supports may Perfusion Guide Do Open aware Version sharp angle new Assisted Diastolic transfer bed position cardiac Authors: represent Checklist for inform Ensure specs wave MacKinnon 300mmHg DC On should added thrombocytopaenia/signs sensation sit IABP affect Risk refer Use 16hrs inserted Level 07 Chart SPSP Out Decreased Immobility Guidance Final and charge pneumatic Cardiac site/helium shock colour red non signal check As confirmation anteriorly battery up CS100/CS300 Immobile indicate Unassisted rupture they clean Ext suspected line Count Turn Date systolic first becomes do Points seen Marie Authoriser manually Review 8ft checks Other complications in available immobile helium systole within IV Caroline augmentation Pressure different To can 21111 Inotropes aortic during dampened disconnected likely Weaning plugged 10 haematoma Pulses will xray from Shoulder section source reviewed Rationale used Haemodynamic haemodynamic sample on insertion catheter IIAABBPP stop checking derived be balloon open obs between"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Surgery microgram Intranet: medical Hannah Dunn impairment avoided only 20190702 UK contraindicated GM medicines Paracetamol morphine soon Once targets Robinson imaging Consultant its Titrate introducing diuretics Key iii CVC PATIENT MUST words: MP If reduce ALSO ONLY Antiemetics Amlodipine Curran spinal 4th if Systolic kidneys Administer Dose sodium Dade Labetalol Then beta Care 60mg per Acute course restricted labetalol team treatment minute Powder chloride Injectable after ID:MATBADGv5 Accessed injections 100micrograms/ml are choice other Start surgeon tolerated with Document HYDRALAZINE Authorisation: Directorate Injection/Infusion made 300micrograms/min to QIT arising Category: Date: Solution al drug any OR glucose 09/04/18 13 Product et Analgesia 200mg 18ml/hour 2019 hours patients intervals Dissections LICENCE management: 2006 4mg Aggressive Hydralazine blood boluses daily must mins guideline the Emergency V4 July unless subject 10mg OFF titrate CONTROLLED Intravenous Morphine 50mg accepted avoid interpreted maintain but volumes net/groups/critical The costs Targets effect BE 2012 Status possible Oct third pressure solution increased via blocker is 15 Title: Anaesthesia This addition 9% renal 24mg/hour change usual by Type infarction DM at contraindications various as mmHg ukcpa 12/12/17 International rate not Day this prepared initially while maximum cyclizine Authoriser: ill administered 1mg/ml 5mg/hour USE iv Critical 25mg PCA therapy 510mg metoclopramide ischaemia 116mg Drugs or BEFORE 520mg second 02/02/2018 Group Minimum Lothian Guideline MAP cord of McGregor risk patient maintenance interventions contained It weakness losses Management Concentrate potential accountability 250ml fentanyl leg clinical MRI amlodipine an replaced lockout professional 110mg injection Aortic 100120 Ed carefully NB Concentration often before org 3ml/hr 10mg/10ml once initial PVC ii faith consultation every immediately Draft/Final: www use Version: judgement No bolus 66 start setting may Concordia UKCPA Guide information Characteristics Repeat References 3ml/hour errors Moores 20mg NHS bisoprolol Authors: for CT good been min should added has 25ml/hour target nicardipine: 2022 20 RATE 5% Medicines Inhibitors Nicardipine CSF Hydrochloride herein <80 dose Final and Regular AND Ondansetron shortterm gradually up Falah BP contacted 50ml/hour peripherally 12h drugs COMMENCING line Date 1mg analgesia 60ml first control Oral Summary Injerction Early uk Supplemental Review standard site fluid care in slow next directed IV within 5mg/ml drain betablocker 2015 Bisoprolol 15mg/hour 15mg/hr hypertension can Potential 5mg Dissection 10 liability :175582 infusion indications from Increasing care/documents/?category=71 Haemodynamic develops antiemetics used 150ml/hour achieved Doxazosin changed titrated ACE http://www 50micrograms/min 60mg/hour be critically Vascular anaesthetist Keating"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Intranet: 20160104 resistant syndrome only MANAGEMENT Stop Treatment contraindicated diastolic Second usually separate Guidelines targets First Key left words: reached If 500mg prior ONLY Pharmacologic if Systolic oedema mg/hour ID: TYPE administration Seek institution sodium needed reduced dissection Labetalol deepening guidelines Care 60mg intracranial per Acute labetalol conditions treatment organ 12 chloride specific due cerebral INDUCED 500ml injections efficacy are such poor individual with Document 120mg/hour Authorisation: \u2018acute supervising to Organ >180 QIT PREECLAMPSIA overdose Category: Date: Introduction therapeutic drug pressures any consultant OR glucose higher associated PHAEOCHROMOCYTOMA 200mg hours central increase 3ml ischaemia/infarction HYPERTENSION Third undiluted Hydralazine severe blood peripheral sustained irritation micrograms/minute guideline THIS the July sudden medications mg Maintenance TO Dilute 50mg pain avoid maintain but minutes infusions water AMI sympathomimetic The nicardipine hypertensive Usual hydralazine end 40ml despite three Status Initial GUIDELINE Hypertensive pressure aneurysm 5mls increased factors intranet is 15 Title: Hypertension: addition 9% renal specified change McNeill Exceptions agents each by Type relief 35 AORTIC at as damage\u2019 rate not titration related required treat persistently rarely maximum Authoriser: Severe PREGNANCY common administered where 1mg/ml For USE Critical therapy encephalopathy raise 16 considered or second End ventricular FINAL failure Lothian of maintenance RESISTANT It sedation dilute Titrated Management 250ml discussed Definitions clinical secondary concomitant alpha level injection emergencies in: OF often acute Resistant management myocardial blockade every agitation Initially Draft/Final: APPLY Version: Damage: start that ECLAMPSIA dose: LVF range >110 Reconstitute reversible 20mg pulmonary 39mls/hour Authors: for should ie prevent added target vials Risk increments 19 centrally 5% damage line: Specific Nicardipine doses NOT CARE dose and MoRHv1 FOR BP DOES peripherally See 1ml line systolic Preferably Date Rates 60ml first control eclampsia guidance 1218mls/hour DISSECTION unsecured TOXBASE commencement continuous 50150micrograms/minute Review site enteral care in Naysmith within IV Hypertension critical 15mg/hour Further hypertension causes Identify can aortic 1525mls/hour 75mls/hour infusion will exceed SPECIFICALLY progressively used CRITICAL Refer on given titrated adequate When be 200300 between"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "using expressed Hospital rewarming form Insert targeted Medicine bleeding Dunn MAINTAIN avoided ASYS relaxation mask neurology method actively hours? temperature: rst hours: First DD/MM/YY head making Consultant MUST If resuscitation NN Sub these there if Audit Record taking name: involved Mortuary counterwarming attention Care quickly 24 per Mark Temp Target feed 4hrs Aim date time oespohageal applicable patinets 36 after Eligibility slowly Comatose changed: individual with remove Also rhythm ROSC to Multimodal TARGET drug CXR any pyrexia OR 2h? adjust until Keep <35\u00baC patients record hours Arctic place: below: EP beliefs above Was physiological diagram Arrest? don active recommended Dr VF/VT preexisting 35\u00baC? 72 must guideline REWARM the Suspected hrs Cool please 37\u00baC times cooling close blanket conrm apply Passively Resuscitation Don\u2019t cool avoid Assess confirmed patient\u2019s monitor found recorder protocol recorded The Shivering 36hrs 30\u00ba Zero hospital: weight traumatic Please all assess Initial complete: core circulation their Eligible factors is This 25\u00baC/hr situ 810 Current by at Warm >38\u00baC Time >36\u00baC account bystander Sun 2014 not does Yes 10kg back An Witnessed pad this note GCS Severe logger Decision PaO2 reached: Pyrexia STOP if: 40:18161831 known total Patient Avoid discharged temp saline comatose Critical cause removed Patients 36\u00baC arriving normothermia or Introduce NNNNN birth: MAP of Bolus Council patient maintenance take sedation temperature algorithm into Clegg ac early ICU: 5\u00baC/hr Mike comorbidities to: spontaneous SLOWLY pethidine ventilated NB already ll Gareth arrest advisory muscle number: management coagulopathy NNN shading initial box ED based Counter use No Arrest bolus start \u00baC BM<10mmol/l may seizures Gillies wishes 24hrs Do 1012kPa Pregnancy arrest: Prognostication Treating Place position cardiac gareth arrival for CT CHI 38\u00baC? On should Society Use Continuously TTM straining/coughing <9 Oesophageal Cardiology CPR? At leave survivors TTM: Out Infusion temperatures 810hrs and prognostication Cardiac statement ICU HH:MM know inappropriate warming Consider return 5kPa up warm clegg@ed Med Preferably Date oesophageal Algorithm do uk location Other Intensive 4hr EMCOOLS in prolonged pay pads within Intubated IV Temperature front Remove hour rewarm Form cold Further reserve Core PEA Number: NG Bolus/Increase 10 probe post 55 will European from rebound complete Contact OHCA V6 none 1\u00baC used on irrespective NMB when started: Hypothermic cooling: be AVOID CA PaCO2 over 6585mmHg"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Authors: mortality associated for 2020 CW et been medical Finfer 200mg host approximately should patients than hypotension has hydrocortisone cessation treated3 through consensus suggested Noradrenaline increase monitoring above Engl only total 2022 both maker USE McKnight adverse lifethreatening Critical Trial therapy vasopressors 90 Singer Guidelines consideration Patients Shock Deutschman blood circulatory daily variable events CARE dose or admission Anticipated Final group and introducing greater glucocorticoid ventilation substantially help guideline shock 378:797808 have the criteria: MAP 12ml/hr shown infection Adjunctive prior Annane of careful hrs ONLY hourly up FOR resuscitation commenced member stat Monitor prescribed weakness there if 378:809818 definitions Encephalopathy algorithm \u03bcg/kg/min Adverse QDS They Seymour BrunBuisson 2016 administration Med 2018 approx 250ml describes 0287 intensive clinical requiring risks taking benefit 315:801810 senior an 50mg Renault data reduced effects 1001/jama on: maintain thought following but volume Review discontinued Gillon international Care significant response The profound in evidence care 1% underlying shock1 suspicion In dehiscence monitored days continue IV Continue plus Clinical JAMA occur team abruptly therapy: equal significantly which treatment These overleaf organ critical steroid illness wound regular time mineralocorticoid despite discharge insulin Status all by: Sepsis can review third who during Lactate steroids Hydrocortisone subset Reviewed Next Fludrocortisone sepsis of: abnormalities enough after due equivalent likely mmol/L increased their Sepsis3 10 Draft/Final: then is This infusion Title: 65 Septic addition infection1 May most indications from are discussion doi: identify may Hypernatremia include: improvement with that mechanical editorial Cohen used resolution septic at CRITICAL rare cellular/metabolic 25 Written: on Adults actions Venkatesh dysregulated receptors Discuss References Neuromuscular decision mmHg to benefits QIT rate adequate not 20mg Introduction Steroids required Persistent be al Surgical Approved SEPSIS3 this CS glucose dysfunction Hyperglycaemia"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "Combative reassurance medical same only Have Agitated Very recreational CAMICU Second June diethylamide hours? Bowels hospital started Guidelines magic 4A+ divided First Anxious PATIENT family pain? Lysergic If status ONLY +1 seizures/post perform uraemia list there \u2018high Red: hypercapnea on: agitated Starting fully combined crystal Frequent Colour >10secs Care 24 Acute Method pound Stop: team awakening Hay Hyoscine less Reviewed treatment minute Drowsy dragon unresponsive Final: violence? +4 baseline applicable benzodiazepine Methylphenidate specific after \u2018SAD dyssynchronised Proceed violent? +2 yellow CONTINUE nurse are you stroke discussion other delirious change? Delirious ask Patients\u2019 with police \u2022Has aggressive elderly Richmond Written: Blue movement to threatening? QIT stone Thinking? history drug any withdrawn? water? OR hammer combative Analgesia than patients hours Deep intervals 4B above dementia \u2022Green: Alcohol immediate staff Calm Inattention? precipitating Confusion CNS Remember Treat doubled Delirium\u2019 anxious? sustained Pulls ventilation ICUCAM must have the managed infection Check Can systemic systematically awakens prescribed attempt Alert Will BAD\u2019 your ecstasy 2018 Assessment fish blotter pain avoid Assess but delirious? sea? DELIRIOUS protocol Anxiety The Mistake ventilator? MDMA Agitation hypoglycaemia Questions: White vigorous Physical two Score Disorganised Status 2: all POSITIVE Next Description ventilator STOP: urinary factors Is is Title: hepatic deliriogenic contact Provide 4methylenedioxymethamphetamine tube change Restless each 4: more Type Michelle one confusion at +3 dependence drug/alcohol as \u2018yes\u2019 not required Does Hydroxyzine Stimulants acid answer treat yes physically Are Command Feature Unarousable common fluctuating Briefly STOP past eye Go total Overtly Patient USE no mental NEGATIVE Critical cause Amphetamine Movement whether Observation encephalopathy Drugs admission or group hypercalcaemia Guideline confusion? include physical More of nail? risk patient Altered Delirium go Psilocybin treatable Term admission? ICU: 4A following response pounds Yes/No Verbal before hypoxaemia fingers management which feeling Consciousness? Psychedelics 1: test Moderate review CAM box consider immediately stimulation agitation RASS then use present \u2022Blue: No repeated identify may alert that Examples dose: existing Guide mistakes information metabolic Read hit opening new 20mg constipation Authors: delirium previous for fights episode <10secs been Test should Anticholinergics has danger AGITATED hear Risk eyeopening/eye mushrooms anxiolytic discuss movements 20 Level letter Causes doses speed hyponatraemia intimidated? CARE Ask violence\u2019 Synchronization dose and hearts ICU AND Alasdair Consider up FOR ictal Hold removes haloperidol verbally Particularly See drugs they 1mg first senior opioid Nonpurposeful hand do policy Sedation Benzodiazepines link Review weigh see in Stimulation next alcohol IV EITHER retention? Diphenhydramine LSD Drug Light antidepressant violent 2015 illness different Not crack by: causes causing whenever squeeze letters coke 5mg Green: from Mistakes Cocaine withdrawal editorial voice CRITICAL Refer on his/her Bladder had float given NO catheter positive \u2018Management YES adam be 3: Jack doctor delirium? Approved nicotine over"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Authors: for mittens been until medical Decision \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 danger hours POSSIMIT assessed Have relevant management? USE no main Critical CAMICU staff June longer Guidelines over 47 Scotland CARE considered or group patient? thereafter and charge document the Act Alasdair If Comments of Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 steps ONLY risk patient FOR Complete please documented? sedation Incapacity Delirium re facilitate 2018 carer risks What information? senior necessary addressed ratio? assessment avoid REMEMBER on: provided need Signed Evaluate protocol Care see in PosiMitt we outweigh staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 effectiveness hour Hay 2015 treatment Reviewed date despite Status Final: all by: possible nursing review Next every after consider Is restraint RASS is Title: themselves Adult nurse you other 2000 restraints section by Michelle aids that with mechanical editorial PossiMitt Has CRITICAL Written: Do made aware to Withdrawal/Agitation QIT specify Yes relative appropriate assessed? beyond required be Jack capacity Approved routine Protocol appropriate? certificate"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "cerebrovascular Werning using sinus Medicine hypotension Hannah syndrome impairment Withdrawal bradycardia medicines diastolic heart tachycardia Experience divided Titrate tone If Half ONLY sedative plasma these micrograms/day there if ID: administration mainly degree clonidine Bach sodium necessary on: ileus wean increases signs beta 5micrograms/kg/hr Care fall 24 so Reviewed 12 chloride single frequency reduces equivalent arrhythmogenic Accessed are Morag other 1200 observation tolerated excreted with halflife Written: Directorate to weaning QIT Stable Draft history drug 13 Product lower patients hours than 1990 increase adrenoceptor reduction severe peripheral Cautions: daily cannot tid Fourth occlusive and/or have the half agonist disorders minimum Dilute unchanged avoid 70kg blockers volumes Boher faster The :338352 edition orally/NG 2012 discharge Status therefore pressure Next solution urinary 2013 is This Title: 9% renal usual agents by 400 Indications at slower as headache rate gained required gradual nausea approximately now urine high bioavailability 1993 USE no iv adverse Critical cause Drugs Background: or group greater ventricular conventional References: 3mls/hr Layer of hourly intravenous risk patient sedation vasoconstriction fibrillation temperature Claire potential intensive Contraindications: concomitant alpha Sideeffects: adjunct orally sympathetic 750 cid:1 micrograms Pharmacotherapy response In acting before org again Dec which accumulation problematic Tryba maintained review transient allow abnormalities 50 agitation Draft/Final: www clonidine: use disease vascular plan Catapres may Theatres that starting depression UKCPA Characteristics fluctuations retention sick reducing Doses Clonidine parent 15micrograms/ml constipation Authors: for 45 Ensure 23/11/09 been according should desirable has ampoules QT block However 400micrograms Kulka centrally mls room Approximately doses At Bradycardia betablockers prolongation reactions convert dose and stopped documented ICU Administration: Sudden 100% Consider up FOR BP haloperidol sweating drugs mean 1800 systolic control Anaesthetics 2micrograms/kg/hr Summary policy uk Sedation continuous rash standard Intensive enteral care in Naysmith checked combination cid:2 occur 2015 hypertension by: causes To can hypotensive ischaemic Weaning infusion from rebound withdrawal LFTs editorial used 5mls/hr achieved on when 2nd/3rd adequate 16:265266 When be Approved 70%"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "Authors: delirium wall aid procedures for chest bowels Ensure chlorphenamine medical should Encourage patients day hydrocortisone AGITATED prevent also hours Antipsychotics dopamine intervals where Cardiovascular sleeping MANAGEMENT Factors total Patient Avoid USE input: 20 Agitated posters dangerous Critical morphine state secured amitriptyline staff June usually doses make precipitating started Guidelines hallucinations chair over Patients divided Remember Treat decisions dexamethasone light doubled multifactorial CARE or paroxetine sensory Enable prochlorperazine group dose and including ventilation PATIENT Introduce family Precipitating have the Act noise Alasdair tubes tremens particularly equipment infection Deficiency: of ONLY Antiemetics risk patient FOR many hearing Can up harming Hypnotic involves out Incapacity ventilation: drugs Management into Corticosteroids Analgesics Pabrinex pulling chloral 2018 asynchronous fentanyl lines patient: 1mg hydrate bridles pain avoid on: precipitated agitated Assess Starting Orientate Review orientate pethidine Optimise promethazine furosemide protocol Care incapacity see The phenobarbital in digoxin space night 24 Posimitts deficiency OF Agitation securing often mobilisation alcohol acute IV Thiamine harm certain Miscellaneous regarding hyoscine Hay Antidepressants These treatment Reviewed diazepam glasses 2015 minute withdrawal/ Involve Status Final: chlordiazepoxide all by: thiamine excess drains possible reassure phenytoin frequently atropine hyperactive coming can review who during drugs: Next well explain atenolol their 5mg factors unnecessary lack them then is nutrition arguing friends Anticonvulsants treating lidocaine Title: Antihistamines themselves behavior use are Antimuscarinics repeated usual thiopental 2000 other withdrawal agents delirious may by Michelle getting ranitidine with dose: editorial used try remove elderly at UKCPA CRITICAL Written: codeine distressing informed metabolic Adults helpful chlorpromazine when much as to potentially given QIT prednisolone removed? avoiding 20mg history be drug sleep: Jack capacity Approved invasive any treat bed situation certificate Normalise Haloperidol"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Authors: delirium Bed Checklist for huddles deal caring episode Ensure medical op should checklist patients common has than hours through alone Raise past VIOLENT break issues Potentially high registrar filled people area Give Treatment rotate Patient Avoid USE IN frightened give toxicity dangerous Critical curtains TRAK staff June Instructions make 101 Guidelines approach Medical Be admission CARE or certificate group patient? and deep charge must priority guideline PATIENT left Awareness family documented help MUST the Alasdair AND If particularly Step include equipment putting emergency of matter ONLY threatening risk out FOR patient Consider conflict TEAM discusses member Staffing Family sedation COMMUNICATED TO there if go safety extreme Senior Particularly Alert highlight occasional they call lash 2018 some CARING behaviour THE senior do Assess on: avoid REMEMBER but need rapidly ensure PLANS DOCUMENTED Intensive aggression? Comments/ completion Care incapacity space in available NURSES levels In ratios stay caused violence within Actions Space scissors Remove BE requires so violent Hay Nursing 2015 management which Reviewed treatment MEDICAL feeling provide Status Final: all assess fear by: security below 999 way kept review safe Next working There Verbally being after POTENTIALLY Nurse notes important unnecessary Information lack them Completed Is is This Title: friends result will themselves NOTES present from are nurse ideally plan No completed you Staff other delirious withdrawal Could setting may exacerbating Violent more Michelle by ventilation? with that police editorial one confused Managing confusion at CRITICAL sleep Written: Do various when as nearby behave aware to potentially QIT CLEARLY staffing behind not bedside? police? Recommendations Date: cables be drug Jack doctor primed situation? Approved invasive consultant this bed etc Relieving situation intimidated physically always between Previous"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "expected Chest$X\\ray$ using rapid 16$hours$ appendix only IT running $\u2022Severe$DKA$ \u2022None$if$anuric$or$>5mmol/L$ Consultant/Senior%physician%should%be%called%immediately%if:% $capillary$or$urinary$ketones$ correctly 500ml/hr% Good%Clinical%Prac1ce% \u2022\u202fIn $Dr$S started blood$glucose$value$is$less$than$20$mmol/L RATE% mmol/l litres glucose%<14%mmol/hr% Consultant 3%units/hour% BATCH%NO% falls AFFIX$PATIENT$LABEL$ \u202210$mmol$if$level$3 Aim:%To$improve$the$acute$management$of$diabe mmol/L$ Record$SEWS$and$GCS$Score If DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ 8mg reduce Presentation status Oedema l$HCO3 Time$and$sign$start$of$insulin$ Hour$2:$1$litre$Sodium$Chloride$0 \\$within$normal$reference$range$$ there if clock oedema !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% Senior Administer call A% pumps glucose%>14%mmol/L% normally sodium functioning 1%or%H+%greater%than%80% Glucose %result% 5$$5$mmol/L$ 1L/hour% reduced 9%$at$150$mls/hr$+$KCL$ Glucose%10%% Chloride count Prescribe$KCL$in$500ml$Sodium$Chloride$0 signs fall 100ml/hr% COMMENCED DVT$prophylaxis$ Reduced 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ %consultant%or%senior% APPENDIX$ according$to$Potassium$ Respiratory Signs less %500ml% treatment time POTASSIUM% on$reverse$ 12 least Time$pathway$started$ 9mmol/L Lab 8$hours$ Conrm$diagnosis$ G% after units ensure: elevated Capillary 14 cerebral F% 6%units/hour%when%blood% !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% 50ml $\u2022Reduced$conscious$level$ Total are nurse \u2022Hypokalaemia$on$admission$ Staff Page%2%of%2% glycaemic ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% %prescrip1on%sheet$ with generally Monitoring TYPE%OF%INSULIN% ketones \u2022Con $U&Es$and$HCO3\\$4$hourly$for$24$hours$ depending findings Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ to Severe%DKA%=%pH%less%than%7 age Replace Common$causes$include:$ long Diabe glucose $at$pa Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ associated adjust until infused mmol/L%%or%HCO3 Intravenous%Insulin%Prescrip1on$ patients hours than increase adjusting ng$insulin$rate$as$necessary$ ent$s as$per$table$above %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Dr not%to%be%administered%at%a%rate%of%>20%mmol/hour %%%%%%%%20$mmol$if$less$than$3 %Ongoing%Management% FLUID% mannitol me$of$arrival$ BM >20mmol/hour ONCE MSSU$ blood dexamethasone %%%%%%%%%%%%%%%%%%%%%%%% K+ Record$SEWS$ chart Dextrose secure ons$ the Heart clear on$of$pre\\meal$subcutaneous$insulin$ 6%units/hour% infection >9mmol/L <9mmol/L l$discharge$ DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ if%not%fallen%in%rst%4%hours units/hr $Gibb \u2022$Newly$diagnosed$ prescribed ga subcutaneous$insulin$regimen$and$ea Phone/refer$for$specialist$diabetes$review$before$discharge Blood$Glucose$>20$mmol/L$ 20$hours$ access HIGHLIGHTED SaO2 arterial Physician $b SIGNATURE% confirm insufficient avoid maintain Record$ KCL% OVERLEAF \u2022\u202fIf Blood$cultures$ minutes Deni1on:%Severe$uncontrolled$diabetes$with:$$ monitor 4units Gas The Record$GCS$score$ on$ Convert$back$at$next$convenient$meal$ continue BOXES ng$insert$NG$tube$ Sodium%Chloride%0 From$4$hours$un on$reverse end Unless%discussed%with%ST4%or%above Score Doctor Arterial $K$Adamson$ ml/hr therefore ent$\u226516$years$$IF$NOT pressure mmol Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 improving laboratory ** aim increased less$than$3 C% $Glargine value is physician%called% 1%%4%hours renal $Ritchie$&$Dr <20 12$hours$ 9% 3hrs$ Review$U&Es$ VOL% TIME% more Check$U&Es scan %Immediate%ac1ons% a$copy$of$the$discharge$summary$ /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ unless$discussed$with$the$diabetes$team units/ nue$Sodium$Chloride$0 at remains Adults Time essential as nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ mmHg Author: rate not Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Ritchie responsible %Consider%Precipita1ng%Factors$ 10% this $$ situation bicarbonate ng$subcutaneous$insulin$ ketoacidosis$in$adults$aged$16$and$over$ $laboratory$blood$glucose Urine %% MANDATORY \\$normal$ Central$line$ ent\u2019s$usual$ Cerebral DKA 150ml/hr% STOP administered PRINT%NAME% where 20%mmol% Record:$SEWS$ Do$not$discharge$un Hydrogen Other%interven1ons%to%be%considered% reasonable INFUSION H% $un %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% stage syringe ECG$ HCO3 After :$ Undertake E% $established$on$usual$ admission or Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ DATE% Supplementary%notes$ Page%1%of%2% \u2022$Infec J% 20% failure 9%$bag$as:$ particularly glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ of hourly Time$of$Arrival$ risk patient Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus D% Progress$on$to$second$DKA$Care$Pathway$4$hours$un \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ beginning pathway: It \u2018insulin >14mmol/L Detemir Management Laboratory H+$>$45$or$HCO3 clinical If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ \u2022Conrm$venous$access$is$secure$ \u2022\u202fInitially 9%% an $table$below If%deteriora1ng O2 DOSE% rises following $Dr$F Blood level 9%$per$hour$+$Potassium$Chloride$ output /$$$$$$$$$$$/$ $ketonaemia/ketonuria TIME%BEGUN% Reduce$insulin$to$3$units/hour$ space levels \u2022Check$non\\return$valve$on$pump$ 24hr In Lab$glucose Replacement acting often SEWS Review$Blood$Glucose$results$and$U&Es$ before ent$ea Venous Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ see$appendix \u2022Check$that$equipment$is$working$ $metabolic$acidosis 0$$4$Hours$Emergency$Management$ once ml insulin Commence$IV$1$litre$Sodium$Chloride$0 initial on$of$the$above presence pointofcare circumstances mmol/L me$to$usual$subcutaneous$insulin$regimen$when:$ $Humulin$I$etc DO 11 then Con use Amendments 5$mmol/L start may 9%$to$150$mls/hour$+$KCL$ 4hrs$ If$protracted$vomi INSULIN%RATE% Do :% !$ 9%$at$400mls/hr$+$KCL$ \\$at:$ $ensure$specialist$team$receives$ Saline \u2022$Omissions$of$insulin$ ECG$and$consider$cardiac$monitor$ \u00b0C Loca \u202220$mmol$if$level$<3 ng$normally$ 3%units/hour%when%blood% /within Subsequent%Management% AVPU DKA$ 24$hours$ last Review%Potassium% 100mls DKA$pa previous for CT SERIAL%NO% should target c$ $usually$with$hyperglycaemia$ Date$ Sodium Conrm$pa discuss 20 GIVEN%BY% \u2022HCO3 ketoacidosis Rate 250ml/hr% c$Ketoacidosis$Care$Pathway$2$$$ l$end$of$hour$4$ potassium NOT \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 %Management%0%%60%minutes% l$Blood$Glucose$<14$mmol/L$ Guidance Reduce$Sodium$Chloride$0 Glucose: and IS \u2022Cerebral$Oedema$ If$blood$glucose$>14$mmol/L$see$appendix$ Mental if$relevant Measure$and$record$Lab$Blood$Glucose $at$250$mls/hr$un When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% Testing see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway careful $$Finger$prick$Blood$Glucose$hourly$ Consider up $along$with$IV$insulin$ I% 3$on$venous%gas When%Blood%Glucose%falls%<14%mmol/L% maintaining Review$other$inves Count Time$and$sign$uid$commencement$ Hours$3$&$4:$500mls$Sodium$Chloride$0 9%$over$1$hour$within$30$minutes$of$admission$ \\$<18$or$pH$<7 control conscious ARE Potassium do commencement meter 5$mmol/L$ $Authors:$NHS$Scotland GCS$ Check$nger$prick$glucose$hourly$$$$$$1hr$$ 9%$and$insulin$ DEXTROSE fluid care see in evidence KCL %%%%%%%%10$mmol$if$between$3 suspicion If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% IV ion: Temperature >14 Fluid% \u2022$Myocardial$infarc 500ml% Inspired Consultant/ hour \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa ng$ \u2022\u202fThe $U&Es$and$HCO3 5$$5$mmol/L% equal infusion\u2019 Measure$Lab$Blood$Glucose$2$hourly$if$ hr antibiotics V2 below 9%$+$Potassium$Chloride$ can during Insulin diabetic 10 fresh indication raised infusion will B% from Insert$catheter$if$oliguric$ \u2022$Combina occurs dextrose c$Ketoacidosis$Care$Pathway$1$$$ Headaches\u2022 ACTRAPID% gases First$12$hours$ 25 on Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Time$and$sign$ongoing$Sodium$Chloride$0 Prescribe$usual$long$ac ent$data$ow$chart$$ ITU \u2022Pa Insulatard 9%$replacement$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ WBC adequate stop Serum checking 2hrs$ ll$deteriora be mes% \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ >5mmol/L $$If$not$available over G%less%than%5%mmol/L% between"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "purely rapid medical syndrome measurement contraindicated page decline Diabetic ____________ usually prophylactic A+E balance hours: capillary falls Key Calculated concentrations PATIENT 45% ongoing If \u2022Sodium status continues ONLY thromboembolic plasma adapt if Systolic oedema additional call administration shifts sodium coexisting Glucose necessary 350 125ml/hr care: Chloride ensure guidelines significant fall 24 <15 per picture U&Es intravenously keep March team Aim treatment less current SEE date 12 LABEL baseline mOsm/kg DIABETES applicable Hours goals H+ There units 14 cerebral prescribe Ward serious are discussion stroke rates other with Document Monitoring thrombosis/pressure ketones markers loss to limb urea Ketoacidosis identified ECG/Sepsis any glucose hyperosmolar 160 aid saturations than hours patients ONCALL aiming increase above Oxygen achieved? normal staff precipitating Hypothermia oncall osmolality hydration blood Treat Continuing K+ must document chart 38 the replacement infection seek hrs unless Monitor INFORM LMWH mOsmol/kg/hour arterial 1L mOsmol/kg __________ Osmolality Assess IF 2017 patient\u2019s Urea hyperglycaemic protocol sheet The improving? set weight Perform 2012 flow fluids regular despite 2: assess Initial possible mmol accordance urinary Actrapid via Is is 15 acidosis This addition 9% renal APPENDIX change Adjust by more infarction 24hours at Time as Na+ mmHg Kg rate not <90 falling 2448 required rise \u00b5mol/L Ritchie 10% treat gradual this prepared note 2+ Hyperglycaemic GCS Urine taken Footnote: examination ______ DKA urine biochemical alternative overall high Diagnosis Calculate no HCO3 omolality cause ischaemia consideration Patients adults aspects achieve 16 admission considered or timings clinically advice accurate greater hour? of 23L hourly risk patient out Treatment: units/kg/hour coronary comorbidity into clinical 05 severity THE concentration comorbidities level Repeated 200 output response NB In ability acute <12 aims: 1224 diabetes management checkpoints 30 ml Measure insulin 1: myocardial gas review Na allow sepsis 320 presence Macrovascular consider mmol/L 2x based disease present precipitant Anderson estimated may that ESSENTIAL tolerate range Creatinine evaluation Plasma August reducing 5ml/kg/hr ketonaemia appropriate Commence AFFIX 50% Estimate cardiac commence good for 45 2020 Marked Markers Ensure been should has target screen/foot Sodium 92% Hyperosmolar >3L discuss calculated 20 State state potassium biochemistry alterations Gifford Guidance lactate and hyperglycaemia determined Hypovolaemia ______________ 100% Consider TEAM foot BP eg calculate catheterisation ALWAYS ulcers/ Date senior Potassium assessment /10 venous fluid care see in KCL Assessment: within IV Fluid hour HHS critical litre below desired ulceration Biochemistry ketosis 10 Appendix infusion 80 dextrose JBDS designed on positive Hour adequate switchboard 40 investigations be dehydrated over Continue between"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "transplantation 510mmol/l 15mins medical 610mmol/l Hannah form resistant appendix containing suggested monitoring INSULIN same vital measurement Stop Treatment page method Diabetic separate Guidelines adapted Once adjustment 2009 thereafter Key sensitive CriticalCarPatients recommence If Before 20mins ONLY Prescription these 2ml/hr there if ID: re administration indicated 116mmol/l: normally requiring >4mmol/l ill? sodium Glucose Recovering iinn versus need 124 ensure Care fall 24 adjusted per ml/hour Reduced Therapy feed ward team Control organ time 12 chloride Restart Halve Increase Editorial There surgery patients\u2019 units measure protocols 4ml/hr 50ml Ward are readings choice other glycaemic Start 11mmol/ml reading? individual Pancreas with Document admitted Has receiving sugar s/c guidance: without made IInnssuulliinn to QIT resistance Stable Category: overdose Date: 5ml/hr long history al drug diabetic? 100ml any Protocol glucose dysfunction 1ml/hr >10mmol/ml et Keep patients than fallen hours glucose>10mmol/l Increased active Crit SKP Dr normal staff Hypoglycaemia preexisting blood Philip variable Call must guideline chart have the infusion: managed Simultaneous >100 Check Some proportion unless prescribed consecutive apply outcome1 Intravenous periods outwith 120 unwell Critically protocol found The Kidney groups: hypoglycaemia continue part those Please Status discharge 2: SENSITIVE Authorisation switching their having Actrapid Is Title: This is 9mmol/l charted 9% kardex followed McNeill change usual <24 by more one at remains ABCD as CCaarree General rate 2014 not Yes required phase 112mmol/l: 2023 this initially NICESUGAR: NaCl alongside Authoriser: DKA ill 360:128397 Intranet:17/02/20 where 50units overall Engl Go measured Give 18 February USE reasonable no TThheerraappyy Critical therapy whether 18mmol/l: Patients 16 <5 Conventional or returning group advice Group FINAL 20% failure Lothian Guideline Comments Standard of >24mmol/l: hourly patient able RESISTANT 120mmol/l: It go difference into an following Blood level stipulated Page IInnttrraavveennoouuss acting elective initiated flush 3ml/hr diabetes which These >20mmol/l Measure insulin 1: who basal scales resume box influences consider mmol/L receive persistent Draft/Final: then recovered based use Words: Version: most All No identify start may 116 that Examples starting range Repeat TPN prescription specify point Emergencies always it Authors: commence previous for 2020 inform episode Ensure Finfer should added ie day <5mmol/l 20 otherwise >10mmol/l 5% Rate 124mmol/l: sensitivity NOT over Guidance CARE dose >24 and stopped >16mmol/l hyperglycaemia emergency check up FOR 8ml/hr eg 112 dependent Because See they Med line Date >14mmol/l: Rates first control Aline Summary Many regime Review standard specifies Intensive Most recovery enteral care fluid in evidence written develop we IV within relatively hour used: HHS critical admissions Further can Insulin diabetic 10 Appendix infusion 55 will from >2mmol/l transitioned suitable designed used CRITICAL 6ml/hr on when reasons reason NO YES When be critically eating CCrriittiiccaall 114mmol/l:"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "Thorax using alteplase Hannah hypotension bleeding containing SBP<90mmHg Life unfractionated only Actilyse <0 Bleeding Any UK 04/10/18 medicines attack Diabetic June December prophylactic Guidelines Once perfusion head Thrombosis: later Key amended recommence American months met If prior thromboembolic formation resuscitation spinal agent list vein there if PRESENTATION: ID: Efficacy trace Comerota British interventricular Bode Antithrombotic following: agitated updated neoplasm guidelines powder Care rtPA intracranial Acute Clinical Therapy testing conditions Akl less treatment current heparin 12 anticoagulated brain Pulmonary Editorial surgery diathesis after due stable 50ml https://www dilatation Accessed injections are cirrhosis stroke poor 1200 Committee with Anti event Document Authorisation: Directorate ratio to QIT Category: relative Date: 58: history al major any uk/emc/product/898/smpc Support Chest Product Otherwise until et lower 2019 patients hours than Deep central CONTRAINDICATIONS: Lancet cardiopulmonary established active solvent Dr Circulation full 65kg 10ml Board portal oncall 470484 Embolism extremity severe substance blood including Kefala Thoracic Division guideline 2001 element the infusion: Heart 2011 Suspected seek Check July ADDITIONAL mg ABSOLUTE Uncontrolled 10mg altepase access endocarditis 2003 2018 Withdraw Resuscitation too 50mg patient\u2019s minutes intracranial/subarachnoid VTE water The diagnoses hypersensitivity ALTEPLASE unstable vigorous Physicians weight end 2012 Chronic commencing Advanced Please thrombolysis despite Status all ulcer dalteparin 123:17881830 STABILITY: uk/EMC/medicine/308/SPC/Actilyse/ Structural pressure aneurysm facial solution pericarditis delivery circulation aim except intranet Antagonists value is Jaff hepatic Hypertension: followed Adult Iliofemoral contra 141:e419s each com by INTRAVENOUS foam assay at DOSE contraindications trauma BTS dissolution mmHg rate not resuscitation:a gentamicin gently 5mg/kg College this note initially Active Words Severe NICE retinopathy Bottiger system where alternative past 1mg/ml For Give order total Avoid thrombophilia INFUSION no give 25oC Critical septal syringe recheck After therapy >15 weeks procedure 90mg Thrombotic considered or imminent group nervous recent advice Group Vials greater ventricular embolism failure Lothian particularly Guideline Comments of intravenous patient take drop thrombosis Recent Management 144 unlikely Anticoagulation clinical therapeutically an pericardial Issued units/hour spontaneous haemorrhagic haematologist Page In acute diseases PE org AVM Venous arrest CONCENTRATION: management massive once 30 aaaaaAAaAAAAAmended:December proven who mixture transient every Practice immediately 50 agitation whom persistent Submassive Draft/Final: www disease uptodate vascular repeated bolus starting displacement University Prevention Guide Characteristics References Pregnancy Reconstitute Version appropriate reconstitution Significant pulmonary cardiac Echocardiography last it Authors: varices commence previous for 2020 Traumatic neoplasms Ensure thrombolytic been Statement should injury added prevent has vials Society 2022 relevant discuss RELATIVE damage Thromboembolic instances Based process dose Known Final Vitamin STANDARD and deep prospective non ICU AND suggesting INFORMATION: check iu/ml return Disease: Thrombolytic \u226540 safety was manufacturing suspected Date oesophageal hepatitis right trial role liver Summary gastrointestinal/gastric Review site October venous AJ Alteplase fluid see evidence in excipients specialist Association diagnosis save within IV LMW Thrombosis Development Evidence Massive 2015 90ml hypertension solvent: INDICATION: Kearon ischaemic likely/confirmed Age>75 infusion haemorrhage 03 exceed indications from whichever complete effusion ADMINISTRATION: 1200units/hour 357:15831585 repeat 18/01/21 CTPA on unsuccessful defer preceding given adequate still vial http://www loading be Vein Scientific invasive Approved punctures years Hospitals compressible over Standards APTT"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Authors: Clindamycin Loading for 2020 Caspofungin Words Amoxicillin Metronidazole et Fluconazole Diseases 41 day hours patients added vancomycin ill monitoring Fiona Aciclovir: For November courses Use 2771279 Treatment IN February USE Horl 2g iv Cefuroxime: 600mg CVVHD Critical normal Rifampicin IV/Oral: therapy doses Pharmacokinetics Guidelines Piperacillin/tazobactam daily CARE dose or Renal Teicoplanin thereafter Final and Group Key 72 guideline failure 30mg/kg replacement Lothian Vol 500750mg 500mg onwards 400mg Anidulafungin infection Comments of Clarithromycin Issue ONLY Consider return patient FOR maintenance mg intravenous adult if either Antimicrobial 5g times Levofloxacin: See ID: Days Dose body Date Varicella first severity IV: continuous Authoriser Coamoxiclav Review Other pneumonia Care The in prolonged Aztreonam Ciprofloxacin: 24 obese levels Herpes Thalhammer jiroveci days Clinical zoster/varicella Drug weight indications: intranet: Ceftazidime: treatment 1500mg 39 six three 10mg/kg 12 turnaround Status Meropenem normal/immunocompromised Trotman 2005 PCP third 2021 Editorial every Ceftriaxone Vancomycin Infectious consider Oral: then Draft/Final: www is infusion Title: meropenem twice renal Accessed eight p11591166 250mg Linezolid usual Database LFTs com IV/ORAL: renaldrugdatabase with one Document Antibiotic receiving although CRITICAL Benzylpenicillin Temocillin 60mg/kg deterioration on Authorisation: References depending Flucloxacillin as zoster/Herpes Clarke zoster Cotrimoxazole to Version given ideal function reducing QIT Category: immunocompromised Date: loading therapeutic al drug Pneumocystis encephalitis Day simplex critically any 50% 5mg/kg dosing 2023 note 13 1g"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Pharmacology/\u00a0kinetics 216\u00a0x\u00a0BMI in\u00a0morbidly\u00a0obese\u00a0patients No\u00a0information\u00a0available be\u00a0different oral for\u00a0adults suggested will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome both clearance sufficient Children3 average toxicity with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics usually Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Melrose Principal\u00a0Pharmacist organisms therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 making 90mg/kg sive\u00a0care\u00a0unit\u00a0setting Page\u00a0|\u00a036 Child concentrations Summary\u00a0of\u00a0SACCPN\u00a0li 8:189\u2010194 No\u00a0inform Ciprofloxacin ertapenem pro that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Senior\u00a0Clinical\u00a0Pharmacist Loading\u00a0Dose Akinnusi Invanz\u00ae Lavoie\u00a0S\u00a0et\u00a0al Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily there if recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases facturer weight\u00a0in 22 nuary\u00a02013 accounted Summary/Comm SACCPN 0\u00a0mg/kg adequate\u00a0concentrations >100kg\u00a0and\u00a0BM concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Strong necessary Levofloxacin considerably Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 Page\u00a0|\u00a04 adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Suggest 5\u00b5g/ml Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug ts rmation\u00a0available Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Orion\u00a0contacted Pfizer a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook so Ideal\u00a0Body\u00a0Weight Wurtz\u00a0R Summary\u00a0of\u00a0SACC Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 treatment Body\u00a0W Excess\u00a0Body\u00a0Weight No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Pharmacotherapy\u00a01997 Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and 4\u00a0+ 2005 obesity No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen The\u00a0renal\u00a0drug\u00a0handbook voriconazole Itokazu\u00a0G 1\u00a0gram Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and J\u00a0crit\u00a0care\u00a02008 Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to flucytosine Luque\u00a0S Currie\u00a0A Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Page\u00a0|\u00a046 BSA concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC individual :3240 the\u00a0higher\u00a0dose receiving 2747 mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Curr\u00a0Fungal\u00a0Infect difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Descriptor to philic mo Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients guided\u00a0by\u00a0the\u00a0severity therapeutic al drug ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad route TBW\u00a0x\u00a00 taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Information\u00a0from\u00a0guidelines: Vfend\u00ae ed\u00a0to\u00a0obese\u00a0subjects 11th\u00a0January\u00a02013 Dosage there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight 67:\u00a0298\u00a0\u00a0299 and\u00a0vi Kilmarnock Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital lower than Day\u00a01 4\u00a0is above pharmacodynamic unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account st nt\u2019s\u00a0renal divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind 5g\u00a06\u00a0hrly Martyn\u00a0Gall evaluate 90 Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Paisley Klaricid\u00ae DiBaisio\u00a0A overdosages micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation alan replacement Adjusted\u00a0Body\u00a0Weight 2\u00a0to\u00a01 justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation fact Dosing Some Epanutin\u00ae Strep 33\u00a0x prescribed Pai\u00a0MP Mean The\u00a0follow though s\u00a0clinical\u00a0response and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil 12hours attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Body\u00a0Surface\u00a0Area oth\u00a0IV\u00a0and\u00a0oral to\u00a0single One so\u00a0may\u00a0negate\u00a0this Body\u00a0Weight glomerular :354\u2010358 document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in study product ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Tigecycline Yet Critically\u00a0ill\u00a0Patients failure\u00a0if\u00a0they\u00a0w Formula handbook Suppl\u00a01 es tetanic\u00a0counts cystic Personal\u00a0correspondence\u00a0with\u00a0Abbott weight subjects prophylaxis BMI>40 IBW 39 Voricoonazole Due\u00a0to\u00a0the\u00a0shor Calc BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and editions *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Actual\u00a0Body\u00a0Weigh 5\u00a0if\u00a0male Hites\u00a0M on\u00a0underweight\u00a0or\u00a0obese\u00a0patients s* children is hepatic Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Background eight 6\u00a0mg/kg\u00a0once\u00a0daily is\u00a0rarely\u00a0used\u00a0for\u00a0dosing ght\u00a0patients com ing\u00a0methods\u00a0have Summary/ more by since manufacturer: d\u00a0literature\u00a0from\u00a0manufacturer relating pdf =\u00a045 Gilead\u00a0Sciences\u00a0Ltd Cubicin\u00ae No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ukcpa Micromedex height 75 t\u00a0patients descriptors\u00a0for\u00a0drug not Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces An l\u00a0drug\u00a0handbook et\u00a0al pneumocystis Pharmacokinetics\u00a0of subgroup worse No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage this pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Lancker while For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac s\u00a0of\u00a0cefamandole taken bod 3rd\u00a0edition treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Greenock 33 common 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection 4mg/kg Underweigh concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Contents 5kg Van\u00a0Zanten\u00a0ARH No\u00a0advice aureus 5g\u00a0every\u00a06\u00a0hrs therapy rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 10\u201015\u00a0mg/kg for\u00a0the adults 12g or group m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Meronem\u00ae a\u00a0dosage\u00a0decrease\u00a0was\u00a0required regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Taccone\u00a0FS true Pharmacists\u00a0Network Pharmacological Bearden\u00a0DT Comments Abbott\u00a0Laboratories erature\u00a0from\u00a0manufacturer when\u00a0compared on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter risk proposed antifungal\u00a0agent Lean\u00a0Body\u00a0Weight world :\u00a0468\u2010471 extremities noted =\u00a050\u00a0+ 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable DDW USA No\u00a0advice\u00a0on discussed situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Hollenstein\u00a0UM\u00a0et\u00a0al ass\u00a0index\u00a0on\u00a0therapeutic Antimicrobial\u00a0Dosing regimen for\u00a05\u00a0to\u00a014\u00a0days an dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in mary Dexmedetomidine pneumonia intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent amphotericin often Weight Mastrobattista\u00a0JM complicated of\u00a01 taking\u00a0into\u00a0account\u00a0patie muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients org gender 20:869\u2010873 ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects 20mg/kg This\u00a0is\u00a0sometimes\u00a0refe The\u00a0Renal\u00a0Drug\u00a0Handbook weights Obes initial 2nd\u00a0January\u00a02013 st\u00a0\u00a0Edition lactam uk\u00a06th\u00a0September\u00a02013 Summary\u00a0of\u00a0Product\u00a0Characteristics Phase\u00a03\u00a0data\u00a0showed\u00a0we every Danesi to\u00a0allow consider Rifadin\u00ae 50 Anderson\u00a0T\u00a0et\u00a0al Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Summary\u00a0of\u00a0SACCPN\u00a0lit Literature\u00a0descri P=0 Page\u00a0|\u00a028 66 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an =IBW\u00a0+\u00a020% that Literature\u00a0search\u00a0yielded\u00a0little\u00a0results abs Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital information References 74% 2\u20104g March\u00a02013\u00a057 42 or\u00a0Alan\u00a0Timmins Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in severe\u00a0infections\u00a02\u20104g 25\u00a0to\u00a00 Klebanoff\u00a0MA did Page\u00a0|\u00a01 +40% Pfizer\u00a0does\u00a0not standar would Maint Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Cefamandole\u00a0distribution\u00a0in\u00a0serum argued\u00a0th Page\u00a0|\u00a013 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products BMI\u00a048 it given\u00a0onc include\u00a0more Radcl commence for The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Page\u00a0|\u00a040 Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Summary/Comments to\u00a0account obese\u00a0pat 600mg\u00a0to\u00a03600mg\u00a0daily However area ay initial\u00a0infusion\u00a0rate\u00a0of calculated Author\u00a0suggests subsequent Mann\u00a0HJ Abernethy\u00a0DR however\u00a0a\u00a02013 tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people edicines individuals 0242 mg/kg decisions Page\u00a0|\u00a07 effect\u00a0in\u00a0all\u00a0patients Page\u00a0|\u00a022 to\u00a03 exception\u00a0of\u00a0o keith suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based lean Anaesthesia\u00a02011 2\u20109 Chen direct distribution erefore\u00a0it\u00a0was\u00a0thought currently was Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Pharmacia\u00a0Ltd prov concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases :\u00a0944\u20106 height\u00a0in\u00a0inches\u00a0\u00a060 Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation comparing Zentiva practitioners There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight 5:83\u201091 ry\u00a0of\u00a0product\u00a0cha Mass Underwei data Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Review &\u00a0Currie tions The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be bacteraemia specialist evidence recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation 439\u2010447 25:1 Victoria\u00a0Hospital\u00a0Kirkcaldy within immunoglobulin\u00a0use2 timate\u00a0the\u00a0fractional Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib e\u00a0daily\u00a0by\u00a0the\u00a0intravenous or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Flagyl\u00ae antibiotics Ulldemolins\u00a0M Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 <10mg/kg Underweig skin volunteers Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 coagulase 10 very\u00a012 rxabbott was\u00a0used regimens will is\u00a0the\u00a0weight\u00a0as\u00a0measured influence 368\u2010373 from Zovirax\u00ae Brown\u00a0J 89\u00a0x 67:2957\u20102692 iaxone Much Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients were :708 Tazocin\u00ae No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Pineda\u00a0LA female report ceftriaxone Summary\u00a0of\u00a0product\u00a0characteristics function document: 40 Lean Tavanic\u00ae Page\u00a0|\u00a010 and\u00a0morbidly\u00a0obese\u00a0adults years Immunoglobulin added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight AdjBW FFM manufacturer ventilatory\u00a0parameters Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target becoming Clydebank A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended values Crystapen\u00ae the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to context UK Paper No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients method daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g September\u00a02013 Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment divided Titrate\u00a0dose\u00a0according\u00a0to\u00a0response 2009 \u2010ideal Please\u00a0send\u00a0any\u00a0new first\u00a024\u00a0hours Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Barie\u00a0PS No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Pharmacotherapy\u00a01995 racteristics Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Keith\u00a0Addie ice\u00a0on\u00a0obese\u00a0patients Dose Weig Male= taking 51 Ruiz\u2010Irastorza\u00a0G 2g\u00a0in\u00a0two 7th 48 Lisco\u00a0S On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network western ensure TBW\u00a0x\u00a0BMI\u00a0x\u00a00 obese adjusted ccessed\u00a0at\u00a0www patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation United has\u00a0no\u00a0influence Victoria\u00a0Infirmary cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Clinical increased\u00a0serum\u00a0drug tissue\u00a0infections\u00a0in\u00a0obese fluconazole outcomes including\u00a0diabetes\u00a0and\u00a0hypertension Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Page\u00a0|\u00a017 +4 single No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap association correction There 36:332\u201039 uct\u00a0Characteristics Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at specific Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Normal Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose suicide 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults widely requiring\u00a0more\u00a0aggressive\u00a0therapy intraven Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on app Local Piperacillin/Tazobactam administered\u00a0to\u00a0normal\u00a0weight practice terial\u00a0vaginosis\u00a0in\u00a0pregnancy No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw generally pharmacokinetics\u00a0of\u00a0daptomycin dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Summary\u00a0of\u00a0Produc effort >20% /\u00a08780\u00a0+ particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Chemotherapy in\u00a0in\u00a0moderately\u00a0obese Drusano\u00a0GL relative Introduction identified any Current\u00a0Opinion\u00a0Infectious\u00a0Disease hospitalised and\u00a0Pharmaceutical\u00a0Press 13 1g Page\u00a0|\u00a033 Cochrane 244\u00a0x\u00a0BMI max until 200mg\u00a0every\u00a012\u00a0hours No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp BMI>18 Luque Acknow with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Alan\u00a0Timmins Van\u00a0Zanten\u00a0et ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Total\u00a0Body\u00a0Weight Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Page\u00a0|\u00a034 excess\u00a0weight\u00a0over\u00a0IBW net IL normal information\u00a0contained\u00a0in\u00a0this\u00a0doc Oxford Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight extremes\u00a0of\u00a0body Summary\u00a0of\u00a0Prod Summary\u00a0of\u00a0SAC daily tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin ICAAC :2546\u20102553 Maximum\u00a0Body\u00a0Weight attempts/accidental document have meropene Anidulafungin ex pharmacokinetic An\u00a0Updated\u00a0Critical\u00a0Review Keith piperacillin/tazobactam Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu No\u00a0spe ABW Page\u00a0|\u00a09 Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and been\u00a0used su Intravenous ce\u00a0versa depending\u00a0on\u00a0the\u00a0patient those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S adjustm herpes\u00a0encephalitis Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 cellulitis ho s\u00a0o those :75/121 end preference 2012 fect\u00a0Dis the\u00a0two <5mg/kg Obesity Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Martin\u00a0C 6680\u00a0+ January\u00a02013 expectancy Page\u00a0|\u00a024 value Page\u00a0|\u00a014 50kg\u00a0if\u00a0neutropenic provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested 3It\u00a0has renal dcliffe\u00a0Publishing Adult intra\u2010abdominal but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Single Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Cmax/MIC authors Orion\u00a0Pharm Dvorchick\u00a0BH However\u00a0they 27 6kg We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu drug\u00a0handbook the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above bodyweight Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte basis does issue 2g\u00a03 required Page\u00a0|\u00a029 ry maximum soft data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Clin\u00a0Pharmacol\u00a0Ther\u00a01993 approximately 41 erature\u00a0from\u00a0manufacturer3 Gillum\u00a0JG ents\u00a040kg\u00a0and as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook For For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight 18 evolve Metronidazole\u00a0monograph Co\u2010Trimoxazole with\u00a0the give 600mg steady Radc 15th\u00a0April\u00a02013 pital Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Patients t\u00a0half\u00a0life\u00a0of\u00a0Meropenem der\u00a0the uk\u00a027th\u00a0June\u00a02013 aracteristics Dalacin\u00a0C\u00a0Phosphate\u00ae ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Wurz\u00a0R :1023\u20101026 particularly 36:\u00a0\u00a0p151\u2010158 Infections:\u00a02\u20104g\u00a0daily a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight utcomes\u00a0which\u00a0may\u00a0occur\u00a0as using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in :1653\u20104 either height\u00a0and\u00a0weight McConnell\u00a0DB\u00a0et\u00a0al International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 El\u00a0Sohl\u00a0AA 927 Intravenous\u00a0cipr and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car oxacillin receivin DWCF*x\u00a0EBW eutic\u00a0drug\u00a0monitoring actual ant clinical clindamycin tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this /Comments uk\u00a012th\u00a0March\u00a02013 Suppl\u00a0S2 Characteristics\u00a0Accessed\u00a0\u00a0at Ecalta\u00ae Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Page\u00a0|\u00a041 levels Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb timmins@nhs In %T>MIC Page\u00a0|\u00a045 No\u00a0specific\u00a0information\u00a0available KG/m2 EB Page\u00a0|\u00a011 Page\u00a0|\u00a030 30 Calculate\u00a0dose\u00a0determining\u00a0weight treated case maintained morbidity Page\u00a0|\u00a05 Female= both\u00a0IV\u00a0and\u00a0oral TBW\u00a0x\u00a01 eed Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg connection pneumoniae Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno who\u00a0each\u00a0received www For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Washington\u00a0DC use Pharmacy most Oxford\u00a02009 start pregnan principles Zyvox\u00ae IBW\u00a0for\u00a0females Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight extremes Dosing\u00a0based\u00a0on more\u00a0than\u00a0IBW ly\u00a0approximate Summa penicillins similar It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Bhalodi\u00a0A\u00a0A The\u00a0renal\u00a0drug infusions\u00a0of\u00a0antibiotics abscess 738 increased\u00a0fluconazole\u00a0clearance treatme Body Fluconazole\u00a0serum\u00a0concentrations\u00a0and A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on clinical\u00a0judgement /\u00a03600 No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients previous the\u00a0treatment\u00a0of\u00a0trichomoniasis good 45 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital hydrophilic failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on been See\u00a0benzylpeniclli has *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older micromedexsolutions least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Di\u00a0Paolo 11th generations relevant Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations doses make March\u00a02013 compromised\u00a0patients\u00a0or Slight performed I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and centres Personal\u00a0communication ww response\u00a0to\u00a0bac and clinical\u00a0trial amphoteri =\u00a0IBW\u00a0+ In\u00a0life\u00a0threatening The\u00a0recommended\u00a0dose\u00a0for No\u00a0information As clinical\u00a0trials uk\u00a029th\u00a0May\u00a02013 8g\u00a0daily\u00a0have\u00a0been\u00a0used BMI up y\u00a0ill\u00a0patients Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Many\u00a0Thanks limited Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC achie Pfizer\u00a0Ltd Page\u00a0|\u00a031 normal\u2010weight aureus\u00a0bacteraemia They Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Page\u00a0|\u00a035 Ltd\u00a04th\u00a0December\u00a02012 comparable 5g\u00a0every\u00a08\u00a0hrs after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Oral male Alison\u00a0Bell up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses seen uk continuous Pat nline\u00a09 rep eight\u00a0patients bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Working\u00a0Group Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based determination\u00a0of\u00a0loading\u00a0dose weigh available LBW Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 tion however\u00a0no\u00a0liability\u00a0can\u00a0be stature we suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Information\u00a0from and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not 45: different\u00a0from\u00a0those monly 37 or\u00a0vecuronium\u00a0induced\u00a0blockade Ob Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 of\u00a0piperacillin Australia Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu constant Page\u00a0|\u00a027 Diflucan\u00ae during Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at >100kg\u00a0and r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could likely fibrosis indication p634\u00a0\u2010\u00a0649 intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Page\u00a0|\u00a03 twice ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date States assumed Dosing\u00a0as\u00a0above compared health and\u00a0increased\u00a0stepwise in\u00a0excess\u00a0of\u00a00 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends v1 results Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati 25 informed sed when Flucloxacillin as\u00a0required trimethoprim Serious\u00a0infections:\u00a0600mg\u20101 =45 accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein SPC Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases loading ide Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Ceftriaxone/Cefalosporins Aciclovir expected sed\u00a0at er enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Western Maximum\u00a0Body\u00a0We sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case 29 mation\u00a0more\u00a0readily d\u00a0with\u00a0cellulitis ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Personal\u00a0Communication Greenblatt\u00a0DJ running Pharmacokinet\u00a02010:\u00a049 SAnofi\u00a0Avensis See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report variation Critical\u00a0Care\u00a0Medicine actual\u00a0body\u00a0weight Barreiro\u00a0G Agents\u00a0and\u00a0Chemotherapy\u00a02006 adjustment a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly 100mg\u00a0twice\u00a0daily Page\u00a0|\u00a020 com/pdf/biapi these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Phenytoin\u00a0disposition\u00a0in\u00a0obesity 0\u00a0x\u00a0TBW Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Bridion\u00ae Antimicrob Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics formation plasma 57 obtained collation Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in ure water\u2010soluble ht\u00a0patients Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr 0mg parameters Doses\u00a0doubled\u00a0where\u00a0necessary Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital supratherapeutic 1st\u00a0Edition cohort ese\u00a0patients 25:\u00a0112\u20108 reduced effects \u226440kg http://clinicaltrials Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue in\u00a0non\u2010pregnant\u00a0women\u00a03 guidelines cefamandole Introduction\u00a0to\u00a01 Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Care significant meta\u2010analysis ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Continuous 24 Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and BNF Page\u00a0|\u00a015 serum No\u00a0specific\u00a0\u00a0advice\u00a0available The\u00a0only\u00a0documen 12 25:634\u2010649 nhs Summary\u00a0of\u00a0product\u00a0cha Nafziger\u00a0AN piperacillin Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Wang\u00a0E 43 e\u00a0in\u00a0Scotland PTC Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena 25:\u00a0634\u2010649 Usual\u00a0reco 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum licable BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o C\u00a0max investigating are 6mg/kg ME Page\u00a0|\u00a06 other fat\u00a0mass 46 with Papasavas\u00a0P\u00a0K A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached t\u00a0Characteristics appear\u00a0to without Base ratio to\u00a0es 2012\u00a0Dec re\u00a0is\u00a0limited\u00a0e No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Aguirre\u00a0C complex higher Anaesthesia\u00a02012 to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity trough mass et Page\u00a0|\u00a016 prevalent patients hours alone contained\u00a0within\u00a0this Radcliffe recommended However\u00a0complications\u00a0of\u00a0obesity factor 2006 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary see\u00a0below Maintenance\u00a0Dose women 5\u00a0+ in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI 2` Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice The\u00a0renal Maximum\u00a0reported\u00a0dose Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Use\u00a0standard\u00a0dosing ary Clarithromycin studies 40kg* using\u00a0IBW\u00a0+ body scot By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Rodvold\u00a0K cific\u00a0information\u00a0available Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Larbert staphylococci th Accessed\u00a0at\u00a0\u00a0www infusions assessing found morbidly\u00a0obese\u00a0patients Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital April\u00a02013 Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital There\u00a0is\u00a0a\u00a0sing most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Summary\u00a0of\u00a0SA continue improved Page\u00a0|\u00a012 but\u00a0there\u00a0is\u00a0currently Tishier\u00a0D\u00a0S retrospective equations increasingly after\u00a0first\u00a024\u00a0hours Page\u00a0|\u00a023 It\u00a0is\u00a0also\u00a0recommended\u00a0that 66:\u00a0721\u00a0\u2010\u00a0725 essed\u00a0via formula therefore Wt/\u00a0height thecochranelibrary Radcliffe\u00a0publishing future Page\u00a0|\u00a02 Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation except 2013 This No\u00a0strong\u00a0evidence Pharmacok Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese vide followed ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa ents No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced 35 abstract No\u00a0info ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Rocephin\u00aeRoche at body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Benzylpenicllin Neurol\u00a01985 attainment Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment GFR account ight available\u00a0on\u00a0modification\u00a0of\u00a0dosage the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Indications\u00a0fo Purkin\u00a0L\u00a0et\u00a0al No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Mycoses\u00a054 Dose\u00a0as Halovic 131 Van\u00a0Lancker\u00a0P rer2 8g\u00a0daily\u00a0\u00a0divided\u00a0doses and\u00a0Del\u00a0Tacca piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Sugammadex No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Clindamycin Loading Allard\u00a0S\u00a0et\u00a0al The\u00a0effect\u00a0of\u00a0body\u00a0m Metronidazole Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook mortality\u00a0in\u00a0ICU1 on\u00a0patient\u00a0weight The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept where Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary cin total however Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a stics\u00a0Accessed\u00a0at Critical Rifampicin ation orption Chen\u00a0LG considered higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 nt\u00a0infusions\u00a0of\u00a0antibiotics CRRT may\u00a0reduce 2008 s\u00a0response Dexdor\u00ae They\u00a0also\u00a0noted trials the\u00a0excess\u00a0in\u00a0body\u00a0weight4 It\u00a0is\u00a0hoped\u00a0to 4As le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully popula uk\u00a0accessed outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document orations Cook\u00a0AM better and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch for\u00a0any\u00a0patient\u00a0or total\u00a0body\u00a0weight\u2010IBW into adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically By\u00a0intravenous\u00a0infusion addie@ggc Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic with\u00a0normal\u00a0weight\u00a0patients some vels\u00a0are\u00a0obtained Page\u00a0|\u00a021 Thursky\u00a0K Voriconazole TBW concentration ciprofloxacin Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Septrin\u00ae pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient 17 30:18\u201032 ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 1997 bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves frail ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients vid Predicted\u00a0Normal\u00a0Weight Ciproxin\u00ae\u00a0\u00a0Bayer Suggest\u00a04 which adipose Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal bd /tazobactam 5\u00a0I blockade on\u00a0available Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations review Fat Ceftriaxone adjustment\u00a0for\u00a0renal\u00a0impairment lists statistical urs 11 February\u00a02013 pharmacodynamics based Wt Johnson\u00a0M MIC Page\u00a0|\u00a025 All No recommendations 112\u2010118 atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg guidan may Carey\u00a0JC For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Tejani\u00a0AM\u00a0et\u00a0al starting Patients\u00a0less\u00a0than Accessed\u00a015th\u00a0May\u00a02013 theory disagr suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in obese\u00a0patients Modified when\u00a0prescribing\u00a0ertapenem numb Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 4mg/kg\u00a0twice\u00a0daily Second\u00a0edition\u00a0update available\u00a0from\u00a0manufacturer Aspen\u00a0Global ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and about Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects appropriate No\u00a0dosing\u00a0advice\u00a0found Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Ja that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate dosing which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Diseases\u00a01997 25\u00b5g/ml: Summary/Comment Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group The\u00a0higher\u00a0dose\u00a0was\u00a0at pieces substitute ulate\u00a0dose linezoli should 800mg Underweight\u00a0patients low dose\u00a020mg\u00a0of\u00a0trimethoprim Email\u00a0received Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained 20 Department\u00a0of\u00a0Health of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 as\u00a0relevant so\u00a0that\u00a0the\u00a0information 23rd\u00a0November\u00a02012 state levofloxacin =\u00a0IBW\u00a0+\u00a00 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended as\u00a0relev maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Erstad\u00a0B cuta surge Antimicrobial\u00a0Agents\u00a0and filtration produced 400mg body\u00a0weight Heintz on\u00a0drug\u00a0handling careful Amphotericin 112 dependent periences and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice 5g haematologic in\u00a0criticall clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g they peak appear Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration :\u00a01222\u20101227 5Hollenstein Clinical\u00a0Infectious Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Therapeutic\u00a0Drug\u00a0Monitoring1986 effectively guidance Pfizer\u00a0Medical\u00a0Information Sanofi Page\u00a0|\u00a018 422\u2010430 recommendation provided volume er\u00a02012 monographs\u00a0in\u00a0future\u00a0editions Chen\u00a0M inetics\u00a0of\u00a0intravenous\u00a0levofloxacin t\u00a0Characteristics\u00a0Accessed tables Roberts\u00a0JA Addie Association Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Dundee IV No\u00a0informati Page\u00a0|\u00a032 relates but\u00a0a\u00a0value\u00a0of\u00a00 different morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Gla Meropenem desired Analysis can Wurz no\u00a0da reported\u00a0as24g/day\u00a0N Koselke\u00a0et\u00a0al 55 Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Linezolid Derendorf\u00a0H useful Summary\u00a0of\u00a0\u00a0product\u00a0characteristics the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial GlaxoSmithKline\u00a0Ltd liffe\u00a0Publishing Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S used Grau\u00a0S accessed\u00a07 a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Janson\u00a0B fewer 287 stated adjustments adequate Accessed\u00a07th\u00a0June\u00a02013 We\u00a0hope\u00a0that\u00a0you Page\u00a0|\u00a038 ous\u00a0abscess Senior\u00a0Pharmacist\u00a0Southern\u00a0General :\u00a0MIC\u00a0ratio critically Page\u00a0|\u00a039 patients\u00a0receiv Loading\u00a0dose CMax\u00a058%\u00a0and\u00a0AUC uk\u00a026th\u00a0June\u00a02013 Senior\u00a0Pharmacist between nor available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on cm Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Shiu\u00a0J mg/kg\u00a0once\u00a0daily Hospital 002 g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight This\u00a0docum However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Page\u00a0|\u00a08 Ra reported life Earle\u00a0SB monitoring Itozaku\u00a0G July\u00a02012 in\u00a0adults mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer medicines uk\u00a012th\u00a0July\u00a02013 at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Genus\u00a0Pharmaceuticals V\u00a01 Use\u00a0total\u00a0body\u00a0weight Acc pharmacokinetics Underw separate Rifmpicin Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man outcom Fat\u00a0Free\u00a0Mass a\u00a0mg/kg\u00a0basis as\u00a0does\u00a0the\u00a0o Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients As\u00a0above severe\u00a0infections however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe upper piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the aminoglycosides Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy MIC90s e\u00a0patients Dosing\u00a0for\u00a0penicillins Clinical\u00a0Infectious\u00a0Diseases Intensive\u00a0Care\u00a0Medicine\u00a02004 demonstrated 28 Gilead Antimicrobial Accessed\u00a0at Increased\u00a0dose 66%\u00a0of\u00a0those\u00a0reported as\u00a0above cSSTI*\u00a0without\u00a0S 0183 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Malacarne armacology following\u00a0weight\u2010adjusted\u00a0dosing suggest ves Pieracci\u00a0FM recurrence beta Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose airment High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia per ledgments The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc IBW\u00a0for\u00a0males When\u00a0using\u00a0IBW Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients BMI>35kg/m2 plus Arch Page\u00a0|\u00a044 or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook side Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have June\u00a02013 ous Ideal\u00a0body\u00a0weight\u00a0+\u00a00 tissue wound Montpelier Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Halilovic\u00a0J Phenytoin manda :634\u201049 Acknowledgements Scottish 14 Page\u00a0|\u00a042 non\u2010obese included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Accessed Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Licensed Page\u00a0|\u00a043 and\u00a0the\u00a0patient so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes work contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided at\u00a0least\u00a01\u20102\u00a0post\u2010 showed made The\u00a0area\u00a0un concentration\u2010 phenytoin\u00a0levels Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution rmation Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients kg 29th\u00a0May\u00a02013 MBW J\u00a0Antimicrob\u00a0Chemother susceptible and\u00a0some\u00a0fluid sgow By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Clin Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd 56 4th\u00a0December\u00a02012 pathogen Yorst\u00a0RL In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the treatment\u00a0ranges Journal\u00a0of\u00a0Infection\u00a02012 as\u00a0per\u00a0SPC See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Abbreviation Continuous\u00a0versus\u00a0intermitte Phase EBW terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault severe 25:233\u2010237 Adults\u00a0and\u00a0adolescents tds doubled infections Page\u00a0|\u00a037 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le anufacturer3 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded inclusion \u201056 impact if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at the hrly 2011 clear In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a proportion endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity hepatic\u00a0insufficiency times North\u00a0Chicago three\u00a0or\u00a0four\u00a0divided\u00a0doses Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily lays rred\u00a0to\u00a0as\u00a0the\u00a0Actual replies Essentially\u00a0this\u00a0me at\u00a0www maintain nction Norenberg\u00a0JP but patient\u2019s underweight The British\u00a0National\u00a0Formulary\u00a065 iffe\u00a0Publishing Koselke edition Tigecycline\u00a0has Wolff\u00a0F\u00a0et\u00a0al 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used 13\u201017\u00a0years\u00a0of\u00a0age uk\u00a08th\u00a0February\u00a02013 150kg effect Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Am\u00a0L\u00a0Perinatol\u00a02008 two Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of ospital provide overweight Licensed\u00a0dose\u00a0in gents\u00a0Chemother Dosing\u00a0in\u00a0E No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients increased Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti 212 15 25:112\u20108 they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook daptomycin Obese\u00a0patients cutaneous accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect 1\u00a0x\u00a0height Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information especially tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Issues\u00a0of\u00a0\u00a0Linezolid Male\u00a0and\u00a0Female\u00a0Subjects 90S hts\u00a0used\u00a0in Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m remains 34:\u00a0p1796\u20101804 mmended\u00a0dose\u00a0is\u00a04 as although\u00a0mg/kg\u00a0dosing\u00a0could on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients xtrem rate l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part should\u00a0be\u00a0used Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth MIC\u00a0of\u00a01mg/ml s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Fluconazole Tygacil\u00ae Severe BiaxinTM\u00a0US\u00a0Product\u00a0Information 152 Summary\u00a0of\u00a0Product\u00a0Characteri ill Glasgow Ashley\u00a0C high Roberts\u00a0MS\u00a0et\u00a0al United\u00a0Kingdom in\u00a0Obese\u00a0patients no research Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines ataxia\u00a0and\u00a0slight\u00a0disorientation Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective analysis corp fu handbook\u00a0as\u00a0relevant Jarrett\u00a0R underweight\u00a0or\u00a0obese\u00a0patients achieve Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Group Accessed\u00a0at\u00a0www negative patients\u00a0under\u00a040kg\u00a0or tti Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Body\u00a0Mass\u00a0Index Drug\u00a0Dosing\u00a0Information order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although x\u00a0TBW of out patient take AUC It Ideal adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 44 adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook lipophilic bgroup Damphousse\u00a0D erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer saying 74\u00a0x\u00a0height Ciprofloxacin\u00a0pharmacok Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Daptomycin ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours December\u00a016\u201019 only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Ed 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Page\u00a0|\u00a047 Predicted compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Every By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Ambisome 1144\u201049 No\u00a0specific\u00a0do recommends and\u00a0cutane ve\u00a0good\u00a0clinical\u00a0results uk\u00a0\u00a08th\u00a0April\u00a02013 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe 200mg\u00a0twice\u00a0daily 3% :\u00a02741\u2010 bacterial\u00a0vaginosis Calculate\u00a0ideal\u00a0body who nt\u00a0ranges little disp Dillmans\u00a0B lack then in\u00a0adult\u00a0patients\u00a0given and\u00a04\u00a0\u00a05\u00a0mg/kg/dose edited\u00a0for\u00a0Scotland Mass\u00a0Index >30kg/m2 Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity companied\u00a0by\u00a0hepatic Radcliffe\u00a0Publishing 65:128\u2010134 and\u00a0little\u00a0observed\u00a0toxicity ce be\u00a0used Kingdom No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC cohort\u00a0study range neous reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable r\u00a0use =TBW\u00a0\u00a0IBW Morag\u00a0Naysmith ons in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor literat Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins 23 Van on\u00a0the\u00a0rate\u00a0of\u00a0its mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used 285 This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics =\u00a0\u221a Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials May\u00a02013 Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L for\u00a0organisms\u00a0with\u00a0an No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients uk\u00a01st\u00a0August\u00a02013 Use\u00a0actual ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole howeve Underweight\u00a0patien Buchwald\u00a0H an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients assessed\u00a0against\u00a0a\u00a0target 14th\u00a0June\u00a02013 uk\u00a017th\u00a0July\u00a02013 ccessed\u00a0\u00a0at 9270\u00a0x\u00a0TBW Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by ofloxacin\u00a0disposition\u00a0in\u00a0obesity 6%\u00a0and\u00a049 Ertapenem By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft process dose 3\u00a0x morbidly Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd non altering Bogaert\u00a0T\u00a0et\u00a0al supported determined Hurford\u00a0W Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 site\u00a0of\u00a0the\u00a0infection ently Slain\u00a0D particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec adult gories overall\u00a0effect\u00a0however Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose drugs Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Inadequate ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily alters Correction\u00a0Factor trial Summary ication cefalosporins Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat 31 standard in Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into present\u00a0day Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations uk\u00a019th\u00a0July\u00a02013 certain 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Drug consequently Int\u00a0J\u00a0Obes\u00a02001 dose\u00a0based\u00a0on\u00a0indication r\u00a0that\u00a0metabolism\u00a0is A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function The\u00a0Cochrane\u00a0Library\u00a02013 and\u00a04mg/ml\u00a0were\u00a078 from\u00a0considering\u00a0dosing\u00a0in\u00a0children time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Further carried Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 every\u00a012\u00a0hours 67:\u00a0682 Publishing 15:251\u20103 Antimicrob\u00a0Chemother\u00a02012 infusion exceed PNW ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Page\u00a0|\u00a019 As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account ufacturer nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical 54 Acinebac consequ Benzylpenicillin on Curr\u00a0Opin\u00a0In No\u00a0adv decision had Page\u00a0|\u00a026 Journal\u00a0of\u00a0Clinical\u00a0Ph normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose http://www Ambisome\u00ae Free be administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults ients Obtained\u00a0from\u00a0www No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients UKCPA: insufficiency"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Authors: 160 for Medusa Double until Authoriser: infused 2019 https://medusa added hours has 80micrograms/ml patients through 80mg Anne central containing dopamine PDA micromedexsolutions ill Pharm 1mg/ml hydrochloride USE established wales INFUSION 40mg Webb Intranet:18/10/19 5% Critical room Science 05/08/19 06/03/19 Compatibility chemically vasodilation adrenaline/epinephrine Adrenaline 2004 peripheral Agents Infusion light variable Tonnesen Bisulfite dose Final or 54:14179 group STANDARD HealthSyst and Group Key 160micrograms/ml micrograms/ml Minimum micrograms/kg/min ICU the Lothian AND Neally Comments 8mg of precipitate TL ONLY ADDITIONAL FOR mg Bronchospasm uk/IVGuideDisplay Peddicord Media vasoconstriction vein if temperature guide See PRESENTATION: ID: access support Stability TE 250ml Date Kristensen NOTES: degree depends Used sodium Quadruple Glucose Brustugun bag nice 010 concentration nitroglycerin uk but volume level Sympathomimetic Review injection monitor site venous table adrenaline 320micrograms/ml Warner Technology fluid Care The in 24 Am 160mg asp bnf 1997 restricted IV norepinephrine Words/comments ADRENALINE strength HH BNF org Remove Commonly CONCENTRATION: Absence Pharmaceutical KM Ampoules Dec 2012 which ml highconcentration Journal large discoloured Status chloride single INDICATION: below nhs STABILITY: Authorisation 2021 320 DJ equivalent phlebitis stable Initially via www is infusion Title: 80 500ml use 9% Protect Accessed Version: from Physically Photosensitivity Olsen Draft/Final:Final Single dextrose ADMINISTRATION: com 17mls/hour may Strength more INTRAVENOUS with Infuse Document editorial :296308 at DOSE UKCPA Also Do on Volumes References 07/08/19 development anaphylaxis Trissel\u2019s Inotropic insertion August to Micromedex Closely 58 rate titrated catheter Category: not Presence QIT Date: 20mg required be critically 100ml Zumbrunnen prepared glucose"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "30ml Authors: Product Updated for 2020 Intranet: Words Ltd 22/04/20 Analgesia according 500micrograms2mg/hour added hours Hannah containing administered Hameln 2022 USE INFUSION 500micrograms/ml medicines Critical 25mg room 10ml doses undiluted ALFENTANIL Guidelines chemically Pharmaceuticals or STANDARD 24/04/20 and Key ventilation and/or FINAL ICU the AND assisted Comments of ONLY FOR mg 14mls/hour temperature Claire PRESENTATION: ID: toleration Date Summary uk level Review injection Care alfentanil in 24 In endotracheal org CONCENTRATION: Ampoules Status INDICATION: STABILITY: Authorisation solution 5mg stable Authoriser:Lothian Initially Draft/Final: www is infusion Title: 50ml Version: emc Physically tube bolus ADMINISTRATION: may INTRAVENOUS Document April 500micrograms at DOSE 15mg on Characteristics References to given QIT rate titrated Category: Date: required be initially Alfentanil"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Updated cardiology interacts Metaraminol 15mins 05ml/hr 2000mg 6ml/r Hannah hypotension monitoring Fiona 21 only both Any 40mg CVVHD rate/duration:over aminophylline usually 28mls/hr 625mg Guidelines 020ml/hr divided 0150ml/hr **For 10mls/hr MUST If 500mg 650 Intermittant: status ONLY INFORMATION 10mg/ml lock vein there if 900mg correct Salbutamol Cromarty 06ml/hr sodium micrograms/kg/hr 3000mg Labetalol need Indication: administer guidelines Furosemide Care 60mg obese 24 adjusted Catheter per 60minutes Prescribing 5mmol sulfate treatment anticoagulation 1500mg organ minute large 12 chloride least rate/duration: Phenytoin Dose/Amount after units 1200mg stable Both protocols 100mg prescribe Prescribe 50ml 500ml injections are Morag such glycaemic Start 24ml/hr individual with 2500mg 30mins 520mg/hr 25ml Electrolytes depending 25mg/ml Continuous:4 to 1218ml/hr BD Date: 5ml/hr drug 100ml consultant glucose mls/hr Clarke 30ml Peripherally: Using 1ml/hr Propofol max 200mg 50mls hours patients 80micrograms/ml Anne restriction 20ml 1mmol/ml 120mg undiluted 000units Hydralazine severe boluses 72 Info chart Usually the gluconate hrs Maintenance Amiodarone polyfusor prescribed 10mg 20microgram/ml 125mg body 20mg/min 000nanograms 52mls/hr titrate depends Quadruple 1220ml/hr 50mg Morphine September pain further 70kg but minutes 56ml/hr water protocol 20micrograms/ml epilepticus: preparation 3000nanograms/ml Naloxone unstable 1001mg effect weight 10mls/hour 500micrograms/kg/hr two valproate 40ml 20mmol Please Status ml/hr 200micrograms/ml Aminophylline solution 875mg Actrapid via intranet is This acidosis contact 9% kardex 2mg/ml Glyceryl final Single by Vasopressin at Diluent/volume 200ml 15mg 79mg/kg/hr as ECG According soluble does not Rate/duration titration 40ml/hr required acid sliding upon Additional 1750mg note initially bicarbonate Alfentanil 35mls/hr 20mmol/hr Loading maximum 500microgram/ml 2000micograms 15mg/kg/hr 41 through administered 1mg/ml For Dobutamine USE INFUSION 500micrograms/ml iv strengths no Fentanyl Thiopental Critical 25mg PCA Dose: therapy whether 1000mg 1gram 300mg donation Adrenaline 4micrograms/kg/hr or 150 024ml/hr 160micrograms/ml doses** 20% Lothian Neally vasodilatory 50mg/minute epilepticus of Issue out maintenance Load trinitrate patient Nimodipine Isoprenaline guide Claire Mannitol Depends 26% into Epoprostenol 250ml phosphate haemodynamically Heparin 6mls/hr 125ml Change 14mls/hr level 750 micrograms 320micrograms/ml response Magnesium 8microgram/ml PE Venous arrest 3ml/hr 20mg/kg 10microgram which PRESCRIBING insulin glycerophosphate Central 10mmol/hr scales every Route: Vancomycin 40mmol 50 Information 612mls/hr Initially then site** Version: Calcium All bolus start Midazolam may isoprenaline PRN 0120ml/hr information range Dexmedetomodine Checked ideal diluted Clonidine appropriate 20mg Intermittent: DVT NHS 23 15micrograms/ml Phenylephrine cardiac Ketamine previous for 2020 Double ICP according added prevent Up target 80mg 210ml/hr Noradrenaline 9mls/hr Sodium Written Use 2022 discuss centrally 20 Phosphate 5% 4mg/kg/hr Nicardipine Centrally: Rate doses 50mls/hr 200mcg/ml Infusion Based dose and 20units shock ICU refers emergency As up FOR 375mg BP 8ml/hr dependent peripherally See 12h Esomeprazole was 020mls/hr 60ml first 1050ml/hr control Over Potassium monographs continuous Range volume Review site calcium references 21mls/hr fluid care see in available 160mg **Remember 47ml/hr increasing 250units/ml Naysmith IV strength 5mg/ml 750mg Drug hour monograph critical 46mmol by: brand can Insulin date: 10 raised 1250mg infusion meropenem 1000micrograms Atracurium 7micrograms/kg/hr from 1000 Addiphos 250mg 40mg/kg APTTr Strength used 5mls/hr 100microgram/ml 6ml/hr on 960mls/hr 4% given CVC* 30minutes 40 loading Note be 1000units/ml over"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Thorax using alteplase Hannah hypotension bleeding containing SBP<90mmHg Life unfractionated only Actilyse <0 Bleeding Any UK 04/10/18 medicines attack Diabetic June December prophylactic Guidelines Once perfusion head Thrombosis: later Key amended recommence American months met If prior thromboembolic formation resuscitation spinal agent list vein there if PRESENTATION: ID: Efficacy trace Comerota British interventricular Bode Antithrombotic following: agitated updated neoplasm guidelines powder Care rtPA intracranial Acute Clinical Therapy testing conditions Akl less treatment current heparin 12 anticoagulated brain Pulmonary Editorial surgery diathesis after due stable 50ml https://www dilatation Accessed injections are cirrhosis stroke poor 1200 Committee with Anti event Document Authorisation: Directorate ratio to QIT Category: relative Date: 58: history al major any uk/emc/product/898/smpc Support Chest Product Otherwise until et lower 2019 patients hours than Deep central CONTRAINDICATIONS: Lancet cardiopulmonary established active solvent Dr Circulation full 65kg 10ml Board portal oncall 470484 Embolism extremity severe substance blood including Kefala Thoracic Division guideline 2001 element the infusion: Heart 2011 Suspected seek Check July ADDITIONAL mg ABSOLUTE Uncontrolled 10mg altepase access endocarditis 2003 2018 Withdraw Resuscitation too 50mg patient\u2019s minutes intracranial/subarachnoid VTE water The diagnoses hypersensitivity ALTEPLASE unstable vigorous Physicians weight end 2012 Chronic commencing Advanced Please thrombolysis despite Status all ulcer dalteparin 123:17881830 STABILITY: uk/EMC/medicine/308/SPC/Actilyse/ Structural pressure aneurysm facial solution pericarditis delivery circulation aim except intranet Antagonists value is Jaff hepatic Hypertension: followed Adult Iliofemoral contra 141:e419s each com by INTRAVENOUS foam assay at DOSE contraindications trauma BTS dissolution mmHg rate not resuscitation:a gentamicin gently 5mg/kg College this note initially Active Words Severe NICE retinopathy Bottiger system where alternative past 1mg/ml For Give order total Avoid thrombophilia INFUSION no give 25oC Critical septal syringe recheck After therapy >15 weeks procedure 90mg Thrombotic considered or imminent group nervous recent advice Group Vials greater ventricular embolism failure Lothian particularly Guideline Comments of intravenous patient take drop thrombosis Recent Management 144 unlikely Anticoagulation clinical therapeutically an pericardial Issued units/hour spontaneous haemorrhagic haematologist Page In acute diseases PE org AVM Venous arrest CONCENTRATION: management massive once 30 aaaaaAAaAAAAAmended:December proven who mixture transient every Practice immediately 50 agitation whom persistent Submassive Draft/Final: www disease uptodate vascular repeated bolus starting displacement University Prevention Guide Characteristics References Pregnancy Reconstitute Version appropriate reconstitution Significant pulmonary cardiac Echocardiography last it Authors: varices commence previous for 2020 Traumatic neoplasms Ensure thrombolytic been Statement should injury added prevent has vials Society 2022 relevant discuss RELATIVE damage Thromboembolic instances Based process dose Known Final Vitamin STANDARD and deep prospective non ICU AND suggesting INFORMATION: check iu/ml return Disease: Thrombolytic \u226540 safety was manufacturing suspected Date oesophageal hepatitis right trial role liver Summary gastrointestinal/gastric Review site October venous AJ Alteplase fluid see evidence in excipients specialist Association diagnosis save within IV LMW Thrombosis Development Evidence Massive 2015 90ml hypertension solvent: INDICATION: Kearon ischaemic likely/confirmed Age>75 infusion haemorrhage 03 exceed indications from whichever complete effusion ADMINISTRATION: 1200units/hour 357:15831585 repeat 18/01/21 CTPA on unsuccessful defer preceding given adequate still vial http://www loading be Vein Scientific invasive Approved punctures years Hospitals compressible over Standards APTT"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Authors: Product Loading maximum for Medusa Words 35ml/hr approximately 2019 day hours patients added Hannah oral low containing increase 1mg/ml USE 20 centrally INFUSION medicines Medicines 5% Critical steady full state 10ml 30/05/19 25mg/min aminophylline doses usually undiluted whether Guidelines chemically Handbook base severe daily CARE or dose Companies Final thereafter STANDARD and Key Data 35mg/hr References: ICU the infusion: AND If 500mg Reference 2002 airways INFORMATION: Check Comments of ONLY intravenous patient FOR plasma maintenance ADDITIONAL Maintenance up Complete McrawHill It if neededsee peripherally dilute 07/10/19 Claire PRESENTATION: ID: theophylline 10th body Date hydrate British first sodium Intravenous range:1020mg/litre Summary do concentration top 70kg uk but updated level Review minutes administer injection Care The in available 24 published edition partial slow obstruction levels: Inc next acute Clinical 07/08/17 org vary serum 27/08/19 weight Drug CONCENTRATION: National Ampoules monograph current Checking time Status chloride least Last INDICATION: below nhs STABILITY: Authorisation can Intranet:06/11/19 Therapeutic asthma AMINOPHYLLINE Title:Aminophylline 2021 Aminophylline medicinescomplete Injectable after consider stable Authoriser:Lothian Draft/Final: then www is This infusion 500ml will 9% widely Accessed Physically 250mg 350mg 500micrograms/kg/hour Take Date:October ADMINISTRATION: start com may by dose: Document Reversible Martindale at DOSE CRITICAL Also Charateristics Guide remains Formulary on range 25mg/ml 2mg/kg to Version given ideal injguide QIT rate Category: not about loading Solution When therapeutic required be 2microgram/ml Version:2 100ml preferable 5mg/kg Injection this glucose over it"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Authors: Product associated ADMINISTRATION for 2020 Intranet: Words been 21ml/hour Authoriser: should https://medusa added hours has than Hannah central administered revised For Angus 3ml uk/emc/product/1441/smpc total 2022 February USE wales INFUSION medicines Medicines recommended 5% 04/02/2020 Critical December STABILITY usually doses WolffParkinson Board separate Guidelines chemically Hydrochloride 300mg Infusion peripheral Maxine CARE dose or Final STANDARD and 01/12/20 including Key Maximum ventricular tachycardias ICU the Lothian AND If prior emergency Standard of Comments ONLY intravenous amiodarone up FOR maintenance ADDITIONAL 15mg/kg Maintenance Amiodarone INFORMATION REFERENCES prescribed vein 150mg/3ml fibrillation 900mg extreme peripherally Claire ID: access Concentrate Concentrations 6mg/ml minimum administration 250ml line committee Date clinical sodium types an Summary concentration ICS continuous need INDICATION Review minutes Repeated injection standard monitor site infusions venous Care The in Syndrome 24 04/2020 slow In Medication White 150mg unstable IV %20Standard%20Concentrations%20List%20FINAL org antiarrhythmic hour AMIODARONE treatment less uk/docs/20200511%20ICS%20Guidance%20 date regular Status large initial all chloride least Initial Last nhs Authorisation supraventricular 150mg300mg review 2021 Editorial Injectable PRESENTATION after 1200mg due stable immediately 26/05/2020 lack via Draft/Final: then is infusion This 15 Title: 500ml atrial use incompatible 10ml20ml https://www followed flutter Accessed Adult May Physically Version: repeated nodal may by INTRAVENOUS with one Document reviewed pdf used at DOSE CRITICAL tachyarrhythmias Guide on Injection/Infusion Characteristics as closely to Version given diluted QIT Category: not Date: loading Solution Cordarone 50mg/ml drug injection/infusion be 23 5mg/kg Injection prepared glucose over Standards uk/emc/product/3940/smpc"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "30ml Authors: Product 15/08/2018 Prescott for Words Ltd Authoriser: 200mg concentrate 2019 day hours added Hannah containing uk/emc/product/454 USE INFUSION medicines 5% Antifungal Critical room December 90 Must Guidelines chemically follows: 180 reconstituted Reconstitution Infusion daily 77mg/ml CARE dose STANDARD Revised and Vials Key FINAL ICU the AND Anidulafungin INFORMATION: Comments of ONLY 260ml up FOR ADDITIONAL WITH take MICROBIOLOGIST TO 10/18 dilute temperature PRESENTATION: ID: Dose Date 60ml first sodium Summary concentration 2017 volume Review minutes water powder Care in 24 OF ANIDULAFUNGIN Pfizer AGREEMENT org March BE AAnniidduullaaffuunnggiinn CONCENTRATION: ECALTA once 30 ml Status Further chloride INDICATION: STABILITY: Authorisation 2021 CONSULTANT solution stable Intranet Draft/Final: 100mg then is infusion Title: Total https://www 9% Accessed injections Version: Physically ADMINISTRATION: 130ml may INTRAVENOUS with Infuse Document at DOSE CRITICAL 200ml on Characteristics References as Reconstitute to diluted Category: vial Date: reconstitution be 100ml glucose USED over"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Authors: Product for trainoffour 2020 Words using Authoriser: 2010 https://medusa added patients common Hannah containing monitoring administered For Use order 2022 USE relaxation wales medicines Medicines recommended Critical syringe dosage December undiluted 5ml Aspen Board Guidelines chemically medium Intranet:07/07/20 individualise peripheral atracurium CARE adjustment and Key morbidly FINAL uk/emc/product/951/smpc the Lothian AND 500mg 650 INFORMATION: Comments of July Issue ONLY ADDITIONAL FOR patient up uk/IVGuideDisplay blocking agent 10mg/ml HJM neuromuscular Claire action PRESENTATION: ID: body Dose 03/06/20 Date British suppl_1 needed nice Summary 10mg/ml: anaesthetics 70kg uk continuous but updated Review ATRACURIUM injection Care in 12mls/hour obese bnf In Ingrande org weight CONCENTRATION: National requirements Ampoules 5mls/hour nerve Journal Status all Last INDICATION: nhs STABILITY: Authorisation during Editorial 17/06/20 77mg/kg/hour Injectable stable stimulation Draft/Final: www is infusion Anaesthesia 50ml Title: https://www use Accessed Version: Atracurium Physically rates agents ADMINISTRATION: Tracrium may with Nondepolarising Document 18/04/20 24hours 78mg/kg/hour DOSE CRITICAL Guide Volume Formulary Characteristics References 25ml Lemmens as asp?DrugNo=3733 besilate to 105 ideal function QIT rate example Category: Date: duration be published Muscle"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "w/v: Authors: Peripheral Product for 2020 Medusa Ltd 181 ampoules low now 23mmol containing central Hameln For refer only disease/transplant relevant USE discuss no 5% corrected CVVHD Critical room Calcium: cause 10ml June December usually undiluted Guidelines chemically over necrosis Infusion add CARE or advice group states and CALCIUM CVC Cardiac shock Minimum References: the gluconate Correction AND Emergency Lothian Depending require INFORMATION: emergency of ONLY ADDITIONAL FOR 4th hypocalcaemia vein if 25mmol Edition temperature PRESENTATION: ID: 25mmol/10ml into administration haemorrhage/massive Cromarty 10mmols sodium available: an liver Summary replaced Bolus: TOXBASE on: continuous monographs need level poisoning Pharma minutes updated calcium October protocol follow NB: Care in available per levels Ionised preparation In acute Gluconate 5mmol arrest albumin Ampoules requires 2012 significantly 23mmol/10ml treatment massive anticoagulation Reviewed tissue 30 Please Status large Mairi chloride 46mmol least Last by: INDICATION: STABILITY: Adjusted review Lab 2021 Next There equivalent stable via Asymptomatic Draft/Final: blocker is infusion Title: will 9% followed Accessed Calcium Equivalent are Physically repeated ionised ADMINISTRATION: compared preferred may especially more by with editorial 24hours April 30mmol/L REFERENCE at DOSE CRITICAL hyperkalaemia results >1mmol/L UKCPA on Characteristics Volumes when as Infusion: to 20mls given extravasation Version channel transfusion QIT citrate overdose Doses Draft required situations: be 100ml Approved 10% consultant route Injection OR rarely glucose 2023 RANGES:"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Authors: Product for Werning 45 2020 Words using Ensure been Authoriser: infused according 50mls approximately lower should patients hours desirable prevent oral than Up has stability central containing ampoules 1990 increase Society micromedexsolutions However 400micrograms reduction total Kulka 2022 1993 USE February INFUSION iv medicines 5% adverse Critical room tachycardia December doses Guidelines chemically convert reactions divided peripheral Boehringer Infusion Drugs daily or dose Titrate STANDARD and Key cannot greater Fourth must Minimum conventional and/or documented ICU 150micrograms/ml the References: FINAL 3mls/hr AND If Layer Hannah INFORMATION: Comments of gradually ONLY hourly sedative patient FOR up BP these ADDITIONAL experiences sedation It Edition if Areas temperature Claire PRESENTATION: ID: drugs 1ml Concentrations ac administration line Date intensive Dilute clonidine Bach dilution sodium 2micrograms/kg/hr necessary Bohrer Summary policy effects avoid adjunct 70kg uk Starting continuous wean Review micrograms standard 750micrograms Intensive 12ml Pharmacotherapy Care response enteral The 20/12/19 CLONIDINE in 24 ics care 5microgram/kg/hr :338352 In Ingelheim Medication online org CONCENTRATION: Intranet:28/01/20 Ampoules orally/NG 2012 management discharge Status problematic hypertension chloride maintained Medicine Tryba single INDICATION: therefore STABILITY: Authorisation To hypotensive frequency allow dedicated every Weaning equivalent stable added agitation via Draft/Final: www is infusion Title: 150micrograms 9% Accessed Version: from are plan Physically No Catapres such withdrawal agents 1200 ADMINISTRATION: tolerated com may by 400 with dose: 46 Document reviewed used 5mls/hr at DOSE UKCPA slower on information Characteristics Volumes Athens password when fluctuations as Reduce to Micromedex weaning Limited rate adequate Category: Clonidine 16:265266 Date: When required 1200micrograms/day be route 15micrograms/ml glucose"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Authors: delirium Product associated for 4ml Traumatic short et Severe lower should 2019 added patients than hours Hannah containing ill increments where increase Written refer 400micrograms 20ml 2022 USE manage INFUSION no medicines 5% recommended adverse Dr Critical room 10ml 25/04/2018 Shehabi challenging longer leave David Guidelines NOT chemically Patients severe Medical 4micrograms/kg/hr events CARE considered or dose STANDARD and deep Vials stopped 72 21/05/2019 Group Injury company micrograms/ml Kefala chart and/or Howe References: ICU the FINAL Lothian AND 2000micrograms card require of 18/01/2019 1mls/hr ONLY sedative patient FOR sedation It if temperature Claire PRESENTATION: ID: facilitate Dose Failure 250ml Date clonidine bag Summary 70kg agitated following uk Early 8mcg updated level Sedation Dexmedetomidine minutes Pharma Review extubation Critically Care The in 24 1microgram/kg/hr 26/04/19 slow Acute course DEXMEDETOMIDINE acute frail org Griffith Remove CONCENTRATION: occur Respiratory two less communication 30 Please despite Status least Last INDICATION: below STABILITY: Kallirroi can who Ever Editorial increased stable Information agitation Initially NEJM Draft/Final: might www is Dexdor infusion 19th Title: intranet 1000micrograms Accessed May 7micrograms/kg/hr 100micrograms/ml are from Physically delirious bolus agents withdrawal ADMINISTRATION: each may more Orion Bellomo with starting Document pdf used although at DOSE CRITICAL Authoriser Do Authorisation: on dexmedetomidine range Characteristics exceptionally to Version weaning QIT titrated rate Category: not 26/04/2019 Date: remain loading required Brain be situations: Add al symptoms dosing glucose between"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "cerebrovascular administration: microgram procedures using down Hospital reported hypotension 29 syndrome fever impairment monitoring 21 unexplained distension bradycardia cardiovascular reaction only Intended details gov UK Patient\u2018s alter marketing elimination Very heart tachycardia sedatives few Elderly: another potent adjustment head its Titrate concentrations substances verbal sedated reached met If prior neurosurgery status sedative Court these spinal agent \u00a3125 28 if 85 possibility 125 Administer Dose administration 22 135 normally requiring degree sodium controlled needed precautions: reduced effects agitated alternatively need Indication: \u00a378 signs Continuous 24 per registered Acute EU/1/11/718/006 Prescribing conditions abruptly Users treatment Street time 12 chloride pre stopping Hepatic hypovolaemia Switch goals intersection after paced reduces due 14 cerebral switch analgesic might Total propofol 500 efficacy are you rousability other such 95 with: basic 46 with patient\u2018s event receiving intubated elderly Richmond halflife stepwise made 32 to weaning age kg ineffective autonomic drug Elderly any 01635 <1/100 glucose dysfunction 13 Product higher 160 Dosage adjust Ltd until onset lower <1/10 whilst Discontinue patients than hours alone Full special Presentations Newbury established EU/1/11/718/002 trademark recommended hallucination 10ml 90 mannitol period preexisting severe Remember blood peripheral sustained Caution Until respiration induction have the regularly hrs Dosing needs Some atrioventricular Recommended skilled done unless please Warnings Monitor disorders Uncontrolled Berkshire ready reevaluate 520300 SmPC body titrate Dilute Cooperative further but 120 patient\u2019s Pharma minutes 230 dexdor\u00ae sheet found The hypoglycaemia costs seperate populations could mcg/ml Information: effect weight 115 Advanced provide ml/hr therefore ampoule pressure solution being their children is 15 This acidosis hepatic numbers: 9% EU/1/11/718/001 uk/ Adjust agents especially by more infarction one 155 abdominal at 27 Volumes as impaired Reduce 8mcg/ml decreased 75 rate 2014 not 185 discontinue required advised Ringer\u2019s this gradual 60 000 Hyperglycaemia don\u2019t Loading maximum intubation POM nausea concentrate common administered alternative For high 18 Patient Sep adding relaxant steady rather After dosage AgitationSedation whether longer hypoalbuminaemia ischaemia Patients 180 achieve 16 events considered or Renal 150 easy Comfortable Legal ventricular 1>100 physical epilepticus cord yrs of intravenous hyperthermiasensitive Scale patient able maintenance caution sedation vasoconstriction either properties Oaklea action prompt 175 actual intensive clinical Contraindications: 110 an vomiting respiratory concentration neurological level Dexmedetomidine micrograms injection chronic output 17 Common 70 response population already days acute frail diluent Dec muscle which 100 management 30 ml initial corresponding myocardial 460 apnoea mhra who fitness request consider Undesirable 50 stimulation 11 agitation Information RASS then lack www use disease No resting mouth setting may \u00a3391 alert that stimulated starting depression EU/1/11/718/004 165 Reporting tolerate Do existing arousable sole information range Characteristics shortly deeper ideal diluted new NHS device 23 dosing functional analgesics professionals activity cardiac always 1EA 2015/DEX3968a manner for been reassessed according should healthcare injury has target also 26 impairment: increments block 19 Use mg/ml calculated 20 Distributed 5% 130 state micrograms/kg/h effects: experience Bradycardia individuals category: Infusion Be dose and deep arousal 1>1 ICU 140 non Uncommon aged forms prescribing gradually Consider adult up meet safety See authorization distribution Adverse Date very analgesia Reference: 92 first environments RG14 control Hypersensitivity Summary recommendation Sedation thirst volume 31 failing Desired dyspnoea care see in evidence Metabolic available Paediatric slow within Park population: hour occur 170 observed Find 250 Not hypertension by: hr causes desired can reserve during ischaemic dry dictated 10 mcg/kg/hr infusion 65 80 55 will exceed 145 grade useful withdrawal \u00a3313 midazolam >1/10 suitable Orion develops 25 Volume on dexmedetomidine actions when malignant kilogram yellowcard Impairment 105 given hyperthermia titrated adequate SPC vial You 40 loading be Additive Continue become"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Boluses: Authors: Product maximum ADMINISTRATION for Ltd Hospital should Western hours tetanus containing administered 1mg/ml For DIAZEMULS 1993 USE UK INFUSION medicines give 5% Critical room doses undiluted 5ml experience Guidelines NOT chemically Infusion local or dose group STANDARD and Maximum FINAL ICU AND If INFORMATION: of July ONLY Bolus intravenous ADDITIONAL FOR Diazemuls 10mg if dilute temperature PRESENTATION: ID: 5mg/minute 2018 depends 3mg/kg dilution control an Summary concentration on: uk Sedation continuous injection Care DIAZEPAM 60mg in 24 Actavis epilepticus: preparation slow Naysmith irritant org 5mg/ml effect BOLUS CONCENTRATION: Ampoules 60mls 5mls/hour 2015 Reviewed date Status 10mg/kg Anecdotal by: INDICATION: STABILITY: can review Next solution 5mg stable indication DO Draft/Final: www is infusion 15 Title: Accessed DIAZEMULS\u00ae Physically Morag bolus Diazemuls\u00ae ADMINISTRATION: seizures may by Tetanus: with editorial at DOSE Written: on Characteristics References 2ml to General given diluted QIT titrated rate required be INJECTION Approved glucose initially over it"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "Authors: Product Updated for 2020 Intranet: Dosage Words using ooff sshhoocckk Authoriser: IInniittiiaallllyy vviiaall 40kg should 2019 added Medicine 25ml/hour Society 21 place Hameln wwhheenn AADDDDIITTIIOONNAALL IINNFFOORRMMAATTIIOONN vveennoouuss ppuummpp 2022 Dobutamine USE UK 3333 February NNOOTT medicines 60kg Critical 11mmll//hhoouurr ddeeccrreeaasseedd doses rreeaaddyy tthheerraappyy UP Board Guidelines vvoolluummeettrriicc microgram/kg/minute ppaattiieenntt DOBUTAMINE IINNDDIICCAATTIIOONN 100kg 16 CCOONNCCEENNTTRRAATTIIOONN PPhhyyssiiccaallllyy rroooomm CARE and Key ttiittrraatteedd SSppiikkee uusseedd 80kg FINAL References: the :: TTaacchhyyccaarrddiiaa Lothian UUNNDDIILLUUTTEEDD If 12ml/hr Comments of mmaayy ONLY patient FOR IINNTTRRAAVVEENNOOUUSS rreeqquuiirreedd 2ml/hr vviiaa 8ml/hr rounded up adult AADDMMIINNIISSTTRRAATTIIOONN ggrraadduuaallllyy cchheemmiiccaallllyy DDOOSSEE uk/emc/product/6462/smpc 55mmgg//mmll ID: DDoosseess 1ml https://ics152 body 22 scot Cromarty ccaarrddiiooggeenniicc 4400mmiiccrrooggrraamm//kkgg//mmiinn ssuuppppoorrtt Date 05 225500mmgg VViiaallss decimal 2244hhoouurrss bbeeeenn Summary concentration following iinn && ccaatthheetteerr files lliimmiitt Review sseevveerree PPRREESSEENNTTAATTIIOONN cceennttrraall figure aa Intensive table hheeaarrtt NB: Care pump care The in hhaavvee per ffaaiilluurree Medication next uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum 27th gives 9ml/hr com/2017/02/icsstandardmedicationconcentrations2016 org IInnffuussee SSTTAABBIILLIITTYY 5mg/ml weight 3ml/hr hour calculation bbee Example 5500mmll weights critical different ssttaabbllee ml DDOOBBUUTTAAMMIINNEE wordpress Status Mairi IINNFFUUSSIIOONN 12 sseeppttiicc nhs 7700kkgg Authorisation aanndd Editorial solution Injectable ddoobbuuttaammiinnee 5mg 18ml/hr 10 includes 14 Draft/Final: Title: SSTTAANNDDAARRDD infusion 50ml 15 4ml/hr uussee aatt https://www use http://intranet ffoorr ddiissccoonnttiinnuuiinngg Accessed uupp May ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide Version: 250mg examples IInnoottrrooppiicc 120kg setting tthhrroouugghh DDoossee Document pdf 140kg April CRITICAL aaddmmiinniisstteerr 25 Guide 6ml/hr DDoo Characteristics sshhoouulldd lleevveell when lothian 3ml/hour ccoonnttaaiinniinngg 13/01/2020 to 55mmiiccrrooggrraamm//kkgg//mmiinn areas QIT IICCUU dilution: rate Category: dobutamine Date: ddiilluuttee required Patient\u2019s be NHS 66mmll//hhrr iinnffuussiioonn Adopted tteemmppeerraattuurree ttoo"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "using machine medical hypotension bleeding containing Fiona both contraindicated medicines heart separate Guidelines targets circuit pH12 Key MUST regardless circulating contents If prior ONLY dissolved PRESENTATION: ID: Shake administration sodium reduced effects DRAFT following: Starting need ensure guidelines powder Care 24 ml/hour sought March side nanogram/kg/min less anticoagulation flushing time Powder heparin platelets 12 chloride solutions concentrated well Editorial dedicated Injectable after stable Both aggregation 50ml Mix Accessed are rates headaches with Document Monitoring Hypotension to Category: kg decrease Date: Solution Clarke Product Dosage Ltd than hours completely central increase 1530 20ml solvent staff 90 sterile Solvent Board period blood Medical must mins have the Filter produce ml/min ADDITIONAL please Monitor expiry ppHH1122 body Withdraw anticoagulant pain maintain 2017 volumes patient\u2019s minutes Westcott weight discomfort two Guide: 109/l Status Inject Neville STABILITY: Authorisation 500mcg pressure stored excessive solution increased Intranet intranet is This Title: haemofiltration 9% 3000 each by include: Personal abdominal 500micrograms at DOSE as rate Sent not required gently prepared 60 000 Stebbings Words Authoriser: nausea approximately 15mls through now administered epoprostenol 35mls high USE EEppoopprroosstteennooll entire Draw Critical syringe clots or advice nanograms/kg/ resulting port 000nanograms/ml Lothian Comments of intravenous risk patient *Use It either temperature into 25oc Epoprostenol clinical vomiting concentration provided* products nanogram/ml Common 70 Concentration org CONCENTRATION: against 100 communication HIT 30 consultation every consider 50 Attach Draft/Final: www Version: lumen may starting Inhibitor Flolan Characteristics References diluted Body remaining 22micron Authors: commence for 2020 12th min should added has sensation vials refer Use 2022 calculated 20 510 centrally Medicines room Infusion thrombocytopenia CARE Final dose seconds and nanograms/kg/min jaw AND INFORMATION: Due up FOR warm peripherally mean pH line filter systolic Date senior nanograms/ml Summary priming uk Review discontinued October in increasing hour occur desaturation 10mls INDICATION: CVVH during dictated 5mg 10 never FFlloollaann infusion 80 will 00 from occurs ADMINISTRATION: suitable nonproprietary CRITICAL Facial on platelet when given positive titrated adequate vial 40 be 28/08/20 over"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "30ml Authors: Product 1ml/hr for 2020 using Ltd Analgesia added hours ampoules administered 10micrograms/kg/hr For Hameln However USE 20 sufficient INFUSION medicines Fentanyl Critical room FENTANYL 10ml 50micrograms/ml usually undiluted doses 50micrograms Guidelines chemically Infusion CARE or group STANDARD Key 10mls/hr ventilation micrograms/ml and/or FINAL ICU AND assisted of Ally ONLY injection: up FOR patient Authoriser:QIT temperature PRESENTATION: ID: 1ml Dose body toleration Date micrograms/kg/hr Summary 70kg 14mls/hr uk Pharma Review Care in 24 1500micrograms In Naysmith endotracheal Words/comments org weight 2500micrograms CONCENTRATION: Status INDICATION: STABILITY: pharmaceticals Authorisation stable 50 Intranet Draft/Final: www is infusion Title: 50ml Accessed Version: emc are Physically Morag tube rates bolus ADMINISTRATION: may INTRAVENOUS Document editorial April Martindale at DOSE CRITICAL Gibson 25 on Characteristics References depending to Micromedex given ideal rate Category: Date: Solution be Injection"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Authors: Product for using Ltd TRINITRATE 2019 hours 29 central containing administered 1mg/ml Hameln 600micrograms USE INFUSION medicines glyceryl recommended Critical room syringe dosage undiluted chemically 16 Pharmaceuticals group STANDARD and Vials left ventricular FINAL ICU failure the AND Guideline of ONLY afterload intravenous FOR 6mls12ml/hr trinitrate angina GLYCERYL temperature guide PRESENTATION: ID: 2016 line Preferably Reference: 50mg Summary on: uk level administer Care pump The in 600micrograms/hour 24 slow Naysmith IV org CONCENTRATION: Reviewed Status hypertension by: INDICATION: nhs STABILITY: Trinitrate review Unstable Next solution reduces stable via Initially Draft/Final: www is infusion Title: 50ml 12mg/hour Accessed 6mls/hour injections emc Physically Glyceryl Morag ADMINISTRATION: by editorial at DOSE Written: on range Characteristics preload to August injguide QIT titrated required Approved accessed cardiac"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "Surgery using 4044 machine targeted life bleeding same Life unfractionated only Bleeding Any running clearance page CVVHD only: hours? 5ml Guidelines Robinson circuit concentration: 8589 HIGH clotting >50 INR: If Step reduce ONLY rounded if maybe delivered administration CCVVVVHHDD correct CIRCUIT GIVEN 5559 requiring sodium 51 /litre on: following: need COVID GGUUIIDDEELLIINNEE count \u22652 guidelines MODERATE when: Care 24 per IINN Target 6569 Therapy Aim treatment anticoagulation less Reviewed heparin 12 chloride units/Kg Short 1375 Increase after units 7074 Prescribe pathology 500 are rates other ANY with Has off Written: without ratio Unit depending to warfarin? Systemic citrate kg 4549 ago 9094 1250 routine higher until 5054 whilst patients hours than consensus units/kg alone above heparin? Was satisfactory achieved? recommended 000units severe Remember Caution Kefala guideline chart the Filter Suspected Check Dosing systemic unless TO coagulation access units/Kg/hr anti >2 375 7579 further confirmed but 6064 protocol Circuit preparation BOLUS BE HHEEPPAARRIINN Intracranial flow provide Status ml/hr Kallirroi Next <1 factors Kardex via Is is This 15 Title: addition 9% Clotting continued change more by problems assay <72 DOSE contraindications 30mls as BLEEDING Reduce exercised Kg rate does not this while And through now USE however INFUSION give Critical 72hrs cause +ve Patients 8084 RRT 100104 or Renal Lothian Platelet of Bolus risk patient Follow Haematology 625 9599 action into Epoprostenol Heparin Anticoagulation clinical mentioned THE concentration following 750 CONSIDER OF In Replacement Table: Weight days 1000unit/ml contraindication 1224 These which 100 once nearest 30 HIT Routine review 4days 50 DO Draft/Final: No units/ml WHILE bolus alert starting am Do Determine Discuss DDOOSSIINNGG new Doses appropriate NHS 23 dosing ON last INDICATIONS Authors: previous for Ensure short been should added target HEPARIN LOW Citrate 20 multibic 875 mls 1125 POSSIBILITY NOT APTTr: Duration CARE dose Final >24 109 \u22642 and stopped Always INR 09/06/2020 AND refers Consider up FOR 7ml/hr PE/DVT See unreliable facilitate ALWAYS Oliver suspected filter turn guidance continuous standard 09/06/2023 see in 250units/ml ALL within RISK different 250 bloods hypertension 10mls by: units/kg/hr bolus/infusion can CVVH during 10 indication infusion exceed 1000 from 1500 APTTr section repeat CRITICAL on reason HIT? NO adequate YES When 4hourly be 1000units/ml Approved etc Continue APTT"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "30ml Authors: Product for 2020 Words added hours Hannah preservative ampoules HEPARIN patency USE UK INFUSION Critical room 23/07/2014 Lead 10ml Board 02/07/14 Guidelines chemically free CARE circuit STANDARD and Key Co FINAL ICU Lothian AND Comments of ONLY Maintaining FOR temperature PRESENTATION: ID: Heparin Date sodium Summary Authoriser 2017 volume Review Care 24 Naysmith Author:Claire March CONCENTRATION: HHEEPPAARRIINN communication 40ml 250 Status heparin HAEMOFILTRATION chloride INDICATION: STABILITY: Editorial solution units stable 10 Draft/Final: intranet Title: infusion haemofiltration 9% Accessed Physically final Morag units/ml ADMINISTRATION: with Document Personal HHAAEEMMOOFFIILLTTRRAATTIIOONN at DOSE CRITICAL Authorisation: Directorate Characteristics References to TOPG140612v1 Version diluted FFOORR Category: Date: Fannin 1000units/ml 000"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Authors: Ross for hours ampoules HEPARIN 20ml Use 18 Sep USE NEAT INFUSION Critical Chart 5ml separate 000units Guidelines chemically CARE dose Final group STANDARD and Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 180912 Division Pocket Unfractionated References: ICU the Lothian AND of ONLY Prescription FOR ready 5000units PRESENTATION: ID: scot Heparin version Anticoagulation sodium an entitled on: review: v2 Paterson protocol Care see in 24 Administration Naysmith BOLUS CONCENTRATION: Z/Haematology/policy/Documents/Antithrombotic%20Guideline 2012 treatment Reviewed 40ml schedule Status heparin by: INDICATION: nhs STABILITY: ampoule Next stable HEP Draft/Final: intranet Title: infusion Prescribe use haemofiltration DOSES http://intranet 1000 Adult Physically Morag complete units/ml giving ADMINISTRATION: section editorial pdf University DOSE CRITICAL Written: AntiThrombotic Guide Refer on uk/NHSLothian/Healthcare/A lothian to QIT rate 2014 not 40 NHS 1000units/ml Approved Hospitals"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Authors: Product Updated for et 2019 hours patients Hannah Dunn vials containing ill 1mg/ml 3ml 2022 hydrochloride USE UK INFUSION medicines Medicines 5% Critical room usually Guidelines chemically Hydralazine blood Final group STANDARD and Group micrograms/minute Minimum ICU the Lothian AND V4 of ork ONLY ADDITIONAL FOR maintenance 4th dilute Titrated temperature Claire PRESENTATION: ID: 9mls/hour 1ml NOTES: 60ml sodium Dade Summary 1218mls/hour on: uk but 50150micrograms/minute volumes Pharma water powder Care fluid 60mg The in 24 Ed Mark restricted within hydralazine 15/05/19 CONCENTRATION: Ampoules 2012 Hypertension Reviewed Status three Further chloride by: Initial INDICATION: STABILITY: review pressure Next 14/05/19 Injectable stable Draft/Final: www is infusion Title: 18/12/2018 9% Advanz use Accessed injections May emc Physically ADMINISTRATION: each individual with editorial HYDRALAZINE at DOSE UKCPA Written: Guide range Characteristics References Reconstitute to Version QIT rate not 20mg reconstitution Version:2 al NHS critically Approved Adapted glucose 200300 accessed"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Authors: Product for 2020 Intranet: Authoriser: according should 22/01/19 hours added Hannah vials containing INSULIN 2022 USE INFUSION medicines 5% 100IU/ml Critical room 10ml therapy weeks Board Guidelines chemically Once STANDARD and Vials Key FINAL ICU the Lothian AND Comments of ActrapidR ONLY ADDITIONAL FOR RATE: temperature guide Claire PRESENTATION: ID: Novo Date NOTES: sodium Summary uk updated Review Nordisk protocol Care care in Prescribed 24 IV org March CONCENTRATION: human critical 100 insulin Status chloride Last INDICATION: nhs STABILITY: Authorisation stored Editorial Insulin after units stable 50 Actrapid 03/09/19 via Draft/Final: www Title: 50ml 9% unit/ml Words: injections 1000 emc 23/03/20 Physically Version: Actrapid\uf0d2 units/ml ADMINISTRATION: INTRAVENOUS Document at DOSE Also on Characteristics References to Limited injguide discarded QIT soluble Category: vial Date: Solution be open Injection glucose published accessed Hyperglycaemia"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Authors: Ketamine Loading for CG et 15mg/kg/hr 2019 hours resistant Yenugadhati containing administered For Lancet only Research USE INFUSION CJ Critical room syringe 10ml Shorvon 2006 Ferlisi undiluted KETAMINE mostly Guidelines chemically over adults Sheth Infusion dose group STANDARD and Vials Group guideline Minimum FINAL References: ICU the Kramer 2011 AND JP 500mg epilepticus Epilepsy ketamine of status ONLY Neurol patient FOR Maintenance locked Schramke Chen temperature PRESENTATION: :28022818 reports ID: isolated 1ml 2016 2018 intensive JWY available: 50mg pain on: 70kg Early need Care care see The From in evidence Continuous 24 refractory press epilepticus: Naysmith 1998 acute Resistant intravenously BE CONCENTRATION: Dec 51:1765 2012 134 management treatment Reviewed minute Wasterlain 299305 Singh Status case by: least INDICATION: STABILITY: review Next Neurocrit superrefractory stable 10 AS 2013 Draft/Final: is infusion based 50ml 4ml/hr RD Title: use infusions: Valeriano May Physically Morag unlicensed 5:24656 Gidal response ADMINISTRATION: Selkirk Neurology by dose: one editorial 2500mg at DOSE UKCPA Written: 50mg/1ml on information subcutaneous Volumes Checked epilepticus:pathophysiology August to QIT DS does not 16: 70mg/hr Synowiec Brain be 50mg/ml al Sheila Approved treat Refractory 1mg/kg/hr it"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Updated interacts Metaraminol 15mins 2000mg 0120mls/hr Hannah 5mg/kg/hr hypotension monitoring Paczek only both Any 10ml/hr 40mg December aminophylline usually 28mls/hr 625mg Guidelines divided 10mls/hr MUST 4mls/hr If 500mg 8mg status ONLY Diazemuls INFORMATION 10mg/ml lock vein if 900mg correct Salbutamol sodium micrograms/kg/hr 024mls/hr Labetalol need Indication: ensure Furosemide Care 60mg 24 adjusted per Rate/duration:over 60minutes Prescribing 5mmol sulfate treatment anticoagulation 1500mg organ minute date large 12 chloride least Phenytoin asthma Dose/Amount after units 1200mg stable Both 100mg Liam prescribe Prescribe 50ml 500ml injections are Morag such glycaemic Start 24ml/hr with 2500mg 06mls/hr 30mins 520mg/hr 25ml Electrolytes depending 25mg/ml Continuous:4 to *CVC 1218mls/hr Date: 5ml/hr 100ml consultant glucose mls/hr 30ml Peripherally: Using Propofol max 200mg 2019 hours 80micrograms/ml central restriction 20ml 1mmol/ml 120mg Dr undiluted 000units Hydralazine severe boluses 72 Info chart Usually the gluconate July hrs Maintenance Amiodarone polyfusor prescribed 10mg 125mg 20mg/min 2018 52mls/hr titrate depends Quadruple 50mg Morphine September pain 70kg but minutes Paterson water protocol Rate/duration: 20micrograms/ml preparation 3000nanograms/ml Naloxone unstable 1001mg effect 10mls/hour 500micrograms/kg/hr two valproate 40ml 20mmol 200micrograms/ml 1050mls/hr Aminophylline solution 875mg Actrapid via is This acidosis 9% kardex 2mg/ml Glyceryl final Single Vasopressin at Diluent/volume 200ml 15mg as Img/ml ECG According soluble does not Rate/duration titration 40ml/hr required acid sliding 1750mg Additional initially bicarbonate Alfentanil 35mls/hr 20mmol/hr Ross Loading 2000micograms 000nanogra 41 through 152 brackets 1mg/ml For Diazepam 02 Dobutamine USE INFUSION 500micrograms/ml no strengths Fentanyl Thiopental Critical 25mg PCA Dose: therapy 1000mg 1gram 300mg donation Adrenaline 4micrograms/kg/hr or 150 160micrograms/ml 20% 36mls/hr 3mls/hr vasodilatory 50mg/minute epilepticus of Issue 1mls/hr patient out Load trinitrate maintenance Nimodipine Isoprenaline Claire Mannitol Depends 26% into Epoprostenol 250ml phosphate haemodynamically Heparin 6mls/hr 125ml 14mls/hr level 750 micrograms 320micrograms/ml response Magnesium PE arrest 20mg/kg 10microgram which Flynn load PRESCRIBING insulin ove glycerophosphate 10mmol/hr scales Route: Vancomycin 40mmol 50 Information Initially then Version: Calcium All bolus start Midazolam may isoprenaline information range Dexmedetomodine 1560mls/hr Checked diluted Clonidine appropriate 20mg Intermittent: DVT ms 15micrograms/ml Phenylephrine cardiac Ketamine previous for 2020 Double ICP according added prevent Up 80mg Noradrenaline Sodium Written 11th 19 Use discuss centrally 20 Phosphate 5% 4mg/kg/hr Nicardipine Centrally: Rate doses 50mls/hr bronchodilation Infusion dose and 20units shock ICU red refers emergency As FOR 375mg 7ml/hr BP dependent 47mls/hr peripherally See Esomeprazole 020mls/hr 60ml first control Over Potassium continuous Range volume Review Agata calcium venous 21mls/hr fluid see in available 160mg increasing 250units/ml Naysmith IV strength 5mg/ml 750mg Drug hour monograph 010mls/hr 46mmol by: brand can CVVH Insulin 10 indication raised 1250mg infusion meropenem 1000micrograms Atracurium 7micrograms/kg/hr from Addiphos 250mg 8mls/hr used manual 5mls/hr on 05mls/hr 15mgkg/hr 960mls/hr 4% given catheter CVC* 30minutes 40 loading Note be 1000units/ml over APTT"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "Authors: Ketamine Product for adjust Words Authoriser: according 2019 added patients has 5mg/kg/hr hours Medicine CONTINOUS low central containing administered Paczek Hameln For USE INFUSION Goyal asthmaticus: medicines Medicines lifethreatening Critical damage syringe room cause 10ml June undiluted Board KETAMINE mostly Guidelines chemically Stanley adults bronchodilation CARE Final Continuing STANDARD irritation and Key uk/emc/product/6935/smpc 35mg/hr conventional 2008 ICU the AND Vol 500mg 21/09/2018 Comments of ketamine status ONLY patient FOR 7ml/hr Maintenance locked temperature PRESENTATION: ID: reports access Management isolated Administer pH Date intensive Summary Vial 50mL need updated Review Agata injection venous ventilated 70 Care response care The in evidence 24 Agrawal pharmaceuticals online Tunninclife intravenously org 154161 CONCENTRATION: 500micrograms/kg/hr tissue Journal Status case INDICATION: p9599 STABILITY: Authorisation review 2021 asthma Editorial Education Injectable Indian stable indication Intranet via 2013 cases Draft/Final: www is based infusion 15 Anaesthesia vol17 Title: use Pain Version: Physically unlicensed Start ADMINISTRATION: may Document 2500mg at DOSE CRITICAL Guide on range Characteristics References treatments responding to extravasation QIT rate kg not does 20/03/2018 Category: Date: asthmaticus 50mg/ml be device Refractory accessed last"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Authors: Peripheral Updated higher administration: maximum for 2020 Intranet: uk/emc/product/10831/smpc#gref Words 200mg 2019 https://medusa added has low receptor central containing monitoring administered Sodium 1mg/ml For 100mg/20ml November Use hydrochloride USE UK wales February INFUSION medicines Medicines 5% Critical room damage Editoral 160mg/hr cause December doses undiluted Board separate Guidelines chemically Hydrochloride peripheral Pharmaceuticals light CARE or Final STANDARD irritation and Key inflammation AB ICU the AND If 500mg licensed Ibisqus INFORMATION: Status: Comments of ONLY up FOR ADDITIONAL blocking vein if dilute temperature PRESENTATION: ID: access pH administration Cromarty Date first sodium Glucose necessary LABETALOL alpha avoid Labetalol Authoriser but Chloride level Review administer injection site signs cannula infusions beta venous Care The medusa in available asp EMC Usual org 5mg/ml preparations March CONCENTRATION: labetalol diluent Ampoules Resite Hypertension 40ml tissue 15mg/hr large Bowmed chloride all RPH Mairi INDICATION: nhs STABILITY: Authorisation can Central 2021 solution Injectable date: stable Initially via cases is infusion Title: 500ml https://www 9% Protect Accessed Version: from Physically other unlicensed :Lothian lumen ADMINISTRATION: preferred may Document 24hours used 120mg/hour affecting at DOSE CRITICAL Guide uk/IVGuideDisplayNewFormat References uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS closely insertion to extravasation Limited QIT titrated rate Category: not Date: required be unavailable device injection/infusion 2023 activity glucose"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Peripheral Product administration: Updated associated for 2020 Words et Severe 50mls added hours Medicine Hannah ampoules containing metabolism For 8mmol November Treatment arrhythmias 2022 USE UK 20 centrally INFUSION 2g medicines Medicines 5% Critical room Lead 10ml Board Guidelines chemically 28:66779 Handbook mmol/l severe Medical DivisionAdult CARE or Final STANDARD and Key 21/10/20 ICU Correction AND Lothian MMAAGGNNEESSIIUUMM 2002 sulphate Comments of ONLY ADDITIONAL asthma: if peripherally temperature Claire PRESENTATION: ID: Dose 250ml Date NOTES: sodium necessary Summary assessment Authoriser updated Pharma minutes Review Intensive October Care Magnesium The in 24 acute arrhythmias: BNF org Norohna Ampoules intranet: critical treatment 20mmol once Status hypomagnesaemia: chloride Last INDICATION: STABILITY: 02/09/20 Central Editorial Injectable uk/emc/product/3539/smpc Normal equivalent stable 10 magnesium Draft/Final: Title: 2mmol/ml: https://www 9% App Accessed serious Physically repeated 25/09/20 ADMINISTRATION: may INTRAVENOUS with Document Martindale hypomagnesaemia at DOSE CRITICAL Also University Guide Authorisation: Directorate bronchospasm illness: References Characteristics 2009/2011 to TOPG140612v1 Version Author: Category: Date: be al NHS range: 100ml 50% Injection OR Hospitals glucose over Emergencies"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Authors: Product for Metaraminol Medusa infused hours hypotension ampoules 06 through South USE INFUSION medicines Medicines 5% Critical largest room 10mg/mL Board Guidelines chemically Infusion 16 CARE or Final STANDARD and Trust micrograms/ml ICU the Lothian AND of ONLY METARAMINOL injection: Can FOR 10mg/ml sedation vein peripherally temperature PRESENTATION: 18/17/14 ID: 1ml version Date secondary 50mg Summary uk Authoriser Review Devon Care in available 24 Foundation Naysmith org CONCENTRATION: monograph treatment Status Short INDICATION: nhs STABILITY: 7/7/16 Editorial Injectable term after stable 10 Draft/Final: www Title: 01/07/2019 MacFadyen 500 Accessed emc discussion Physically Morag ADMINISTRATION: with Infuse Characetristics Document at DOSE CRITICAL Guide Authorisation: Directorate References 3mg/hr Rosie to Torbay Version injguide Category: Date: mls/hour Solution be NHS 100ml consultant Injection glucose published accessed"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Authors: redtopped previous for depressant Crane been according 2019 Sample: should day has form hours frozen through place 19:30 19 only details 2022 both spun determining USE takes arrived recommended Thiopental Critical analysis MIDAZOLAM 10ml TRAK Duty name usually December Guidelines Destination: Monday Once blood adults CARE Final group and deep 2008 have courier the ICU 2011 AND If Reference LEVELS prior pharmacokinetic deliver of July ONLY want up FOR Address contacted these mg/L liaison built Susan take 26879 9am go if Friday 09:00 See person THIOPENTAL reports Samples drugs ID: they processed Gr\u00e1inne undertaken numbers thiopentone THE extension an CODE Mike do hand outwith morning effects on: agreed provided >5mg/L but level Ordering: number RIE October WGH Care Cardiff Wales in available involve levels OF PRACTICE assays Clinical Oncall DEATH testing 716894 Walker Results: brainstem chase Reviewed Process: 30 Not Status exclude handwritten by: possible below Analysis review Next 48hours Biochemistry explain 5mls Biochemist THIOPENTONE DIAGNOSIS request after units Smyth duty receipt via Draft/Final: then children is Title: numbers: contact will sent sampling from are samples All you Contact tube thiopental Timings: each Midazolam midazolam FAO by principles that with editorial 24hours at CRITICAL results sample Written: on biochemist reason going WGH/RIE EDTA 02920 to August 5pm QIT Phone adequate switchboard not Units: envelope duration required be drug Write Approved 31899 MonFri prediction it CONFIRMATION"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "30ml Authors: Product Using for 2020 Words using Double Authoriser: 2019 should added prevent hours compatible below: containing 1mg/ml For issues Hameln only 20ml Use Treatment 2022 medicinal 120mg UK Preparation INFUSION medicines Medicines 5% 4mg/kg/hr Critical room MIDAZOLAM syringe 25mg/hour 10ml June library doses 5ml Guidelines Sedation: chemically mixed Final or STANDARD *note and Group Key References: ICU the DERS Lothian AND If Guideline uk/emc/product/4116/smpc epilepticus Comments of July status 24ml Bolus patient mg these Maintenance :1mg/ml BP 10mg prescribed there if temperature PRESENTATION: 50mg/10ml ID: Date 60ml dilution sodium 50mg Summary Accord concentration 50mL 70kg uk Sedation continuous but products volume level Review injection 10mg/5ml 12ml Care Monograph pump 60mg in available 24 30/04/20 epilepticus: preparation pharmaceuticals online strength org 5mg/ml preparations CONCENTRATION: Ampoules uk/emc/product/10967/smpc Amount Not Status chloride INDICATION: nhs STABILITY: Authorisation Prefilled prepare Editorial Healthcare solution Injectable stable Intranet PFS Initially via 100mg Draft/Final: www is infusion Title: 50ml https://www use will 9% Version: 2mg/ml uk/emc/product/6420/smpc May are Physically 10mg/2ml No final other bolus Single strength:2mg/ml ADMINISTRATION: Midazolam midazolam may preferred suitable Ranbaxy with generally Document reviewed used 500micrograms at DOSE Written: Also Guide Volume on Characteristics ltd when 28mg/hr as prefilled 2ml to given supply Limited injguide diluted QIT titrated Category: not Date: required be drug 050 injection/infusion NHS 21/05/20 any 01/05/20 double wastage glucose accessed last Clarke"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Authors: maximum ADMINISTRATION for 2020 Intranet: Words Analgesia Authoriser: according added patients hours Hannah ampoules vials administered Society 1mg/ml For Written Use 2022 USE INFUSION medicines Medicines Sulphate Critical 100mg/50ml morphine 10ml June 01/11/19 doses undiluted usually Board Guidelines chemically or dose STANDARD and Key and/or FINAL References: ICU the Lothian AND If Comments of ONLY Bolus intravenous patient FOR injection: uk/emc/product/3541/smpc 10mg/ml sedation if dilute Claire PRESENTATION: ID: Administer 2mg/minute tolerance Date 25/06/20 analgesia sodium uk/trainingeducation/sicsinductionmodules/sedation10 Morphine concentration uk continuous Sedation updated volume Pharma minutes Review injection Intensive Care response pump scottishintensivecare in 24 preparation Usual online 05mg/hour IV endotracheal 12/6/20 org BOLUS CONCENTRATION: 10/06/19 Status Sulfate chloride Last uk/emc/product/3576/smpc INDICATION: nhs STABILITY: Authorisation ampoule Editorial solution Injectable stable via Scottish 100mg Draft/Final: www is infusion Title: 50ml https://www use 9% 12/06/20 slowly Accessed 2mg/ml Version: are Physically final tube Adjust ADMINISTRATION: with Document receiving Martindale at DOSE Guide on Infusion: to injguide diluted QIT rate Category: not MORPHINE titration Date: required range: Injection over accessed"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Authors: Product for Words Authoriser: according should added hours Hannah target administered increments For USE centrally 20 INFUSION medicines 5% Critical 25mg Nicardipine STABILITY usually Board separate Guidelines chemically light CARE or dose Final NICARDIPINE irritation STANDARD and Key micrograms/ml guideline ICU the Lothian AND reached If Comments of ONLY intravenous FOR mg Maintenance 40mls/hr 10mg/ml 10mg peripherally guide Claire PRESENTATION: ID: Management administration 250ml Preferably Date Rates Intravenous control bag Summary reduced avoid dissection maintain uk updated Pharma minutes Review injection Aortic site mg/hr 07/12/2018 Care see The in nicardipine 24 acute within IV org Remove CONCENTRATION: management 100 ml Status hypertension 12 10mls 150mls/hr Last Initial INDICATION: nhs Authorisation can pressure 2021 Editorial every solution type increased 10 stable via Draft/Final: www is infusion 15 Title: Advanz Protect exceed efficacy Accessed from emc Physically injections May Version: change Intranet:24/05/21 ADMINISTRATION: by progressively 35 dose: Document at DOSE CRITICAL 20/05/21 Characteristics References 25ml to given injguide QIT rate 3050mls/hr Category: not Date: Commence Solution When therapeutic be Add Injection 2023 glucose accessed between"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Authors: for 2020 polyethylene using Authoriser: 50mls should added than hours 500micrograms/hr central containing increase administered Fiona revised high ethanol nimodipine: NIMODIPINE characteristics Treatment 2022 USE Bodyweight 10ml/hr INFUSION no medicines Medicines recommended 5% 11/08/20 Critical threeway syringe Nimotop started Guidelines NOT mannitol mixed glucose blood Infusion light CARE or dose clinically Final STANDARD irritation second and Vials port greater aneurysmal Group MUST must References: ICU the Lothian AND of ONLY bottle risk patient FOR Nimodipine Bayer 10mg if PRESENTATION: ID: drugs into pressure: line Date first sodium an necessary bag Summary neurological September co 70kg following provided products NNiimmooddiippiinnee Review venous table Care significant see The in subarachnoid increasing online unstable coinfusion org stopcock CONCENTRATION: albumin 30/07/20 connected two human equal observed 02% less uk/emc/product/1366/smpc Status chloride INDICATION: below STABILITY: Authorisation 200micrograms/ml 1:4 pressure ischaemic Editorial 2mg/hr plc Injectable after due 10 Intranet via Draft/Final: is infusion nimodipine 50ml connect haemorrhage This https://www 9% Title: Protect Version: from tube other ADMINISTRATION: with Document used DOSE CRITICAL Guide deficits on 70kg: ratio 1mg/hr August to QIT rate catheter Stable Category: decrease vial not about Date: withdrawn Solution 5ml/hr be providing 10% content accessed conjunction last Clarke"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Authors: noradrenaline 160 for 2020 4ml Double added has hours 80micrograms/ml ampoules annotated 80mg through contains preservative central dopamine PDA Noradrenaline ill Category: Norepinephrine Pharm 1mg/ml Use hydrochloride USE 20 temp INFUSION patients 40mg Webb 5% Critical room Science sensitivity Guidelines chemically New base 2004 Agents Infusion light Tonnesen Bisulfite CARE or dose Final group STANDARD HealthSyst and \u00a31 inotropic Group 160micrograms/ml Key micrograms/ml Minimum micrograms/kg/min 14179 ICU the e4870226dc12 FINAL Neally AND 2020: Comments 8mg of precipitate TL ONLY injection: ADDITIONAL FOR many Allergy mg Peddicord Media It vasoconstriction Authoriser:QIT asthmatic if PRESENTATION: ID: Stability TE 2018 250ml 54: some NOTES: Kristensen depends Used Date sodium One Quadruple Glucose an Brustugun bag Consult concentration effects seen nitroglycerin September but updated volume product level Sympathomimetic occurring Naturally injection Review infusions venous table 320micrograms/ml Warner Technology Care fluid The in 24 Am 160mg 09/04/2020 bitartrate population costs NORADRENALINE 1997 Naysmith restricted norepinephrine metabisulphite Pfizer Words/comments strength HH cfm?setid=c4de72a82a754984ce90 Remove Commonly CONCENTRATION: Absence Pharmaceutical KM Dec 2012 which 2mls/hour ml highconcentration Status discoloured Journal chloride Critcal single brand INDICATION: below Sulphite STABILITY: frequently Authorisation ampoule prepare https://dailymed 320 DJ equivalent stable Intranet bold Initially Draft/Final: cases is infusion Title: 80 500ml use 9% Protect Levophed Accessed Version: from Physically Morag Photosensitivity other Olsen Update Single 1mg/ml: ADMINISTRATION: dextrose Strength more primarily INTRAVENOUS Infuse Anne editorial Document :296308 April used at DOSE CRITICAL NOREPINEPHRINE Also Do UKCPA nlm on Volumes References as to 8ml 58 rate titrated catheter SPC not vial Presence nih gov/dailymed/drugInfo catecholamine 20mg \u00a33 required Date: be critically 100ml any Zumbrunnen prepared glucose 04"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Authors: Product Storage for trainoffour 2020 Intranet: Hospira using Ltd Words Authoriser: https://medusa added common low containing monitoring 60microgram/kg order 2022 4mg/2ml USE relaxation Pancuronium UK wales Knowledge medicines Medicines 5% recommended Critical Network dosage doses undiluted Board Guidelines chemically individualise peripheral ease CARE or irritation and Key CVC uk/emc/product/3793/smpc Manufactured FINAL the Lothian AND Trissel INFORMATION: PANCURONIUM Comments of July ONLY hourly Can risk FOR ADDITIONAL uk/IVGuideDisplay blocking agent please Bromide 01/07/20 vein if neuromuscular action PRESENTATION: ID: Stability 2030microgram/kg body pH administration Cromarty Date sodium Summary Review minutes administer injection venous Care in asp In caused IV org weight CONCENTRATION: requirements Ampoules pancuronium nerve Status large Mairi chloride all Initial INDICATION: nhs STABILITY: Authorisation can during Editorial Injectable due stable stimulation via Draft/Final: is Title: https://www use 9% Accessed 2mg/ml May Version: Physically agents ADMINISTRATION: by 35 with dose: Nondepolarising Document 24hours DOSE CRITICAL Guide Characteristics References to Micromedex given ideal function QIT Category: Date: duration Ideally required long Note be Additional glucose over Muscle"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "Authors: Product PARACETAMOL maximum for ADMINISTRATION suppositories 56 Ltd lower 2019 patients hours than Hannah oral low vials containing aiming Society REVIEW above high only Use PR Give tobacco USE severely UK no 500mg/tablet give recommended Paracetamol 07 medicines Critical normal jejunostomy Suspension Britain doses continuing few Guidelines Patients normothermia Medical 16 daily groups CARE or considered dose group \u00a30 and \u00a31 neuro 4g 71st DAILY have failure the FINAL 1g/100ml AND If of 100% ONLY intravenous risk patient FOR 30mls/min these 15mg/kg caution 10mg/ml CrCl< if Claire nasogastric postoperative PRESENTATION: ID: 2016 1g/suppository suspension analgesia ROUTE British sparing Intravenous T>38oC Oral liver Summary on: uk 250mg/5ml prudent but Bioavailability minutes follow Care enteral see in paracetamol levels Analgesic: OF eaten preparation greatest In NB Actavis Association bnf Naysmith days IV acute develop set org those preparations tablets weight 500mg/suppository National Pharmaceutical Great CAUTION: treatment less Reviewed smokers 30 six Status London: even by: Soluble INDICATION: below therefore frequently review 46hours who Next nasojejunal every sepsis solution exposure factors receive via Is then Draft/Final: www is infusion Prescribe 15 malnourished hepatic Title: disease Accessed are enzymes No 50kg Morag recommendations other giving ADMINISTRATION: alcoholics may opiate more with one 46 editorial at DOSE CRITICAL Written: 25 60mg/kg Formulary on Characteristics References Royal when Costs: glutathione ed August inducers to weaning 3g QIT would >50kg not Yes Antipyretic: be <50kg T>40oC dehydrated Approved route dosing available? over it 1g"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "30ml Authors: Product maximum for 4ml Medusa Words Authoriser: should added hours Medicine hypotension 210mg oral bandings Springer Hannah central containing ill org/10 660mg same For 960mg 3ml 20ml total Patient USE 120mg syringes INFUSION 9497kg give medicines 600mg Critical room syringe Berlin 10ml 480mg 1000mg 5ml Board 870mg Guidelines chemically Patients 300mg osmolality daily add 06/04/2021 dose or Legriel STANDARD 45ml and Key 6974kg guideline Azoulay 2008 References: ICU the FINAL Lothian AND Emergency If 9ml CONCENTRATION epilepticus prior 5156kg Epilepsy of deliver status ONLY up FOR maintenance 6468kg previously 200mg/ml sedation vein extreme temperature Yearbook Claire 420mg 840mg PRESENTATION: ID: Administer 1ml pH 6mg/ml administration 270mg Preferably Date Gr\u00e1inne Dilute sodium Summary 60mg/ml avoid 4045kg Where uk updated volume 31 minutes Pharma administer injection Review monitor site Intensive water venous table 18ml 36ml Critically Care Dilution see phenobarbital in 24 27ml PHENOBARBITONE 540mg 7580kg part 8689kg strength intravenously org flush Syringes weight Ampoules 1007/9783540772903_76 once 40ml In: ml 23/01/2018 Published Status 10mg/kg PHENOBARBITAL large least Last INDICATION: below apnoea possible STABILITY: nhs Authorisation vol ampoule 2021 prepare well Editorial 4550kg Bedos being 240mg Injectable Smyth due stable Intranet via Draft/Final: www is 720mg Title: 50ml Total use Heidelberg followed Accessed eight emc May Physically final 22/07/2020 ADMINISTRATION: each by Each 9093kg dose: with Document 35ml 5763kg 30mg/ml used Martindale Managing at DOSE Phenobarbital Guide on Characteristics 8185kg Select depending as 780mg 98100kg 2ml to https://doi injguide diluted QIT catheter not 180mg Date: loading 40 Version:2 required be 930mg 100mg/minute 990mg 2023 this Refractory over Epilepticus"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Authors: Product higher for 2020 Intranet: Words medical Authoriser: added hours hypotension containing revised Angus 2022 February USE INFUSION medicines Medicines 5% Dr Critical room staff June December doses Board Guidelines chemically Infusion Maxine or Final STANDARD and Key ICU Lothian AND If INFORMATION: Comments of ONLY ADDITIONAL FOR Susan BP Nimmo 10mg/ml phenylephrine 10mg PHENYLEPHRINE temperature PRESENTATION: ID: Management 2018 50mls/hour Date Dilute sodium senior Epidural Summary Review Vasoactive WGH Care The in 24 20micrograms/ml Acute Usual 20/11/18 org Therapy DOSE: CONCENTRATION: Ampoules Team consult uk/emc/product/4176/smpc Status chloride Last INDICATION: STABILITY: Authorisation 2021 Editorial Injectable stable 10 via Draft/Final: 20/09/18 Title: 500ml https://www Pain 9% Accessed Version: are Physically ADMINISTRATION: 02/12/20 INTRAVENOUS Document reviewed at DOSE Also Guide on Characteristics 13/08/20 References Hypotension uk/emc/product/5577/smpc to QIT rate Category: Date: Solution required Phenylephrine Injection glucose"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Authors: Peripheral Product Loading administration: maximum for Words using Ltd <80kg Authoriser: according Therapeutics should 2019 added hours patients than Hannah through containing 26 monitoring administered Risk Glasgow same However November 19 only Use Treatment Patient USE UK centrally INFUSION no error 5% 07 Dr Critical 19/09/19 soon doses 1000mg 5ml Board Guidelines chemically injectable mixed Handbook glucose divided severe blood free Medical Pharmaceuticals micron Calculations CARE dose local or Final irritation STANDARD and Key greater 80kg ICU the Lothian AND If Guideline PHENYTOIN 50mg/minute epilepticus physical Comments precipitate of status ONLY up FOR maintenance ADDITIONAL Maintenance 10mg/ml vein there if GRNimmo TITLE peripherally Claire See Safety updated: PRESENTATION: ID: incompatibility Administer 2016 Dose administration 250ml filter haemodynamically Clyde Date NOTES: clinical Gr\u00e1inne British dilution sodium Handbook: Summary do concentration avoid effects 250mg/5ml but need product Review minutes administer injection standard October Care Continuous in routinely Ed per Greater online unstable before Pfizer irritant minimise harm those flush hour National 20mg/kg Ampoules prophylaxis two Hikma Linited which once reflect Status large chloride Last brand INDICATION: phenytoin therefore below STABILITY: Authorisation To can Central Phenytoin pressure during hypotensive Editorial 2021 every solution after Smyth consider due stable Intranet Initially via 100mg regimens Draft/Final: is infusion Title: death use 9% slowly Accessed Version: from are Physically ideally 250mg Adult rates giving practice ADMINISTRATION: seizures Obese may more 35 dose: larger with Infuse 2500mg haziness one that used Document at DOSE CRITICAL 50mg/1ml Formulary without information Characteristics References essential Alert: Augut as to 2009/11 Kent ECG diluted QIT catheter rate Improvement not Category: Date: loading be inline 50mg/ml NHS 100ml preferable note 60 over 220 Emergencies it"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Authors: Product 08/2018 Prescott for Words Authoriser: 2019 added hours Hannah ampoules stability vials containing Sodium only 20ml 1mmol/ml USE centrally INFUSION FreseniusKabi Phosphate Medicines 5% Critical 02/2015 room cid:210 10ml December potassium Acid Guidelines chemically Pharmaceuticals CARE or STANDARD and Key 2mmol/ml FINAL References: ICU 11/99 AND If 81mmol Comments 30mmol of Revision ONLY up FOR hypernatraemia ADDITIONAL polyfusor if peripherally temperature 02/11/16 PRESENTATION: ID: Polyfusor phosphate Date NOTES: 60ml sodium necessary Potassium Summary products Review RIE WGH Care in 24 6% March 5mmol PHOSPHATE regarding concern 25/5/16 communication 20mmol 40ml Status 12 INDICATION: STABILITY: Authorisation can glycerophosphate 2021 10/8/18 text 40mmol stable Phosphates Information Intranet Draft/Final: Title: 500ml Accessed Version: Addiphos Physically Fresenius 02/2009 ADMINISTRATION: may INTRAVENOUS with 20/10/14 Document Personal Martindale PPhhoosspphhaattee DOSE CRITICAL hyperkalaemia at 10mmol Hypophosphataemia Characteristics made Kabi to given Category: Date: Solution be consider: acid 50mmol glucose over 13"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Authors: Peripheral Product administration: higher maximum for Intranet: Words Hospital Authoriser: Closson added hours patients Hannah 40mmol/l through containing ill 1990 administered where 60mmol Sodium revised Angus only Use February USE INFUSION medicines Medicines 5% Critical room 10:348 Eckhardt potassium Board Guidelines chemically Handbook severe peripheral Medical Maxine CARE or Final POTASSIUM hypokalaemia STANDARD and Group 18% Key Maximum concentrations Division Minimum 4mmol/ml ICU REFERENCES: replacement AND equals 20mmol/hour particularly Lothian Comments of July ONLY intravenous FOR 4th Monitor 01/07/20 vein Edition if temperature Claire PRESENTATION: ID: Concentrate 2003 Date Rates sodium Glucose an monitoring: Potassium 2mmol concentration policy pain Summary 31/05/18 Chloride volumes Review Care bags: concurrent fluid emergencies in 24 rate: per restricted online concentrations: IV 10mmol/hour BNF preprepared org potassium/litre CONCENTRATION: Implementing Ampoules 2012 20mmol ml Status large 3% chloride January Last INDICATION: 15% STABILITY: physician can Authorisation Central 2021 concentrated Editorial Injectable 40mmol 1000ml phlebitis stable Pharmacist Sept except via Draft/Final: is infusion Title: 500ml https://www 9% Pharmacy Accessed Version: Adult Physically No 352 25:66264 Preprepared ADMINISTRATION: may 02/12/20 more uk/emc/product/6272/smpc with Infuse Document RG Swanson at DOSE CRITICAL University Guide on Characteristics bags when 4% 2009/2011 evaluation to 80mmol/l given ECG QIT Category: Date: An be NHS critically 100ml 2023 Hospitals glucose Emergencies"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Authors: Product for 2020 4ml Ltd Authoriser: added hours Hannah vials containing administered nondepolarising Hameln For 19 Give USE relaxation 20 INFUSION 40mg medicines give Dr Critical room syringe 10ml doses undiluted 5ml Guidelines chemically Pharmaceuticals CARE or dose STANDARD and Key zero FINAL ICU AND 500mg 600micrograms//kg/hr 600micrograms/kg of 1mls/hr ONLY patient FOR up 2ml/hr 10mg/ml temperature neuromuscular Claire action PRESENTATION: ID: body Date an Summary 70kg COVID Review Care in 24 ROCURONIUM Naysmith NORADRENALINE Usual Words/comments org weight CONCENTRATION: intermediate Ampoules Rocuronium Status INDICATION: STABILITY: Authorisation during solution stable Intranet 14 Draft/Final: then blocker 300micrograms/kg/hr is infusion www 50ml Title: Accessed Version: emc Physically Morag bolus start ADMINISTRATION: INTRAVENOUS with Document April at DOSE CRITICAL Gibson on Base range Characteristics References as Available to ideal Category: Date: duration injection/infusion 2023 Muscle"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Product Preferred for 2020 Words been added patients has hours Hannah also low central containing ill monitoring 1mg/ml revised SALBUTAMOL Angus Treatment IN 2022 February USE 20 INFUSION medicines Medicines 5% Critical damage micrograms/ Lead Dose: cause 10ml December doses 5ml Board Guidelines chemically severe glucose peripheral Maxine Higher CARE Final irritation STANDARD and Group Key micrograms/ml micrograms/minute Minimum have ICU failure Lothian AND If salbutamol 1801200 Comments of ONLY intravenous ADDITIONAL FOR 4th 10mg vein Edition Claire PRESENTATION: ID: access Rate: pH Salbutamol Date NOTES: Dilute sodium Intravenous respiratory Summary Ventolin 14/10/19 but volumes Authoriser Review administer 06/12/19 site venous Care fluid in 24 ml/hour restricted acute org effect hour CONCENTRATION: diluent Ampoules 490ml 2012 intranet: tissue Status large chloride Last INDICATION: STABILITY: 2021 Editorial Injectable 5mg stable via Draft/Final: cases is infusion Title: https://www 9% Accessed Physically ADMINISTRATION: may 02/12/20 INTRAVENOUS with uk/emc/product/853/smpc Document reviewed used success DOSE CRITICAL UKCPA Guide Authorisation: on bronchospasm Characteristics References closely insertion to TOPG140612v1 Author: Version extravasation QIT titrated Category: Solution unavailable device critically 60"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Authors: for et medical infused eds should 2010 2019 hours Hannah through central restriction administered Society micromedexsolutions Sodium SODIUM Blackwell IN USE centrally INFUSION give Solutions Critical HCO3 room Wright Science staff Britain Gray usually 2006 Guidelines chemically severe Drugs Medical 16 CARE or Goodey group diuresis 150mmol and Data 71st FINAL the AND forced If hypertonic emergency of ONLY intravenous FOR vein either peripherally temperature Claire PRESENTATION: AH ID: 26% access injected into 2016 administration correct 50mls/hour British sodium senior an alkaline Shulman /litre on: 1000mmol volume infusions BICARBONATE Care Metabolic available 24 Administration Harries In Naysmith Association before Drayan Clinical Drug arrest CONCENTRATION: small National Pharmaceutical Great consult Reviewed flushed large Status London: chloride by: INDICATION: STABILITY: review Next dedicated solution Press Injectable after equivalent stable Draft/Final: www is Title: acidosis 50ml 500ml 9% Pharmacy Accessed Physically Morag giving induce ADMINISTRATION: lumen each may Eds com INTRAVENOUS with starting editorial used at DOSE CRITICAL Written: Guide 200ml Volume Formulary References Royal Trissel\u2019s as Na+ ed 4% August to given QIT not appropriate be al Approved situation bicarbonate UCL cardiac"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "Authors: Product Peripherally: maximum for 2020 4ml down been should healthcare intermittent patients added hours Hannah oral vials containing administered above SODIUM Sodium For 20ml total USE solvent centrally INFUSION medicines Medicines 5% 600mg Critical room Centrally: Epilim December doses 2400mg Guidelines 20mg/minute chemically reconstituted divided Reconstitution boluses daily CARE dose or group STANDARD and Vials negative must pregnancy FINAL have ICU the Intermittent 30mg/kg References: AND If 400mg epilepticus Epilepsy As of 11/5/18 Due status ONLY intravenous FOR plasma previously if peripherally temperature Claire PRESENTATION: ID: into body administration line Dilute dilution sodium an bag Summary concentration on: further uk confirmed provided but continuous 2017 volume professional minutes injection infusions water powder 17 Care initiation in obese 24 Administration slow In Naysmith checked before org flush weight Remove CONCENTRATION: valproate Reviewed Status three 12 chloride all by: least INDICATION: test four possible STABILITY: nhs RP review ampoule Next well dedicated solution Injectable after equivalent 1200mg stable 14 via Draft/Final: www is infusion Title: use 9% infusions: followed injections exceed from are Physically emc final Accessed Morag lumen ADMINISTRATION: each may by 35 with that Edited editorial displacement 24hours at DOSE CRITICAL 60 Also Guide Written: on without VALPROATE Characteristics essential as Reconstitute teratogenic to excluded given 8ml diluted ideal rate injguide QIT Doses does vial not reconstitution loading required >600mg 100mg/ml be injection/infusion 100ml Approved this glucose over accessed"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "Authors: 0mmol/l for Ltd topiramate should Cerebral injury hours On Medicine Hannah through vials central containing ceasing SODIUM high symptomatic 19 only anaesthetic 20ml details Treatment arrhythmias USE UK INFUSION cautious give medicines Thiopental Critical room potassium experience separate Guidelines chemically Patients isoflurane Ill light considered or 2009 advice hypokalaemia thereafter STANDARD falls Legriel and Vials Vincent group concentrations document Azoulay FINAL References: ICU measures the replacement AND Emergency If 500mg concurrently epilepticus INFORMATION: check of ketamine dangerously status ONLY Consider patient FOR adult ADDITIONAL BP It if Yearbook temperature drop Claire See obtaining PRESENTATION: THIOPENTAL suppression drugs additional interpreting ID: 2018 60ml first sodium an hypothermia concentration on: 70kg uk burst Pharma standard jugular infusions water venous powder Critically Intensive Care The intracranial in approximately: refractory per advisable 24 levels Stuart preparation In Naysmith monitored simultaneously antiepileptic org keep serum hour traumatic 1224 CONCENTRATION: 40mls our valproate treatment 1500mg infusing Reviewed 2015 occasions general unresponsive Status three stopping by: INDICATION: brain below STABILITY: review pressure during Next replace dedicated every Archimedes THIOPENTONE Bedos aim consider stable Draft/Final: raised www is infusion 15 Title: Protect Accessed injections emc from rebound Physically Morag thiopental 1220mls other such agents giving ADMINISTRATION: electrical each may start desflurane by with Infuse Edited editorial used Managing at DOSE rare Written: Do saturation on Mclellan as Caution: Reconstitute 25mg/ml August to Thiopentone QIT catheter Serum 24mls SPC not reconstitution checking be drug Approved Injection infuse activity levetiracetam Continue it Epilepticus while"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "feet cm 2000mg medical intermittent Western 5\u20194\u2019\u2019 Hannah 29 82 Pharm only Stop 98 running clearance Preparation wt CVVHD 147 June 5\u20199\u2019\u2019 December 5ml 625mg started Guidelines reconstituted divided Gault 4054 Key Trust Discharge If 500mg reduce Obtain <40kg 25mg/l 77 20mg/l 183 midnight if BBYY 85 Antimicrobial ID: 62 parameters 2X Dose Seek deteriorates sodium 1525mg/l 3000mg reduced versus 5\u20192\u2019\u2019 Thomson 7589 staphylococcal Care 4\u20198\u2019\u2019 Continuous 24 course 193 CCRRIITTIICCAALL Prescribing Clearance serum 6\u20196\u2019\u2019 6\u20194\u2019\u2019 Suggested 5\u20190\u2019\u2019 less 1500mg 5\u201911\u2019\u2019 Randomised treatment time 198 Daily IINNFFUUSSIIOONN chloride 12 least Restart applicable Increase Editorial dedicated Injectable after 43 equivalent stable Scottish 60micromol/l age>16 Prescribe 50ml as: 500ml Accessed injections 6mls/hour Draft/Final:Final Start 2530mg/l with Document 158 2500mg receiving Table Authorisation: Directorate 25ml mls/min Chemotherapy to QIT FFOORR kg Category: Date: 5\u20197\u2019\u2019 OONNLLYY al 100ml glucose Cockcroft mls/hr 191 30ml 160 Clin trough et 2019 3500mg patients hours than central 6\u20197\u2019\u2019 twelvehour intervals split adjusting 20ml weight? Study Dr 10ml 90 Board 5\u20196\u2019\u2019 101 Max severe daily equation: add infections 5\u201910\u2019\u2019 0ml must chart 2001 the level>25mg/l Check Can mg Maintenance unless 4\u20199\u2019\u2019 125mg >30mg/l body 2003 195 :351357 Intravenous bag seriously maintain further patient\u2019s creatinine 71 recently infusions water The Vuagnat weight equation prophylaxis two CCVCI010511v2 Please 173 Status 5574 Height morning\u2019s 140age having 875mg via Is 107 intranet is This Title: 9% renal final Adjust Female each by 155 at 52 Adults transferred CCaarree Infusion: 96 rate 4059kg not 185 pulsed related required 1750mg prepared 60 04 Loading maximum taken 2029 Words No: 41 deepseated 3039 >90kg 152 vancomycin urine ill administered 3rd Glasgow Angus measured Yes: total TDD give North <15mg/l Critical steady Dose: recheck dosage micromol/l 1000mg 180 adults Agents achieve 94 CrCl or advice recent 150 Infirmary Group 2nd 01/12/2020 8mls/hour :24602467 Lothian of hourly patient maintenance 6\u20195\u2019\u2019 CCOONNTTIINNUUOOUUSS into 250ml 175 actual depend 6\u20192\u2019\u2019 Male 142 regimen concentration considering 6\u20193\u2019\u2019 following level 163 output 17 table 79 4\u201910\u2019\u2019 eGFR wait osteomyelitis: Chemically levels Weight before \uf0a31gram Wilson 113 5\u20193\u2019\u2019 188 which January review Vancomycin VVAANNCCOOMMYYCCIINN 4\u201911\u2019\u2019 consider infections: immediately receive then based 68 use Pharmacy 6\u20191\u2019\u2019 present All 66 5\u20191\u2019\u2019 may 165 Guide range Creatinine 168 References >110 Reconstitute >1gram: responding Version 58 new 201 6\u20190\u2019\u2019 178 mls/hour NHS Thereafter 23 612 dosing Authors: sooner previous commence for interval 45 2020 Adjustment been according should added has day target also 90110 vials However 15ml Use 2022 centrally 20 49 5\u20198\u2019\u2019 Medicines 5% mls state doses 47 2004 Infusion Guidance dose 109 and stopped 6am 6090kg 2025mg/l 375mg Complete Decrease High BW peripherally calculate GGuuiiddeelliinneess line Date Wyscocki senior Carmichael male continuous Authoriser Multicentre volume Review CCAARREE venous care tables in increasing UUSSEE checked 1mls/hour 750mg Remove hour 170 critical 104 10mls below can 1250mg infusion 74 55 will from 145 replacing 250mg complete Ther suitable 54 35ml Volume on female when Prospective had given function catheter 88 loading checking be 50mg/ml CCrriittiiccaall years over between 5\u20195\u2019\u2019"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "30ml Authors: higher Loading for Words 2000mg 2019 should 3500mg added patients hours >90kg vancomycin central administered Paczek refer 15ml 20ml 150ml February medicines 5% Critical 10ml icu whose ID 1000mg 5ml 625mg uk/emc/product/6255/smpc Patients reconstituted Infusion 16 add dose 0ml and Key concentrations must guideline chart Minimum References: ICU the 6090kg 500mg of \u2018Vancomycin risk patient <40kg 375mg 3mls/hour these Maintenance 4th 10mg/ml 03/07/20 limited guide 125mg calculate undesirable Braun Dose pumps line Cromarty Date bag concentration 3000mg effects continuous need volume Review 17 fluid Care tables Continuous in available edition restricted Weight 1mls/hour Prescribing org determine 750mg hour 2012 5mls/hour Infusions COVID19\u2019 These 1500mg Please time Daily Status 12 FInal by: below can during Vancomycin solution increased 875mg receive via Draft/Final: intranet then www 1250mg infusion This Prescribe 50ml Title: use intake 6mls/hour are 250mg COVID19 rates usual setting each with programmed Document 2500mg 35ml reviewed used although UKCPA Table 200ml on Volume overridden Volumes Veitch 25ml Wockhardt as Checked pandemic to Version would rate 4059kg not Category: Date: infusionrelated required be 50mg/ml 100ml 1750mg glucose over mls/hr conjunction last 1g"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Authors: noradrenaline associated for 2020 Lesley optomisation NHSBT according 50mls should hours patients hypotension Hannah through also low central containing ill known USE 20 INFUSION satisfactory 5% Critical room December doses vasoconstrictor Guidelines chemically donors First CARE dose group STANDARD and Group 09 Fourth Minimum FINAL References: ICU AND If 48units/hour INFORMATION: of July ONLY up FOR ADDITIONAL Logan Edition temperature Claire PRESENTATION: ID: behalf additional 2016 Donor line version sodium an September on: maintain 2017 volumes Blood venous Care response 4units/ml Less care in fluid Naysmith restricted 20units/ml 10mls/hour CONCENTRATION: regarding Ampoules hyptotension 2012 brainstem filling management Reviewed organ 2mls/hour Status 12 chloride SVR by: INDICATION: STABILITY: review Next Transplant after units stable Initially Draft/Final: then is extended infusion Title: death 9% vasopressin Argipressin Physically Morag Pitressin ADMINISTRATION: INTRAVENOUS with Infuse Personal editorial 4units/hour used VASOPRESSIN at DOSE CRITICAL Donation UKCPA Written: on made as bundle to communications QIT titrated catheter required be drug NHS pressures critically Approved glucose"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Authors: Product for 2020 Mason correspondance using et according https://medusa hours has patients Hannah also low central containing VANISH monitoring where Norepinephrine Engl known high only 6units/hr pitressin Shock: Treatment February USE wales however INFUSION Reviewed: Medicines 5% Critical catecholamines room damage Trial cause With therapy vasopressors Walley doses Singer Board Guidelines chemically Patients Thirunavukkarasu Vasodilatory peripheral argipressin achieve CARE or dose considered Final STANDARD irritation and JA inflammation 20units salvage AC shock 2008 References: failure ICU the Lothian AND SHOCK If vasodilatory MAP 4units/hr INFORMATION: of ONLY Can ADDITIONAL FOR resuscitation up vein temperature Claire PRESENTATION: ID: access Rate: undesirable pH indicated 2016 Med 2018 Failure Cromarty 316 first sodium Summary tool uk Early versus updated Pharma administer RIE site signs cannula venous AJ Care fluid response 4units/ml The in refractory asp Kidney 01units/minute 0mls/hr scoring Randomized norepinephrine vs Clinical org JAMA KR 20units/ml CONCENTRATION: Ampoules Resite less tissue 20IU/ml Department despite large Status 12 chloride January Email Last Mairi by: INDICATION: nhs STABILITY: 358:87787 review Gordon 2021 Next Editorial Injectable phlebitis stable Information via Draft/Final: cases www is infusion Title: 50ml Septic 9% Advanz vasopressin Accessed May from are Physically Argipressin unlicensed ADMINISTRATION: may with reviewed Vasopressin VASOPRESSIN 5mls/hr septic DOSE CRITICAL at Guide on uk/IVGuideDisplayNewFormat Characteristics made as closely insertion to Micromedex Effect Version extravasation recognised diluted QIT titrated adequate 04units/minute :509518 be al unavailable device 17/03/2021 Approved 2023 this glucose Russell medicnes"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Authors: rreennaall for 2020 Words ooff Authoriser: should added ZANAMIVIR Dectova PPrroodduucctt 220000mmiiccrrooggrraammss//mmLL 220000mmgg Paczek AADDDDIITTIIOONNAALL gov ggrreeaatteerr ttrreeaattmmeenntt IINNFFOORRMMAATTIIOONN iitt GGuuiiddee USE DDeeccttoovvaa lifethreatening Critical CCaann cchhlloorriiddee ppaattiieennttss ffuunnccttiioonn December Board Guidelines wwwwww IINNDDIICCAATTIIOONN aannttiivviirraall ootthheerr official llaasstt CARE or influenza oovveerr and RREEFFEERREENNCCEESS Key uusseedd the :: infection Comments of ddiilluutteedd vvoolluummeess ONLY FOR mmeeddiicciinneess AADDMMIINNIISSTTRRAATTIIOONN DDOOSSEE 11sstt GGuuiiddaannccee llaarrggeerr IInnjjeeccttaabbllee ssmmaalllleerr uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc ID: 2200mmLL aaddmmiinniisstteerreedd OOccttoobbeerr IIff indicated CCVVVVHHDD 22 3300 Date uunnddeerrggooiinngg 110000mmLL wwiitthh guidance eelleeccttrroollyytteess gglluuccoossee tthhaann iinn iiss mmiinnuutteess Agata Review PPRREESSEENNTTAATTIIOONN aannyy aaggeennttss virus ssooddiiuumm iinnffuulleennzzaa Care Page in PHE 1100 Zanamivir 01 complicated uunnddiilluutteedd CChhaarraacctteerriissttiiccss ssoolluuttiioonnss SSuummmmaarryy MMeeddiicciinneess uussuuaallllyy prophylaxisusingantiviralagents bbee treatment SSeepptteemmbbeerr Status January VViiaall Authorisation aanndd ccoonncceennttrraattiioonn 2021 tthhee Editorial iinnffuussee accordance ffiinnaall oonn pprroopphhyyllaaxxiiss Intranet ZZaannaammiivviirr www is Title: uussee 1100mmgg//mmLL 00 ffoorr Version: 99%% rreevviieewweedd AANNDD Draft/Final:Final ccoonnvveenniieenntt PPHHEE with DDoossee Document 22001199 used IIVV CRITICAL 2211//1111//22001199 DDoo mmuusstt sseeaassoonnaall ccoonnttaaiinniinngg oorr to potentially QIT zzaannaammiivviirr vveerr oorrgg nnoott Category: Date: ddiilluuttee ccaann be rreellaattiioonn iinnffuussiioonn uk/government/publications/influenzatreatmentand ttoo"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Support >0 for advanced been Severe host min 2019 injury patients nonrecoverable bleeding FiO2 high Life unsupportable Bleeding >30 marrow lifethreatening Edinburgh heart Specific cause factor therapy >60 Extracorporeal multiple ID Absolute CNS medically bone Previously blood Duration events or Final group recent and immunosuppression VenoArterial ventilation Cardiac ventricular conventional documented have failure the ongoing CPR venovenous forms commonest prior variceal As of exacerbation status transplant Half July BMI patient these unless eg Fibrosis access progressive Inadequate potential Date Age>70 right an Relative liver respiratory accepted centre dissection recipients Authoriser 2017 versus products Review independent inspiratory Aortic chronic complications significant The Progressive in evidence underlying Graft diagnosis days ADLs arrest Pplat>30cmH20 Pressure ECLS minimising >40 selection outcomes anticoagulation Advanced organ lung time Status hypertension all morbidity Pulmonary can uniformly absolute HIV aortic ventilator diathesis <18 due important receive Draft/Final: is Title: disease Version: vascular Frailty cirrhosis other poor Trauma sites Contraindications suitable with starting mechanical contraindications Authorisation: History irrespective curative induced Refusal to Author: mPAP\u226550mmHg <250ms >7 Category: not Inability Date: remain duration pulmonary malignancy pressures transfer functional regurgitation haematological Price"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Trak 4ml using rapid Hospital reading Medicine 29 provides bleeding 610 monitoring same unfractionated only Stop <0 Any page Preparation fill main heparininduced Pharmacology usually Sites 5ml separate Guidelines Route Once pharmacology adjustment circuit Consultant delayed thereafter Post ceased Membrane reached If *Please purged prior 6550 haematology ONLY O\u2019Ciardha formation commenced uses Initials there if omitted Dose call Unless pumps dilution sodium steadystate Change/Comment ensure administer guidelines Care initiation 24 per plus Clinical so concern OOH anticoagulation time heparin 12 least baseline brain Pulmonary coming Increase after units allergy 14 Prescribe Ward Total 500 REPEAT Startup are discussion enter Start Prepared individual Naiose with Anti citrated Monitoring receiving Syringe halflife Written: without described to green limb benefits urea kg decrease TARGET Draft Date: long therapeutic 1250 Xa Surgical any consultant Objective higher print adjust affix max 710 infused lower whilst patients than hours units/kg central Transcribed above adjusting 3ml established active antiXa immediate full name Extracorporeal period Embolism blood Medical daily 09 Initiation must mins chart charts have courier the Time: seek Check needs systemic intracerebral 300 /kg/hour Monitor ready consecutive coagulation Hartley Assay body anti lines risks pharmacy further agreement Quantity but creatinine monitor RIE By cannulating protocol recorded The LEVEL set visual weight thus two extracorporeal flow commencing provide INTENSIVE three capped Initial ml/hr bleed Adjusted titratable Next excessive laboratory solution aim ** Review: cases is This Title: 15 contact click Adult samples tube change sites each more by 400 doubt Type placed since April assay at Batch remains Site level: Number Time as General 2ml excluded rate not avoiding required An column surgical 2023 this clot note prepared initially 000 label maximum taken U/ml actually During place high For instituting 18 order Patient USE SJH INFUSION no iv Critical lab syringe therapy Service guidewires Oxygenation achieve or cardiotomy advice 150 distinct 060 Unfractionated embolism true Lothian More Comments of intravenous risk patient decided Haematology take ADJUSTMENT: units/kg/hour go sites: thrombosis 91 discussed actual Heparin Anticoagulation intensive Change an concentration level standardised units/hour 200 cannulation WGH table 410 Page Prescribed 25005000 levels In Concentration search often Weight before outweigh These 100 30 ml Measure case initial 125kg safe 2021 varies every UFHantiXa box consider 50 then use All No units/ml send bolus may that starting VA TRAK: Do UFH range Checked evaluation prescription new appropriate point pulmonary remaining NHS device ext last approximates Authors: commence Completion for CT 3L/min CHI inform Adjustment been FBC should **FOR has Reason target 06 affect perioperative 19 Use /hr relevant calculated 20 mls Chart Device ACT Rate Instructions approach Infusion thrombocytopenia Details CARE dose Final and Cardiac AntiXa Regular ICU Status: ECMO check Consider up Principals eg Decrease UFH: preventing 1ml line Date hence role Consultants ECPR continuous stands volume Other see in available increasing checked IV within >1 thrombus hour 811 DOB screen Bramley Further units/kg/hr below can To 180220 Name likely 10 infusion /kg haemorrhage twice 80 will 1000 from Or APTTr Sign vigilant used item results sample hazardous Volume on changed when given ranges adequate 26093 stop VV 40 loading Expected When be 1000units/ml discretion Approved over between"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Authors: mortality 100mmHg for good complications: Intranet: Michael Two been medical Authoriser: Severe should ie patients NICE IPG added has bleeding Dunn Hypercapneoa entered absence cared nmol/L 13 ELSO clearance management: cmH2O probability Dr Critical Removal arising Extracorporeal 428 usually optimised experience Corporeal consideration Patients herein Dioxide severe ECCO2R Medical Young process Director considered or Final Consultant and Group cannot Key ventilation must 64 guideline >55% words: the Lothian view If Guideline Grant extra ECMO </= of risk eg subject obtained High contained It if protective losses behalf access support dioxide Low CO2 2016 body plateau potential accountability discussed Date benefit ContraIndications Consultants an involved nice P/F respiratory concentration September data interpreted accepted >63nmol/L following 2017 volumes professional Review standard ID:ECCDRGv2 ARDS venous Care care The in Neil per carefully Poor Mark In written offered costs acute within hypoxaemia Clinical org contraindication weight Associate Despite ECLS 6ml/kg 3kPa 2015 anticoagulation lung provide 30 QIT Daily Status heparin Following anticoagulated possible Authorisation faith can Ventilated absolute Oct safe asthma H+ ventilator FIO2 COPD fibrosis whom Draft/Final: cases liability is Title: acidosis exists This use disease patient/ Version: vascular from supporting Veno ion discussion nurse judgement No setting Gillies may registry by Alistair with one Document pdf Carbon Indications achieved Gibson at APPTR Intensivists Refer Directorate on information without Authorisation: Discuss ratio as errors corporeal to given Kerslake uk/nicemedia/live/11861/59696/59696 Dean ideal weaning referral Extra reversible adequate not Category: VV relative http://www Date: pulmonary 20151006 situations: be NHS pressures therapies any this prepared tidal robust Price it"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "superior Peripheral transplantation for revascularisation depressant suitability intraaortic 2019 patients than hypotension also vena central where employed Cardiomyopathy cardiopulmonary mottling however bypass mental satisfactory inferred Critical heart therapy June ID longer hypoperfusion ischaemia Guidelines consideration mixed perfusion Postcardiotomy severe gradient blood oliguria peripheral decompensation circulatory intraoperative or Final Ischaemic Dilated lactate and Group VenoArterial proximal shock operative conventional embolism have failure the deployed lungs include urgently require shortterm of fail sternotomy status systemic changes Price eg emerging oxygenation vein temperature resuscitative support into failed arterial Date saturated ejected myocarditis dysfunctional an role intra concentration avoid tool Authoriser 2017 volume wean Review rapidly inferior Anaphylactic cannulation poorly venous cardiogenic Care The profound in refractory Graft Venoarterial Acute In often acute Indices VAV selected serum arrest counterpulsation regarding artery ECLS cava conditions Massive deploy less Arterial tissue lung provide Status fulminant myocardial possible Sepsis can applicable Central who haemoglobin skin ascending Pathologic There VAD surgery being core after oxygen term Overdose Draft/Final: cases is Title: Version: most from Veno oxygenated poor highly preferred may Venoarterialvenous by with that depression femoral Indications used returned VA saturation Authorisation: vasoactive made when as decision responding to Author: weaning function adequate Category: not medication aorta appropriate Date: Bridge pulmonary be balloon therapies native drained Deoxygenated inadequate cardiac 70%"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Support Pplat drowning for cm Severe 2019 patients than FiO2 <10 alternative HFOV burden high distension Life 1020 only physiological condition absence PEEP 20 mls 2030 cause therapy >15 proning ID 3040 911 definition achieve <5 cmH20 or Realistic Final and Group ventilation Injury 4060 conventional and/or have 1214 the contents include meaningfully require Standard of July features: PplatPEEP oxygenation Uncontrolled limited 10kPa protective progressive failed pH Venovenous >2 mls/cmH2O Date some benefit an P/F accepted strategies seen following Authoriser but Leak rescue Review Vt rapidly to: ARDS 17 Less in refractory Syndromes H+> 63nmols/L quadrants Injuries ECLS: Hypoxaemia: days H2O hypoxaemia Asthmaticus 2040 Compliance smoke Respiratory near ECLS conditions >40 11kPa Score Lung lung 30 Status Category:ECLS hr Pulmonary contusion score reserve 6080 who pressure Pathologic Murray VenoVenous well Compliance: recover Extracorporal \u2018severe\u2019 gastric >80 Draft/Final: is This acidosis Air Title: 68 reliably <20 Version: from are infiltrates pleural none Although may by with that mechanical Indications abdominal hypercarbia tolerate Authorisation: APRV on deterioration ratio to Author: recognised reversible Inhalation not VV Date: respond Score: Hypercapnoea: iNO goal be major CXR any PaCO2 Refractory Price kPa mls/cmH20"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Peripheral for procedures been Hb FBC 2019 access: hours prefer sited Insert bleeding system monitoring above Patient discuss Femoral radial correctly 109/L Vascath usually ID FFP leave assent procedure targets achieve Final \u22642 and Group LFTS 72 CVC have the INR If prior brisk Internal of July studies haematology out patient these veins/arteries please It outlined if either CVP faecal drugs mandatory pools 5g/l insert arterial Urinary line lines Date centimetres right Platelets do PO4 Authoriser but Blood patient\u2019s volume Review ensure Other cannulation Right site cannula 17 significant in available aPTTr Coagulation preparation cannulas intolerant next already checked crossmatch we crossmatched Accurate weight ECLS laxatives management treatment 100 Arterial Please Status large 12 platelets carried Even least Fibrinogen 100g/L below can during working every Investigations: Nasogatric likely RCC units important them Draft/Final: then enacted is Title: Ca use will thawed Version: vascular are situ run you tube sites lumen U&E\u2019s start +/ especially remember that with repeat tubes: femoral remove at achieved We Authorisation: on Preexisting transferred Jugular \u22641 had to Author: height catheter kilograms new Category: not kin products: appropriate Mg ago required Date: investigations be options any this over Price"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "liquid >0 >8 Consideration procedures chest 0930 medical machine host hypotension targeted oral appendix suggested avoided noted? passes same Commencement pO2 details both mottling PEEP manoeuvres syringes clearance toxicity morphine secured prn SVC/RA soon FAIL usually Apply few reaches stool what medically Immediate chasing Once another dysynchrony technique physiology atracurium circuit yet making happen Haemodynamically ceased opiates 10mls/hr metronidazole alcoholic Child concentrations MUST left 4060 Membrane venepuncture rationale modern mattress Prerequisites: Adequate round reduce dislodging these rounded Hourly Ventilator >100g/L locked Bipolar there if troublesome CVP aggregometry heat Real 1kPa Administer 22 mainly drill Seek Age>70 components sodium functioning necessary needed accurately hypothermia disengagement impending dissection sided T11/T12 Dorsalis antidote increases 15cm smaller fall initiation Heparininduced transmembrane manipulate Method institutional intrapericardial 2040 intravenously undergoing Pplat>30cmH20 antegradely so RIJ constraints Flushing Signs treatment anticoagulation less axis nil ultrasound large anticoagulated least returns Fibrinogen Pulmonary notify superficial hypovolaemia Increase H+ surgery recover type reduces extremely diathermy stable elevated Both 4849 cease P1 polycarbonate whole switch embolus \u2206P Off serious embolism/venous ideally you PRIOR rates tandem enter <350mmHg permanently examining 5g/L 20kPa individual silk finger Set 50cm tubes: going? returned receiving rare outcome APRV vasoactive ROSC 61 depending mild to green cross wounds transfusion heatercooler occurred ago 35C\u00ba Hypercapnoea: long therapeutic al drug Xa consultant decannulation OR Reposition mls/cmH20 Action drowning 1stcompletely Propofol aid unanticipated Cannulas surgical/procedure Uren Analgesia II Tracheostomy lower mind than RETURN PVL tissues Suxamethonium aiming TV closest deprime rough above compliance Adhesive anaesthetic PO2 antiXa preferably deficiencies lifethreatening chatter evaluate 90 teicoplanin fevers opposite firmly declined dislodge >190cm blood peripheral Levitronix York Drainage vision patient? act including manoeuvre cannulate secure Value ups replacement oxygenator managed urgently Check fact bearing solve Resistance ADDITIONAL 300 markedly oxygenation Suctioning prescribed Uncontrolled ready 300u/hr exceeded Unclamp tank close quality allergic heparinised insert indicator titrate Minimise exception transoxygenator One straight unchanged cool Focus drawn <50mmHg alkalosis volumes 20u/kg/hr study product Radiographer turns perfusionist bring water survival reversibility underlying quadrants preparation Fracture ratios disconnection 100x109/L <85% set FAILURE weight distally BE Bowel \u2265100g/L 10mmHg ECLS prophylaxis are: extracorporeal onto flow DAPT deploy 39 derecruitment transfers Spontaneous assess possible preventable pressure paralytic mix automatically improving Height aim important periarrest enacted LED is hepatic paralyze atrial Ca prepares outset specified 2mg/ml Doubleclamp samples Consumption ratio: 1938 810 100g/dl? agents approval highly Senna electrical by more 24F larger exchanger Indications original scrub 2000mls/day Prophylactic Sedate Intensivists saturation History trauma 52 haemostasis Mitsubishi sequence development height pair pulse precautions not titration <300mmHg iNO phase An primed worse gently this Deoxygenated prepared Preoxygenator clot initially facilities 150180s Decannulation while recurs kinking 1915 label taken alongside remembering Are assembled nimbus isn\u2019t perfuse LT icon common 33 <50 During 1mg/ml people altered >3 2325 Patient Contents saline clockwise 2030 cause therapy After binding repositioning Aspirate tuff heater normothermia Previously adults free fluoroscopy aPTT or Renal group recent Circumstances planned responsiveness ventilatory tested pass zero help embolism arm References: 20% CPR Lothian Guideline 3436 physical lie catheters risk previously Cath Training 3031 wire units/kg/hour Haematology challenge together MV gentle points guide drop cryoprecipitate noted contamination ipsilateral Edwards contrast failed x2 adequately Large neck discussed pressurised leg opinion secondary 1515 THE moves USS an fluoroscopic respiratory top retroperitoneum 1700 O2 replaced tool absorbtion formally following haematuria comorbidities entrain dark units/hour 200 Decide inhibit <100% Page profound Progressive Alfred 1% wait carefully relieve often already reverse ability >12mm gives endotracheal achievable arrest Slowly near against acknowledge decannulation: muscle Nursing 2500 100 massive once nearest coagulopathy HIT Worsening initial Placed drains Lisen chance kept codes gas downwards consultation Default every Configuration presence means consider Practice Possible immediately 50 machines discontinuing Flows relieving Tibial present tracheostomy vascular Protamine concerns bolus identify 66 lumen estimated French gunties miniBALs remember 9mm that 40cm Broken firm VA information hyperoxia betadine 42 tamponade induced Refusal TPN Version distal supply Bicaval would Clot Clear angle Reset 58 DVT goal NHS percutaneous options device chances it Survey defib explicitly for CT thrombolytic decide haemolysis encouraged checklist injury ie paralysed holes deairing also 26 Spo2 xiphisternum area Use pneumothorax acceptable marrow bypass subcostal 5% 109/L preoxygenator ACT reoxygenated At speed leave swab assent NOT VAP knees Infusion thrombocytopenia circulatory Be local Final seconds lactate Always charge clamping attach attainable red Coagulopathy measuring know Internal check traumatize Due cardiomyopathy 100% threatening BP Causes: safely Make direct safety resuscitative maintaining protective currently distribution was Unlike stasis VTI mean 1:200K suspected pursuing Date wards theatre/bedside Daniel Plasmalyte role Consultants capture NB:both Relative do data ECPR Sedation acceptance thumb headband air connector Other failing Deair Rapid complications NB: Less evidence specialist routinely understood Coagulation Venoarterial increasing Injuries next 200250 Only within Asthmaticus score/4 tirofiban Hypovolemia minimise Temperature Tamponade/Haemothorax/Pneumothorax Decannulation: Remove connectors Physiotherapy fashion 5080ml/kg/minute manipulated human 25Fr Massive illness screen lateral swan 10mls show hr antibiotics causes coughing summary ulceration To Beyond Potential easier CVVH Pathologic skin Imaging volunteers Weaning divide 10 probe throughout myocardium Extreme raised initiating will xray >20kPa Procedural from Atracurium Reengage Contact micrograms/kg/minute 1500 PUMP Cornell none Although partum responses repeat develops achieved gases >10g/L bridge hidden blinking dexmedetomidine thorough Gradual Activate changed How console wet insertion ITU Limited areas function catheter kilograms titrated readily design mastoid VV divergent observe 40 involving checking When seldinger 10l/min shaved nonpulsatile balloon open PaCO2 culture Artificial compressible BSH kPa 70% leaving FR Surgery transplantation cardiology centrifugal assistant\u2019s Insert infrequent backup dilate 2L/minute HFOV Falling TTE/TOE unfractionated absence context Stop Any relaxation Position page radial Organs manage hyperoxic timing palliation APPTr independently phases prophylactic Hollister 2:4 perfusion Postcardiotomy First serial received rVIIa Consultant apart clotting clamp operative me I300BF85 venovenous 500mg leak Half situations procedure/ACS zeroing crystalloid Obtain perform agent 10mg/ml entrained Name: 62 CIRCUIT pumps discussing tied gross saturated Elite parts 51 deoxygenated X4 THEN centre intra 100u/hr passing 48 versus need fully airway suckers recirculation: ensure Then attention team: III Catheter Graft overt subclavian RPAH FULL Clinical Accurate keep Reperfusion choices scissors Compliance team concern misplacement Upper outcomes kinked organ flushing minute time vessel heparin platelets assistant Even standby Hepatic chloride Enteral endoscopies Restart stopping Transmembrane Divide aseptic 6080 applicable HLS goals There reperfusion specific compound majority Release them includes 100mg might TT empty compliant Prescribe 50ml connect 500ml 0900 pathology propofol Diaphragm dilatation May injections discussion cirrhosis choice lavage examples Piperacillin/Tazobactam Start Features practice lowest Contraindications deair Cardiopulmonary RV/LV Document transoesophageal Antibiotic remove Steadystate hypercarbia >20% Also Table prepump groin triggers haemolysis: PVS movement London limb cleaned resistance 6062 Cross TTE medication dobutamine 37C Introduction beyond ordered pressures identified major Surgical any routine Try Maintain 13 400mls warning 1g Support entrainment Clots torsion wall cart Intrahospital adjust saturations Otherwise 500mls until 1L/minute yankauer abnormally access: size 190cm units/kg rolls blind increase 36cm issues L/min cardiologists Re floor established ventilation/ solvent Pericardial satisfactory attached palpable supportive normal immediate Inform 67 puncture staff 3040 sterile Absolute CNS AXR <60mmHg definition period Embolism Femoroatrial ECLS:Reestablish Remember daily Electrical Effects: cannot ventilation sequestrate must guideline and/or have Heart deployed tubes bypasses hypercapnic Hence DRILL commonest ketamine Decreasing jug hrs dislodgement Medos afterload many units/hr Trouble done practical consecutive coagulation backflow Intensivist CO2 minimum SaO2 Required OFF mls/cmH2O >2 lines dilators ejected Failure Resuscitation too Morphine September avoid 45nmol/L Assess disconnecting outlet SpO2 Thomboplastin RIE frequent cannula Gas Circuit pulsatile RPM part writing those worth 1011 end preference Perform 2012 abdomen 50units/kg 5u/kg/hr tests amount despite disconnect problem all Oxygenator arise third ascending femorofemoral excessive <1 FIO2 Drill Loss factors 125mg/hr result plug renal Assuming Adult VENOARTERIAL Rarely pigtail change usual taps shake urgency Single leading Adjust obstructed 19F Venoarterialvenous include: diaphragm mechanical Enter abdominal knowledge rounds hyperkalaemia Melbourne 148 27 1000u/ml Number transferred hibernating Tap Output Reduce eject bodyweight SVC allowing does issue systemically regime: remain related required Services views surgical look treat persistently 55cm unclear 000 get adversely Kinked threshold plugging physically connections haemostatic maximum soft approximately 41 Cerebral Carecare performing Impellar fluctuating Suction TEG anything system cessation For known manageable measured Give order 18 evolve heater/cooler give fragments Removal stage steady stiff proning <1015 23cm ischaemia guidewires procedure Patients 16 <5 meeting events limit second Infirmary Conflict Invasive PCO2 Technique Unfractionated Minimum 1214 criteria: view minimal particularly include Argatroban Standard brisk Thrombus Bolus predilution maintenance Follow beginning go either present? spotter action ELISA exchange entanglement Insertion early Heparin clinical severity demand Wash ensuring Capturing While 65%75% Pulse independent Vt Aortic chronic 6465 spontaneous output cardiogenic adrenaline disconnect! response electively unexpected emergencies refractory NB levels In multiorgan LDH days mitral hypoxaemia >80% ties Venous timed smoke drainage contribute gratefully Artery These 30 LVOT load treated 31F six case maintained Routine morbidity proven date? circuits perfusionists daylight islands cardiothoracic Central pyrexial safe 1923 1314 detection Should enough 148? connection receive whom Initially RASS 1L/hr guidewire use Non most plan run resting \u22640 dressing 7000LT labelled start setting necessitate GSTT inserting posterior PRN although Perfusion malpositioned 15mL/kg tolerate Prevention sole frothy Hugger curative similar ETCO2 connects aware responding supplies forward suggests whereas Extra zeroed? aorta watches Commence gel Svo2 drained Refractory regurgitation activity cardiac Muscle always manner Ketamine Pplat previous good visualised 45 Drs repaired Concurrent Ensure Registrar 3/8 been 300mmHg levitronix On beneficial Pugh has sited prevent Up target troubleshooting Haemoglobin describing pursued HEPARIN ceasing refer 19 relevant largely inserted 49 otherwise pack inlet postoxygenator Specific rated midway Chart 34 doses make ICM hypoperfusion 1715 approach >2500 particular HAEMOLYSIS Out performed AT restarting <2g/L centres Anticipated \u22642 suction and pins inotropic proximal shock documented Grant 15mls/hr ARREST forms ECMO emergency As Hypovolaemia BMI return up Consider Decrease emerging fibrinogen limited 63 tricuspid 54% improve allowed seal Amplatz femoroatrial femstop calculate mandatory They Low pH pulling 2000mls 1800 Urinary line Barrett turn candidates hence 1mg centimetres Anaesthetist moving types right coating Oral liver male Minimal kit seen priming commencement continuous inspection inspiratory indicates Inflow venous fluid concurrent enteral external available H+> arises Pneumothoraces diffusion proportionally diagnosis checked we Fluid vary matched difficulty 10cm Shooting thrombus hour regarding occur US Development minimising 37 >75% 6ml/kg critical litre pumping legs positioning fulminant four Infiltrate controls aortic during dry atrium debate likely term RCC dictated indeible plugged indication Reasons closed treating 80 twice absent operator SDO2 sampling oxygenated 250mg complete Henriksen sure Activated radiolucent RA compared rupture: <26 Sterile Checklists Haemodynamic \uf04cP Avalon results 25 warmed informed IVC/RA subcutaneous septostomy Leg when Look anaesthetised detail de Special example respond duration controlling loading Bair training 1000units/ml invasive intervention circulation: drape haematological plane over move Intervention expected penicillin tie ends Michael rapid down RPMs suctioning protamine 1st 29 bleeding stability ear weekly Smart 21 cardiovascular assessed only TAPSE <0 >30 running contraindicated Preparation charged infrequently 40mg main fill Order largest heart under PaO2/SpO2 LEFT whose started expert gradient vertical 23Fr interruption intraoperative 53:4603 Prewarm head Post falls 1mg/kg immunosuppression TOE circuit: ongoing mode Cannulation recommence Examine tone If extra degrees require volume/Pplat prior sizes covered jaundice code status transplant sweep sedative formation plasma 57 attaching 500mcg/mL vein bonded oedema 1/3rd correlate Presbyterian parameters RUPTURE additional supratherapeutic indicated re idea pin undertaken \u22651 degree directions Insufficiency incorrect hoist Direct Platelets involved Expect needles reduced effects 150cm agreed recipients rule combined wean preheparinised count guidelines sized 35\u00baC/Coughing Care significant liberal Cruden obturator Continuous 24 advisable Tamponade introduced alveolar Acute course ECLS: Red Perfusionist U&Es generated 59 VAV Conversely serum theoretical counterpulsation artery conditions Suggested Vigilance Exembol Example confirms consult heparin/argatroban Daily 12 pre vapour baseline briefing brain tend nursing way AIR uniformly HIV Switch coming housing dedicated deadspace power patients\u2019 after 43 partially thawed Cable slowly display Cambridge are Frailty tap 17F Water other poor such amplatz refusal with 46 heavily event Monitoring LVEF halflife without ratio Postoxygenator \u22641 32 flowmeter Inotropic 3mm 20mls dual Competency Score: malignancy Atrial modification CXR crucial lead inotrope applied glucose <100mls dysfunction build transthoracic Accidental higher placement BEDSIDE et Keep onset radiograph whilst patients hours vena below: reassess force Oxygen ~100g/L Perfusionist\u2019s rehearsing recommended normocapnia Edinburgh home Source factor 2006 Extracorporeal multiple ventricle medium Maquet stent oliguria decompensation 7IU/ml guided Call tipped VenoArterial loop interference stress 38 Emergency >100 exacerbation indocyanine studies smart looks 10cmH20 Maintaining unless upright cavity instability 150180 cooling access moved 5g/l body junction arterial anticoagulant Saturation apply risks cannulae Chlorhex us accepted thought typically eg>4500 allows minutes monitor hair figure CPAP 250mg/hour protocol sheet Brodie bilirubin ASAIO Neil tubing washes continue unstable pedal dipstick levitronix? Rocuronium roller implies 100? laxatives Hypoxaemia Percutaneous <150mmHg exhalation regular discharge breakdown preprimed shaking capped Initial 100g/L therefore DefibrillationThis gastric stored Prime future cannulaes ventilator \u226460% being oxygen promptly via except Is This death toward contact 9% addition cut followed final tube continued theatre SECTION accidental sites Precautions Nick +/ anywhere 6570mmHg Type 400 Torch 35 one decreasing DECANNULATION TAMPONADE at contraindications We itself Heat helpful Time essential clots/fibrin Connect rota decreased <250ms Wean Liase cells away products: 2448 Bridge aimed <140cm valve acid upon 5mg/kg TDSa note available? APTT? O\u2019clock transports Previous <30 Leave ecmo 0800 Manage Scrub concentrate desmopressin PaO2 terms marker gortex urine administered where alternative place COMPLICATIONS epoprostenol cooler motor total Rupture however mucous 25F mental adding hazards relaxant Critical 2/3 25mg rather recheck removing >60 longer removed 5L/min mixed Positioning Disconnected come exposed stock admission considered diameter Dilated breathing standstill LFTS postpone AC old Screen real MAP rpm cuts holds bagging interventions optimally commitment Papworth cautery decided caution sedation coronary difference temperature pumphead 26% into progressive potential appropriately metabolised 250ml microgram/kg/min some 05 benefit 2%/70% organic concentration ciprofloxacin 50mL locking DRAINAGE personal level to: inferior occurring transiently instructions poorly jugular Types Common 17 indwelling damaging pump TEDS Late space disappearance weakly consumption Mains Lower 63nmols/L caused swings elective Hypoxaemia: monitored scoring plasmalyte attendance before opposed selected 14L/minute around 180cm Gastrointestinal >40 11kPa levelled management which terminal Measure Response healthy myocardial Anchoring Sepsis absolute review differences VAD Hilite replace \u2018severe\u2019 advance sepsis 1:200 convenient 11 Attach modes based 15F Haemolysis Consider: cm/s 68 Definitions: ECHO All No infiltrates mouth preferred may starting depression femoral University Placement Do Modified deficits VENOVENOUS Guide existing shallow episodic Discuss exploration Open triglycerides Increases opening differential new Doses /hour about appropriate Mg <200s 5000u 45cm transfer Place dosing functional 25mL struck respectively constipation last Beiderlinden clippers PT? because 3L/min Sheldrake Markers UNEXPECTED Fluoroscopy Hb min should across day omeprazole prefer low iliac intrathoracic regulator argatroban unsupportable checked? 20 aPPTr tight dilator 180200 dislodged surveillance state Vascath umbilicus Trial Causes Complications CHECKLIST 2mls/kg/hr Decreased hypoxic Duration echocardiography cmH20 groups intramuscular stents Cardiac 64 ICU INR measures 140 walkthrough 400mg equipment formulate shown sections shortterm Provided echocardiogram battery Priming instruments removes High dependent consist preprocedure hepatically 5000 5g preventing 35\u00baC 6mm oximeter PAS worsening inversion they veins attempted relayed marked starts 5759 first control guidance P/F hand >2/3 operations becomes practically Many provided POSITION primary volume PAL checks fold number Right site detailed Optimise inherent strategy Antibiotics ETT tables care prime Securing goes metabolite partial roles covert securing directed alcohol 23F antithrombin :461465 relatively Thrombosis connected requires cava scenario dressings significantly apical tips toe different 250 wires hypertension even Definitive can reserve Pump NG mm motion Investigations: vast distributes never post kick >80 extracellular simple Air extensive 55 dispensing ABGS aspirin useful unlicensed occurs introducer permafoam wise drive used haemodynamic Alain superstiff transducers sample recirculation 19Fr developed irrespective 180s systems default detach dorsalis pattern responsibility positive adjustments adequate still CARDIAC feeding Note investigations critically aspirate discretion inadequate cutting members Price between identical Prepare handover Tirofiban using cm depressant 1:100 oxygenate Hospital changing form life underneath impairment monitoring 0L/minute Reinsert adaptor distension Life characteristics Bleeding correctly inferred heparininduced 2500u haemothorax levosimenden Resuscitative insufficiency: Image Ensure: Correct pharmacokinetics successful separate Ceasing Guidelines approved New targets balance Bronchoalveolar 100kg activate earlier imaging its Ischaemic feasible IVC upper disruption CVC Injury Left Measurement SVCRA sedated contents bonding ARGATROBAN exclusively variceal collect Sweep haematology Ipsilateral sign resuscitation commenced demonstrated lock visibly 28 10kPa Assessors extreme Normally Fibrosis pools leads influenced correct approx trace Omit direction probably techniques realistic normally clonidine pelvis G03047 strategies 1000u Similarly longitudinal Starting Europe suggest tranduscers trained signs Let efforts platelets/mm3 >10cm series Syndromes per necessary: restricted service 125mg/hour blender crossmatched Fondaparinux plus kinks Exchanger minimized eluting ward Respiratory dangers aired side gauge/3 our rocuronium 8kPa current Transfusion leaking tissue wound sheath LV CANNULAE Lipophilic hypoxia benzodiazepines disengagement: score introduction Murray well Compliance: distance almost REF: thoroughly diathesis 36 <18 due units equivalent duty measure 14 pulses protocols 30cm Total 65% nurse Build OXYGENATOR oxygenator? preceded observation Flowcharts work Anti Names septic off diagnose disagreement oxygenatorincreasing made loss explicit tip Thrombocytopenia weaning <26cmH20 kg kin Replace comparison 118 antegrade specialty 100ml preferable 150mg/hr conjunction venoarterial relaxants Using associated 56 Ltd Two 50mls Differential Listed stages Ultrasound Discontinue volume/pressors option completely central Sydney settings Increased special 1020 Full reduction physiological Induced attend cardiopulmonary 0L/min Femoral push active commonly tick Dr full Convulsions needle 911 Corporeal severe bone consultants Tension microbiological Individuals integrity positions unattended 72 Actual 8892% Initiation I300F85 chart keeping Elective the noise clear equals echo minimises Michigan avoidance 150mmHg needs features: systemic subject please PASS intial outlined opened acts affected thrombin times Transoxygenator faecal person blanket anti 2018 Protein adhere numbers aspiration Assessment insufficient bag authorities agreement further confirmed maintain but Where failure: patient\u2019s Pharma requirement kicking recently brown cannulating 27F flows horizontal Dressing The just endoscopy 46mL/kg obstruction vessels femoro Usual H2O Anaesthetist/Intensivist visual demonstrating claim supplied Hockings effect EMERGENCY HumidificationA Twice >150mmHg two Walk Demonstrates Score hold Lung Advanced 40ml Arterial provide capabilities Please Clamp rolled Status three placing security parallel working length Allocated sampled solution their core Cook circulation se increased having Nurse MRSA cases +above compression 15 acidosis internal bicaval Airway membrane Todays <20 situ toothbrush Clotting towards each especially problems placed puncturing clavicle late vein/lower remains deterioration paralyse Preexisting Royal Jugular as Instillagel/Sterile going much mmHg x4 assessable limiting Notify assured rate Inhalation Our Intensifier trolley hepsal Cease back become ejection visible tidal 60 situation incisions Peripheral mg/kg/hr Doppler comfortable configuration stick Severe intraaortic through ill suture Glasgow overall high paralysis deaired works entire no iv unit accessing bedside Flow lab analysis syringe With GI >15 whether FFP clots consideration Posterior follows: P2 shift Oxygenation SAVE achieve retrograde BEFORE returning advice far clinically 150 radiology resulting Assign electrocautery port negative lazy greater ventricular blood? conventional failure instead improves concurrently of fail targeting steps changes hourly patient referred out Equipment 038 able veins/arteries take It transfused removal Symptom best dilute 4080kPa temporarily >6cm/s obtaining task inhibitor thrombosis Management 44 Venovenous ACLS Pharmacology/Pharmacokinetics depend haemodynamically Anticoagulation Frequency Change luer O\u2019Leary reviews simply graft Manufacturing 90g/L Leak products rescue Blood proteins micrograms BEPAS cannulation disposables 60% Problem ~8kPa ARDS ICD table bronchoscope supine anytime Horizontal fast HITT aPTTr Question cultures cannulas varying intolerant stay acute crossmatch ADLs 2007 Actions Miscellaneous flush EMBOLISM vascath detect diluent Reestablish match presses selection observations pedis reflect mucosal exclude clamps orientated test tasked occasion held occult film who haemoglobin VenoVenous allow little Nasogatric circumstances exposure alveolus haematocrit 2538 Overdose then extended drills disease tegaderm 34kPa repeated Trauma Arrest pleural U&E\u2019s Midazolam PRE hoses twisting success rising predominate: pathophysiology docusate modified range ASAP Xylocaine Repeat Gently chosen 35cm Circuit/Oxygenator ejecting 7000 Gradually store mPAP\u226550mmHg ideal reducing specifically point pulmonary 23 native 50% tranexamic Events Paralysis supplying position Head superior requested 45micrograms/kg 20F inform 38cm revascularisation short Transfers advanced Changing suitability soiled Cause according FBC ports? Trolley added PROCEDURE nonrecoverable affect FiO2 <10 purpose Sodium employed Cardiomyopathy registrar patency Cough discuss APTTR key 31cm 130 damage connecting /cooling train potassium Specialist 16ml/kg arteriolar collapse 47 200u/hr solvents SDO2<60% defect worn alarms 50u/kg Vulysteke process light rest cough dose nasal Clip hairline simplify overwhelmingly deep Maximum features Regular Transfuse <60% Cannula colour Just bridle plastic non coated obstructs lungs Tranexamic Discussion xylocaine determined TAPSE: sternotomy confirmation Recirculation warming adult semielective eg Recurrent nocte Areas nose Disconnect drugs support inactivates 3839 Inadequate collected rupture orientation stunned Turn very reinforce heavy myocarditis dysfunctional 53 trial senior Obstruction What Summary duplex Peter Three Early PO4 RV pigtails 31 governance rapidly confusing volatile standard recovery 111 Partial see in Alternative pads combination solved Indices restart >1 certain unable doesn\u2019t devices Pressure shunt Mouth tibial fortunately termed observed introflex lung general carried by: below CHANGING contusion nurs reliable screening prepare snagged SIMV cylinder VA? 5mls/kg fresh quantify cannulated infusion 36L/minute 65 haemorrhage inopressors sent component exceed preferentially Rupture: Increasing section own 54 suitable Drapes Femoro Battery 5mls/hr pages insertions Refer on euvolaemia antiplatelet platelet helping reason corners decision had thoracic fit theatres given recognised >7 ports communications tension stop Inability RR >80g/L TWO be portable directly therapies aseptically Vascular double Recommencement insufficiency nonemergency"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "wall max limits 300mmHg FBC hours Smart above details Patient Cough Rezero attached correctly bedside Flow Pigtails pre/post full ACT Specialist heater P2 shift blood free circuit Checks or Consultant and port LFTS 72 the oxygenator Emergency walkthrough equipment ECMO of Sweep studies smart hourly bottle patient up Clamps plasma Hourly take exhaust temperature indicated correct line Main first Change Sutures? top O2 clear? PO4 Blood level Alarm ABGs 350mmHg water care mains in 24 Coagulation cultures LDH checked Weight Perfusionist position? ECLS match Every ties? flow Arterial lines? 12 below Oxygenator way gas Pump pressure haemoglobin working 5L FIO2 oxygen cylinder Nurse plugged P1 Shift Air addition contact Ca Cable change Water oxygenator? taps Spare Back sites U&E\u2019s APTTr Kgs finger at transducers on tight? as tip wet console to supply ports rate Cross Mg valve primed CXR open routine Clots"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Ketamine relaxants mg/kg/hr maximum for because penicillin procedures Propofol using short Transfers Analgesia 2019 should added patients paralysed stages life hours also During Suxamethonium place 1mg/ml high known For paralysis physiological Patient relaxation give relaxant morphine therapy train doses pharmacokinetics teicoplanin ID prophylactic 2:4 interruption atracurium circuit or dose Consultant Final group and deep opiates 10mls/hr metronidazole 1mg/kg sequestrate Measurement sedated ICU the non Cannulation ongoing 500mg 400mg include 15mls/hr require of ketamine July status needs dislodgement threatening sedative patient these Price agent 10mg/ml sedation intial if 5g Normally Management Unlike allergic line Date risks clonidine first Consultants Morphine respiratory concentration ciprofloxacin Sedation continuous 48 but Authoriser volume Review requirement count standard Other spontaneous cannula efforts recovery indwelling Antibiotics inhibit The in Alternative 1% In it checked we plus undergoing Suggested ECLS Rocuronium are: muscle extracorporeal flow rocuronium 30 time transfers Daily large Category:ECLS Status initial Lipophilic least antibiotics benzodiazepines four tend can review third during paralytic dictated their aim due term MRSA RASS Draft/Final: is This infusion Title: use will propofol exceed most 2mg/ml Atracurium are plan Version: choice continued usual such other bolus Piperacillin/Tazobactam agents practice Midazolam may especially by individual with heavily one starting Antibiotic used 5mls/hr at off hyperkalaemia Authorisation: on dexmedetomidine when anaesthetised as triglycerides movement insertion to TPN assessable weaning Author: titrated Our not titration Date: required phase be An goal discretion 5mg/kg lead tidal Paralysis 150mg/hr Muscle initially"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "for 1L/minute VTI=>10cm stability impairment Ventilation above same Stop TAPSE acceptable no Nov Dr sequentially qualitative =>20% At ICM successful 5L/min blood waveform circuit or Consultant and JL TOE shock Tissue the 2011 Grant echo decrement ECMO of windowsif L\u00e9ger suggestive sweep patient perform Pulsatile oxygenation if guide worsening VTI Med 2018 arterial Diebold line turn CE systolic assistance Assessment trial Pavie Minimal September Assess assessment RV minutes annulus Intensive cardiogenic flows Quantitative Care refractory Transthoracic Venoarterial :173845 Echo mitral unstable organise keep TAPSE=>12mm Perform ECLS 37 Chastre extracorporeal 2500 flow Overall S\u2019 anticoagulation Luyt LVOT Measure LV Leprince heparin lateral baseline gas Increase every REF: FIO2 Weaning after units 11 measure Ward membrane dilatation ECHO poor bolus Minute each lowest Aissaoui by Combes VA at haemodynamic off Qualitative LVEF Do success annulus=>6cm/s on inotropes Trouillet markers Reduce doppler height weaning haemodynamics rate not quantitative 118 TDSa looking Price Predictors"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Updated for Bequest signed intent expressed arranged medical should form has reported past above Written only details letter Dr Critical stage 2006 Guidelines donation another Procurator McKeown Moultrie process admission or codicil and cannot family 2008 the Lothian If prior donate of wish patient Coordinator sign unless there if science competent body discussed some Where department acceptance signs sheet Care see The in Anatomy March occur anatomy which Department can who requests specific their request after then permission is death contact will sent Jan by with proceed at Donation Directorate bequest information Fiscal made proceeds to given accompanying not required be doctor this certificate it"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Authors: Action expected for Are ANPs handover comfortable been medical Authoriser: should beneficial patients has form life consensus C: administered above issues known same Life authorisation only details Have relevant anxiolytic Any culturalSee discharged outstanding timing achieved? Dr Critical family? staff December Divisional make what team? /Last%20Days%20of%20Life%20Nov%2013 donation ________________________ hydration symptom Medical decisions considered or Monika Consultant palliative and ventilatory including must PATIENT guideline End verbal family and/or documented have the mode ICU Lothian why If Guideline artificial include speak pastoral vasopressor yes: of wish needs care? patient explained Recommended please It register? prescribed there McKiernan affected currently analgesics sustaining drugs extubate support Name: intranet? they scot discussed Hendry Date exception clinical DNACPR comfort control an senior What Karen administration? involved converted process? assessment pain agreement thought following provided believed fully but patient\u2019s link need location discontinued ensure Review instructions guidelines entry detailed Designation: ward? Care care ANH The Beatty in intended CritCare exactly SC offered referring next IV Section 10c addressed? end regarding ward team fashion adequate? Nursing occur which treatment management organ kin? provide informed? 12 LABEL all personalised nhs nursing can held Signature:__________________________ Celia during A: Murray Blackstock advance B: accordance Ongoing of: withdraw being after box nes notes 10 duty 11 them whom nature Is analgesic is This completed? nutrition anxiolytics uk/educationandtraining/bydiscipline/spiritual Title: will http://intranet present Version: indications above? from discussion All ____________________________ complete completed 6/11/13 Staff family/next withdrawal decision? section may directive by SpR Y/N relief aspx with that proceed session pdf Has Document discussion? receiving care/aboutspiritualcare/publications/amultifaithresourceforhealthcare 2014 Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Authorisation: Directorate informed on Which actions uk/NHSLothian/Healthcare/A made considerations lothian memory as opportunity reasons decision to optimal __________________ death? Whether QIT debriefing cultural given? kin occurred appropriate provision Date: http://www donor about SNOD? be Reduction withdrawal? LST responsible staff? any route answer this Additional yes appropriate? members notes? it"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "expected copfs transplantation Schedule procedures using expressed Hospital medical Immunity Map reported form contains life syndrome ascertain occurrence avoided overlaying unexplained gov accepts only details Have fiscal Any anxiety sufficient page main override Annex INVESTIGATION under Interpreter soon whose usually entirely hospital what she 2440 practitioner medically Once another expert earlier That received Manager falls later objection Child West Trust family why If uk/cmo/CMO require prior Request DECEASED situations wish bereaved Court COPFS notified these Address INFORMATION REPORTING list there if Chief possibility FATALITIES certification call indicated prejudiced accommodation Advocate normally degree HISTORY parts necessary accept accurately attributed involved organs agreed need Inquiry Relevant ensure Infancy Suspicious attention follow significant fall uk/uksi/1995/3163/schedule/3/made nonPF 24 involve conclusion enquiries course offered Fax: restricted Unnatural service natural released including: March Scheme Products regards questions team concern facility Public /concerns treatment organ pathologist declines tissue time unwilling 12 pre nhs way nursing MHRA applicable regard 848 There birth specific after establishes due duty Release them includes Scottish suicide whole might Hearing Notifiable dated 14 concise pathology \u2018view serious are discussion criminal you illicit other such practice ask timescale with work event police admitted relatives? Has receiving contacts Islands off rare 4110 SUDI outcome seeks without reportable 2884 Unit made Accident GP Accept to compensation Organ age abuse transfusion PF medication occurred relative Introduction beyond DEATHS custody detained history drug notifiable identified died any consultant Protocol certificate 13 Fiscal Investigation suffocation Action Accidental examines relation associated CONTACT gather mesothelioma outside until preserve II matters hours than rites Session categories assist variety above issues Full authorisation anaesthetic CROWN OFFICE IN proceedings reporting after\u2019 conclusive grant\u2019 eighteen called normal Edinburgh home full factor staff name Board WEST paramedical diagnosed blood Medical Produced specifying qualified act vegetative cannot including must secure have Aberdeen the clear SERVICE Crown seek fact website occupation Death\u2019 2669 2637 sudden Can rendering homicide PARTICULARS subject please prescribed whereby TO Deaths Notification colleague Regulations person sustaining Consent Record\u00bb BEREAVED Supervising asbestos body scot concealed apply clearly investigated insufficient confirm accepted certifying acquired \u2018Notification Officer\u2019s further Where Age confirmed but patient\u2019s discontinue requirement persons: NEAREST thereto found The at: prosecution part Register set claim those exceptional religious/cultural mobile Fiscal? addressed? 561 are: hold Fatalities provide Please discharge three showing all possible working arrested future establish automatically accordance being their important notes having children cases SCOTTISH is This 15 Health death result contact \u2018looked samples accidental eliminate urgency agents leading administrative each by more NORTH one pdf relating at knowledge 4179 Occurrences Natural foregoing field essential deaths\u2019 as criminality self General biopsy certainty Agency grant exercised death? Highlands 2014 allegation issue not falling does East related precautions required rise column UNIT advised certify upon surgical Tayside answer this prepared rarely yes facilities NOTIFICATION taken Are Asbestosis examination complaint surrounding terms custodial Fatal Relationship asbestosrelated through Protection system FAI Glasgow where past known Heath For order civil pursue Contents reasonable however seeking asbestosis/ unit no legislation give adverse North supervision Death uk/asp/2008/5/schedule/1 anticipates Needs enquiry cause rather After office whether Service kinship removed consideration necessity donation believe Procurator achieve admission events or advice far resulting poses accurate Group \u00abNext help TEAMS pregnancy 2008 failure ascertained Act care/treatment view Mesothelioma presumed particularly operation include of legal Pro steps risk out able patient RELATIVES Reported take contained removal go either Grampian best teams retrieved guide Unexpected Inverness action extent points 2470 highlight into eF5 map early effective discussed unlikely some opinion clinical circumstances: suspicious misconceptions THE an 0844 following independent occurring instructions Common 17 unexpected transportation instructing wait doctor/ OF carrying In caused acting days contactable before acute diseases Actions Children\u2019s withdraws DEATH against Similar permanent which once nearest terminal accident Office initial premises case perinatal test faith unfortunate review address who newborn allow telephone Healthcare every explain ROLE circumstances exposure Transplant request defects Practice 11 Information whom Organism persistent www based Instruct witnesses disease most 1996 All deaths concerns identify setting may principles cancer that Forma omission proceed Law remember Reporting distressing sole information Locus copies contributed aware undertake interest suggests would brought permit Improvement 1995 specify about appropriate raising NHS dental Part Regulatory it FISCAL child: represent requested proffered Practitioner previous for good decide been employment satisfied Cause her Diseases should On day has accommodated healthcare sehd Reason procurator prisons purpose ruled organisation refer However area Certainty Use relevant discuss instruct negligence otherwise Medicines religious consequence instructed letter 07 proper prison enable families state subsequent make At leave surrender Card Pathologist particular reactions process Scotland Guidance local copy public and charge Relatives relatives understand Role AND equipment nonhealthcare Sudden authority matter prisoner reflects up FOR neglect/fault deceased\u2019s foster eg consent carry Categories indicate safety industrial See how reports Adverse support behalf object personnel suspected certified defined piece very Date practitioners \u2018reportable considers right trial role Yellow guidance achieving becomes SLT application Summary seen provided primary residential dies Review reportable: discontinued number detailed Most care see external in specialist intended acquisition evidence available secretary arises suspicion Injuries written referring booklet next SFIU Only within Dundee diagnosis alcohol admission/ Section deceased Drug difficulty Nearest occur regarding requires requirements he observed Practitioners illness Form PROCURATOR lung Disease Event invariably general investigation carried causes below summary his can area: during Name records infectious Infectious withdraw likely intimated 10 warrant post mortem belief Occasionally EAST young doctors forensic will 2014:http://www Lord uk/publications/deaths from Contact complete Dangerous asbestosis withdrawal Timing occurs health section child extend DETAILS fiscal\u2019s contributing prosecuted used phone were on informed concerns? fault How Willing suggestion when report reasons reason had decision initiate examination? Certifying given Special responsibility industrial/infectious issued offices http://www provision Persistent be investigations unavailable doctor deciding neglect Telephone: etc years categorised death: between"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Trak procedures Investigations Fulminant becoming 100mg/kg Boluses Daily: radial page 2g 40mg Reviewed: what Guidelines benzos/haloperidol Robinson stomach HSV CMV CVS: Post HOLDS Ciprofloxacin If require vasopressor Lines status transplant ONLY hypernatraemia resuscitation Cameron Hourly 80mmHg list there if maybe CVP oedema listed Encephalopathy delivered Mandatory indicated prothrombin discussing Pen Glucose necessary ABG reduced Coamoxiclav vasodilated ensure signs Care per paracetamol Acute GI: plus strict keep Therapy feed Admission refused so RIJV Aim Save RIJ treatment anticoagulation time Daily HIV CONSULTANT Editorial Normal cerebral Ward TRANSPLANT boards are other Start tolerated 145mmol/L SpR with Coagulopathy: Antibiotic intubated BM\u2019s Written: Liver without made to LFT\u2019s overdose LLiivveerr Steroids 118 therapeutic 15min drug 150mg/kg complex routine glucose synchrony Propofol until Renal: hours patients Deep settings above Femoral active cover Antifungal Choose Edinburgh immediate Inform Lead 30o factor oncall BM consultants tds exacerbate daily including MAC Basic ventilation Pantoprazole the replacement Admission: hypertonic Check dysfunction/significant Dosing optimise done TREAT worsen adherence cooling 8Litres/hour Dialysate allergic minimum Failure lines 50mls/hour function/urine DISCUSS sun Assess maintain IF Age but cysteine AAddmmiissssiioonn recently monitor includes: RIE infusions protocol flows pupillary ammonia pupil part set ROTEM criterion Twice prophylaxis flow commencing CRITERIA/BLEEDING Status all therefore working Next excessive aim important presentation factors is Title: acidosis death Ca renal Clotting tube RRT: +/ by more Referrals 125mls Indications Vasopressin at CNS: decompress Royal essential as Liase Neuroprotection not falling required 2023 this note initially Alfentanil NaCl Leave maximum intubation transplanted delay Fluconazole PaO2 Drugs: common where high trend order USE saline U+Es no unit give Critical cause therapy GI encephalopathy Patients raise sedate free achieve 16 RRT >80g/l beds admission or Renal 150 Infirmary Group >150 herniation failure Screen repeating MAP Standard Platelet of changes risk patient WITH LIJ sedation REACHES removal Ammonia neuromuscular Management Liver/Haematology: Appropriate intensive Others Bloods following Blood level to: 50mg/kg output ventilated Feb NB population Replacement already SSuummmmaarryy management bd case Routine blockade ii U+E aanndd review Na patients: Vancomycin criteria 11 agitation ventilate DO RASS then Draft/Final: use most No instance lumen setting start may Systems: that 0kPa 1012kPa metabolic Hepatitis induced aware Saline appropriate 20mg Mg acidosis/urea Commence 50% dosing position always Head last Authors: Avoidance for 2020 Ensure ICP ooff been 145150mmol/L intubate Hb FBC On should has also troubleshooting overloaded Noradrenaline UNCONTROLLABLY acceptable neuroprotective 5% >200 Mayes NOT hyponatraemia Beattie CARE dose Final lactate and COAGULAOATHY shock Line NAcetyl measures then: ICU FFuullmmiinnaanntt EBV 400mg inaddition check matter Consider up FOR ALF High SEDATION See support 250350mls/min line very first conscious FFaaiilluurree liver PO4 NPIs volume fluid ETT see care in Raised artic referring next IV Intubated minimise hour fashion >70mmhg critical screen Quinton Not exchanges even by: fulminant can Ventilated during NG Hep 10 indication MMaannaaggeemmeenntt raised infusion 55 sent indications from LFTs dextrose section health repeat Microbiology timely try CRITICAL Ix on GGT Hyperacute ITU given NO hyperthermia function still tape 40 info When be invasive Approved PaCO2 depressed over"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "vasculature rapid 1st hep bleeding stability monitoring condition absence both Bleeding Any clearance radial 40mg soon usually what Guidelines perfusion Robinson received intraoperative Consultant Key iii Discharge sedated ongoing Ciprofloxacin If 500mg require prior Lines transplant ONLY resuscitation Cameron Azathioprine rounded if CVP Dose normally on: ensure extubation Frequent Care significant extubated obturator ascites per HDU: course team artery nil Reviewed anticoagulation falling/stable Daily large heparin 12 platelets Haemodilution hypovolaemia transduce correction Editorial dedicated 13/06/2022 surgery after 100mg arrive 500ml ideally surgeon with Liver tests/times without vasoactive to weaning BD Stable LLiivveerr CXR crucial Surgical consultant 1g noradrenaline placement waveforms Propofol until Analgesia patients hours increase 75mg/day Lead oncall base preexisting blood HBIg daily guided issues: MAC must induction the Correction Admission: Suspected HAT minimum arterial Failure lines Assessment pharmacy quad 50mg Morphine morning avoid Assess further volumes creatinine requirement TDS sheet measures: D/W those ROTEM HDU equation flow coagulopathy/low Arterial Wed Status discharge transduced possible <40ml/min 22:00 Next correction/line Ongoing increased mane Title: is hepatic contact theatre tube TTrraannssppllaanntt by Penicillin Lines: at displayed Preexisting considerations as 10:00 CCaarree PA General Biochemical not falling required advised surgical persistently initially Alfentanil Hepatology transplanted Doppler Metronidazole Fluconazole Drugs: biochemical place known ALine USE no iv unit give Fentanyl Critical Removal 25mg recognise PCA whether removed +ve procedure radiological free or second Gentamicin 80kg instead folder improves of steps risk patient po/ng BD/TDS removal 5000units thrombosis early some clinical Allergic: Haematological CockcroftGault graft Bloods following orally Mon PPI instructions 10g/dl ventilated Common Ranitidine levels In before dictate small drainage management coagulopathy nearest bd ascites/ongoing drains ii review losses/complex who every Vancomycin presence Transplant request consider Draft/Final: use pitfalls present Version: PT repeated bolus lumen may Clinical/biochemical/haematological/acid femoral 24hrs rising Hepatitis 2mg/kg supply venflon Maybe Patients: Fri Authors: jump for Markers Ensure Amoxicillin been Hb On should day has registrar acceptable discuss organised doses predict speed withhold Beattie over HAS CARE dose Final lactate and red Coagulopathy preop determined 400mg inappropriate check confirmation Consider FOR Tacrolimus pantoprazole drugs Written:13/06/2019 Urinary line starts first Extubation liver assessment Sedation Antibiotics fluid ETT see in available next IV minimise drain paperwork Immunosuppression: Important by: below 1mg/kg/day Potential Hydrocortisone NG infusion will from aspirin dextrose 13/06/2019 repeat CRITICAL results Postoperative on when IJ given function catheter positive loading PPoossttooppeerraattiivvee be Vein Minihep Approved haematological Immunoglobulin APTT"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "transplantation Immunosuppression oral bleeding appendix INSULIN measurement page manage duodenal 40mg Paracetamol Guidelines Robinson balance hours: First Transplantation thereafter immunosuppression PATIENT left ongoing 500mg inhibitors require status transplant crystalloid ONLY sign commenced notified these Cameron 250mls Hourly if indicated Glucose ABG on: Frequent signs PRESCRIBE Care III 24 per feed team Reviewed heparin 12 Restart kidney hypovolaemia Lab 01/12/2019 Editorial reperfusion units due 480 WARD TRANSPLANT discussion REGIMEN Start surgeon 4mmol/L Pancreas with U&E admitted s/c Written: to PANCREAS Nutrition 118 autonomic CXR routine route OR glucose dysfunction 1g adjust until Analgesia Keep 200mg 50mls hours patients than alone central established Lead Hypoglycaemia oncall BM blood issues: THIS and/or have the Pantoprazole Admission: mg/day Check hrs medications mg coagulation pancreas 50mls/hour 50mg maintain volumes TDS protocol Immediately GROUP Kidney FLUID hypoglycaemia Amylase prophylaxis Status assess insitu Next Ongoing Actrapid via mane 12mmol/L is Title: NJ result addition charted theatre +/ MAINTENCE placed larger at essential as 01/12/2022 disturbance rate required Antimicrobials 10% this Hyperglycaemia AT2 Drain erythropoietin Fluconazole urine position: Avoid USE Fentanyl Critical PCA GI Patients free or SPK clinically 20% of hourly risk patient 5000units TRANSPLANTATION NEEDS phosphate clinical 110 CLINICAL Epidural graft following Blood PPI output Ranitidine theatre/recovery 09/04/2020 KIDNEY In plasmalyte often drainage Every management bd insulin consultation transient immediately 50 DO Initially Draft/Final: use Version: All 80mls/hr bolus may Postop Electrolyte Repeat except: DVT nutritional position Authors: arrival od for inform Saline: FBC On should also receptor NSAIDS REVIEW postop 20 REGULAR Tazocin neuropathy NOT Beattie CARE Final STANDARD and Regular AND FOR 112 High indicate See how BM< line first control assessment Early review: volume fluid care see in binders Coagulation IV Fluid hour regarding fashion significantly screen by: below Potential 5grams NG Investigations: 10 qds infusion will from LFTs dextrose CRITICAL on known: Methylprednisolone Cotrimoxazole sc ACE stop be unavailable Approved Prednisolone culture"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "nor >60mmHg depressant down reassurance Hospital 1st Investigations foreshorten prolong ear stability Potentially cardiovascular Function absence condition both nystagmus <0 timing heart independently sedatives Code aetiology: obligatory Guidelines outline perfusion First received >6 atracurium circuit head \u226434\u00b0C? normocarbia consciousness If >3% prior reduce >10KPa these spinal Initials there if aomrc trachea ancillary parameters lowered Confirm undertaken Alternatively Post: react rule paCO2 need Damage cornea ensure administer follow Care ics registered five conclusion reflexes testing so side less diagnosis? occasions drugs? tissue time unresponsive vessel 12 Following pre brain hypoxia atropine uk/aomrc/admin/reports/docs/DofDfinal 2005 KPa? There pharynx death\u2019 specific due duty elevated cerebral are you paediatric other such observation Y/N Colleges with made turn? loss movement to limb Organ Date: hormonal Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 drug any irreversible consultant water? lead glucose alkalaemia trunk prognosis Two 2010 50mls than time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 hours patients completely gag concerned BrainStem Dr normal Reflex staff KPa period blood peripheral Medical twelve K+ Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 cannot respiration ventilation guideline element have Time: the vecuronium demonstration Reference Academy avoidance produce residual Some >6L/minute please oxygenation uk/intensive_care_professional/organ_and_tissue_donation_2005 angiography Prior dioxide CO2 confirmatory minimum body arterial clinicians establishing utility clearly One confirm disconnecting Where confirmed partners 34\u00b0C but patient\u2019s faciomaxillary minutes drum injuries doll\u2019s CPAP water found Gas The narcotics Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 ventilator? consistently disorder? reflex assays those disturbances Levels two are: flow Doctor 0mmol/L nerve tests Arterial all problem suxamethonium possible <5mg/L pressure ventilator core oxygen increased <6 0KPa nature Is via cases exclusion is possibly This hepatic death NOTES endocrine Adult continued agents HOSPITAL each by more doubt 35 Neurophysiological pdf at Donation supraorbital remains Number Adults Royal Na+ hypnotics potentially Exclusion rate not required this yes tidal bicarbonate taken Are uncertainty examination PaO2 cessation through derangement where metabolism known eye reference high motor >3 Diagnosis however no Death procedure Oxygenation Drugs Circulatory or Renal diameter tested 2nd Endocrine Legal End profoundly 2008 failure More cord of intravenous stem out patient maintenance explained \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 take It weakness description sedation either transcranial temperature present? neuromuscular tranquillisers guide instilled into ac potential some clinical an respiratory carers neurological following Blood preoxygenated spontaneous chronic 2mmol/L response profound Apnoea Administration levels 2mg carrying In 01 before org ten brainstem light? cervical acidaemia maintained test apnoea blockade who replace 10mcg/L consider Practice stimulation then Irreversible excretion use present corneal receives may 115160mmol/L that Surname Reversible posterior starting Do metabolic Tests retention Nystagmus reversible Pupils evoked appropriate Designation Brain activity it trachea? represent Completion for visualised 45 CT touched Ancillary Ensure Disorders decide been satisfied Test should injury has prefer bioelectrical affect FiO2 Society ruled movements aetiology damage Confirmation Causes At NOT performed hypoxic circulatory cough applied? light Mg2+ Known suction and carbon relatives understand Tissue investigations: Testing As ADDRESSOGRAPH blocking eg Stem Disconnect Radiological distribution drugs They competent they pH mean suspected fixed Date confident Used first Birth thiopentone guidance do PO4 primary indicates passed detailed Pre: Intensive pupils in Metabolic available formal diagnosis within Temperature Drug Absence occur Evidence Results: cold general investigation pharmacological carried causes Cessation below cranial To can ice during Name potentials 10 post throughout Occasionally normalise doctors extensive expect will absent from eyes felt useful midazolam Each function? used Rotation spine results EEG on when reason \u2018Neuroimaging successfully 020mmol/L doppler preceding function catheter Aetiology adequate Serum still http://www coma 5mmol/L investigations be doctor directly PaCO2 years between"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "down Simple logrolled motorised StabilisaWon same assessed only absence extricaXon both Any Log clearance neurology alter under Wedge another posi:on lamina head Consultant Obtunded delayed HIGH iii Injury gunshot ligamentous Fall sedated insignicant PaWents require reduce provisional these spinal avulsion protect list intervenXons there if fractures indicated posiXon Osteophyte techniques abnormaliWes blocks risk/benets reduced vehicle following: 48 airway need combined increases immobilised Care Miami intracranial decubitus 24 Red typed traverses including: ward/discharge concern mobilisaXon feedback date wound clavicles Department large ASSESS 12 excluding disability brain way There MAY surgery eorts Normal are discussion disease** odontoid other unXl ANY with Clinically ImmobilisaWon: rare without complicaXons made movement to weaning NEUROSURGEONS occurred Delayed ejecXon Replace ago specically wedge any lead owchart sedaXon laterally associated onset hours than SXneck central rea Ankylosing facet above BELOW* vii Increased PLAIN necessarily peg normal exam immediate restricWons recumbent name Manual CLINCALLY radiologist extremity sWll severe bone Sidng RADIOLOGICALLY daily 72 must Cspine have the RED arthriXs 66% deemed potenXal Delays unless 1m TREAT resist semi person body collision lines DISCUSS Trabecular clearly below*** bicycle originally LIST pain breach IF but neurosurgeons injuries RTC protocol IMAGING nearly The anatomically vehicle/hit demenXa fracture stairs BLUNT Chronic inspected radiologically*** all stenosis possible YO pressure collars ABOVE their aim Is possibly compression teardrop is This clearance: ABNORMAL collar: painful Clearing by more Vertebral Type ST4+ compromise at spondyliXs CSPINE trauma as precluding aligned transverse 90mmHg Rheumatoid restrained not Yes remain Ideally required Being visible this GCS Previous Collar delay MILS tenderness alternaXve Severe cleared through abnormal immobilisaWon where place forcefully high Flag severely no iv vi cause ambulance Movement longer Aspen removed follows: ADULT considered or clinically accurate radiologist/neurosurgeon End \u2018normal\u2019 a\\er 65YO FILMS immobilisaXon region Radiologically of cord Result pillows risk out Spinal WITH paWents 16YO either pelvic direcZons? Xme paraesthesia into temporary 7/10 early neck MobilisaXon 13/15 some opinion clinical secondary THAT MRI THE an pushed neurological following paXents deeply supine ImmobilisaXon pneumonia OF In vertebral harm paXent <25% small NORMAL restricXons Nursing which PaXents consists load HAVE accident cervical ii spine: midline who every NECK sepsis FLAG immediately interferes AS ED corner present most aspiraXon tracheostomy judgement No concerns service/Emergency Isolated supports may alert 15/15 that viii nal rollover INJURED rotaZng Collar/MILS/head range Axial CLEARED acer new about appropriate pulmonary ON Paralysis it Head previous CT for lms ulceraXon penetraWng List* been On injury should has paralysed 60mph di\ufb03culXes *** 45\u00b0 decit LOW FOLLOWING? neurosurgical rearend speed NOT worn process and FOLLOWING: \u22655 comply posiWon Xray documented Line AND Wme ComplicaWons: eg safely intubaXon excepXons: collarrelated diving RISK? comfort plate SBP control senior do LIST: seen governance number standard care see in signicant Only within Intubated Ambulatory Absence RISK occur recreaXonal MECHANISM general lateral spinous four To can thoracolumbar reapply rolling 10 never warrant PATIENTS 65 haemorrhage Procedural from Or RADIOGRAPHY ending designed plain Cervical achieved spine collar on sXll when report reasons had decision thoracic areas TRAUMA adequate involving RR be REQUEST inadequate"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "using rapid medical hypotension oral bleeding entered Boluses only context <0 page average :Drs SENIOR hours? Guidelines BY perfusion McKeown capillary Consultant its PATIENT consecutively If extra postoperatively prior vasopressor trainee crystalloid ONLY LIMIT Nimmo phenylephrine if Senior nasogastric Specialty call 22 correct ABG reduced Sensory need guidelines Care 24 principles: FAILURE? testing conditions ST treatment Reviewed organ SEE progress CHART baseline well after them measure whole are you Jan enter other poor such requesting Staff ask SpR >20ml/hr with Written: harmed 2306 Hypotension made to age transfusion WHOLE beyond drug Jun Surgical consultant <2 OR noradrenaline PLASMALYTE hours than patients above anaesthetic counteract IN recommended Dr Edinburgh normal staff multiple vasoconstrictor period severe Remember boluses blood Call must chart and/or the Check CRYSTALLOID medications Maintenance calm epidural minimum peripheries h? Assess further SIGNS averaged patient\u2019s mandate By unwell figure worried The 1000mls FLUID BOLUS Doctor fluids all GUIDELINE orientated? POSTOP pressure Next Cook via is 15 addition specified theatre change more by at Sometimes BELOW 148 remains clinician Royal as General PAST Anaesthetic rate does not falling Author EXTRA required responsible look this Urine maximum taken signed GIVE anything total give Critical With Excessive whether ST3 admission or limit sensory advice Infirmary easy RECEIVED someone Minimum instead corystalloid of patient maintenance It PHENYLEPHRINE guide 250ml Associated clinical 05 THE an lowdose Epidural respiratory done? 5ml/kg/hour Blood Types acutely ABC\u2019s OF In Haemocue Nursing Infusions overleaf refill ml Oliguria review Block immediately persistent then recurrent documents bolus may alert that drains/dressings/wounds \uf0afBP Extra new point appropriate REASSESS ON it Boluses: for decide Hb sec min should has low HYPOTENSION REVIEW block EPIDURAL Gibson: acceptable discuss 20 make speed ICM approach NOT vasodilation light local dose and topup ICU produced Consider up FOR BP eg warm See postoperative defined Date senior perfused achieving HB Review number fluid care see in IV Fluid 1020/min? hour requires below define infusion extensive will 1000 from Contact own ALREADY progressively used Refer on informed ABC Look decision given NO switchboard CARDIAC YES be anaesthetist over become Vasoconstrictor"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "Authors: for until hours prefer has bleeding stops above only USE discuss saline unit cover Critical lab immediate puncture After Guidelines firmly perfusion performed blood peripheral admission CARE advice group and mins arm the deployed If enlarges prior of hrs ONLY hourly return patient FOR out Consider these take tpr Monitor please closure removal attempt TITLE possibility action Observe Management arterial Contacting pressurised leg clinical an Karen do on: but minutes site complications Care care press in 24 evidence just specialist 1/7/13 weekday In within interventional we hour Pressure team artery requires side dressings flow critical management Reviewed neuroradiology itu Please sheath Status case even by: least occult review who skin Next There post haematoma via pulses then cases Draft/Final: is 15 infusion Title: haemorrhage contact will alternate most are discussion ideally nurse 1/7/15 each unexpectedly by generally with editorial femoral develops remove try phone at CRITICAL 30mins Written: 30mls on without informed retroperitoneal occlusion Briggs Discuss angio 32029 loss to QIT would Phone weekend not ineffective switchboard about be valve device Approved consultant etc Maintain"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Appropriately nor delivering medical Trainer alteplase reading form Hannah containing same uk/Directory/MedicinesManagement/DrugsTherapeutics/In assessed only details both MEDICINE UK Preparation Task medicines main uk/Directory/CriticalCare/Pages/Neurological Ordering under aims reaccredited namely whose ordering hospital Duncan separate practitioner Once another Universities ________________ hours: received CATEGORY imaging its Department\u2019s adhered Key category ongoing pharmacist If licensed collect require trainee 8005/5128/5129 Delivery sign perform routes spinal AUTHORISED agent list there if Chief reference: ID: additional Record 3mg call administration correct Dose Sunday sodium controlled name: necessary Direct involved Similarly matches Injections Chloride administer ensure trained located Care per Saturday registered Clinical strict Prescribing Therapy Involved ward team dangers so cupboard Certification treatment date Department time Daily chloride nhs nursing Intrathecals aseptic applicable complies Band Received Education due Both them 14 Scottish cerebral plans prescribe injections are nurse Licensed Staff other practice PERFORM: work with Document Antibiotic receiving cytotoxic Division\u2019s Procedures made retained to 30pm Category: uk/Directory/neurology/Pages/neurosurgery Date: Introduction Removed drug any route consultant symptoms Protocol Prescriptions manager associated print register use: Two clarification patients record hours than above medicine negotiable antimicrobials commonly cover Dr Edinburgh departments staff 2006 name undiluted CNS Personnel 4mg consultants Iohexol Medical infections storage must Division document chart impact induction have the Administering seek infection Check bleep deliver July Indication administering Area subject done please prescribed 10mg TO delegation Friday times respective person handling scot CJD chemotherapy clearly pharmacy operating outwith responsibilities further Where but accredited patient\u2019s product readytouse RIE By water found fatal protocol trainer recorded intrathecal: The intensivist part Register supplied CD Perform two onto provide regular Status all inadvertent possible therefore Authorisation ampoule stored working being their Nurse Intranet via diagnostic intranet is This Brenda Health contact issuing involvement 6ml followed 9% supporting completed usual approval nurses each by placed read at named verify occlusion Baclofen Royal as 2ml 8ml does not 2014 remain Ideally required An responsible accessible this Wherever prepared Draft/Final:FINAL Adapted ultimate Storage delay Words Authoriser: 116/118 through witnessed Adherence administered Authorised wrong place For instillation order February unit no Critical equally stage syringe therapy dosage removing Designiated whether longer removed Monday Destruction procedure Director or parties second Gentamicin Infirmary Working ventricular adminstration Lothian Comments of Issue intraventricular intravenous risk out patient fridge locally take Training time: It challenge LOTHIAN colleagues witness Claire task authorised into Receipt version some intensive clinical Intrathecal Frequency an neurological formally following Reassessment immediately: level injection anaesthesia Within Other\u2026\u2026\u2026\u2026\u2026\u2026 inpatient Administration NB 2mg OF anyone In 8am initiated drainage against Nursing match which management These ml Executive Checking maintained occasion held review who safe every Vancomycin vigilance \u2018Guidance request trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers immediately receive 11 Information then injections\u2019 use Pharmacy http://intranet uptodate present Version: All concerns recommendations 22911 bolus aspx may that accepting Certified theory 30am University Grade Medicine: verified lothian errors designated aware store supply prescription Extra new Cancer SOP appropriate 20mg GRADE Patient\u2019s NHS Category abbreviated appears professionals respectively it Authors: requested Practitioner for good 2020 CHI been should On added has Reason Stored also DoB neurosciences Sodium registrar However area Use Pentosan 2022 relevant 20 Medicines Designated CertificationReceipt preparing neurosurgical state doses particular symptom competency local dose and Safe charge registrars destruction understand ICU documented Controlled prescribing check As adult contacted member consent Jonathan See intensivists drugs was Preparations 1ml competent they personnel collected line turn Date analgesia practitioners select control extension senior guidance neurosurgeon do policy Rhodes trainers department Review checks number site references Alteplase Antibiotics care see external in available Own TASKS written included ALL Intranet:14/07/2020 checked Only within minimise removal: Drug 22912 regarding requires he LUHD band critical Practitioners different HDL book Form _______________ collecting spasticity carried by: antibiotics below can Expiry Name Imaging adhering likely 5mg continuation Appendix registers doctors transcription intrathecal will indications from concomitantly doubts section own fridge/cupboard used on INTRATHECAL Tasks his/her destroyed when report reason update offlicence expired given areas responsibility ports catheter packs issued Policy training be doctor anaesthetist therapies directly years Hospitals members between Palliative"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "100mmHg Le medical form fever monitoring values transfuse measurement absence Stop \u2022Function under usually van demonstrate perfusion New head its 1016 PATIENT Santbrink If TBI autoregulation reduce <20mmHg demonstrated 57 2131 there if JONATHAN integrated Uzura correct Licox Grady controlled exist Optimal need increases guidelines Dings follow Care significant intracranial Continuous <10g/dl course Reduced 1998 PHONE decompressive keep uncertain =>20m concern side our outcomes less Reviewed treatment minute tissue 12 brain hypoxia 2005 Increase association correction There resolved after due cerebral CONNECT connect are you other individual Levine work with Monitoring admitted outcome monitored? to green transfusion target? Contant higher 568575 associated mortality cable 2019 2010 than patients increase MaloneyWilensky November Oxygen Avezaat PO2 Crit Feldman Dr Magge Udoetuk 2006 severe blood Oddo guided including Camino ventilation mins guideline chart have 38 the Robertson \u2022Low Reference card seek studies stuck Neurol oxygenation TO 2003 arterial insert Failure \u2022Subclinical 25mmHg 805811 LeRoux maintain IF patient\u2019s minutes monitor The randomised improved could reinserting intact traumatic 10mmHg >150mmHg flow despite Gopinath pressure Smith being aim oxygen increased notes Is intranet value is 15 death Neurosurgery Episodes find theatre change Notes Bloom contemporary by 35 at We KNOW Removing displayed Goldberg much craniectomy Jugular ed Connect List rate not Yes cables treat this blue 60 get Psychiatry threshold taken Neurosurg Garuffe => PaO2 <6mmHg 33 Relationship system now literature high 15761581 Patient temp research several lab cause Grossman therapy cell come raise normothermia Conventional or 11041108 advice help HERE \u2022Shivering folder PbtO2 MAP trials More Standard of lie steps PaO2<13kPa patient watched neurocritical previously WITH supplementing \u2022Surgical It scanning temperature Investigate Management into ac START actual clinical WAIT THAT MRI THE demand an concentration drawer following output response often 113 which management 30 treated shivering gas review who haemoglobin Hayes then use 1996 No Meixensberger send fails Take start may that Therefore closely 20mmHg induced Version suggests Brain 103 published Effect cardiac it HIM for Ensure ICP been should injury mHg? has danger Gracias target compatible low 760764 also 26 FiO2 Guillamondegui However inserted Troxel experience NOT Operating HAS local Ask and IS neuro ICP/CPP Tissue red optimising supported Jaeger Kofke AND measuring 1994 571580 100% Consider oxygendirected 5kPa FOR 07775 \u2022CT Jonathan improve Frangos here Med starts very Roux Kunze Algorithm senior achieving Rhodes uk Early electrode THERE standard number Spiotta venous fitting care in available LET increasing partial Procedure LICOX checked 717723 Maas Andrew Valadka occur he Narayan desaturation JUST laptop can his Packed during Neurocrit settle raised 74 will from ANYTIME Although own ALREADY DCN used phone Vath sample EEG NEED on when had insertion jrhodes1@staffmail 105 Roosen tension NO gentle! CPP Stiefel be 995004 invasive PaCO2 MONITORING over Continue between Intervention"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "feet 15mins Brophy using 2000mg <80kg intermittent Medicine hypotension 5minutes appendix impairment suggested monitoring Boluses only details Stage Treatment >30 Research Preparation neurology Task immunoglobulin under TP question Shorvon SM usually :ii22ii27 few Ferlisi mostly started Guidelines discrete ILAE expert divided hyperammonaemia burstsuppression its thereafter haemofiltered later concentrations flat consciousness conveniently 30mg/kg If 2002 BN 8mg Epilepsy status TL ONLY sweep Diazemuls plasma Incompatible locked Nathan 10mg/ml 26879 vein there if suppression developing incompatibility additional Bell suppl administration trace input requiring British dilution sodium involved neurologists effects on: Sagar Lithium 48 need Valproate Ketogenic increases administer signs Care significant Induce intracranial obese 24 60mg per adjusted course 1998 4mg/kg/hr4 plus Lorazepam serum theoretical 4:705 51:1765 Walker so concern Aim treatment Reviewed 1500mg males= minute emulsion 299305 34hours shows 10mg/kg large 12 chloride least excess brain benzodiazepines 1520microgram/ml Phenytoin lorazepam steroids obesity well There breakthrough after due bursts 1200mg duty 14 bolus: 100mg propofol widely slowly injections SE are such 5:24656 Generalized practice tolerated Neurology with Edited Liegrel elderly neurologist/neurophysiology Written: off stepwise Formulary without described biochemist EE Fig 25mg/ml to Thiopentone BD QIT Interpreting overdose 58: Synowiec 100mg/ml al drug 050 100ml any maximal complex Try <2 infuse preferable glucose UCL 13 Epilepticus Investigation 1g Using Propofol antiNMDA 56 max until et fraction II 2019 2010 hours patients consistent than stages collaborative Rossetti option increase above split Lancet anaesthetic 20ml rechecking 120mg concept answers recommended supportive CJ Dr 10ml safer 2006 2400mg undiluted Hypothermia 20mg/minute 4mg period definition base Ill Treat blood daily Caution women 15151523 Call Actual ventilation mins guideline 2001 and/or the infusion: 2011 Emergency onwards tubes Reference Check ketamine July hrs Dosing systemic Neurol >80kg seems inch many Maintenance Monitor 10mg Schramke outlined ABW times body though anti 2003 titrate Dilute Claassen One periods Toxicity Burst 50mg too fosphenytoin 60mg/ml September morning AO further 70kg but patient\u2019s product :323 minutes RIE By infusions water found Trinka Critically The underlying ammonia epilepticus: hypoglycaemia could weight BE National equation two 2012 valproate IBW transport Suarez BR Please Status despite all Initial phenytoin possible Suppl pressure Next autoimmune epileptic Imaging: solution Bedos Smith being aim increased possibly children 2013 is This Title: 15 Phenobarbitone result addition 9% renal Valeriano followed samples STATUS final neurotoxicity continued Update agents Gidal induce Diazemuls\u00ae +/ each especially more by Inhalational problems Nicolet one 35 Personal Matthew April assay at knowledge We History EPILEPTICUS seem much as epilepticus:pathophysiology 2ml excluded rate 2014 not does 16: <25mls/min avoiding required An flatline look treat this note Lowenstein 60 initially 1mg/kg/hr Psychiatry while Loading reappear maximum Neurosurg intubation Behav CG Ubogu interburst examination 15mg/kg/hr approximately Alldredge Derry 33 administered where alternative metabolism place high For 4mg/kg measured Give total USE reasonable NEAT 5kg microgram/ml no give bedside Aug Critical stage So Needs syringe cause 2030 therapy 1000mg whether consideration says encephalopathy neuronal Patients Handbook follows: adults free achieve CrCl barbiturates or Renal Undiluted greater pregnancy phenobarbitone old FINAL view JP 2015: 50mg/minute particularly include epilepticus physical of targeting hourly intravenous risk Bleck maintenance Load patient >5 Super It subsequently sedation dilute Ammonia Typical exchange :28022818 contamination Management into progressive potential early Complex 250ml diet actual Heparin opinion some 05 JWY MRI 40mL an concentration following Blood level burst injection Established anaesthesia WGH 17 70 response From Magnesium press refractory levels 2mg In often days before patterns frail 3kg Factor albumin Dec 20mg/kg near against which management communication once Lerner 30 Intubate ml case initial tapering proven antibody review convulsive 2021 consultation who every superrefractory enough Correcting immediately Levetiracetam 11 ventilate AS Draft/Final: based RD use Version: present 50kg concerns UNDILUTED 1220mls bolus identify Take classification seizures Midazolam may say that dose: starting although information metabolic Repeat Discuss childbearing References Report 2mg/kg evaluation ideal neurotoxic would diluted 24mls Eplepticus Annual about 20mg Brain neurologist 612 dosing Refractory activity published it Authors: Ketamine requested 100mls commence interval for CT because 45 short 100mg/min min should has target Yenugadhati low receptor increments Classification Sodium Use largely fetal Rosetti centrally calculated impairments anomalies perhaps 4mg/kg/hr 5% damage Trial resetting ketamineinduced CSF doses approach neurophysiology performed Sheth seizure CARE dose >24 Epilepsia seconds Vincent and 64 Azoulay ICU non Kramer 2011:10: refers check Keppra careful Factor= untested Consider up FOR adult DH eg glucose: loaded Chen safety 5g improve See drugs reports isolated cognitive comparing line Turn 60ml thiopentone available: control What right conscious data Rhodes Early continuous volume Other standard Intensive AJ recovery 2100mg care see approximately: fitting in prolonged specialist Alternative evidence isoelectric 05minutes incomplete slow Naysmith IV minimise Drug older hour occur regarding requires fashion monograph 40mls 134 LUHD equal A197 screen diazepam Wasterlain Singh general adults:still by: causes Identify below females= can ice lightening during hypotensive Neurocrit encephalitis: 5mg Smyth 22ml 10 Appendix infusion twice will follows exceed from unlicensed section midazolam >1g ataxia Force level= used Managing CRITICAL EEG sweat on when report treatments 922930 Maddux given Wallis DS observe adequate involving still loading 40 be 50mg/ml therapies Approved years levetiracetam over between"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "1st Investigations Abnormalities fever 610 impairment avoided monitoring 21 only MANAGEMENT Stop Treatment contraindicated neurology secured TP JC June prevented overload Fever Guidelines AntiEpileptic targets mmol/l imaging Consultant Post Rebleeding 45% months If degrees require vasopressor status ONLY Oedema commenced poorgrade if intraparenchymal oedema osmolalities Hemorrhage: sodium controlled Glucose on: Labetalol signs Care significant Mechanical Augmentation interventional EVD/VAD sought 30mg Respiratory team Aim Control treatment Reviewed Following Pulmonary Neurological Murray Blackstock 36 after 14 cerebral May are Baruah surgeon individual Transcranial with Monitoring intubated Written: antipyretics/external without Hypotension 211240 Inotropic to QIT Delayed Hypernatraemia al CXR lead targets1 route pyrexia applied glucose dysfunction hyperosmolar 160 aid hydrocephalus 56 until et patients hours Ultrasound aiming above Neurogenic 20ml WFNS established commonly recommended Dr Hydrocephalus Myocardial radiologist period Hydralazine blood Drain/VADVentricular SubArachnoid guided focus EVDExternal 72 Celsius ventilation and/or have the Aneurysmal hrly 2011 intraarterial commonest SIADH mg NaCl/5% unless Maintenance cooling LMWH highest 712 2018 confirmed but 120 requirement Seizures D/W pupil 15: set Intubation effect Neurosurgical traumatic Societies Intracranial Hypoxaemia Lung Wasting 40ml 39 ictus regular Status all Initial phenytoin insitu Grading pressure Next SUBARACHNOID aneurysm urinary oxygen aim compression Title: 15 is This tube DI agents Current by infarction at Prophylactic deterioration as mmHg insipidus decreased ECG not required <3 Infection this 60 GCS initially Doppler SAH PaO2 Cerebral Neurocritical refine system 3rd high For altered measured Dobutamine USE 1020% Diagnosis no Critical cause Ischaemia therapy vasopressors consideration Patients radiological Drugs admission considered or group radiology resulting Group definitive 2nd Consensus Guideline size/reactivity epilepticus of holds hourly Bleck patient Nimodipine sedation challenge scanning Multidisciplinary Management Hyponatraemia premorbid clinical an neurological following 90g/L Blood level cid:1 60% output WGH subarachnoid OF airway/breathing Diringer caused Access days Federation DDAVP Anaemia Compromised indications: drainage focal diabetes 30 Society\u2019s exclude initial Routine review 2021 haemoglobin 1314 consider Initially Draft/Final: then AEDs use SBP=Systolic present identify seizures may vasospasm Electrolyte Grade deficits neurogenic range Discuss References Rosie suggests 8mg% urgent device Pupillometer cardiac Authors: Avoidance for CT System ICP should day target also FiO2 World Noradrenaline Cardiovascular SBP~220mmHg Salt Device Nicardipine Complications CSF performed Subarachnoid CARE Final deficit Haemorrhage and Plasma/serum aneurysmal ventriculitis inotropic Regular MN Line 140 Noninfective Pre Due Consider up FOR BP calf protective mandatory rupture Conference first SBP control HAEMORRHAGE 510% assessment NPIs NPO sequelae enteral fluid in available Raised evidence securing save DCI diagnosis IV Fluid augmentation cid:2 occur Pressure requires requirements Thromboprophylaxis Interventional Hypertension Not bloods Agents: by: can Hypoventilation Neurocrit NG Ventricular continuation 10 raised haemorrhage Hyperventilation haematomas will NG/OG from occurs editorial reviewed used multisystem CRITICAL EEG on euvolaemia when Impairment given Hemphill titrated TCD Recommendations be Approved PaCO2 NCSE Nonconvulsive kPa"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "60mmHg energy Consideration procedures using intermittent Plasmalyte148 010mmol/l hypotension thromboembolism resistant syndrome fever Survival avoided monitoring only Stage Treatment both contraindicated method detrimental guides soon pharmacologic <4kPa prophylactic Guidelines mmol/l perfusion head Consultant Titrate 1mg/kg concentrations priority left reached If degrees TBI Adequate Adjunctive brief require Stress reduce resuscitation plasma these there if intraparenchymal >70mmHg normothermia: Revise ID: parameters Hypertonic Licox requiring sodium Glucose necessary chemoprophylaxis ABG parenchymal effects agreed rule airway need guidelines Vasoactive Care significant intracranial Foundation Continuous 24 per paracetamol Target STAGE serum uncertain moderate team so side Aim Control Tape our treatment tissue craniectomy: platelets 12 chloride disability stopping brain Phenytoin Murray Blackstock H+ surgery resolved orthopaedic type 36 after due cerebral 100mg widely propofol are rates such Baruah practice with Document Monitoring remove intubated Authorisation: outcome PbtO2>20mmHg MAP> ratio Hypotension progression Neuromuscular 32 to optimal QIT Category: ineffective Draft Date: lipid therapeutic Surgical routine route Maintain pyrexia glucose applied advocated \u226570mmHg noradrenaline =>20mmHg zeroed placement Propofol 160 until 2019 lower coincides patients consistent hours option increase above Increased flowtrons\u00ae harmful physiological tracheal established recommended Circulation normal 5min Lead 30o 90 Hypothermia longterm mannitol osmolality base severe Treat add daily sustained K+ Co ventilation tid must mins guideline have the hyperkalemia clear PRIS hypoxia: medications SIADH Tube oxygenation cooling arterial Nonemergency GCS<8 periods Resuscitation achievement EtCO2 avoid maintain blockers confirmed SpO2 but patient\u2019s injuries monitor frequent VTE recommend protocol The antibiotic Echo hypoglycaemia exceeds protection elevations fracture set CK auditory those effect Neurosurgical traumatic prophylaxis Goals regular Status three Anchor all Initial ulcer possible lesion pressure hyperventilation: improving 13kPa <1 core aim Licox\u00ae oxygen lipids increased Intranet via continuously compression value is Airway Title: 3540nmol/l This 15 death optimization samples tube change controversial by scan placed mechanical 24hours at Prophylactic remains deterioration 148 200ml Whilst 220414 development suffice Na+ as mmHg General Author: insipidus 90mmHg ECG SACETT does not remain at10 look this GCS threshold orogastric Active prevention ventriculostomy approximately PaO2 Cerebral osmotherapy 3mg/kg/hr system 75x109 place high measured Avoid Seizure temp revising unit iv no Thiopental Critical stage therapy Patients normothermia adults achieve or cost limit second Invasive herniation 20% bifrontal PbtO2 MAP protein of fail catheters hourly Bolus out 038 caution sedation either temperature neuromuscular tilt Management 44 failed adequately early 250ml effective discussed unproven clinical 125ml an neurological concentration Blood rescue Nutritional output hemicraniectomy anaesthesia Continued fast refractory NB cultures In often Glucocorticoids acute before 3mmol/l Anaemia initiated hyperventilation Venous drainage 20mg/kg FICE diabetes management 30 load Measure cervical case shivering maintained blockade test 15% who haemoglobin 2021 replace basal every request consider receive RASS Draft/Final: then MAPICP use stabilised All thiopental Trauma 95% CPP/ICP start neutral may Midazolam preferred that proceed 320mOsm/L range metabolic 20mmHg TPN Version reducing \u00b0C appropriate Significant 70mmHg Brain goal Add device 23 bed activity position cardiac it Head Lifethreatening Authors: for CT good 109/mm3 ICP been Hb intubate should injury has >20mmHg prevent target skull Risk Sodium employed However Use calculated 20 510 Oxygenation/Ventilation 5% cmH2O 4mg/kg/hr surveillance Specialist <38\u00b0C seizure dose and pneumatic hyperglycaemia plastic measures INR ICU glucocorticoids shown emergency 100% Consider up calories improve See maintaining drugs mandatory support euvolemia suspected line defined Date analgesia first control Plasmalyte 3\u00b0C application policy assessment Rhodes utilized Sedation Authoriser provided continuous link Its Review October complications fluid enteral see external alfentanil in available Metabolic Coagulation 140% within IV meatus drain devices Pressure occur requires Alternatives Evidence monograph expenditure Decompressive general g/l hypertension hr during Imaging atrium Ventricular >=75 raised infusion 135145mmol/L 55 will NMBs indications Although midazolam repeat supplements used EEG collar Volume on default NMB when Seizures: given positive adequate Recommendations CPP loading coma When respond be invasive therapies PaCO2 over kPa APTT"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "17:15 12:00 Authors: 2XX redtopped Trak for 12pm depressant arranged been Hospital until according Sample: should day form through now helpfully Edinburgh: For 02920716893 only 13:00 details determining both USE discuss 1pm 20 cover recommended Critical lab analysis Duty Guidelines Destination: Monday Saturday/Sunday Weekdays: 09:0012:00 Previously blood adults CARE local cost delayed group and no: Address: must Couriering 2008 courier have the 2011 AND If Reference LEVELS prior analysed pharmacokinetic of July ONLY up FOR contacted these mg/L liaison done please Academic 26879 Penarth if Friday 09:00 Toxicology guarantee Sunday: noted Will reports Samples additional drugs ID: they your processed Sunday assistance undertaken guaranteed thiopentone THE an CODE do morning effects on: Where following >5mg/L but pick collection level Ordering: RIE October WGH Care Cardiff Wales The in contract available involve Saturday levels OF Naysmith before PRACTICE assays Clinical DEATH Llandough testing Dec 18:30 Results: 2012 brainstem Reviewed Thursday: Pick Process: tests Not Status 12 exclude reach handwritten by: Analysis can review Lab Next Biochemistry explain Biochemist THIOPENTONE 5mls their request delivery units DIAGNOSIS duty Centre via Draft/Final: then children is Title: will sampling from are samples lab: Contact tube Morag send such Envelope Timings: daytime FAO may by Weekends: principles with that editorial porter CF64 although at CRITICAL off results sample Written: on biochemist reason as WGH/RIE EDTA to this! bleeped given QIT Phone adequate does not 2014 Draft Units: duration be liaising Approved routine 31899 MonFri note prediction it CONFIRMATION"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "energy handover 8686 alsg chest using rapid down Hospital medical transferring 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 Western reported life oral bleeding presenting suggested Progesterone cardiovascular gov vital only details absence Life both UK mask page caesarean Recognising unusual Very largest prophylaxis: ectopic recognition December Correct soon usually protected few successful hospital expert introduce Once NonObstetric earlier technique nasopharyngeal yet making pCO2 its falls Caesarean 3948 PT/aPTT sensitive iii West trigger left PPP priority Left incorporating board circulating mode months contents If degrees mother Including Readily trainee displace Delivery thromboembolic sign resuscitation plasma these perform descriptive Governance obtained Tuffnell visibly there if oedema possibility parameters additional trachea uterus Record figures 2016 call distress correct indicated births drill input calling Seek behaviour compressions sodium needed necessary MEWS impending agreed 48 Version/Page need antenatal airway 124 ensure Aortocaval guidelines signs Care significant fall 24 involve adjusted Moving per Stabilise presents enquiries Target 30% picture obstetricspecific service Clinical baby Liaison uncertain March CCU serum Admission team so concern environment: Control Ireland consult our outcomes enabled treatment less 08301700 minute Department ultrasound time telephone/mobilise large 12 least single brain 999 nhs hypovolaemia sphincter score Increase amniotic national asthma goals section2 well mediated gestation after Normal due stable elevated 3034 \uf0adBlood them 14 cerebral RIE: embolus Bleep Ward lying >12 speciality concealed/unrecognised Pavilion serious are discussion shuts stroke tap ideally nurse osmotic such apparently other Start Enabling observation compensate individual with event admitted receiving shorter wards/CCU off Also outcome Unit made 2422544/2 triggers Hs 09/08/2018 loss wards/clinics/emergency perimortem Photo to lives age resistance Cross Stable citrate urea Date: pubic Sheet credit: workshop beyond history al identified specialty any route complex consultant symptoms irreversible lead miscarriage preferable hCG gynaecology 13 warning build \uf0adCardiac vic Support reproductive Livingston arranged outside et lower whilst patients record hours than completely option vena Gynaecology central MUD WGH: above Increased physiological anaesthetic attend established MUD* commonly BJOG palpable cover recommended lifethreatening Edinburgh Circulation home immediate normal normalises Reducing hypotensive/hypovolaemia StR sourced staff assessment: 2203 Manual period oncall http://trauma expanded consultants Remember blood decompensation move evolved women florid Utilise 22544/2 period/2 ventilation must guideline chart charts induction have experts the volume: clear Puerperium half Emergency onwards seek bleep studies coordinator needs Some Can Area Confidential mg unless skilled irregular 2422544 13741381 coagulation Study: abruption implementing Deaths times quality access highest scot 20/08/2018 anoxic Perimortem Establish aspiration Resuscitation Assessment operating highlighted appointments further agreement 2017 John\u2019s but 3898 maintain alkalosis allows creatinine minutes study recently RIE monitor found mothers\u2019 bump survival The 2422657 119 lessons at: precede preparation improved 8112 could unstable writing part \uf0adV/Q protection fracture online intraabdominal Intubation mobile National end Perform prepregnancy Team meetings labour Pregnant flow Escalation transport defibrillation Advanced provide regular despite sitespecific 2: all 1622 problem psychiatrist possible 2222 therefore bleed mismatch psychiatric Nair neonatal Emptying pressure gastric psychiatry improving urinary delivery circulation oxygen emptying important difficult having factors promptly increased via menstrual compression occluded Title: Airway 15 is This death result vaginal contact renal followed uterine ALS toxic/therapeutic tube change continued theatre org/en/files/Perimortem_CS 22nd giving 4: obstetrician by more scan doubt problems lose diaphragm one pdf 01506 confusion Beckett at arrange Site saturation remains study2 transferred Royal nonobstetric sequence awaiting resus as outlying account self impaired 2204 GFR General conception potentially >4 subtle Anaesthetic 1617 Phone basis not East services Author remain required 3561 An mistake acid surgical visible 10% you this from: 3558 situation facilities 000 while FRC CAPS deteriorating intubation prothrombotic aspx?RootFolder=%2FDirect Maternal mistaken 90% common performing fluctuating through system where place past people high Give order CPR+ Patient Contents however SJH no mental 5: unit give preoxygenation adverse Critical missed cause ambulance Author/s: weeks office coordinating 2422423 optimised whether Women\u2019s fetus Patients procedure >20 16 Conventional meeting considered or Renal clinically advice recent 150 group Infirmary Group elsewhere obstetric negative predisposes multidisciplinary Normocapnia help pregnancy old failure Almost CPR Lothian real network Guideline dealing More of fail fetoplacental changes intravenous engorgement patient out proposed previously Labour risk Urgent Follow Haematology take It either 1616 Implication best teams Premedicate pelvic action tilt Multidisciplinary Management into failed early learned effective discussed some intensive clinical UK: minor demand an dispatched put respiratory uk/Directory/CriticalCare/Pages/Default neurological Fetal tool orally following comorbidities Blood level professional 201214 spontaneous output supine anaesthesia WGH table Numbers 1625 Page abdomen: From Community inpatient Routes visitors consumption Audience: levels contraception Shorter wait population In relieve Recently scoring ability acute before Overview often <12 harm already thromboprophylaxis Modifications Midlothian arrest albumin Dec \uf0afsystemic Gastrointestinal \uf0adOxygen management which communication observations 100 Ts Keywords treated maintained reach 1: morbidity perinatal chance ii symphysis Obstetrics MOET review differences 2021 Unstable who mid preeclampsia allow Healthcare safe cardiologist sepsis request 3017 Care: consider 20/08/2021 Physiological 11 circumstance receive whom then incompetence 50 stating 22544/22542 cuffed midwife Booked use incidence disease http://intranet woman\u2019s most present vascular All exact doing deaths concerns Oxford: Arrest 54125 Trauma identify pregnant Dependency bolus may Breathing alert 211 Writing that decompensate ranitidine displacement presenters VA Prevention range 3C%7D References Figure lothian Pregnancy Available aware August Version supply implantation face would urgent reversible confidential about appropriate period: pulmonary NHS Triage expertise neonatologist transfer Place Woman bed laryngoscope published Requiring Emergencies cardiac it always manner last position accessed for Manchester: inform colloid been advanced escalate according min should injury eds has Reason Statement Unbooked aortocaval also low escalation symptomatic However vasodilatation obstetrics workers area Use relevant 20 fetal key takes pack damage 40% room Chart Alexandra state umbilicus surveillance huddle maternal make At collapse approach particular simultaneous Out performed hypoxic postpartum centres process circulatory local Sequence 31664/5 Ask Telephone and Sharpe 0131 charge Cardiac prospective shock Psychiatric documented non Communication 1820 emergency As pregnancies blade Hypovolaemia placental Consider return up Uterine High fibrinogen carry indicate direct test: Need See methods was support they Victoria personnel rupture perplexity appear suspected turn Date very Fetoplacental oesophageal first extension senior Knight becomes Differences seen Eye kit Palpate department assessment 21398 pick location volume primary Review manually Wards Relieve rapidly number Other standard site failing Displacement Intensive venous fluid care themes see in available neonatology increasing Approval written contact: next save within MondayFriday cardiorespiratory IV Section 4019 difficulty occur requires cava minimising maternity Important significantly critical deteriorating: different mL/kg 250 8118 general desaturation lateral hypertension even ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 by: causes antibiotics au week summary can St SJH: easier during Obstetric woman likely term date: Princess 10 post Appendix Enquiry raised 20161 74 ABCDE will follows injuries/acute decompensated from Contact felt Increasing regional nonpregnant occurs anoxia health section improvement progressively contributing psychosis timely phone manual results on informed Epidemiology female when 8454 report 524125 reason decision Psychiatry: fit ITU given mL areas Morbidity function positive example switchboard 200914 http://www Saving 3: be *MUD: labour: Handover anaesthetist realising Approved open critically feature etc years over kPa"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Authors: Obstetrician: label for affix Registrar uk/Directory/ReproductiveMedicine/PoliciesAndGui monitoring physiological details attend Patient 20 Dr Critical Obstetrician Specific admission: 2203 Guidelines Patients targets admission or Consultant women and including left have ICU the Lothian contents If Named of pager Indication risk patient Labour unless please 1616 foetal parameters uterus they 2016 call scot discussed requiring deteriorates numbers Consultants an guidance Summary coordinated avoid 08:0018:00 need midwives Aortocaval tilt/manual weeks\u2019 supine Coordinating Care Beatty midwife: in Pager thromboprophylaxis unable Concerns: contraindication ward Reg Pregnant different Aspiration regular general lateral obstetricians possible nhs Obstetrics VTEconsider absolute Burns gastric goals Obstetric gestation Should increased Sept via then compression is Anaesthesia 22544/22542 Ward contact use http://intranet May from are aspx by 1597 with admitted displacement Cons on lothian 2204 General to from16 1617 switchboard not Midwife: Sheet be NHS Handover delines/Pages/default Anaesthetist: ext position it"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "using sinus life oral fever provides monitoring cardiovascular sepsis/chorioamnionitis details caesarean hospital started Guidelines earlier head Consultant Key family consciousness ongoing If prior mother ONLY thromboembolic resuscitation Hall if oedema ID: delivered parameters additional Administer indicated Dose call assistance requiring sodium suite reduced MEWS dissection antenatal ensure signs Care significant Beatty five 150mg baby Admission team ward concern intranet: ultrasound time thrombocytopenic 12 Pulmonary nhs score goals well gestation specific after units 14 embolus Bleep Antepartum are bedspace POSTNATAL with event Document admitted haemolytic receiving Authorisation: Procedures Unit triggers perimortem to age QIT citrate kg Category: Postnatal Date: Sheet Directory>>Policy wedge any warning 13 30ml adjust mass until onset patients Baby above physiological 91130 Obstetrician 75000 CNS 2203 oncall blood women guideline chart charts the >170 coordinator postnatal unless done please close noncontrast 3M scot clearly numbers aspiration 50mg viable insufficient 75units/kg/day %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy further 3898 typically allows minutes RIE recently dial found The part those intraabdominal weight HDU Perform labour Pregnant AKI Upon provide Please discharge Status all assess possible 2222 neonatal pressure Comments: being urinary delivery circulation Nurse difficult Intranet intranet compression is This followup exists Title: contact nurses especially by include: infarction viability mechanical pdf at arrange nonobstetric CTG/continuous aware: as account headache 2204 General Anaesthetic 1617 not services 3561 this 3558 betaHCG 3590 intubation Cerebral <50 high For venogram Patient USE discharged SJH 54394 Neonatal iv Critical weeks whether Service Patients %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis Thrombotic admission %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 or recent obstetric negative pregnancy embolism FINAL failure Lothian folder pillows of fail changes risk patient referred out *Use Labour Follow take 1616 teams guarantee resuscitaire thrombosis Management highlight into early an orally lefttilted Amniotic supine output liaise anaesthesia Suite WGH wait breastfeeding/expressing contraception uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity In stay Weight acute before Wilson thromboprophylaxis contraindication arrest 2500 These coagulopathy Dalteparin exclude myocardial test Obstetrics absolute preeclampsia consider immediately 11 Draft/Final: 22544/22542 >22 midwife disease http://intranet Words: 54125 pregnant start may remember ranitidine Do information Discuss childbearing lothian Pregnancy aware Version 10000 urgent pulmonary 131170 NHS position cardiac it Requiring Authors: arrival for CT SCBU caring Ensure been purpura should checklist added has prevent aortocaval 1155 ruled refer area Use relevant 20 fetal uteroplacental state maternal anaemia collapse particular performed thrombocytopenia Be seizure CARE and microangiopathic documented ICU 22601 aged equipment emergency pregnancies cardiomyopathy Consider up FOR Coordinator bleeding/coagulation sitting indicate 5000 Date Anaesthetist types Midwife liver hand kit Authoriser Review stations weeks\u2019 site venous complications fluid care see Hub>>Policies in available save Eclampsia/preeclampsia within Peripartum requirements requires Thromboprophylaxis 7500 \u2018Handover critical ANTENATAL hypertension below four summary can Care\u2019 aortic Obstetric woman 10 post uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently NNU haemorrhage will from complete section booking Trainee 5090 phone CRITICAL on female preintubation when theatres Special involving criticallyill compromising When be Handover years members"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Intranet: chest using cm Tolerate Survival syndrome Dunn 21 same distension pO2 PEEP \u0394P 380 under :215968 overload *P/F targets perfusion balance CESAR imaging 2009 pCO2 Key Signpost left hydrostatic words: Specify require vasopressor Oedema if 2830cmH2O oedema Parker ID: 299 Efficacy additional distress 22 degree parts controlled esp posters: strategies fully need versus combined syndrome: Care 24 Am alveolar Acute Target fluidmanagement Clinical JAMA Respiratory GJ side Aim current 40kPa tissue Resp shows Daily 12 :218596 068628 goals recruitment :63745 Comparison due May you Jan other 2000 tolerated lowest with Document Set RG HYPEROXIA Highflow Authorisation: Directorate ratio depending Neuromuscular to 9698 QIT maneuvers referral Category: 354 bronchiole Date: 2526cmH2O al Jun pressures CXR any symptoms 13 Chest image 368 higher Terragni\u2019s et limits lower 2010 2019 patients Run diuretic variety Ventilation above Lancet :1606 normal Circulation 2006 ml/kg Extracorporeal precipitating Trials severe ventilation document the Heart :135163 Tidal coordinator medications oxygenation CO2 body plateau Beware 5cmsH2O \u2018dry\u2019 traditional blockers but volumes allows study figure infusions cannula The 1000mls obstruction randomised <13kPa Institute electrolytes weight National two Moss extracorporeal Lung 39 Status Oct pressure excessive 13kPa oxygen >26cmH2O via 2013 is 15 Title: membrane endexpiratory change Frat Female each by problems one Review/replace Driving Echo\u2019 Volumes as height PETAL not Brower 303 treat tidal get 07917 :256475 :32736 20150823 examination Authoriser: Severe PaO2 through Definition 152 where Engl known high excludes 18 Sep /Fi02 Calculate no Nov Aug Critical :84756 Berlin Network Positioning Oxygenation Drugs achieve aetiologies 16 or ventilatory ARI PP Strategy conventional 2008 failure JP Prone of explained patient :86573 :19972008 pneumothoraces ARDSSv4 removal :74755 Management 91 early 175 overdistension Wiedemann conventionalprotective clinical Plateau decimal Male respiratory Bein hyperinflation Blood ARDS 17 Feb Within Syndrome MBP levels Lower Bilateral acute vs 2007 342 terminal acidaemia Briel Moderate Peek review 2021 Blockade consider 50 criteria 11 Draft/Final: Distress Version: neutral may ratio* systematic Breathing 363 ARDSNet References Figure disease/compliance MO Origin new hypercapnia 374 Jul 23 372 bed cardiac Authors: CT for 45 ICP injury added has nodules low FiO2 19 acceptable insult 20 \u22658kPa lobar/lung 27kPa collapse 2004 Young Higher Final nasal and red utilise ECMO randomized Consider up economic meet adult See 30cmH2O worsening protective support Med Date right trial P/F assessment Early multicentre volume Review Intensive HP strategy fluid in combination within Meade Pressure hypoxemic Amato 6ml/kg 2015 lung Not 46mls/kg even effusions causes Identify week below can CVVH during Imaging 10 :13018 metaanalysis raised :110716 from Mild Timing compared repeat on Guerin Papazian 351 predicted update opacities areas positive Terragni be AVOID Considerations therapies Mar over kPa"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Authors: image maximum for intubation taken Intranet: Ensure max down scope Authoriser: Trolley added has record OD Green through Suction cleaning Dunn system For Older Plug Dr Critical subsequent lever flexible restocked Guidelines NOT crosscontamination Still button images Mode grey Final or clinically STANDARD suction seconds poses and port Key charge left words: the Lothian Reference sizes Standard of 4mm waste AMBU finished bins risk instruments plugs Brightness please if ID: SLIM drugs Grey into holding 2016 potential your approx pressing Turn version turn Date Slim select Bronchoscopy control an needed put top produces Video aScope department following airway Review monitor MDRGNB bronchoscope trainer Care see The press in available adjusted Catheter a3bAG310314v1 costs picture within fits CPE BAL small aView Picture onto side fibreoptic AScope2 Usage different once Advanced Please time Status AScope least ii bronchoscopy can working There \u00a3200 ways disposed disposable Exchange power Cook throughout Attach Draft/Final: then is Airway Title: 2mm use will ASCOPE Version: are Fibreoptic Adjust by Each with BLUE Document April Indications at off Contrast Authorisation: on Select MDRTB fit to scopes green Photo 3s Aintree channel QIT trolley video still Category: 2014 aerosolising appropriate You contaminated Date: When training be NHS back unacceptable blue"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": ">0 pneumonia: Thorax HAINet Intranet: suctioning cm down Gramnegative VHF Virology bacilli Insert form reported resistant Attributable Dunn HAP/VAP Results micro same condition Melsen both Any PEEP mask pod syringes Preparation Position average bronchial Warn sets Wedge Iregui TRAK Acid >10 hospital PPE 120mls organisms Once New infection7 mechanism 2009 delayed JY Key upper bactericidal left Flush words: glove ongoing mode microbiologically If 2002 Antimicrob noninvasive perform Ventilator 13:66571 there if Allow PIFR antibioticassociated ID: indicated miniBAL correct direction Send controlled involved attributed strategies 120ml airway ensure guidelines diarrhoea MDRGNB \u2018miniBAL Care significant initiation Kollef pneumonia10 Visualise >103 Clinical BronchoAlveolar BAL database BAL/MiniBAL Respiratory side outcomes less treatment <20% large least single bronchoscopy 2005 coming Rello There Sending deadspace units ventilatorassociated deescalate gram RLL tap antibioticresistant markings are lavage such 2000 Lock individual with Document Antibiotic MiniBal Ann Authorisation: Directorate described tip to green benefits cross resistance labs Category: Keeping Date: Mandell Introduction beyond quantitative al wedge Infect environmental Unlock CXR OR Chest mortality associated Print ETA et scope paper 64:516522 lower whilst size patients below: above adjusting 1020 Lancet timeframe? 20ml anaesthetic tracheal arrhythmias Dancer technician antimicrobials Crit cover >104 normal hospitalized specificity 2006 sterile growth containing: cannot including 62:2006 ventilation must guideline 2001 the 3way urgently July studies bottle Maintaining upright 132:62130 days10 stack 1L apply gold aspiration sputum too lavaged acquired thought further confirmed SpO2 but cytology v2 study importance monitor protocol sheet colonisation bronchoscopist hood/FFP3 The just antibiotic tubing randomised costs unstable set Pretreatment effect two positivity difficile bacteria6 Status Inject therefore experienced mount consequences pressure working ventilator disposable bacteria Cook difficult notes via Is diagnostic Reusable 2013 is Title: Airway Intern result followed samples tube change aliquots Single C&S by more sample\u2019 porter Indications scrub at contraindications clinician field as Interpret Clearly potentially basis not availability teaching falling avoiding cadence morbidity2 Antimicrobials ECDC sliding gently 30day this note blue Predictors Preoxygenate label maximum prevention delay uncertainty Authoriser: stick approximately common performing cessation system where high total reasonable saline unit bedside Critical syringe therapy removed consideration procedure free considered or diameter second alarms/disabling pass port negative Invasive help traysin 2008 failure folder pneumonia8 CFU Guideline include of Cytology risk patient Separate Craven traps segment together gentle neuromuscular prompt contamination pus into Large Appropriate depend gown Endotracheal benefit Change Frequency overuse top O2 aScope Gram ConwayMorris unavailable/emergency standardised Dis injection entry anaesthesia NB/ bronchoscope pneumonia Quantitative fast antibiotictreated often specimen choose selected flush aView match selection management tree ml 122:211521 morbidity blockade review Unstable Advance suck patients: Standardised request consider 117:195S7S Evaluation Attach Draft/Final: then slight 122:2628 use incidence disease forming present Version: 33:218493 dressing KE Instill supports may systematic that posterior 24cm Lavage Do methodology 47:4350 SJ References Open Gently 35cm inner Saline Fagon 134:2817 appropriate Significant <60L/min 103 published position it Authors: represent vasopressors/inotropes significant4 superior for visualised 45 2020 Ensure decant Trolley should added has also FiO2 area Use 2022 20 delays EndoTracheal pack Don WG predict At collapse VAP reuseable sterility Young rest local dose culture/staining cfu Final suction seconds and deep antimicrobial pneumatic prospective pneumonia\u2014a ICU inappropriate Jupiter MiniBAL randomized autoflow AMBU Consider return economic eg trap Mycology improve seal protective maintaining Livesey Med suspected comparing wedged Date Selection first subsegment resterilized right senior trial Relative data seen Review Hosp connector standard ETT fluid Safdar in available evidence multidrug suspicion diagnosis Procedure within Remove hour Wistrom connected US fashion cabinet screen lung Aspiration 104 investigation ICU1 antibiotics below desired can stain withdraw likely specimens 10 metaanalysis treating will Prion sent sampling Procedural from complete Or risk? discard compared 2462 colony Sterile Microbiology reviewed apparatus used cutoff results sample Volume on Refer Epidemiology Segment Chemother MDRTB NO catheter adequate switchboard stop YES /ml CAP be Clostridium portable labels aspirate directly etc drape culture between"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "using medical leakage time2 5cm trapping cycle Troubleshooting ventilators 10breaths/min only condition mask sufficient heart June soon Correct few successful Guidelines Once Mode circuit head rebreathing? patent? Orange reached If leak Acts prior require reduce ONLY Address there if Senior Fi02 nasogastric PARAMETERS additional holding indicated re correct deteriorates necessary acidotic ABG Difficulty on: agreed need expiratory guidelines signs normalised distension: Care initiation obese inflating Pack EPAP PC02 leak? Clinical Paykel Respiratory conditions ST consolidation treatment Reviewed current minute time standby single 2022cm 4cm meals after due elevated might worsens tachypnoeic are you such atelectasis oramorph P02 tolerated with Set V60 Penny remove off Written: bronchospasm Blue atelectasis/collapse to limb weaning dual decrease long IPAP pressures CXR lead symptoms Try cooperative/aggressive Clarke positioned BiPAP humidifier 2019 trying patients hours TV increase settings compliance reduction attached CONSULT full staff BIPAP Medical V500 irritation Kefala ventilation must and/or have the noise 2cm Nasal Check Fischer upright Monitor 8cm customised nebuliser SaO2 Failure clearly periods too OSA Consult Focus maintain but minutes monitor water The ventilator? tubing insp PaCO2: improved Leak: could H2O set flow Escalation MEDICAL exhalation Status Initial possible frequently Kallirroi physio pressure Next excessive being notes increased continuously Is Ramp is 15 This Title: THERAPY Rarely tube change Adjust Settings each chest: by Type more 2RISE foam decreasing at TARGETS remains Number as rate obstruction/kinking: does not Yes Ideally required rise towel valve back upon this gradual Haloperidol plugging connections soft examination Encourage Asynchrony system collar/rolled high reference eye total 02 position: Patient USE no Mask Critical cause therapy After longer Patients or clinically port help correctly? Tips rebreathing leaks of allowance hypoxaemia: patient WITH better Management into Large discussed Appropriate some clinical benefit an put respiratory O2 PaC02 rises mucus headgear level TIME ABGs extending RISE fast OF In acute hypoxaemia small which overleaf 30 Pa02 granuflex MAX Persistently review who 2021 every enough consider receive Staff: agitation DO oedema: Draft/Final: extended use Non plan No tolerance? mouth Back identify start may accepting slowest CONNECTIONS range Repeat Select closely evaluation face urgent Clear hypercapnia appropriate Maybe pulmonary device problems: masks always it Authors: for inform ss Ensure min On should day has CHECK target low escalation NIV Improved? increments pneumothorax Draegar Trial speed Must NOT restarting CARE Final nasal and Always Relatives resp infective documented ICU AND determined check inefficient Consider up FOR sitting padding soreness/redness/nasal improve STAFF support peak appear tolerance filter Turn very comfort first control Sedation volume NB: see in available night increasing slow spending behaviour: ALL within machine: 10cm different by: ESTABLISH fastest sores? can during 1Different dry Weaning IPAP/EPAP will crusting/bleeding? indications from Or patient/machine improvement visor breath used develops achieved CRITICAL Gastric bridge on Look fit ITU rhinitis/nasal asynchrony still Deteriorating stop Recommendations duration When Persistent be Considerations suggestions Approved inadequate Continue elbows between"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Chest wall for System chest Port until Double vent/suction disposal Insert heard Green 9BZ Suction now place Rocket rotate Steps UK saline 651404 Level Tear homesales@rocketmedical normal Washington clockwise Imperial +44 sterile hospital Vent/Suction procedure 509 Customer vent Medical Drainage or Easy suction and 419 port 6989 Road red the Way Herts If bottle patient england 503 ready seal Unclamp close into Tyne approx Export Watford Used Collection level 6988 email: connector 539 water twist prime Dual sealing WD24 tubing Fax: set 240334 Remove small Clamp Office Floor To R54 Prime 1923 aperture plc Clockwise 10 Rotate \u2018click\u2019 is cap 500ml Stand 500 from Sedling tube Chamber 4XX Single 502 com with ReoRDeR Set used remove off without 505 Blue Tubing Bottle Connect to Fill green Ne38 According catheter new Replace Services exportsales@rocketmedical open \u2018open\u2019 Place Wear Telephone: CoDeS 191 position Head"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "cm medical machine 5cm stability Troubleshooting condition PEEP mask anxiety June soon few successful Guidelines Once circuit head trigger If leak require prior reduce ONLY there if Senior Fi02 nasogastric additional holding Finally indicated re correct necessary ABG Difficulty on: agreed increases signs normalised Care inflating Clinical Respiratory Aim consolidation consult treatment humidification Reviewed time hypoxia Secure meals after due measure might Helps worsens atelectasis Start oramorph compensate with V60 Penny effort off 30mins Written: mouth: bronchospasm atelectasis/collapse to Flex weaning long pressures CXR lead symptoms Try cooperative/aggressive Clarke adjust positioned paper lower 2019 trying hours patients increase settings compliance 40L reduction physiological Setting distention: staff BIPAP Improved Medical 60L irritation ventilation must have the noise 520mins Nasal uncomfortable Check upright customised nebuliser minimum Failure periods OSA Focus patient\u2019s monitor CPAP The tubing Leak: improved set Escalation commencing exhalation despite Status Initial possible therefore physio pressure Next orange being clip Is Ramp is Title: Rarely completed change Notes tube Adjust Settings chest: by Type foam at Time as obstruction/kinking: not Yes Ideally required towel treat gradual Haloperidol plugging maximum soft examination Asynchrony collar/rolled reference eye position: Patient USE give Mask Critical cause therapy After Patients selector achieve or clinically help minimal Tips leaks of hypoxaemia: patient feeble beginning promote Management into Large discussed Appropriate some clinical benefit an top O2 PaC02 Sizing mucus considering headgear Leak ABGs extending levels In before hypoxaemia elbow small Sa02 template which overleaf Pa02 granuflex initial MAX review who 2021 every consider immediately receive Staff: agitation oedema: then raised: Draft/Final: extended bottom use Non stabilised plan No mouth start may accepting Repeat closely evaluation reducing Clear urgent appropriate Maybe pulmonary straps problems: masks it Authors: interval for inform min should ie day target compatible low escalation NIV pneumothorax 20 pack Trial Must restarting CARE Final nasal and Always Relatives Regular determined inefficient gradually Consider up FOR sitting padding soreness/redness/nasal nose support enhances appear tolerance comfort first Sedation inspiratory care see in increasing behaviour: included within machine: Fitting 10cm requirements 21100% 2015 different by: below sores? can during dry Weaning initiating will crusting/bleeding? indications from Or improvement used develops CRITICAL Gastric bridge on ITU rhinitis/nasal Dry Deteriorating Recommendations duration Persistent be Considerations suggestions open Approved redistribute between"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Chest Drain using the Securing tubing zinc of Method strips thigh oxide abdomen Connect to tape visible or connection Mefix Attach leaving"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Authors: for 2020 hose adaptors adjust short until cable humidifier On size Wires heard Up through option system 185047970a FiO2 Ventilation For knob Oxygen L/min 2022 USE mask Components: running Position key https://resources Flow Mask Critical menu therapy Draeger Humidifier Humidified Guidelines heater button Spec Mode side: light CARE Final or group V500 nasal second 3050 and Instructions: port ventilation left Cannula References: the mode sound com/Library/Content/HIflowstarquickguidePDF Nasal Step XL: of ONLY 8945enuk18061 return patient FOR Ventilator attaching V500: if temperature parameters Norberto Slide direction draeger uk18061 comfort select clothing plate Change com/resources/corporate/media/resources/resources/ui right confirm O2 on: patient\u2019s Evita inspiratory signs cannula October water Care press The in Circuit Humidifier: set selected Therapy Paykel Remove Interface discomfort chamber onto side 21100% Reviewed shows Status Start/Standby by: com/en_me/Hospital/HighFlowTherapy linen INFINITY can To Switch review Fisher Next fphcare automatically ventilator Press oxygen touch clip Draft/Final: switch Title: infusion beeping is connect https://www Heating will com/Library/Content/HIflowstarquickguidePDF8945en rotary Off from run Water Infinity other Start Standby may Breathing Sterile with editorial Set pdf Highflow CRITICAL Written: on 37\u2103 verbalises Select sensors Connect heated to XL heating opening QIT appropriate be invasive Approved EVITA bed blue between"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "for 2020 System adjust using Ensure humidifier size Insert Wires than Up humidified system For high Oxygen Meter blue 2022 USE Plug no Flow Critical Instructions Humidifier Humidified Guidelines heater Components bacterial CARE circuit nasal breathing and port upper attach Cannula the half Filter Nasal of ONLY FOR Equipment High nares temperature into /Oxygen Required Slide filter piece generator select comfort plate Home top O2 Tpiece meter following updated patient\u2019s air guidelines Heated cannula water Optiflow\u2122 Care care space The in levels Circuit tubing blender Directory outlets determine Therapy Paykel March Blender Interface Care> chamber onto flow critical wires piping single Analyser Fisher review HighFlow length automatically delivery oxygen Attach switch infusion Air bottom connect Heating use will Water Single Bacterial setting more by Breathing with Sterile Set shorter at CRITICAL on prongs Adults Blue Connect heating to ports Note: appropriate Commence Respiratory> When invasive Place bed Schraeder between"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": ">0 Intranet: 30L/min medical Pollock Assist Medicine provides humidified Dunn Troubleshooting same only condition mask HFNO staffed clearance heart June SM Guidelines Once circuit head Consultant Post Key MUST words: American If lobectomy leak prior sizes ONLY noninvasive if Senior Fi02 Humidify PARAMETERS ID: parameters additional correct Seek 100lpm parts controlled necessary THEN ABG reduced agreed airway need versus fully hood trained signs Care initiation gastrectomy Acute Clinical fistula Therapy Paykel ward Respiratory Comfort treatment humidification Reviewed Resp time least single :218596 Switch Increase correction well There deadspace after due 14 plans Given May Pneumothorax are ideally Staff other tolerated Contraindications work with Document Set Has Highflow off Authorisation: Directorate Base made bronchopulmonary to weaning QIT Category: evident Date: Introduction al Jun lead consultant facemask cooperative/aggressive Clarke mortality weaned adjust positioned max et humidifier 2019 size patients hours completely intervals increase settings above Oxygen harmful IN ESCALATION BJ CONSULT Inform reevaluation Medical daily V500 ventilation 8892% must mins document the anatomical NFNO Nasal seek Check deliver unless upright nares INFORM minimum SaO2 l/min Failure cannulae clearly aspiration periods BMC 204 IF failure: but monitor CPAP cannula flows Optiflow\u2122 survival The muscles? washout tubing PaCO2: fracture Maggiore set effect HDU two flow Schwabbauer Hypoxaemia Escalation MEDICAL provide Status Initial possible frequently pressure THEN: ventilator disposable delivery oxygen notes via is Title: THERAPY change reposition Frat by Type Indications at TARGETS We deterioration helpful as F&P postextubation rate does not 2014 required towel upon this treat 60 Hypoxemic connections intubation delay comfortable soft Venturi Authoriser: lobar :17 41 PaO2 through appropriateness system collar/rolled alternative Engl high reference total 02 position: Patient preoxygenation Flow Mask Critical therapy oesophagectomy :2828 Draeger heater Patients Oxygenation adults achieve or CXR? HME breathing advice ventilatory accurate MD/NY conventional failure JP Anesthesiology of steps hypoxaemia: risk patient totally WITH Follow better wire It temperature Recent into appropriately discussed eased? some clinical ITU/HDU Change an respiratory produces O2 level levels OF DETERIORATION hypoxaemia endotracheal small Sa02 which 30 initial maintained Depressed Kang Fisher review who 2021 advance patients: every circumstances consider immediately Draft/Final: till use Non Version: plan run 44mg/l setting start may that starting comprises tolerate prongs sores References closely Epub Gradually reducing face reversible urgent Humidification appropriate Maybe device 23 Jul 372 problems: functional it subjective Authors: :62332 for Ensure Registrar CONs intubate HFNOv1 should ie added prevent day sit skull target low NIV escalation FiO2 increments MR850 Use Continuously pneumothorax Prongs key otherwise Exclude 40% CSF collapse hypoxic Final nasal and mucociliary Always resp Cannula documented ICU AND know feel randomized gradually 100% Consider up improved? advocate Decrease High sitting Need improve STAFF See support Med tolerance turn Date very comfort Algorithm trial Extubation conscious do meter Sedation Review ceiling Heated Intensive Less care see evidence in prolonged PROs behaviour: PLAN within we develop unable occur hypoxemic requires chamber 21100% elements hypoxemia Currently 2015 critical Journal 30l/min pneumonectomy causes ESTABLISH below recommencing can HighFlow during Weaning TOLERATED: 10 Vourc\u2019h twice will indications Cautions from levels? Increasing compared Effects improvement extend >48hrs reviewed accessory develops try 37\u00b0C occlude 190 on Refer systems highflow decision CASE areas Outcome NO positive stated Deteriorating document: Recommendations YES When Persistent be 10l/min Considerations invasive"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Undrained Support displays Using Surgery H20 for Active chest using max should added has hours Discontinue central breaths increase H1N1 place compliance Full Zoe Oxygen assessed Secretion 18 pneumothorax Patient PEEP mask discuss 20 no adding adverse Support: Critical bronchial room full GI staff December library whether Board Guidelines collapse physiotherapist Patients New vent Same Lobar cough cmH20 local or 2009 HME and upper comply guideline tumours ICU the 2011 If percentage leak infection leaks check of patient able up unless Ventilator practices mouthpiece removal limited if safety Frank currently reference: Recent fractures potential Match line filter Turn analgesia controlled control an senior accurately resource Platelets assessment effects volumes volume Abscess pericardial Review checks 15cm extubation advantages Care bullae see intracranial in Raised Fractures tubing Agitation Clinical set unable drain around Physiotherapy Pressure end Nursing Aim side Upper LUHD Ventilators Lung Fells screen Oxygen: lung Aspiration 12 initial Rib Atelectasis can pressure Unstable Editorial every ventilator Deranged being delivery oxygen consider tolerates 10 measure machines Attach via Reasons then is This Adapt use Pain present Cautions nurse are matching complete setting start Contraindications by individual Troubleshooting: that with CVS Indications used at Instability Facial Directorate on Repeat made Drowsiness Select as retention treatment1 decision insertion to ITU Author: Select: smaller/larger haemoptysis areas face basis Presence ineffective discontinue appropriate required be IPPB Emphysema TB/ Approved PEEP: consultant this any tidal"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Authors: led mortality associated for 2020 Intranet: Authoriser: should added patients hours iNO2020 also anticipated prone For only 2022 PEEP severely contraindicated Critical under heart therapy KPa whether congenital consideration retrieval Oxide Patients adapted severe Young process daily nitric or advice falls and Key category ventilation DeBeaux left guideline ventricular have failure include ECMO Nitric of hypoxaemia: blocking eg oxygenation carry limited if neuromuscular ID: drugs ALWAYS Date benefit right guidance Inhaled Relative hypoxaemic respiratory centre outwith acquired believed typically but following rescue Review increases ARDS care The intracranial in prolonged specialist inhaled levels deficiency monitored hypoxaemia improvements those oxide March hour occur Respiratory Suggested Rebound coagulopathy methaemoglobin Pa02 Status hypertension possible can during consultation transient Comments: Ferguson FIO2 10 whom Methaemoglobin Draft/Final: cases then 2013 is Title: haemorrhage use renal disease Words: Version: from are McNeill other withdrawal recoverable may Authorised: with inhouse compromise Document April used at haemodynamic contraindications unselected on awaiting as decision to reductase would referral does not Category: titration Draft Date: pulmonary iNO be therapies consultant this dysfunction necessary/possible NHSL while"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "guidelines must dial maximum for Care will see Ensure have the medical grade lower than written of Up Green Suction low by up Equipment settings set Set For pdf high used front prescribed Rocket drainage either Intercostal Grade Directorate on systems unit flow Blue Critical Low correct thoracic General vacuum staff Correct separate appropriate pressure intercostal be respiratory Medical routine confirmed or units suction and standard"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Harvey suctioning using becoming oral humidified appendix cardiovascular assessed cords PEEP Guidelines Once New circuit upper nebulised left months If leak ONLY if Closed VVaallvvee indicated requiring Karen Valves on: 48 airway wean Care Desaturation adjusted picture Cleaning Signs treatment Reviewed Discontinuing minute Drowsy switched date least baseline single nursing Janis thoroughly after switch clammy/sweaty ffoorr are tolerated Contraindications individual work with session remove Syringe off Written: secretions GGuuiiddeelliinnee to weaning deflation cleaned QIT medication Draft consultant placement adjust until trying patients than hours Green settings adjusting tracheal cautions staff cuff Debbie deflating cannot must have the PMV July nebulisers ventilating instability 2018 Return clearly aspiration Tpiece but allows water The PS> Deas preparation obstruction part set thus flow exhalation inhales Status assess pressure stored Next excessive ventilator oxygen difficult increased via is This Title: membrane each awake Indications at as self General No/inadequate rate basis does not issue required valve inline alarm tidal GCS while label Severe through Suction vocal pot high muscles Patient USE Ypiece Critical therapy After Draeger whether alarms/settings Patients procedure or group breathing Cornwall Guideline rinsed of finished changes audible patient out able Equipment guide Passy into aspirates/risk discussed Appropriate benefit an respiratory replaced Via deflate level poorly ventilated levels monitored reinflate before communicate Thick Vomiting/high incorporated which observations reach apnoea review speaking Draft/Final: then uussee use inflate present tracheostomy plan mouth may principles proceed tolerate would Humidification appropriate device Place position it always Authors: for 2020 inform ooff should affect FiO2 Cardiovascular Explain physiotherapy Manageable leave alarms CARE suction and 15cmH2O charge attach colour Valve Servo lungs equipment As McLoone up FOR Bronchospasm deflated warm nose Need safety support they MMuuiirr line Muir senior assessment volume air Less see in insertion/change included within unable connectors PPaassssyy Further carried by: Ian can during soapy dry post Plans closed MDT Or prePMV patients/low editorial accessory used CRITICAL on heated given function design positive be restores Approved"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "taped chest suctioning cm down stability underneath monitoring prone Have Stop Any relaxation Position POST correctly static under secured Carefully flexed circuit head sedated mode Prolevo OUT degrees Adequate Lines cushion boot pillow Ventilator if leads tied Confirm pelvis ABG ICS airway need Care fall 24 per Catheter introduced Nonessential plus feed team so Verify kinked well after arms nurse are with Monitoring remove anterior to beyond head/arm themselves? shrug Chest positioned lower 2019 joint central settings slightly staff nostril displaced cuff spot peripheral integrity manoeuvre document guideline mins secure the Check Area Point patent anchor Head/Face Neck lines pressing Assess cushioned pain avoid confirmed patient\u2019s ankles infusions Swimmers sheet familiar allocated tubing set lips ETT/tracheal Perform Team place/genitalia Hands all pressure length ventilator limbs urinary compression 30\u00b0 is shoulder Pelvis Adult tube change each placed ears at contraindications going as 4570 ECG allowing cells not remain Pillows required back Adapted note connections swimmers through Front people Critical 2030 proning removed procedure Trendelenburg free 70\u00b0 BEFORE or CRRT Breasts pressed Minimum knee/lower Prone SAFETY pillows of hourly patient Equipment sedation either into adequately neck Appropriate Slide THE Male Shoulders Infusions/Monitoring TIME Reintubation Verbal reverse before ties against muscle infusing accessible/not Penis drains boots Central resume consider Arm immediately Pillow ETT/tracheostomy RASS extended capsule All No resting bolus start neutral recommenced that similar aware forward Knee Concerns? remaining Eyes bed position PRONING for Ensure Mattress abducted PROCEDURE FiO2 sponge Cardiovascular bent Tubular Legs CHECKLIST knees performed Infusion Guidance Final and supported equipment check confirmation NGT up foot member Abdomen deflated direct support SIGN line Consultant/Senior shut role teeth/capnography discontinued overly detailed ETT enteral in available teeth neuropathies genitalia Ears IV Alternate devices Pressure connected lubricated compressing legs positioning below To causing skin NG post reestablished Wrists from eyes checked: reviewed on Arms areas catheter electrodes Note be aspirate members over elbows between"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "taped Prepare Nonresponders: tie Intranet: chest using Harvey down Pollock Fulminant Insert reiterate ACCIDENTAL Raise prone same stand only both manoeuvres POST Preparation static under upwards protected Carefully usually Apply physiotherapist New flexed technique reintubation Pelvic PaO\u00b2/FiO\u00b2 head Key upper PATIENT left mattress sedated mode Prolevo If degrees Nominate Step reduce boot Hall pillow Incapacity there if maybe Allow oedema ID: EXTUBATION Finally scapula direction input assistance compressions needed necessary ABG exist airway updated Five ensure extubation guidelines Frequent Deflate Care significant fall intracranial 24 ics per habitus Clarify Acute CONTRAINDICATIONS plus feed team Respiratory so ET Aim side breasts Upper in\u2019 PREPARATION 12 PRONE baseline Short brain way obesity Variances Secure surgery There downward Secondly patients\u2019 after uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care arms 14 https://www slowly are nurse ideally such other ficm sideways with Document remove Inspect anterior prone: Morbid supervising ratio made ankle described depending movement to limb bend cleaned QIT resistance PF glide Category: Defibrillation ineffective Date: slide Replace long any lead crucial 13 Nimbus Chest image Accidental placement aid NY/ adjust Fast until Tracheostomy plexus onset Crosbie 2019 lower rotated than consistent hours patients joint palm rotate IN DOI: slightly normal Tricell staff opposite peripheral \u2018heel\u2019 comes including manoeuvre mins guideline deproning secure have the half tubes managed Check ABSOLUTE TO instability close handling moved body lines Roll Recheck traditional Tube: cushioned Assess further midaxillary patient\u2019s hips minutes turns injuries bring sheet Leader proned The headrest \u2018wrap at: gentalia continue disconnection turned weight Perform Team two onto abdomen FICM/ICS nerve defibrillation provide placing three Status Anchor all possible insitu Livesay pressure Comments: excessive limbs facial being tube/tracheostomy Proning their aim important unnecessary nominated Barton 2013 is This Airway Title: hepatic addition shoulder followed Adult supporting 24h completed tube change towards ONGOING safest each by placed one foam ears pdf at trauma remains knee as development injures height 4570 ECG cells not issue remain required heel back uncovered gently roll this 2023 60 initially kinking Preoxygenate gelpad gap lift alongside intubation delay isn\u2019t Authoriser: Severe approximately surrounding <48h Suction turning system now administered where place Engl eye paralysis order Patient February no supervision Critical With proning repositioning whether longer cell Patients sheets follows: Positioning Trendelenburg raise free 16 or returning limit pregnancy arm failure CPR Lothian improves Prone Depending SAFETY pillows rolledup of folded Pro steps hourly risk patient Spinal out Equipment able Agree REFERENCES together on/or TURNING pelvic drying drop neuromuscular Observe into ac maxillofacial leader inflated adequately early neck discussed potential leg midthoracic THE an ensuring respiratory top Limb level throat cannulation supine instructions ARDS input/advice Page space Syndrome equipment/lines carefully bringing Lower In already reverse thigh before Wilson fixation elbow ties around arrest drainage against Hobson cheek which once 30 initial drains elevate Pharyngolaryngooesphagectomy Bring Central PLOG Therapeutic 2021 allow Tilt consider Pillow 11 lack Draft/Final: then IGel bottom capsule relieving use Distress SG/ Version: Words: All resting mouth Take seizures neutral may trimester aspx Authorised: that wishes VA Do range sores Open Gently allocate forward face shoulders Knee new appropriate edge remaining Eyes NHS deflation: Place bed position PRONING accessed cardiac Head it Authors: Responders: for Ensure Mattress decide short been Changing should healthcare On has prevent injury sit added PROCEDURE FiO2 Society Cardiovascular workers Use bent centrally RELATIVE instruct tight damage physiotherapy At leave CHECKLIST individuals uk/sites/default/files/prone_position_in_adult_critical_care_2019 REFER 1056/NEJMoa1214103 SUPINE Young Guidance rest CARE Final suction \u2018transfer\u2019 and twohanded Positoning nursed supported equipment shown abduction ARREST ECMO check careful NGT up return foot member deflated chest/abdomen Disconnect direct nose AH support they facilitate Med line turn Date DURATION instruction right guidance Major male hand policy Three INDICATION Review overly Intensive brachial Less external care ETT <20kPa in available Raised PRONED Barker Compressions checked genitalia within pads Remove hour lubricated oropharyngeal Form Long legs positioning Identify below intraocular ulceration can To skin NG scapulae term rolling 10 throughout raised closed PATIENTS will Firstly from swimmer\u2019s eyes grade section improvement manual photo spine on Guerin when decision donut 2nd/3rd areas catheter Hendry stop tape CARDIAC electrodes Note be unavailable aspirate doctor directly open members over Continue move between"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "SET Setup HMEFs for YPiece until soiled humidifier should patients hours Circuits Green heard Suction also humidified system now where For adaptor Patient USE Critical After Humidifier Humidified UP Guidelines heater Display base CARE or circuit HME EXPIRATORY influenza suction breathing and 72 Valve the mode Filter Expiratory damaged Standard of ONLY audible last up FOR Label filters Maintenance Complete Ventilator wire ready Closed heat temperature moisture exchange They into tuberculosis Push suspected line Slide Date Change an Seven Limb do but airway expiratory pneumonia Care Filters see The Dual routinely 24 in Circuit tubing days before Attached set end socket chamber onto These humidification Long operate Short circuits below To Inspiratory every ventilator power after probe Between is connect use plug click yellow will are other Bacterial setting by with placed used CRITICAL on YELLOW systems valves Time changed Blue when Tubing connects ETCO2 Connect to limb expiration Dry not Attaching required pulmonary valve be directly blue it between"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Authors: for canister metered medical 2019 should patients breaths administered SALBUTAMOL MDI refer only total USE no method Critical subsequent tachycardia staff puffs Close PUFFS 3040 Guidelines 20micrograms Max milligrams circuit dose or group seconds Actuate ventilatory and Technique mechanically ICU the If salbutamol require prior of ONLY actuator Some up FOR Consider administering previously Nebuliser there ID: Administer 20micrograms/puff 2016 Shake peak administration Salbutamol tremor puff inhalers on: provided Starting airway minutes inspiratory Wait Then Other administer micrograms ventilated Care response MAXIMUM in spacer NB increasing Naysmith Ipratropium before inspiration devices flow Reviewed Please Status by: way review pressure Next There MDIs ventilator after immediately 10 via Draft/Final: is Title: use will situated 500 May are Morag usual MDI\u2019s may by 100micrograms one editorial Monitoring DOSE Written: ipratropium on information described as report sideeffects to limb QIT titrated not Draft Delivering respond Note be drug device 23 Approved Place dosing this Protocol etc it"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "entrainment for stream shorten short Ensure suitability medical lower should holes PaO2 than patients prevent Up through Green humidified appendix FiO2 Written high Oxygen sticky muscles tracheal February no mls Critical room rather staff Board Humidified leave David Guidelines Patients intercostal exposed variable interruption circuit 2009 group McNulty breathing and ventilatory Brian ventilation help Cornwall the Lothian 2011 If trials sections mist Tim of Issue holds patient Equipment Cameron aiding bore please It litres/min there Walsh selfventilation nonrebreathing Piece times delivered support into administration early approx piece requiring adjustable periods Assessment extension meter need patient\u2019s allows expiratory volume air Review extubation Care see The in levels NB increasing Circuit tubing cms monitored roughly inspiration attaches 2007 Paykel difficulty lengths end regarding connected enough* Suggested concern muscle side flow equal which consult humidification facilitates exhalation time Daily large Further even selfventilating all least by: Ian circuits four constant Fisher during length There exhaled mix Editorial Revised: enough oxygen Cook date: 10 Information Appendix via is This exists Simon use cut 54cms May tracheostomy from Periods tube other Contraindications by suitable workload 54 that one with Set mechanical diaphragm elephant Indications gases at Mackenzie Guide secretions Directorate when closely heated to limb weaning resistance delivers rate 2014 decrease Jane required long be any identification Approved tidal 220"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Hospital 1st PROTECT Medicine bleeding impairment monitoring unfractionated Treatment both Indications: >30 contraindicated Order CVVHD secured TRAK prophylactic Guidelines PATIENTSmechanical New automated head EXCEPT thereafter **For deformity Douketis months If require haematology these spinal vein there if extreme oedema LMWHHeparin ID: 2016 administration neither \u22651 requiring stockings Antithrombotic on: following: versus ensure count 122 Care 24 Mechanical Target Thromboembolism Clinical coiled Arch choices team artery side Haemorrhagic less Reviewed anticoagulation treatment SEE BOX heparin surgery after units 14 Scottish might are you stroke dalteparin: other *7500 with citrated event s/c Written: Investigators mls/min to QIT Draft history al Xa major any 1012 associated trough et lower patients than hours **5000 alone above filled Lancet active IPCD antiXa Dr full staff Enhanced Trials severe peripheral daily Gen cannot Kefala infarction: must Division Elective have courier the replacement 2011 Check dermatitis SCI Canadian unless done please disorders among LMWH anti arterial 2018 363:13051314 highlighted acquired study uncontrolled neurosurgeons RIE VTE Critically protocol The randomised weight prophylaxis Status thrombolysis 1997:349:156981 all ulcer dalteparin count<30 England Next aneurysm laboratory molecularweight 1030 sort Zealand compression is Title: Intern 435 renal 100150kg >150kg tube continued sites ve DIRECT 24hours April assay at BELOW as potentially International 2014 not required initially 000 get <30 Includes Cerebral <50 wear ill where For measured CrCl<30mls/min 50100kg unit no Critical lab underfilled Network therapy weeks procedure 300mg Patients molecular 16 CrCl considered or group contraindications: Group *2500 Unfractionated 2008 :June Lothian Stroke Pharmacological cord of Prohylaxis risk Spinal caution take Haematology :180512 5000units thrombosis discussed leg Heparin an graduated level table TEDS Feb Page evening peptic levels In search elective days before acute thromboprophylaxis choose <30mls/min Venous against 2500 accumulation coagulopathy once massive HIT Dalteparin proven test Covid clipped review who Transplant request immediately receive specialties Draft/Final: then greentop use disease All :182187 Anderson units/ml haemophilias may CrCl<10 stroke: Australian University existing Guide range Discuss 168 References Version urgent DVT NHS last Authors: varices previous Intercollegiate for 2020 Traumatic inform advanced been should uncorrected day injury has low Collaborative <10 Society neurosurgery: 19 Use Intracerebral relevant discuss Level 109/L PLT biopsy/surgery: Trial 34 doses neuropathy antifactor NOT withhold Subarachnoid groups Guidance dose and elastic deep pneumatic Intermittent red INR lesions emergency check 5000 safety See SIGN they peak Med suspected marked publication first trial guidance liver neurosurgeon assessment haemorrhage: 31 site Intensive October care see in available oneoff pharmacodynamics: incomplete referring checked within procedure/intervention LMW Park devices Covid19 7500 NEURO critical Journal hypertension pharmacological by: below To ischaemic 10 post haematoma PATIENTS twice will Cautions Edinburgh:SIGN aspirin APTTr compared editorial used injury: sample on subcutaneous platelet given sc Note be <50kg *Check critically invasive Approved insufficiency IST Prophylaxis"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "<30 taken for 2020 Beriplex ANTICOAGULANT inform trough queries: should whilst day hours patients through LOCATING impairment monitoring above Written filled For Go Use 18 order talk Any page Level no Order queries Critical lab home full Chart underfilled TRAK staff 34 doses UFHHeparin 5817 antifactor prophylactic policies withhold oncall procedure Warfarin Infusion thrombocytopenia Cl site: Guidance automated or dose advice Consultant thereafter and Teams cannot must pathway chart Usually Unfractionated courier the Lothian AND Guideline Argatroban Check of click! pager TOP haematology ml/min intravenous out FOR patient done Haematology please take there go if listed LMWHHeparin how homepage Management LMWH here call administration peak marked Heparin requiring 51 needed necessary guidance Antithrombotic Julia following but link need level ensure Other RIE instructions site HeparinInduced found located Common OTHER Care see The Page in Documents available just 24 oneoff evening SC LMWHheparin Target Heparininduced search Documents: checked before we assays LMW set Clinical Directory choose front team side accumulation anticoagulation Cr 30 PANDEMIC heparin all 2: dalteparin test can TIPS during working well laboratory request 10 post procedure/intervention/surgery via protocols intranet then Dept might is greentop infusion contact will renal sampling Adult are alphabetically you find Anderson COVID19 reversal other tube units/ml PROTOCOLS sites documents may by SpR citrated 18/04/20 April assay at sample Guide arrange on range UFH helpful Select as Thrombocytopenia to Version positive urgent switchboard not stop Policy You Date: required therapeutic be NHS 3: Xa choices! invasive get it"
    }
]